000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki||N05AX08|01.04.2000||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|1475|3107|lyfalmen|V0045|1698|1|20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1475||1475|3107||1 000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|31394|41282|lyfsjukr|||1|1,8|0|24,0000|Icepharma hf|Roche|Epóetín||31394||31394|41282||2 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|47175|61087|lyfsjukr|||1|1,8|0|36,0000|Icepharma hf|Roche|Epóetín||47175||47175|61087||2 000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|10105|14912|lyfalmen|V0457|7883|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10105||10105|14912||2 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|29450|39790|lyfalmen|V0475|15386|1|28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||29450||29450|39790||2 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|38301|50898|lyfalmen|V0540|20065|1|28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||38301||38301|50898||2 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|20602|28686|lyfalmen|V0456|15580|1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||20602||20602|28686||2 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|4790|6913|lyfsjukr|||1|0,9|0|0,0400|Vistor hf|Ferring|Atosíban||4790||4790|6913||1 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4425|8669|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4425||4425|8669||1 000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|12829|17983|lyfsjukr|||1|5|0|0,2300|Vistor hf|Ferring|Atosíban||12829||12829|17983||1 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|15462|22235|lyfalmen|||1|0,36|0|4,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||15462|22235||1 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|30708|41369|lyfalmen|||1|0,72|0|8,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||30708|41369||1 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4362|7056|lyfalmen|V0621|1764|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4362||4362|7056||1 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|0|0|0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr|||1|5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139||1 000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2561|4593|lyfalmen|V0628|4593|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||||2561|4593||1 000530|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|án nála|J07BF03|01.06.2005||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|26683|36317|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||26683||26683|36317||2 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|0|0|0|0|G|0|LTH|0|0|0|100|SEK|1660|3360|lyfalmen|V0075|3360|1|5|0||Vistor hf|Laboratoires THEA|Ketotifen||1660||1660|3360||1 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|4655|7457|lyfalmen|||1|2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4655||4655|7457||1 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3059|5274|lyfalmen|||1|60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3059||3059|5274||1 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|0|0|0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratoires THEA|Ketotifen|||||||1 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|14900|20582|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||14900||14900|20582||2 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2934|5103|lyfalmen|||1|30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||2934||2934|5103||1 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3613|6032|lyfalmen|||1|2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3613||3613|6032||1 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín|||||||1 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|126539|160689|lyfsjukr|||1|6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||126539||126539|160689||2 000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|21405|28746|lyfsjukr|||1|1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||21405||21405|28746||1 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|5462|7883|lyfsjukr|||1|0,5|0|1,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||5462||5462|7883||1 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1394|2996|lyfalmen|V0037|1974|1|10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1394||1394|2996||1 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6089|9419|lyfalmen|||1|30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6089||6089|9419||1 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16143|23089|lyfalmen|V0115|13401|1|100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||16143||16143|23089||1 001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2062|3910|lyfalmen|V0050|2888|1|100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2062||2062|3910||1 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|27310|36157|lyfsjukr|||1|2,5|0|5,0000|Vistor hf|Merck Sharp & Dohme Limited|Ganirelix||27310||27310|36157||1 001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2547|3141|lyfalmen|V0278|1699|2|28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||1500||1500|3141||1 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5847|9088|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5847||5847|9088||1 001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3793|6278|lyfalmen|||1|100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||3793||3793|6278||1 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|883|2184|lyfalmen|V0038|2184|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||800||800|2184||1 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2456|4021|lyfalmen|V0039|3825|2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2143||2143|4021||1 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|21047|28296|lyfsjukr|||1|4104|0||Icepharma hf|Fresenius Kabi|Blöndur||21047||21047|28296||2 001599|B03AC0002|Venofer|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.07.2005||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|14588|21138|lyfalmen|V0637|18795|1|25|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||14588||14588|21138||1 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30669|40372|lyfsjukr|||1|6160|0||Icepharma hf|Fresenius Kabi|Blöndur||30669||30669|40372||2 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|2321|3350|lyfsjukr|||1|10|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||2321||2321|3350||1 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3971|6521|lyfalmen|V0444|6521|0|15|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||3971||3971|6521||1 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|776|2151|lyfalmen|V0004|554|1|7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||776||776|2151||1 001954|N05AX0802|Rison|filmhtfl|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1946|2662|lyfalmen|V0291|2320|2|60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1150||1150|2662||1 001957|N05AX0802|Rison|filmhtfl|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6936|7929|lyfalmen|V0297|6698|2|60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||5000||5000|7929||1 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|0|0|0|0|0|0|BIG|0|0|1|100|SEK|3975|6527|lyfalmen|||1|45|0||Icepharma hf|Bioglan AB|Capsaicin||3975||3975|6527||2 001965|N05AX0802|Rison|filmhtfl|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|3353|3962|lyfalmen|V0292|3757|2|60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||2100||2100|3962||1 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4040|6616|lyfalmen|V0004|2215|1|28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4040||4040|6616||1 001986|N05AX0802|Rison|filmhtfl|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5263|6288|lyfalmen|V0296|5330|2|60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||3800||3800|6288||1 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|8022|12063|lyfalmen|V0011|3009|1|56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||8022||8022|12063||1 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|1274|2832|lyfalmen|V0005|614|1|7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1274||1274|2832||1 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|5654|8824|lyfalmen|V0005|2457|1|28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5654||5654|8824||1 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|4533|7290|lyfalmen|||1|100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4533|7290||2 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4951|7862|lyfalmen|V0011|2687|1|50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4951||4951|7862||1 002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|24777|32978|lyfsjukr|||1|5760|0||Icepharma hf|Fresenius Kabi|Blöndur||24777||24777|32978||2 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9017|13424|lyfalmen|V0012|2733|1|50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9017||9017|13424||1 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2995|5186|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||2995||2995|5186||1 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|16430|23450|lyfalmen|V0492|5471|1|98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||16430||16430|23450||1 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|86703|110695|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||86703|110695||2 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|44195|57347|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||44195|57347||2 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|22500|30120|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||22500|30120||2 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín|||||||1 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||L|1|0|0|0|G|0|ACA|0|0|1|100|IKR|||lyfalmen|V0362|2091|2|100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín|||||2312||1 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|SEK|3207|5594|vetorma|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|||3207||3207|5594||2 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1208|2742|lyfalmen|||1|5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1208||1208|2742||2 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|0|0|0|1|0|1|ALL|0|0|0|100|SEK|24637|32802|lyfsjukr|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||24637||24637|32802||1 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13579|14888|lyfalmen|V0089|2728|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10087||10087|14888||1 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|10037|14819|lyfalmen|V0515|4208|1|100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10037||10037|14819||1 003099|L01DB0104|Myocet|irţ|50|mg|2|sett|1|pakki|ördreifa|L01DB01|01.07.2006||R|0|0|0|1|0|1|TBV|0|0|0|100|DKK|236097|298184|lyfsjukr|||1|2|0||Vistor hf|Teva Pharma B.V.|Doxórúbicín||236097||236097|298184||2 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|17072|24255|lyfalmen|V0253|6913|1|100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||17072||17072|24255||1 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|1|0|0|0|0|0|UCB|0|0|0|100|DKK|33131|44409|lyfalmen|V0516|5624|1|100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||33131||33131|44409||1 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|9545|14146|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||9545||9545|14146||1 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|0|0|0|1|G|0|PFP|0|0|0|100|SEK|14189|20637|lyfalmen|||1|1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||14189||14189|20637||1 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|192529|243506|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||192529||192529|243506||2 003310|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|7840|11814|lyfalmen|V0356|10783|1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||7840||7840|11814||1 003325|R03AK0702|Symbicort mite Turbuhaler|innönddu|84,5|mcg/sk|120|skammtar|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|7352|11147|lyfalmen|||1|120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||7352||7352|11147||1 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3104|5335|lyfalmen|||1|60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3104||3104|5335||1 003859|N05AH0205|Clozapine Actavis|töflur|25|mg|100|stk|1|glas||N05AH02|01.10.2014||R|2|0|0|0|G|0|AGT|0|0|0|100|XEU|2132|4006|lyfalmen|||2|100|0|8,3300|Actavis Group hf|Actavis Group hf|Klózapín||2132||2132|4006||1 003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|1|0|0|0|G|0|MBV|0|0|1|100|DKK|841|2240|lyfalmen|||1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme B.V.|Pseudóefedrín í blöndum||841||841|2240||1 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1017|1728|lyfalmen|V0151|1655|2|28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||467||467|1728||1 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|567|1865|lyfalmen|||1|20|0|10,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||567||567|1865||1 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2389|2564|lyfalmen|V0322|2301|2|98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||1078||1078|2564||1 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2052|3896|lyfalmen|V0469|1910|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||2052||2052|3896||1 004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|21039|28286|lyfsjukr|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||21039||21039|28286||1 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7637|11536|lyfalmen|||1|250|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||7637||7637|11536||1 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1 004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4184|6813|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4184||4184|6813||1 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|571|1870|lyfalmen|||1|7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||571||571|1870||1 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|1111|2609|lyfalmen|||1|30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1111||1111|2609||1 004184|L03AC0101|Proleukin|stl/irs|||1|hgl|1|pakki||L03AC01|01.10.2013||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|31516|41435|lyfsjukr|||1|1|0|5,5000|Vistor hf|Novartis Healthcare A/S|Aldesleukín||31516||31516|41435||1 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5281|8313|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5281||5281|8313||1 004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7074|10766|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||7074||7074|10766||1 004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|9816|14517|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||9816||9816|14517||1 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|20326|27392|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer Limited|Voricónazól||20326||20326|27392||1 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|ţpakki||A04AA01|01.01.2009||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|5542|5015|lyfalmen|V0381|3914|1|10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||2870||2870|5015||1 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4118|6723|lyfalmen|V0458|2725|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4118||4118|6723||1 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|4627|9057|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||4627||4627|9057||1 004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|3133|5375|lyfalmen|||1|56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3133||3133|5375||2 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|594|1902|lyfalmen|||1|100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||594||594|1902||1 004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|4179|6806|lyfalmen|V0226|2740|1|56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4179||4179|6806||2 004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|1|0|1|0|G|0|NOP|0|0|1|100|DKK|7856|11836|lyfalmen|V0228|5071|1|56|0|37,3333|Icepharma hf|Norpharma |Tramadól||7856||7856|11836||2 004502|J07BC0101|Engerix-B|stl|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2218|4123|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||2218||2218|4123||1 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|3189|2772|lyfalmen|||1|90|0|180,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1230||1230|2772||1 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2556|2669|lyfalmen|V0318|1910|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||1155||1155|2669||1 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|33375|43768|lyfsjukr|||1|1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||33375||33375|43768||2 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1368|2961|lyfalmen|||2|25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1368||1368|2961||1 004613|J07BC0101|Engerix-B|stl|20|mcg/ml|1|ml|1|áfspr||J07BC01|01.01.1990||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3274|5568|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir mótefnavakar||3274||3274|5568||1 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4843|5152|lyfalmen|V0320|4783|2|100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||2970||2970|5152||1 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|776|1791|lyfalmen|V0062|1719|2|28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1791||1 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1921|2564|lyfalmen|V0317|1773|2|100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||1078||1078|2564||1 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|926|1791|lyfalmen|V0067|1719|2|28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||513||513|1791||1 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|1|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1844||1 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|36774|48034|lyfsjukr|||1|4,69|0|7,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||36774||36774|48034||3 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1778|3522|lyfalmen|V0318|1070|2|56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3522||1 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|150|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Dextrómetorfan|||||||1 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|166876|211312|lyfsjukr|||1|5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||166876||166876|211312||2 004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|9461|14032|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9461||9461|14032||1 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|626|1946|lyfalmen|||2|24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||626||626|1946||1 004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|14905|2397|lyfalmen|V0282|2397|2|56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||956||956|2397||1 004880|J01FA1001|Zitromax|irs|500|mg|10|ml|1|hgl||J01FA10|01.05.2003||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|5226|7542|lyfsjukr|||1|10|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5226||5226|7542||1 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|360|1582|lyfalmen|||2|8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||360||360|1582||1 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|633|1955|lyfalmen|||2|14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||633||633|1955||1 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|1198|2728|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1198||1198|2728||1 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1796|3546|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1796||1796|3546||1 005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3499|5876|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||3499||3499|5876||2 005096|J07AJ5205|Boostrix|stl|||0,5|ml|10|áf.spr|áfyllt, dreifa|J07AJ52|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|17966|25377|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||||17966|25377||1 005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8464|6985|lyfalmen|V0148|3189|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4310||4310|6985||1 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2138|4014|lyfalmen|||2|30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||2138||2138|4014||1 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|2463|4459|lyfalmen|||2|20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||2463||2463|4459||1 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|0|0|0|0|0|0|ACA|0|0|1|100|DKK|3056|5270|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||3056||3056|5270||1 005241|R03AK0701|Symbicort Turbuhaler|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|23521|32349|lyfalmen|V0356|32349|1|360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||23521||23521|32349||1 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|47557|62514|lyfalmen|V0287|45087|1|100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||47557||47557|62514||1 005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|3119|5356|lyfalmen|||1|10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3119||3119|5356||1 005330|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|fl|sprittlausn|D08AG02|01.09.1982||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992|31.07.2014|R|0|0|0|0|G|0|AML|0|0|1|100|DKK|1088|2578|lyfalmen|||1|2,4|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||1088||1088|2578||1 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.04.1996||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|55443|72411|lyfalmen|V0451|68125|1|1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||55443||55443|72411||1 005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|1726|3450|lyfalmen|||1|200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1726||1726|3450||1 005576|R05CA0301|Tussol|mixtúra|||150|ml|1|glas||R05CA03|01.10.2001||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Slímlosandi lyf nema slímţynnir (mucolytica)- guaifenesin|||||||1 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|5880|9133|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||5880||5880|9133||1 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6180|9543|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6180||6180|9543||1 005606|J07AH0703|NeisVac-C|stl|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|0|0|0|0|0|0|BAX|0|0|0|100|USD|3991|6549|lyfalmen|||1|0,5|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||3991||3991|6549||2 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|1803|3556|lyfalmen|||1|30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1803||1803|3556||2 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|3606|6022|lyfalmen|V0020|3829|1|60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||3606||3606|6022||2 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|9406|13956|lyfalmen|V0020|11486|1|180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||9406||9406|13956||2 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|1|0|0|0|G|0|LLS|0|0|0|100|DKK|4704|7524|lyfalmen|V0020|5743|1|90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4704||4704|7524||2 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6410|8904|lyfalmen|V0324|2858|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5713||5713|8904||1 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|17325|30223|vetorma|||0|5|0||Vistor hf|Merial (MSD)|Ivermectinum||17325||17325|30223||1 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|10193|13848|lyfalmen|V0325|2311|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9327||9327|13848||1 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2650|4714|lyfalmen|||1|1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2650||2650|4714||2 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|15781|20502|lyfalmen|V0326|3894|1|100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14081||14081|20502||1 005910|C09CA0301|Diovan|filmhtfl|80|mg|28|stk|1|ţpakki||C09CA03|01.01.2001||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3443|5799|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||3443||3443|5799||1 005963|J01CR0204|Amoxin comp|filmhtfl|875|mg|14|stk|1|ţpakki|875+125 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|ROY|0|0|1|100|XEU|1880|2006|lyfalmen|V0169|2006|2|14|0|12,2500|Medical ehf|ratiopharm Oy|Amoxicillín og ensímblokkar||670||670|2006||2 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|81179|103762|lyfsjukr|||1|1,5|0|0,7500|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíđar||81179||81179|103762||1 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5577|8718|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5577||5577|8718||1 006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|100680|128236|lyfsjukr|||1|1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||100680||100680|128236||1 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5410|8490|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5410||5410|8490||1 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|0|0|0|1|0|1|TPA|0|0|0|100|DKK|151168|191598|lyfsjukr|||1|3|0|1,5000|Vistor hf|Takeda Pharma A/S|Náttúrulegir fosfólípíđar||151168||151168|191598||1 006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|76889|98378|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||76889||76889|98378||1 006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2386|4353|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2386||2386|4353||1 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|3438|6774|vetalmen|||0|50|0||Vistor hf|Boehringer Ingelheim|||||3438|6774||1 006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|6630|10159|lyfalmen|||1|5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6630||6630|10159||1 006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2013||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|13810|20162|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13810||13810|20162||1 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|469383|590958|lyfsjukr|||1|35|0|7,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||469383||469383|590958||1 006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|0|0|0|0|0|0|LAR|0|0|0|100|IKR|||lyflausa|||0|2|0|1,0000|Vistor hf|Laboratoire HRA Pharma|Levonorgestrel|||||||1 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|14125|20557|lyfalmen|V0099|3780|1|98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14125||14125|20557||1 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4216|6857|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4216||4216|6857||1 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|24510|47235|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim Danmark|||24510||24510|47235||1 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|12748|18829|lyfalmen|V0117|10264|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||12748||12748|18829||1 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|6381|9818|lyfalmen|||1|28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6381||6381|9818|30.9.2014|1 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|18825|26455|lyfalmen|||1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||18825||18825|26455||1 007165|C09AA0105|Captopril Actavis|töflur|50|mg|100|stk|1|ţpakki||C09AA01|01.05.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2477|4478|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||2477||2477|4478||1 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7991|12021|lyfalmen|V0194|9316|1|28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||7991||7991|12021||1 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|23602|32451|lyfalmen|V0195|24912|1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||23602||23602|32451||1 007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|156000|197663|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||156000||156000|197663||2 007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|0|0|0|1|0|1|BAX|0|0|0|100|SEK|297697|375492|lyfsjukr|||1|1|0||Icepharma hf|Baxter|Prótein C||297697||297697|375492||2 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|2788|4903|lyfalmen|V0377|4106|1|3|0|30,0000|Vistor hf|Allergan|Bimatóprost||2788||2788|4903||1 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|94787|120840|lyfsjukr|||1|3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||94787||94787|120840||1 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|239179|302052|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||239179||239179|302052||1 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|3115|5351|lyfalmen|V0374|4315|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3115||3115|5351||1 007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|0|0|0|0|0|1|CPS|0|0|0|100|SEK|8014|11566|lyfsjukr|||1|50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8014||8014|11566||2 007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|0|0|0|0|0|1|OPO|0|0|0|100|XEU|114198|145201|lyfsjukr|||1|100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||114198||114198|145201||3 007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|0|0|0|0|0|1|ABV|0|0|0|100|DKK|22549|30181|lyfsjukr|||1|250|0||Vistor hf|AbbVie Ltd.|Sevóflúran||22549||22549|30181||1 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1899|3313|vetorma|||0|6,67|0||Icepharma hf|Bayer Animal Health GmbH|||1899||1899|3313||2 007505|G04BD0702|Detrusitol Retard|forđahlk|2|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6024|9330|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tólteródín||6024||6024|9330||1 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|4334|6255|lyfsjukr|||1|1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4334||4334|6255||1 007601|A16AB0301|Replagal|irţ|1|mg/ml|3,5|ml|1|hgl|lausn|A16AB03|01.09.2014||R|0|0|0|1|0|1|SHG|0|0|0|100|XEU|238854|301644|lyfsjukr|||1|3,5|0|3,5000|Shire Human Genetics Therapies AB|Shire Human Genetic Therapies AB|Agalsídasi alfa||||238854|301644||3 007760|G04BD0702|Detrusitol Retard|forđahlk|4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6185|9550|lyfalmen|V0618|6099|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tólteródín||6185||6185|9550||1 007769|G04BD0702|Detrusitol Retard|forđahlk|4|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|20997|29181|lyfalmen|V0589|13438|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Tólteródín||20997||20997|29181||1 007778|N05AX0802|Rison|filmhtfl|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1691|2594|lyfalmen|V0290|2457|2|60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1100||1100|2594||1 007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|3860|6370|lyfalmen|||1|3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||3860||3860|6370||1 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB|01.08.2005||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|0|0|0|0|0|0|ALA|0|0|0|100|USD|1268|2824|lyfalmen|||0|5|0||Vistor hf|Alcon Laboratories Ltd.|Ólópatadín||1268||1268|2824||1 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004|30.09.2014|R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|19911|26871|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||19911||19911|26871||5 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|ţpakki||H02AB01|01.09.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|729|2087|lyfalmen|||0|30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|2087||3 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|370|1595|lyfalmen|V0502|1088|1|30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||370||370|1595||2 008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|22139|29667|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||22139||22139|29667||2 008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|27468|36355|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||27468||27468|36355||2 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5311|8355|lyfalmen|V0620|8355|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5311||5311|8355||1 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|0|0|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón|||||||1 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1473|3104|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1473||1473|3104||1 008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980|31.08.2014|R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|293|1490|lyfalmen|||1|20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||293||293|1490||1 008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|34254|44871|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||34254||34254|44871||2 008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|26822|35544|lyfsjukr|||1|6000|0||Icepharma hf|Baxter Medical AB|Blöndur||26822||26822|35544||2 008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|569|1868|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||569||569|1868||1 008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|31340|41214|lyfsjukr|||1|8000|0||Icepharma hf|Baxter Medical AB|Blöndur||31340||31340|41214||2 008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|861|2121|lyfalmen|||2|20|0|6,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||754||754|2121||1 008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1284|2846|lyfalmen|||1|100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1284||1284|2846||1 008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|2780|4892|lyfalmen|V0226|4892|2|100|0|33,3300|Actavis Group PTC hf|Actavis ehf|Tramadól||2780||2780|4892||1 008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|4416|7130|lyfalmen|V0227|7130|2|100|0|50,0000|Actavis Group PTC hf|Actavis ehf|Tramadól||4416||4416|7130||1 008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|1|0|1|0|G|0|EHF|0|0|1|100|XEU|6218|9055|lyfalmen|V0228|9055|2|100|0|66,6700|Actavis Group PTC hf|Actavis ehf|Tramadól||5823||5823|9055||1 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|0|0|0|1|0|1|GEZ|0|0|0|100|DKK|148645|188432|lyfsjukr|||1|2|0||Vistor hf|Genzyme BV|Thýrótrópín||148645||148645|188432||1 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|506|1782|lyfalmen|||1|100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||506||506|1782||2 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|1|0|0|0|G|0|MKA|0|0|0|100|SEK|665|1991|lyfalmen|||1|100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||659||659|1991|| 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|0|0|0|0|0|0|CHP|0|0|0|100|USD|4890|8530|vetorma|||0|1000|0||Icepharma hf|Chanelle Pharmaceuticals |||4890||4890|8530||2 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|10414|20169|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals |||10414||10414|20169||2 008519|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|G|0|RGM|0|0|1|100|XEU|||lyfalmen|V0575|2292|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||2292||2 008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2787|4902|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2787||2787|4902||1 008673|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|10|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|105272|133999|lyfsjukr|||1|2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||105272||105272|133999||2 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|103478|131747|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||103478||103478|131747||2 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1868|3645|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1868||1868|3645||1 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6298|9705|lyfalmen|V0145|9201|1|4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6298|9705||2 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12408|18402|lyfalmen|V0145|18402|1|8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12408|18402||2 008959|R01AA0706|Naso-ratiopharm|nefúđi|0,5|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009078|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|30|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1692|2928|lyfalmen|V0064|2870|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||1344||1344|2928||2 009099|N06AG0202|Moclobemid ratiopharm|filmhtfl|300|mg|60|stk|1|ţpakki||N06AG02|01.03.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4424|5740|lyfalmen|V0064|5740|2|60|0|60,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||3400||3400|5740||2 009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8461|12211|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8461||8461|12211||2 009117|N06AG0202|Moclobemid ratiopharm|filmhtfl|150|mg|100|stk|1|ţpakki||N06AG02|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|4164|5007|lyfalmen|V0063|5007|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Móklóbemíđ||2864||2864|5007||2 009189|N02BA0111|ASA-ratiopharm|töflur|500|mg|50|stk|1|ţpakki||N02BA01|01.09.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|50|0|8,3333|Medical ehf|ratiopharm GmbH|Acetýlsalicýlsýra|||||||2 009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8461|12211|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8461||8461|12211||2 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|0|0|0|0|0|0|IPI|0|0|1|100|DKK|13789|20135|lyfalmen|||1|10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||13789||13789|20135||1 009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|8461|12211|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8461||8461|12211||2 009270|R01AA0706|Naso-ratiopharm|nefúđi|1|mg/ml|10|ml|1|glas|lausn|R01AA07|01.12.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|LYFIS ehf|ratiopharm GmbH|Xýlómetazólín|||||||2 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|50302|65012|lyfsjukr|||1|30|0|3,7500|Icepharma hf|Pfizer Limited|Voricónazól||50302||50302|65012||1 009282|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1892||2 009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|5258|8282|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5258||5258|8282||1 009340|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1100|2594|lyfalmen|||1|8|0|21,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1100||1100|2594||1 009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1214|2750|lyfalmen|V0130|1550|1|8|0|28,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1214||1214|2750||1 009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1404|3010|lyfalmen|V0131|2312|1|8|0|42,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1404||1404|3010||1 009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1758|3494|lyfalmen|V0132|2560|1|8|0|56,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1758||1758|3494||1 009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6867|9911|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6867||6867|9911||2 009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|7156|10328|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7156||7156|10328||2 009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|6867|9911|lyfsjukr|||1|8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6867||6867|9911||2 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|1|0|0|0|0|1|IPI|0|0|0|100|DKK|192018|242865|lyfsjukr|||1|30|0|15,0000|Icepharma hf|Pfizer Limited|Voricónazól||192018||192018|242865||1 009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|5080|8039|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5080||5080|8039||1 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|1|0|0|1|0|1|GSL|0|0|0|100|DKK|57460|73995|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl||57460||57460|73995||2 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9113|13555|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||9113||9113|13555||1 009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9641|14278|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9641||9641|14278||1 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7765|11711|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7765||7765|11711||1 009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|9641|14278|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9641||9641|14278||1 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|7927|11933|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||7927||7927|11933||1 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|0|0|0|0|0|0|DPL|0|0|1|100|XEU|8481|12691|lyfalmen|||1|180|0||Vistor hf|Dentsply Limited|Mepívakaín||8481||8481|12691||1 009993|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|3|g|1|spr||QP52AF02|01.01.2013||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1195|2085|vetorma|||0|3|0||Icepharma hf|Zoetis Finland OY|||1195||1195|2085||2 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2095|3955|lyfalmen|V0329|1773|1|30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2095||2095|3955||1 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|5701|8888|lyfalmen|||1|30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5701||5701|8888||1 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|1|0|0|0|0|1|ROA|0|0|0|100|DKK|202914|256540|lyfsjukr|||1|60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||202914||202914|256540||2 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|0|0|0|1|0|1|MSD|0|0|0|100|DKK|7006|10111|lyfsjukr|||1|1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7006||7006|10111||1 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|12382|18369|lyfalmen|V0331|2594|1|96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||12382||12382|18369||1 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|17458|24740|lyfalmen|V0304|8713|1|96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||17458||17458|24740||1 010290|N06DX0101|Ebixa|mixtúra|5|mg/sk|50|g|1|fl|dćluskammtur|N06DX01|01.08.2010||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|13800|20149|lyfalmen|||1|50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||13800|20149||1 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|22371|30906|lyfalmen|V0605|9185|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||22371||22371|30906||1 010348|J07BB0203|Vaxigrip|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1995||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7157|10880|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||7157||7157|10880|30.9.2014|2 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12103|18019|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12103||12103|18019||1 010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|1|0|0|0|G|0|TIL|0|0|0|100|SEK|6122|9464|lyfalmen|||1|60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||6122|9464||2 010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8887|12826|lyfsjukr|||1|1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||8887||8887|12826||2 010573|S01AE0501|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AE05|01.08.2002||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|1212|2747|lyfalmen|||1|5|0||Icepharma hf|Santen Oy|Levófloxacín||1212||1212|2747||2 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5552|8013|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5552||5552|8013||2 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8539|12324|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||8539||8539|12324||2 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3777|5451|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3777||3777|5451||2 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002|31.08.2014|R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2165|3125|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2165||2165|3125||2 010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|8208|12317|lyfalmen|V0377|12317|1|9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8208||8208|12317||1 010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|2373|2850|lyfalmen|V0006|2142|2|56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1287||1287|2850||2 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|13076|5497|lyfalmen|V0207|2315|1|12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3222||3222|5497||1 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|335338|422732|lyfsjukr|||1|56|0|14,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||335338||335338|422732||3 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|1|1|0|1|0|1|ACV|0|1|0|100|SEK|335338|422732|lyfsjukr|||1|56|0|28,0000|Vistor hf|Actelion Registration Ltd.|Bósentan||335338||335338|422732||3 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|45532|59025|lyfsjukr|||2|10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||45532||45532|59025||2 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|0|0|0|0|0|1|REP|0|0|0|100|SEK|2839|4097|lyfsjukr|||1|10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||2839||2839|4097||1 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|19536|27348|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19536||19536|27348||1 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|19308|27062|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||19308||19308|27062||1 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|33262|44574|lyfalmen|||1|56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33262||33262|44574||1 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|33036|44290|lyfalmen|||1|56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33036||33036|44290||1 011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|17240|24466|lyfalmen|||1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||17240||17240|24466||1 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4363|7058|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4363||4363|7058||1 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4534|7292|lyfalmen|||1|28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4534||4534|7292||1 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19631|25945|lyfalmen|V0327|3483|1|100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||18418||18418|25945||1 011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|1157|2672|lyfalmen|||1|7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1157||1157|2672||1 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1028|2496|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1028||1028|2496||1 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2835|3351|lyfalmen|V0069|2944|2|98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1653||1653|3351||1 011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|7736|11672|lyfalmen|V0357|10653|1|60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||7736||7736|11672||1 011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6156|9510|lyfalmen|||1|30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6156||6156|9510||1 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|2352|3395|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Esketamín||2352||2352|3395||1 011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|8019|10977|lyfalmen|V0624|9463|1|30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7228||7228|10977||1 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|1866|3712|vetalmen|||0|25|0||Icepharma hf|Chanelle Pharmaceuticals |||1866||1866|3712||2 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|0|0|1|0|0|1|PER|0|0|0|100|DKK|4794|6919|lyfsjukr|||1|20|0||Icepharma hf|Pfizer ApS|Esketamín||4794||4794|6919||1 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|skammtar|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|0|0|0|0|G|0|OYL|0|0|0|100|DKK|1181|2705|lyfalmen|||2|64|0||Vistor hf|Oy Leiras Finland Ab|Estradíól||1181||1181|2705||1 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|78428|100310|lyfsjukr|||1|168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||78428||78428|100310||2 011718|QJ01CE0101|Geepenil, vet.|sts|24|g|1|hgl|1|pakki|+ leysir, lausn|QJ01CE01|01.09.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|SEK|2628|5219|vetalmen|||0|1|0||Icepharma hf|Orion Corporation (I)|Benzylpenicillín sodíum||2628||2628|5219||2 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1796|2082|lyfalmen|V0152|2082|2|28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||726||726|2082||1 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4738|3905|lyfalmen|V0323|3548|2|98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||2058||2058|3905||1 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|4120|5946|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4120||4120|5946||1 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|2384|3441|lyfsjukr|||1|20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2384||2384|3441||1 011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|7728|11661|lyfalmen|V0604|3790|1|28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||7728|11661||1 012030|J05AG0301|Stocrin|filmhtfl|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|39287|51188|lyfsjukr|||1|30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||39287||39287|51188||1 012113|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1270|1761|lyfalmen|V0551|1761|2|7|0|1,7500|Medical ehf|ratiopharm GmbH|Flúkónazól||491||491|1761||2 012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|3991|6549|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||3991||3991|6549||1 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|6298|9705|lyfalmen|||1|4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6298||6298|9705||2 012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012290|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|1807|1906|lyfalmen|V0556|1906|2|4|0|3,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||597||597|1906||2 012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|10001|13006|lyfalmen|V0622|10858|1|30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||8711||8711|13006||1 012347|J02AC0104|Fluconazol ratiopharm|hylki|50|mg|28|stk|1|ţpakki||J02AC01|01.10.2012||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|3809|3107|lyfalmen|V0552|3052|2|28|0|7,0000|Medical ehf|ratiopharm GmbH|Flúkónazól||1475||1475|3107||2 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003|31.08.2014|R|0|0|0|1|0|1|WTE|0|0|0|100|DKK|434495|547174|lyfsjukr|||1|1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||434495||434495|547174||2 012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 012864|M01AE0113|Ibuxin|filmhtfl|200|mg|20|stk|1|ţpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|20|0|3,3333|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|718|2072|lyfalmen|||1|80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|2072||1 012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|4371|7069|lyfalmen|||1|9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og ethinylestradíól||4371||4371|7069||1 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|0|0|0|0|G|0|LBI|0|0|0|100|DKK|6339|9761|lyfalmen|||1|30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6339||6339|9761||2 012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2701|3936|lyfalmen|V0250|3933|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2081||2081|3936||2 012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|3537|4479|lyfalmen|V0251|4479|2|100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2478||2478|4479||2 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|5698|8884|lyfalmen|||1|30|0|20,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||5698||5698|8884||1 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|6741|13116|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||6741||6741|13116||2 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|9216|13696|lyfalmen|||1|30|0|40,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||9216||9216|13696||1 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1697|3376|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1697||1697|3376||2 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004|30.09.2014|R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|21578|28963|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||21578||21578|28963||5 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|0|0|0|0|0|1|ZLB|0|0|0|100|SEK|6552|9456|lyfsjukr|||1|2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||6552||6552|9456||2 013259|B02BD0901|BeneFIX|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|28597|37772|lyfsjukr|||1|1|0|0,5600|Icepharma hf|Pfizer Limited|Storkuţáttur IX||28597||28597|37772||1 013270|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2004||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|48404|62630|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||48404||48404|62630||1 013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|1|0|0|0|G|0|ANO|0|0|0|100|XEU|3271|4779|lyfalmen|||2|100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2697||2697|4779|30.9.2014|1 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4427|8673|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4427||4427|8673||2 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|10330|20008|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||10330||10330|20008||2 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1084|2156|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||1084||1084|2156||2 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|132645|168352|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||132645|168352||3 013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|0|0|0|1|0|1|AZD|0|1|0|100|SEK|380325|374766|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||297118||297118|374766||1 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|86704|110696|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||86704|110696||3 013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|1273|2831|lyfalmen|||1|5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1273||1273|2831||2 013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1620||1 013615|M01AE0113|Ibuxin|filmhtfl|400|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|737|1485|lyfalmen|V0562|1485|2|100|0|33,3300|Medical ehf|ratiopharm Oy|Íbúprófen||289||289|1485||2 013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2434|4419|lyfalmen|||1|10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2434||2434|4419||2 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|381|1611|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||381||381|1611||1 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4543|7304|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||4543||4543|7304||1 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1215|2751|lyfalmen|V0168|2668|1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2751||1 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|6003|9301|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6003||6003|9301||1 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2500|4509|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2500||2500|4509||1 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|4484|7223|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4484||4484|7223||1 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|164765|208663|lyfsjukr|||1|60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||164765||164765|208663||1 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|334436|421600|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||334436||334436|421600||1 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2420|4400|lyfalmen|||1|10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2420||2420|4400||1 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|7490|10810|lyfsjukr|||1|50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7490||7490|10810||1 014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|0|0|0|0|0|0|UCB|0|0|0|100|DKK|17556|24863|lyfalmen|||1|300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||17556||17556|24863||1 014094|H05AA0202|Forsteo|stl|250|mcg/ml|2,4|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|0|0|0|0|0|0|ELD|0|0|0|100|XEU|65523|85061|lyfalmen|||1|2,4|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||65523||65523|85061||2 014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|skammtar|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|23210|31959|lyfalmen|V0357|31959|1|180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og budesonide||23210||23210|31959||1 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1575|3244|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1575||1575|3244||2 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991|31.08.2014|L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 014365|M01AE0113|Ibuxin|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|355|1575|lyfalmen|V0563|1575|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Íbúprófen||355||355|1575||2 014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|NOK|2340|4290|lyfalmen|||0|100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2340||2340|4290||1 014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|0|0|0|0|0|0|VET|0|0|0|100|XEU|2218|4412|vetalmen|||0|45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2218|4412||2 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|80053|102349|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Adefovír||||80053|102349||2 014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|5513|10758|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5513||5513|10758||2 014597|M01AE0113|Ibuxin|filmhtfl|600|mg|100|stk|1|ţpakki||M01AE01|01.01.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|894|1751|lyfalmen|V0564|1751|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Íbúprófen||484||484|1751||2 014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1224|2764|lyfalmen|V0596|1896|1|28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||1224||1224|2764||2 014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1105|2330|lyfalmen|V0558|2115|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||907||907|2330||2 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|60969|78399|lyfsjukr|||1|2,5|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||60969||60969|78399||1 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|97548|124305|lyfsjukr|||1|2,5|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||97548||97548|124305||1 014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1290|2256|lyfalmen|V0559|2252|2|100|0|100,0000|Icepharma hf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||853||853|2256||2 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|18681|26275|lyfalmen|||1|60|0|10,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||18681||18681|26275||1 014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|56372|73577|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||56372||56372|73577||1 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|37523|49921|lyfalmen|||1|60|0|20,0000|Vistor hf|Novartis Healthcare A/S|Everolímus||37523||37523|49921||1 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|1|0|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||0|270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín|||||||2 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2641|4702|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||2641||2641|4702||1 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|8324|12476|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8324||8324|12476||1 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|ţpakki||N06AX11|01.07.2003||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1070|2531|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1054||1054|2531||1 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|0|0|0|0|0|0|LOL|0|0|1|100|IKR|2760|4865|lyfalmen|||0|100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4865||3 015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1055|2533|lyfalmen|V0129|1614|1|8|0|14,0000|Vistor hf|Novartis Healthcare A/S|Estradíól||1055||1055|2533||1 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1955|2611|lyfalmen|V0234|1954|1|6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1112||1112|2611||1 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2793|2611|lyfalmen|V0233|2244|1|12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1112||1112|2611||1 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|9917|14655|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||9917||9917|14655||1 015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|307760|388121|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||307760||307760|388121||3 015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|0|0|0|1|0|1|PAM|0|0|0|100|DKK|88914|113470|lyfsjukr|||1|1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabectedín||88914||88914|113470||3 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5142|8123|lyfalmen|||1|30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5142||5142|8123||1 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|13073|19237|lyfalmen|||1|100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13073||13073|19237||1 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5142|8123|lyfalmen|||1|30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5142||5142|8123||1 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|14132|20566|lyfalmen|||1|100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14132||14132|20566||1 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|68205|87480|lyfsjukr|||1|60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68205||68205|87480||1 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|5142|8123|lyfalmen|||1|30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5142||5142|8123||1 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|12935|19063|lyfalmen|||1|100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||12935||12935|19063||1 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|68205|87480|lyfsjukr|||1|60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||68205||68205|87480||1 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|21870|30277|lyfalmen|||1|120|0|10,8000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||21870||21870|30277||1 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|0|0|0|1|G|0|HES|0|0|0|100|DKK|45555|60002|lyfalmen|||1|120|0|21,6000|Vistor hf|Novartis Healthcare A/S|Mýcófenólsýra||45555||45555|60002||1 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3101|5410|vetorma|||0|2,4|0||Icepharma hf|Bayer Animal Health GmbH|||3101||3101|5410||2 015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|5094|8886|vetorma|||0|12|0||Icepharma hf|Bayer Animal Health GmbH|||5094||5094|8886||2 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|pípett|100+10 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2313|4035|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||2313||2313|4035||2 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3227|5629|vetorma|||0|3|0||Icepharma hf|Bayer Animal Health GmbH|||3227||3227|5629||2 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4874|8502|vetorma|||0|7,5|0||Icepharma hf|Bayer Animal Health GmbH|||4874||4874|8502||2 015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1944|3749|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||1944|3749||1 015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|2183|4076|lyfalmen|||1|10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2183||2183|4076||1 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1585|3258|lyfalmen|||2|10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1585||1585|3258||2 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|pípett|100+25 mg|QP54AB52|01.02.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|3103|5413|vetorma|||0|1,2|0||Icepharma hf|Bayer Animal Health GmbH|||3103||3103|5413||2 015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa|||0|60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól|||||||2 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|2023|3857|lyfalmen|||1|28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2023||2023|3857||1 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004|30.09.2014|R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13874|20242|lyfalmen|||1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13874||13874|20242||1 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1178|2701|lyfalmen|||2|10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1178||1178|2701||2 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|20775|28903|lyfalmen|||1|100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20775||20775|28903|30.9.2014|1 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|1248|2797|lyfalmen|||2|20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1248||1248|2797||2 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2648|4712|lyfalmen|||1|14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2648||2648|4712||1 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|6902|10531|lyfalmen|||1|56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6902||6902|10531||1 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4692|7508|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4692|7508||2 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10464|15404|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10464||10464|15404||1 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1748|3481|lyfalmen|||1|14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1748||1748|3481||1 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15208|21916|lyfalmen|||1|56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||15208||15208|21916||1 016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|8567|12809|lyfalmen|||1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||8567||8567|12809||1 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|0|0|0|0|0|1|IPI|0|0|0|100|DKK|93220|118874|lyfsjukr|||1|70|0|7,0000|Icepharma hf|Pfizer Limited|Voricónazól||93220||93220|118874||1 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|4127|5956|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4127||4127|5956||1 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2723|4814|lyfalmen|||1|56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2723||2723|4814||1 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|17027|24199|lyfalmen|||1|28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17027||17027|24199||1 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7691||1 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|1|0|0|0|0|0|OTS|0|0|0|100|DKK|33262|44574|lyfalmen|||1|56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||33262||33262|44574||1 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1026|2319|lyfalmen|V0169|1719|2|12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||899||899|2319||1 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|179324|226934|lyfsjukr|||1|2,4|0|120,0000|Icepharma hf|Roche|Epóetín||179324||179324|226934||2 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|7275|11041|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||7275||7275|11041||1 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|2972|5155|lyfalmen|V0240|5155|3|200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||2972||2972|5155||3 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|1|0|0|0|G|0|LVR|0|0|0|100|DKK|5485|8593|lyfalmen|V0433|8593|3|200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5485||5485|8593||3 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|59336|77297|lyfalmen|||1|28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||59336||59336|77297||1 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|87432|112557|lyfalmen|||1|28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||87432||87432|112557||1 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|1|0|0|0|0|0|AEB|0|0|0|100|DKK|28255|38290|lyfalmen|||1|28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||28255||28255|38290||1 016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|0|1|0|1|0|1|GEA|0|1|0|100|DKK|69727|89390|lyfsjukr|||1|5|0|1,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||69727||69727|89390||1 016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|3448|5806|lyfalmen|||1|56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3448|5806||1 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|1|0|0|1|0|1|GSL|0|0|0|100|XEU|38593|50317|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín||38593||38593|50317||2 016979|N02AE0103|Norspan|forđapl|5|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|3055|5268|lyfalmen|||1|4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3055||3055|5268||2 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|18249|35213|vetalmen|||0|60|0||Icepharma hf|Zoetis Finland OY|||18249||18249|35213||2 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1486|3122|lyfalmen|||1|3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1486||1486|3122||1 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|0|0|0|1|0|1|SKY|0|1|0|100|DKK|256547|323849|lyfsjukr|||1|5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||256547||256547|323849||2 017182|N05CF0106|Zopiclone Actavis|filmhtfl|5|mg|500|stk|1|plglas||N05CF01|01.10.2012||R|2|0|0|0|0|0|AGT|0|0|0|100|XEU|5866|9114|lyfalmen|||2|500|0|333,0000|Actavis Group hf|Actavis Group hf|Zópíklón||5866||5866|9114||1 017193|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|500|stk|1|glas||N05CF01|01.05.2013||R|2|0|0|0|0|0|AGT|0|0|0|100|SEK|5779|8995|lyfalmen|||2|500|0|500,0000|Actavis Group hf|Actavis Group hf|Zópíklón||5779||5779|8995||1 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|143989|182589|lyfsjukr|||1|1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||143989||143989|182589||1 017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|33197|43545|lyfsjukr|||1|6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||33197||33197|43545||2 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|119305|151610|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||119305||119305|151610||2 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|46536|61233|lyfalmen|||1|28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||46536||46536|61233||2 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|1|0|0|1|0|0|ROC|0|0|0|100|DKK|144512|184193|lyfalmen|||1|84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||144512||144512|184193||2 017266|N02AE0103|Norspan|forđapl|10|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|5494|8605|lyfalmen|||1|4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5494||5494|8605||2 017326|N02AE0103|Norspan|forđapl|20|mcg/klst|4|stk|1|ţpakki||N02AE01|01.01.2006||R|0|0|1|0|G|0|NOP|0|0|0|100|DKK|10098|14903|lyfalmen|||1|4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10098||10098|14903||2 017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|1|0|0|0|0|1|MSD|0|0|0|100|DKK|8774|12663|lyfsjukr|||1|3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||8774||8774|12663||1 017365|J01CR0201|Amoksiklav|filmhtfl|375|mg|20|stk|1|ţpakki|250+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|863|2270|lyfalmen|||2|20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||863||863|2270||1 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|2800|4920|lyfalmen|||1|30|0|150,0000|Vistor hf|Recip AB|Prednisón||2800||2800|4920||1 017556|J01CR0201|Amoksiklav|filmhtfl|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.12.2003||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1459|2668|lyfalmen|V0168|2668|2|20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1154||1154|2668||1 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|6513|12678|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim|||6513||6513|12678||1 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10137|14956|lyfalmen|V0197|12443|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10137||10137|14956||1 017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|40584|53763|lyfalmen|||1|84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||40584||40584|53763||1 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|9258|13754|lyfalmen|V0107|10650|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9258||9258|13754||1 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|3768|6244|lyfalmen|||1|0,25|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3768||3768|6244||2 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|0|0|0|0|0|0|BAA|0|0|0|100|SEK|4059|6642|lyfalmen|||1|0,5|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4059||4059|6642||2 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1030|1716|lyfalmen|V0243|1375|1|42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||458||458|1716||1 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|8035|12081|lyfalmen|||1|30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8035||8035|12081||1 018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|13301|18575|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13301||13301|18575||2 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|19701|27555|lyfalmen|V0441|22304|1|90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||19701||19701|27555||1 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|01.06.2004||R|1|0|0|0|G|0|MKA|0|0|1|100|SEK|904|2326|lyfalmen|V0414|2112|1|100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||904||904|2326||2 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|5690|8873|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5690||5690|8873||1 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|16041|22961|lyfalmen|V0440|18676|1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16041||16041|22961||1 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|33462|44825|lyfalmen|V0111|37268|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||33462||33462|44825||1 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|0|0|0|1|0|1|TEP|0|0|0|100|NOK|100622|128163|lyfsjukr|||1|28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||100622||100622|128163||1 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|60691|78050|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||60691||60691|78050||1 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|1185|2357|vetalmen|||0|100|0||Icepharma hf|Kela Laboratoria NV|||1185||1185|2357||2 018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|9550|14153|lyfalmen|V0221|7509|1|5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||9550||9550|14153||1 019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|19297|26100|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||19297||19297|26100||2 019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|6826|10427|lyfalmen|V0220|5836|1|5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||6826||6826|10427||1 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|21778|29214|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21778||21778|29214||2 019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|3785|6267|lyfalmen|V0219|3455|1|5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||3785||3785|6267||1 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|30235|39827|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jóhexól||30235||30235|39827||2 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|31002|40790|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||31002||31002|40790||2 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|37880|49422|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Jódixanól||37880||37880|49422||2 019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|7468|11305|lyfalmen|V0223|8156|1|5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7468||7468|11305||1 019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13163|19350|lyfalmen|||1|98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||13163||13163|19350||1 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|0|0|0|1|0|1|THE|0|0|0|100|XEU|721588|907475|lyfsjukr|||1|10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||721588||721588|907475||1 019308|QG03XB9001|Alizin, vet|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03XB90|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|4087|8020|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Aglepristonum||4087||4087|8020||1 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019372|C03CA0110|Impugan|töflur|20|mg|100|stk|1|glas||C03CA01|01.02.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|400|1583|lyfalmen|V0633|1583|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||361||361|1583||1 019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|dćlur||QJ51CE09|01.04.2010||R|0|0|0|0|0|0|VET|0|0|0|100|DKK|28687|55256|vetalmen|||0|1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||28687||28687|55256||2 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6637|10168|lyfalmen|||1|56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6637||6637|10168||2 019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|47539|61544|lyfsjukr|||1|4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||47539||47539|61544||2 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6637|10168|lyfalmen|||1|56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6637||6637|10168||2 019621|C09AA0504|Ramipril ratiopharm|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1099|1910|lyfalmen|V0496|1910|2|100|0|200,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1910||2 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019669|C09AA0504|Ramipril ratiopharm|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|980|1910|lyfalmen|V0648|1910|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Ramipríl||600||600|1910||2 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019682|C09AA0504|Ramipril ratiopharm|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1706|2868|lyfalmen|V0649|2868|2|100|0|400,0000|Medical ehf|ratiopharm GmbH|Ramipríl||1300||1300|2868||2 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|3634|5245|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3634||3634|5245||2 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|0|0|0|1|0|1|ELI|0|0|0|100|XEU|15964|21917|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||15964||15964|21917||2 019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|181834|230084|lyfsjukr|||1|16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||181834||181834|230084||2 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1040|2144|lyfalmen|V0159|2143|2|20|0|10,0000|Icepharma hf|Mylan AB|Amoxicillín||771||771|2144|| 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|0|0|0|1|0|1|ELD|0|1|0|100|XEU|173972|220217|lyfsjukr|||1|1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||173972||173972|220217||2 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12376|18362|lyfalmen|||1|28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12376||12376|18362||2 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12376|18362|lyfalmen|||1|28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12376||12376|18362||2 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|0|0|0|1|G|0|MLD|0|0|0|100|DKK|46365|61018|lyfalmen|||1|1,08|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Follitrópín beta||||46365|61018||1 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12376|18362|lyfalmen|||1|28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12376||12376|18362||2 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12376|18362|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12376||12376|18362||2 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|ţpakki|hart|N06BA09|01.08.2006||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|12376|18362|lyfalmen|||1|28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12376||12376|18362||2 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|762791|959185|lyfsjukr|||1|6|0|8,9300|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Palifermín||762791||762791|959185||3 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|401|1638|lyfalmen|||1|12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||||401|1638||1 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|68774|88194|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||68774||68774|88194||1 019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1539|2642|lyfalmen|V0160|2553|2|30|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1135||1135|2642|| 020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|1|0|0|0|0|0|AHN|0|0|1|100|IKR|||lyflausa|||0|100|0|50,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Ferrósúlfat|||||||1 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020156|C08DB0109|Dilmin|töflur|60|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|4583|5736|lyfalmen|||2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Diltíazem||3397||3397|5736||2 020227|J07CA0204|Boostrix Polio|stl|||0,5|ml|1|áf.spr|dreifa|J07CA02|01.09.2014||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2681|4757|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Barnaveiki, kíghósti, mćnusótt, stífkrampi||||2681|4757||1 020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|2830|4961|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2830||2830|4961||1 020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|26815|36483|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||26815||26815|36483||1 020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|0|0|0|0|0|0|LVR|0|0|0|100|NOK|2522|4539|lyfalmen|||3|50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2522||2522|4539||3 020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 020305|C08DB0109|Dilmin|forđatfl|90|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|7447|4408|lyfalmen|||2|100|0|37,5000|Medical ehf|ratiopharm GmbH|Diltíazem||2426||2426|4408||2 020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|6607|10127|lyfalmen|||1|90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6607||6607|10127||1 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|51572|67553|lyfalmen|||1|2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||51572||51572|67553||1 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|4882|4498|lyfalmen|||1|84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||2492||2492|4498||1 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|11082|5221|lyfalmen|||1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3020||3020|5221||1 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|23273|32038|lyfalmen|||1|2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||23273||23273|32038||1 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|586|1891|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||586||586|1891||1 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|skpokar|1|pakki|dreifa|M05BX03|01.08.2005|30.09.2014|R|0|0|0|1|0|0|SEV|0|0|0|100|DKK|5549|8680|lyfalmen|||1|28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5549||5549|8680||2 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1785|3531|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1785||1785|3531||1 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|skpokar|1|pakki|dreifa|M05BX03|01.08.2005|30.09.2014|R|0|0|0|1|0|0|SEV|0|0|0|100|DKK|16160|23111|lyfalmen|||1|84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16160||16160|23111||2 020647|J01CA0415|Amoxicillin ratiopharm|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.08.2013|31.07.2014|R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1821|3580|lyfalmen|||2|100|1|5,0000|Parlogis hf|Parlogis - óskráđ lyf|Amoxicillín||||1821|3580||2 020685|C08DB0109|Dilmin|forđatfl|120|mg|100|stk|1|ţpakki||C08DB01|01.09.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|12259|9597|lyfalmen|V0599|9597|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Diltíazem||6219||6219|9597||2 020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|0|0|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel|||||||2 020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|0|0|0|0|0|0|MES|0|0|0|100|XEU|2157|3763|vetorma|||0|7,74|0||Vistor hf|Merial SAS|Ivermectinum í blöndum||2157||2157|3763||1 020861|QP52AF0203|Nematel Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|0|0|0|0|0|0|VEB|0|0|0|100|XEU|2522|4400|vetorma|||0|52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2522||2522|4400||2 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|1958|3374|lyfalmen|V0174|3372|3|3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||1670||1670|3374||2 020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|1|0|0|0|0|0|LLS|0|0|0|100|DKK|2920|5084|lyfalmen|||1|30|0|37,5000|Icepharma hf|Les Laboratoires Servier|Perindópríl||2920||2920|5084||2 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|2322|4266|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2322||2322|4266||2 021149|J01CR0203|Augmentine (Lyf og heilsa)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|0|0|0|0|0|0|HOL|0|0|1|100|IKR|1025|2319|lyfalmen|V0169|1719|3|12|0|10,5000|Lyf og heilsa|Lyf og heilsa|Amoxicillín og ensímblokkar||899||899|2319||2 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|581|1601|lyfalmen|V0188|1520|2|30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||374||374|1601||1 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|0|0|0|0|G|0|GEM|0|0|0|100|XEU|1234|2777|lyfalmen|||1|10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1234||1234|2777||1 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|1|0|0|0|G|0|ACA|0|0|1|100|IKR|1287|2433|lyfalmen|V0189|2178|2|100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||982||982|2433||1 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|8999|13400|lyfalmen|V0437|12737|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||8999||8999|13400|| 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|16622|23691|lyfalmen|V0490|2433|1|98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||16622||16622|23691||1 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|GBP|6863|10478|lyfalmen|V0436|9973|3|60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og fluticason||6863||6863|10478|| 021417|R01AD0504|Rhinocort (Lyf og heilsa)|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|15.12.2004||R|0|0|0|0|G|0|HOL|0|0|1|100|SEK|1528|3180|lyfalmen|V0443|3180|3|120|0|38,4000|Lyf og heilsa|Lyf og heilsa|Búdesóníđ||1528||1528|3180|| 021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|0|0|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl|||||||1 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|16885|24021|lyfalmen|V0491|7144|1|98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||16885||16885|24021||1 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|1533|2213|lyfsjukr|||2|100|0||Icepharma hf|Fresenius Kabi|Própófól||1533||1533|2213||2 021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|4261|6918|lyfalmen|||1|30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4261||4261|6918||1 021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13041|19196|lyfalmen|||1|100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13041||13041|19196||1 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13517|19794|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13517||13517|19794||1 021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6892|10517|lyfalmen|||1|30|0|9,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6892||6892|10517||1 021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|14644|21208|lyfalmen|||1|60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||14644||14644|21208||1 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15331|21123|lyfsjukr|||2|1000|0||Icepharma hf|Fresenius Kabi|Própófól||15331||15331|21123||2 021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|21953|30381|lyfalmen|||1|100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||21953||21953|30381||1 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|15331|21123|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||15331||15331|21123||2 021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23598|32446|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||23598||23598|32446||1 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|4213|6853|lyfalmen|V0171|5230|1|28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4213||4213|6853||1 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8816|12724|lyfsjukr|||2|500|0||Icepharma hf|Fresenius Kabi|Própófól||8816||8816|12724||2 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4449|6421|lyfsjukr|||1|50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4449||4449|6421||1 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18892|26539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18892||18892|26539||1 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|3931|6467|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3931||3931|6467||2 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6205|9577|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6205||6205|9577||2 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|18923|26578|lyfalmen|||1|98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18923||18923|26578||2 021999|L01XX3501|Xagrid|hylki|0,5|mg|100|stk|1|glas|hart|L01XX35|01.10.2012||R|0|0|0|1|0|1|SHI|0|0|0|100|DKK|79252|101344|lyfsjukr|||1|100|0||Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Anagrelidum||79252||79252|101344||3 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18892|26539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18892||18892|26539||1 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|81351|103978|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||81351||81351|103978||2 022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|115578|146933|lyfsjukr|||1|1200|0||Icepharma hf|Baxter Medical AB|Albúmín||115578||115578|146933||2 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ|||||||1 022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|4921|7821|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4921||4921|7821||1 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|284697|359177|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||284697||284697|359177||2 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|302138|381066|lyfsjukr|||1|30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||302138||302138|381066||2 022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|12265|21396|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||12265||12265|21396||2 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|0|0|0|1|0|0|ALL|0|0|0|100|SEK|23031|31734|lyfalmen|||1|1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||23031||23031|31734||1 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2201|3840|vetorma|||0|2,24|0||Icepharma hf|Bayer Animal Health GmbH|||2201||2201|3840||2 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1258|2810|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1258||1258|2810||1 022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1391|2427|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1391||1391|2427||2 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3718|2772|lyfalmen|V0056|1999|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1230||1230|2772||1 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|6537|3758|lyfalmen|V0057|1999|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||1951||1951|3758||1 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2085|3637|vetorma|||0|1,4|0||Icepharma hf|Bayer Animal Health GmbH|||2085||2085|3637||2 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|611|1925|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||611||611|1925||1 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1831|3594|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1831||1831|3594||1 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1350|2355|vetorma|||0|0,7|0||Icepharma hf|Bayer Animal Health GmbH|||1350||1350|2355||2 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|4542|7303|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||4542||4542|7303||1 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2129|3103|lyfalmen|V0321|3103|2|100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|3103||1 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.08.2013||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1554|2156|lyfalmen|V0321|1862|2|60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2156||1 022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4772||2 022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|26383|35941|lyfalmen|||1|8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||26383||26383|35941||1 022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|13191|19385|lyfalmen|||1|4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13191||13191|19385||1 022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|19808|27689|lyfalmen|||1|6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||19808||19808|27689||1 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2931||2 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|1407|2942|lyfalmen|V0124|2937|2|30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1354||1354|2942||1 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|0|1|0|1|G|0|ACA|0|0|0|30|IKR|2450|4309|lyfalmen|V0125|3144|2|30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2354||2354|4309||1 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|77672|99361|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Tenófóvír dísóproxíl og emtrícítabín||77672||77672|99361||2 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|24974|34172|lyfalmen|||1|90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||24974||24974|34172||3 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|1|0|0|1|0|0|SHI|0|0|0|100|DKK|38991|51764|lyfalmen|||1|90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||38991||38991|51764||3 023114|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|3000|3483|lyfalmen|V0125|3144|2|30|0|20,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||1750||1750|3483||2 023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|NEL|0|0|0|100|DKK|19745|27610|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||19745||19745|27610||1 023125|D10BA0106|Isotretinoin ratiopharm|hylki|20|mg|60|stk|1|ţpakki||D10BA01|01.09.2014||R|0|1|0|1|G|0|RAT|0|0|0|30|IKR|6500|6288|lyfalmen|V0125|6288|2|60|0|40,0000|LYFIS ehf|ratiopharm GmbH|Ísótretínóín||3800||3800|6288||2 023154|N03AX1208|Gabapentin ratiopharm|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|14000|20400|lyfalmen|V0256|20400|2|100|0|44,4400|Medical ehf|ratiopharm GmbH|Gabapentín||14000||14000|20400||2 023162|N03AX1208|Gabapentin ratiopharm|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|7500|11349|lyfalmen|V0254|11349|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Gabapentín||7500||7500|11349||2 023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|1|0|0|0|G|0|NEL|0|0|0|100|DKK|19946|27862|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||19946||19946|27862||1 023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2544|3933|lyfalmen|V0250|3933|2|100|0|16,6667|Icepharma hf|Mylan AB|Gabapentín||2079||2079|3933|| 023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3403|4513|lyfalmen|V0251|4479|2|100|0|22,2200|Icepharma hf|Mylan AB|Gabapentín||2503||2503|4513||2 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|0|0|0|0|0|0|DED|0|0|1|100|XEU|19018|26698|lyfalmen|||1|34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||19018||19018|26698||1 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|0|0|0|1|0|1|BII|0|0|0|100|DKK|131196|166533|lyfsjukr|||1|120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||131196||131196|166533||1 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|24227|28728|lyfalmen|V0029|6851|1|100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||20636||20636|28728||1 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3028|5231|lyfalmen|||1|12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3028||3028|5231||2 023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|136932|173732|lyfsjukr|||2|1500|0||Icepharma hf|Baxter|Sevóflúran||136932||136932|173732||2 023641|C09AA0211|Enalapril Krka|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|900|2320|lyfalmen|V0066|2208|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||900||900|2320||2 023649|C09AA0211|Enalapril Krka|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1050|2526|lyfalmen|V0449|2483|2|100|0|200,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1050||1050|2526||2 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|1|0|0|1|0|1|ROC|0|0|0|100|DKK|55013|70924|lyfsjukr|||1|120|0|33,3300|Icepharma hf|Roche|Saquínavír||55013||55013|70924||2 023738|C09AA0211|Enalapril Krka|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.03.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|700|2047|lyfalmen|V0448|1758|2|100|0|50,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||700||700|2047||2 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|0|1|0|1|0|1|IPI|0|0|0|100|DKK|72181|92470|lyfsjukr|||1|90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||72181||72181|92470||1 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2847|4984|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2847||2847|4984||1 024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|0|0|1|0|G|0|JAS|0|0|0|100|SEK|2306|4244|lyfalmen|V0222|3872|1|5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2306||2306|4244||1 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|18818|26447|lyfalmen|||1|30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||18818||18818|26447||1 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|1|0|0|0|G|0|TPG|0|0|0|100|DKK|62066|80723|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||62066||62066|80723||1 024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23598|32446|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||23598||23598|32446||1 024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7429|11252|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7429||7429|11252||1 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|407|1646|lyfalmen|||1|100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||407||407|1646||1 024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7429|11252|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7429||7429|11252||1 024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12517|18539|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12517||12517|18539||1 024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12538|18565|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12538||12538|18565||1 024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12666|18726|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12666||12666|18726||1 024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5356|8416|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5356||5356|8416||1 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|68054|88238|lyfalmen|||1|100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||68054||68054|88238||1 024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|12666|18726|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||12666||12666|18726||1 024603|V04CL0001|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1525|3175|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1525||1525|3175||1 024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|5356|8416|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5356||5356|8416||1 024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7429|11252|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7429||7429|11252||1 024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|7429|11252|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7429||7429|11252||1 024681|V04CL0002|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|0|0|0|0|0|0|ALK|0|0|0|100|DKK|1525|3175|lyfalmen|||1|2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1525||1525|3175||1 024901|C07AB0212|Metoprolin|töflur|100|mg|100|stk|1|ţpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|2341|3415|lyfalmen|V0106|3415|2|100|0|66,6660|Medical ehf|ratiopharm GmbH|Metóprólól||1700||1700|3415||2 025041|C09AA0211|Enalapril Krka|töflur|20|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|3193|5457|lyfalmen|||2|250|0|500,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||3193||3193|5457||2 025046|C09AA0211|Enalapril Krka|töflur|10|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2770|4879|lyfalmen|||2|250|0|250,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2770||2770|4879||2 025052|C09AA0211|Enalapril Krka|töflur|5|mg|250|stk|1|glas||C09AA02|01.12.2013||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2000|3825|lyfalmen|||2|250|0|125,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||2000||2000|3825||2 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|619|1936|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||619||619|1936||1 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18892|26539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18892||18892|26539||1 025239|C07AB0212|Metoprolin|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.01.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1480|2184|lyfalmen|V0051|2184|2|100|0|33,3333|Medical ehf|ratiopharm GmbH|Metóprólól||800||800|2184||2 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18892|26539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18892||18892|26539||1 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|81680|104391|lyfsjukr|||1|30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||81680||81680|104391||1 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|76292|97629|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||76292||76292|97629||1 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|0|0|0|0|0|0|BOI|1|0|0|100|DKK|9362|18149|vetalmen|||0|20|0||Vistor hf|Boehringer Ingelheim|||9362||9362|18149||1 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|16205|23167|lyfalmen|||1|30|0||Vistor hf|ALK-Abello A/S|grasfrjó||16205||16205|23167||1 025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012|30.09.2014|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2515|4200|lyfalmen|||2|90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||2274||2274|4200||1 025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012|30.09.2014|R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2737|4475|lyfalmen|||2|90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||2475||2475|4475||1 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|5126|8101|lyfalmen|V0205|1255|1|1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5126||5126|8101||2 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|13738|20071|lyfalmen|V0205|3766|1|3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||13738||13738|20071||2 025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2942|3305|lyfalmen|V0472|3305|2|90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1620||1620|3305||1 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|0|0|0|1|0|0|ALK|0|0|0|100|DKK|52054|68158|lyfalmen|||1|100|0||Vistor hf|ALK-Abello A/S|grasfrjó||52054||52054|68158||1 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|6932|10005|lyfsjukr|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||6932||6932|10005||1 025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23598|32446|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|dýr||23598||23598|32446||1 025895|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1502|2483|lyfalmen|V0597|2374|2|28|0|3,7300|Medical ehf|ratiopharm GmbH|Oxýcódon||1019||1019|2483||2 025906|N02AA0505|Oxycodone ratiopharm|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|3836|5073|lyfalmen|V0598|5073|2|98|0|13,0700|Medical ehf|ratiopharm GmbH|Oxýcódon||2912||2912|5073||2 025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|0|1|0|1|0|1|CEE|0|1|0|100|XEU|51304|66269|lyfsjukr|||1|28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||51304|66269||2 025927|N06AX2601|Brintellix|filmhtfl|20|mg|98|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|43807|57808|lyfalmen|||1|98|0||Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||43807||43807|57808||1 025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13043|5471|lyfalmen|V0492|5471|2|98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||3203||3203|5471||1 025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4426|7144|lyfalmen|V0491|7144|2|98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||4426||4426|7144|| 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|IKR|2500|4361|vetorma|||0|1|0||Vistor hf|Merial (MSD)|Ivermectinum||2500||2500|4361||1 025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|13342|2433|lyfalmen|V0490|2433|2|98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||982||982|2433||1 025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|1|0|0|0|0|0|POF|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ|||||||1 026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1906|3791|vetalmen|||0|10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||1906||1906|3791||1 026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|820|2211|lyfalmen|V0447|2211|2|100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2211||1 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|9058|15801|vetorma|||0|2,5|0||Vistor hf|Merial (MSD)|Ivermectinum||9058||9058|15801||1 026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|IKR|23430|15450|lyfalmen|V0475|15386|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||10498||10498|15450||1 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18892|26539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|dýr||18892||18892|26539||1 026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|41669|54177|lyfsjukr|||1|2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||41669||41669|54177||1 026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|0|0|0|1|0|1|PFM|0|0|0|100|DKK|208372|263389|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||208372||208372|263389||1 026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|1775|3517|lyfalmen|||1|14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1775|3517||1 026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|6727|10292|lyfalmen|||1|56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||6727|10292||1 026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|3507|5887|lyfalmen|||1|14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3507|5887||1 026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|13891|20263|lyfalmen|||1|56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||13891|20263||1 026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|20816|28954|lyfalmen|||1|56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||20816|28954||1 026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|27741|37645|lyfalmen|||1|56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||27741|37645||1 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1363|2954|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1363||1363|2954||1 026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|1|0|0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól|||||||2 026943|C09CA0106|Losatrix|filmhtfl|100|mg|100|stk|1|ţpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4765|3857|lyfalmen|V0099|3857|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Lósartan||2023||2023|3857||2 026946|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|0|0|0|0|0|0|HOL|0|0|1|100|SEK|1375|2970|lyfalmen|V0160|2553|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amoxicillín||1375||1375|2970||2 026957|J01CA0412|Amoxicillin Mylan (Lyf og heilsa)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|0|0|0|0|0|0|DAC|0|0|1|100|SEK|770|2143|lyfalmen|V0159|2143|3|20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||770||770|2143|| 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|405|1643|lyfalmen|||2|50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||405||405|1643||1 027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2254|4173|lyfalmen|||1|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2254||2254|4173||1 027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6662|10203|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Cýpróterón||6662||6662|10203||2 027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|16226|7907|lyfalmen|V0341|7873|2|100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||4984||4984|7907||1 027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|18628|7921|lyfalmen|V0342|7873|2|100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||4994||4994|7921||1 027505|B05BB0121|Plasmalyte|irl|||1000|ml|10|pokar|lausn|B05BB01|01.05.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2677|3864|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2677||2677|3864||2 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|6882|10504|lyfalmen|||1|56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||6882||6882|10504||1 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|8796|13122|lyfalmen|V0139|13122|1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||8796||8796|13122||1 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|589|1895|lyfalmen|||2|100|0|33,3300|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||589||589|1895||1 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|1|0|0|0|G|0|TDA|0|0|0|100|DKK|685|2026|lyfalmen|||2|100|0|66,6667|Vistor hf|Takeda Danmark A/S|Levótýroxínnatríum||685||685|2026||1 027733|N05AH0409|Quetiapin Orion|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|2109|2485|lyfalmen|V0284|2184|2|100|0|6,2500|Portfarma ehf|Orion Corporation|Quetíapín||1020||1020|2485||1 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|20035|27974|lyfalmen|||1|28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20035||20035|27974||1 027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|31206|41046|lyfsjukr|||1|1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||31206|41046||2 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|23155|31890|lyfalmen|||1|28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||23155||23155|31890||1 027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|45983|59591|lyfsjukr|||1|1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||45983||45983|59591||2 027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|0|1|0|0|0|1|ELD|0|0|0|100|XEU|57924|74577|lyfsjukr|||1|1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||57924|74577||2 028045|G03AB0801|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB08|01.11.2009||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|5189|8188|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5189||5189|8188||2 028110|A10BD0701|Janumet|filmhtfl|900|mg|196|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|22189|30677|lyfalmen|V0387|30677|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||22189||22189|30677||1 028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|1|0|0|0|0|0|MUN|0|0|1|100|IKR|||lyfalmen|||0|30|0|30,0000|Icepharma hf|Mundipharma|Fexófenadín|||||2526||2 028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|22516|31088|lyfalmen|V0386|31088|1|196|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||22516||22516|31088||1 028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|49444|63935|lyfsjukr|||1|1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||49444||49444|63935||1 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2698|4780|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2698||2698|4780||2 028333|J07CA0602|Pentavac|sts|||0,5|ml|10|hgl|+ 10 áf. spr.|J07CA06|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|44093|58167|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||44093||44093|58167||2 028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|36621|48789|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||36621||36621|48789||2 028360|J07BG0101|Rabies - Imovax|sts|||1|ml|1|hgl||J07BG01|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|SEK|9752|14430|lyfalmen|||1|1|0||Icepharma hf|Sanofi Pasteur MSD|Hundaćđi, dauđ veira||9752||9752|14430||2 028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas||M03BX01|01.10.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1777|3520|lyfalmen|V0202|3520|2|50|0|25,0000|Icepharma hf|Mylan AB|Baklófen||1777||1777|3520||2 028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1992|3814|lyfalmen|V0428|3246|2|50|0|50,0000|Icepharma hf|Mylan AB|Naproxen||1992||1992|3814||2 028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|1278|2838|lyfalmen|||1|56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2838||1 028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|5812|3880|lyfalmen|V0245|3481|1|98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||2040||2040|3880||1 028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|10358|8695|lyfalmen|V0232|7770|1|98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5560||5560|8695||1 028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|778|2154|lyfalmen|V0266|2152|2|30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||778||778|2154||1 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|0|0|0|0|0|0|OCO|1|0|0|100|DKK|7769|15090|vetalmen|||0|10|0||Icepharma hf|Orion Corporation (I)|||7769||7769|15090||2 028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4483|7222|lyfalmen|||2|28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4483||4483|7222||1 028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3772|5144|lyfalmen|V0267|5144|2|100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||2964||2964|5144||1 028739|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2378|4342|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||2378|4342||2 028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1362|1768|lyfalmen|V0551|1761|2|7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||496||496|1768||1 028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|4998|3270|lyfalmen|V0552|3270|2|30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||1594||1594|3270||1 028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||2|1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól|||||||1 028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|563|1859|lyfalmen|V0555|1859|2|2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1859||1 028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|2031|1910|lyfalmen|V0556|1906|2|4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||600||600|1910||1 029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|120|skammtar|1|stauk||R01AD08|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1121|2457|lyfalmen|V0625|1747|1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1000||1000|2457||1 029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|7416|11234|lyfalmen|||1|28|0|28,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||7416||7416|11234||2 029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|1|1|0|0|0|0|LLS|0|0|0|100|DKK|18559|26122|lyfalmen|||1|84|0|84,0000|Icepharma hf|Les Laboratoires Servier|Agómelatín||18559||18559|26122||2 029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|2830|4961|lyfalmen|||1|30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2830||2830|4961||1 029276|J04BA0202|Dapsone|töflur|50|mg|28|stk|1|ţpakki||J04BA02|01.04.2013||R|0|0|0|1|G|0|AUK|0|0|0|100|XEU|1081|2568|lyfalmen|||0|28|0|28,0000|Actavis Group hf|Actavis UK Ltd.|Dapsón||1081||1081|2568||1 029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|0|0|0|0|G|0|AUK|0|0|0|100|GBP|261|1446|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||261|1446||1 029381|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.04.2014||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1 029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|61094|78555|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Eribulin||61094||61094|78555||1 029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|22038|29540|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||22038||22038|29540||1 029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|4181|6034|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||4181||4181|6034||1 029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4377|6317|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4377||4377|6317||1 029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15159|21855|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||15159|21855||1 029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|15159|21855|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||15159|21855||1 029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|1|0|0|0|0|0|GAN|0|0|1|100|SEK|6141|9490|lyfalmen|||1|56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6141||6141|9490||2 029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEB|0|1|0|100|DKK|98101|124999|lyfsjukr|||1|1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||98101||98101|124999||1 029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|0|1|0|1|0|1|AEU|0|1|0|100|DKK|196202|248116|lyfsjukr|||1|1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||196202||196202|248116||1 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 030170|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.07.2014||R|0|0|0|0|0|0|IPI|0|0|0|100|DKK|8023|12064|lyfalmen|||1|0,5|0||Icepharma hf|Pfizer Limited|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8023||8023|12064||1 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|20628|28718|lyfalmen|V0138|28718|1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||20628||20628|28718||1 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|9030|13442|lyfalmen|V0277|10866|1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||9030||9030|13442||1 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|1|0|0|0|G|0|HES|0|0|0|100|IKR|2884|5035|lyfalmen|||1|100|0|8,3333|Vistor hf|Novartis Healthcare A/S|Klózapín||2884||2884|5035||1 030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|15774|27517|vetorma|||0|40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||15774|27517||2 030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1317|2758|lyfalmen|V0051|2184|2|100|0|33,3333|Icepharma hf|Mylan AB|Metóprólól||1220||1220|2758||2 031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2081|3936|lyfalmen|V0106|3415|2|100|0|66,6667|Icepharma hf|Mylan AB|Metóprólól||2081||2081|3936||2 031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|0|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín|||||2738||1 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|2953|5129|lyfalmen|||1|10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||2953||2953|5129||2 031201|L01BA0109|Metoject|stl|50|mg/ml|0,25|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2829|4959|lyfalmen|||1|0,25|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2829||2829|4959||2 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1999|3824|lyfalmen|||1|100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1999||1999|3824||1 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|5811|9038|lyfalmen|||1|15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5811||5811|9038||1 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|22758|30444|lyfsjukr|||1|5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||22758||22758|30444||1 031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1907|3698|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Sótalól||1907||1907|3698||2 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|0|0|0|0|G|0|OTS|0|0|0|100|DKK|20657|28755|lyfalmen|||1|150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20657||20657|28755||1 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|0|0|0|0|0|0|MEF|1|0|0|100|IKR|9900|17270|vetorma|||0|200|0||Vistor hf|Merial (MSD)|Ivermectinum||9900||9900|17270||1 032706|C03EA0113|Diuramin|töflur|55|mg|100|stk|1|ţpakki|5+50 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1198|2115|lyfalmen|V0558|2115|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||750||750|2115||2 033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|20937|29106|lyfalmen|||1|1|0|29,6300|Vistor hf|Ferring|Degarelix||||20937|29106||1 033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|0|1|0|1|G|0|FER|0|0|0|100|DKK|41757|55235|lyfalmen|||1|2|0|88,8900|Vistor hf|Ferring|Degarelix||||41757|55235||1 033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|1199|2092|vetorma|||0|7,49|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||1199||1199|2092||2 033195|N02AA5501|Targin|forđatfl|15|mg|28|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|3017|5216|lyfalmen|||1|28|0|3,7400|Icepharma hf|Norpharma|Oxycodonum í blöndum||3017||3017|5216||2 033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|8977|17410|vetalmen|||0|100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||8977|17410||2 033206|N02AA5501|Targin|forđatfl|15|mg|98|stk|1|ţpakki|10+5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|10282|15155|lyfalmen|||1|98|0|13,0700|Icepharma hf|Norpharma|Oxycodonum í blöndum||10282||10282|15155||2 033218|N02AA5501|Targin|forđatfl|30|mg|28|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|6038|9349|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxycodonum í blöndum||6038||6038|9349||2 033229|N02AA5501|Targin|forđatfl|30|mg|98|stk|1|ţpakki|20+10 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|17823|25198|lyfalmen|||1|98|0|26,1400|Icepharma hf|Norpharma|Oxycodonum í blöndum||17823||17823|25198||2 033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1226|2766|lyfalmen|||0|5|0||Vistor hf|Alcon Nordic A/S|Dexametasón||1226||1226|2766||1 033357|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1966|2178|lyfalmen|V0189|2178|2|100|0|50,0000|Medical ehf|ratiopharm Oy|Díklófenak||796||796|2178||2 033498|M01AB0518|Diclomex Rapid|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.08.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|860|1520|lyfalmen|V0188|1520|2|30|0|15,0000|Medical ehf|ratiopharm Oy|Díklófenak||315||315|1520||2 033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|18388|15648|lyfalmen|V0185|15648|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Letrózól||10643||10643|15648||2 033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|92513|117986|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||92513||92513|117986||1 034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|2429|4832|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2429|4832||2 034124|C09BA0202|Enalapril comp ratiopharm|töflur|32,5|mg|100|stk|1|ţpakki|20+12,5 mg|C09BA02|01.12.2013||R|1|0|0|0|G|0|ROY|0|0|0|100|XEU|1919|2706|lyfalmen|V0098|2706|2|100|0|100,0000|Medical ehf|ratiopharm Oy|Enalapríl og ţvagrćsilyf||1182||1182|2706||2 034157|J07AM5104|Diftavax|stl|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|0|0|0|0|0|0|SPM|0|0|1|100|XEU|732|2091|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||732||732|2091||2 034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|16858|23039|lyfsjukr|||1|25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||16858||16858|23039||2 034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7968|11989|lyfalmen|||1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7968|11989||2 034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|0|1|0|0|G|0|ELD|0|0|0|100|XEU|7968|11989|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||7968|11989||2 034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|75187|96242|lyfsjukr|||1|40|0|4,0000|Vistor hf|Orion Corporation|Dexmedetómid||75187||75187|96242||1 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|1679|3386|lyfalmen|V0367|3386|1|6|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||1679||1679|3386||1 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|2808|4931|lyfalmen|||1|12|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||2808||2808|4931||1 034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|165041|209009|lyfsjukr|||1|2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||165041||165041|209009||2 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|7313|10554|lyfsjukr|||1|25|0||Vistor hf|LEO Pharma A/S|Prótamín||7313||7313|10554||1 035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2221|3205|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2221||2221|3205||2 035134|B01AF0201|Eliquis|filmhtfl|5|mg|14|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|2446|4435|lyfalmen|||1|14|0|14,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||2446|4435||1 035153|N02AB0306|Instanyl|nefúđi|50|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9436|13997|lyfalmen|||1|6|0|0,5000|Vistor hf|Takeda Pharma A/S|Fentanýl||9436||9436|13997||1 035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|15675|22502|lyfalmen|||1|300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15675||15675|22502||1 035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1315|2888|lyfalmen|V0050|2888|2|100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1315||1315|2888||2 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1844|1910|lyfalmen|V0244|1910|2|56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||600||600|1910||1 035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|1307|2877|lyfalmen|V0048|2877|2|100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1307||1307|2877||2 035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|2335|4284|lyfalmen|V0049|4284|2|100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2335||2335|4284||2 035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|9220|13702|lyfalmen|V0080|5086|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||9220||9220|13702||1 035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5101|7417|lyfalmen|V0054|7417|2|100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4626||4626|7417||2 036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|1|1|0|0|0|0|GZE|0|0|0|100|NOK|27417|34423|lyfalmen|||1|180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||25174||25174|34423||1 036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|135324|171714|lyfsjukr|||1|2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||135324||135324|171714||2 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|5654|8824|lyfalmen|||1|60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||5654||5654|8824||1 036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7723|11654|lyfalmen|V0081|4403|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||7723||7723|11654||1 036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010|31.07.2014|R|1|0|0|1|0|1|ABV|0|0|0|100|DKK|5961|8603|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||5961||5961|8603||1 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|193027|244131|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||193027||193027|244131||1 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|351111|442527|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||351111||351111|442527||1 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|702198|883141|lyfsjukr|||1|30|0||Icepharma hf|Pfizer Limited|Sunitíníb||702198||702198|883141||1 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|773|2147|lyfalmen|||1|20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||773||773|2147||1 036502|N06DA0301|Exelon|forđapl|13,3|mg/sólh|30|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|20155|28125|lyfalmen|||1|30|0|42,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||20155||20155|28125||1 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1360|2950|lyfalmen|||1|60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1360||1360|2950||1 036529|QI09AB1302|Ingelvac MycoFLEX|stl|||50|ml|1|glas|handa svínum|QI09AB13|01.12.2013||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|4361|7608|vetorma|||1|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Óvirkar bakteríur í bóluefnum||4361||4361|7608||1 036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|0|0|0|0|0|0|AHN|0|0|0|100|IKR|||lyflausa|||0|30|0|6,0000|Aco Hud Nordic AB|Aco Hud Nordic AB|Silíkonsambönd|||||||1 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|2684|4761|lyfalmen|||1|125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2684||2684|4761||1 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|814|2203|lyfalmen|||1|30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||814||814|2203||1 037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|9569|7811|lyfalmen|V0532|6307|1|84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4914||4914|7811||1 037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|19441|11142|lyfalmen|V0533|10668|1|84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||7349||7349|11142||1 037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.09.2008||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|34528|21404|lyfalmen|V0534|21402|1|84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||14800||14800|21404||1 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2776|4887|lyfalmen|V0434|4887|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2776||2776|4887||2 037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1127|2631|lyfalmen|V0627|2631|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1127||1127|2631||1 037584|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|967|1773|lyfalmen|V0151|1773|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||500||500|1773||2 037595|N06AB0604|Sertralin Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2311|2457|lyfalmen|V0322|2348|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||1000||1000|2457||2 037607|N06AB0604|Sertralin Bluefish|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.02.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|4353|3825|lyfalmen|V0323|3620|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Sertralín||2000||2000|3825||2 037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2338||1 037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|1|0|0|0|G|0|LEP|0|0|0|100|DKK|||lyfalmen|||0|250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3708||1 037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|7963|11982|lyfalmen|V0102|3154|1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||7963|11982||1 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993|30.09.2014|R|1|0|0|0|0|0|GSK|0|0|0|100|IKR|664|1609|lyfalmen|||1|20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1609||1 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2667|3266|lyfalmen|V0321|3103|1|100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3266||1 038494|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2134|lyfalmen|V0110|2134|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2134||2 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|1021|2486|lyfalmen|||1|50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1021||1021|2486||2 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|0|0|0|1|0|1|AEU|0|0|0|100|DKK|171242|216791|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||171242||171242|216791||1 039141|B01AF0101|Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|16149|23097|lyfalmen|||1|42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||16149|23097||2 039147|N04BC0701|Apomorfin PharmSwed|irl|5|mg/ml|20|ml|5|hgl|lausn|N04BC07|01.03.2013||R|0|0|0|1|0|1|PSS|0|0|0|100|SEK|38806|50584|lyfsjukr|||1|100|0|25,0000|Williams & Halls efh|PharmSwed|Apómorfín||38806||38806|50584||2 039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|7075|10768|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7075||7075|10768||1 039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|4187|6817|lyfalmen|||1|20|0|10,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||4187|6817||1 039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|1|1|0|1|0|0|SGA|0|0|0|100|NOK|19360|27127|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis groupe|Dronedarón||||19360|27127||1 039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|ţpakki||N06AX03|01.06.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3400|5724|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Míanserín||3388||3388|5724||2 039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|453|1623|lyfalmen|V0541|1467|2|98|0|32,6667|Icepharma hf|Mylan AB|Atenólól||390||390|1623||2 039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|611|1669|lyfalmen|V0542|1512|2|98|0|65,3333|Icepharma hf|Mylan AB|Atenólól||424||424|1669||2 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1265|2820|lyfalmen|||1|15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1265||1265|2820||1 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|1823|3583|lyfalmen|||1|22,5|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1823||1823|3583||1 039837|N02BE0107|Paratabs|filmhtfl|500|mg|30|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1260|1818|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1260||1260|1818||2 039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1630|2134|lyfalmen|V0110|2091|2|98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||764||764|2134||1 039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|7883|5716|lyfalmen|V0182|5467|2|42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||3382||3382|5716||1 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3158|4558|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3158||3158|4558||2 039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|1|0|0|0|G|0|AGP|0|0|1|100|GBP|1883|2088|lyfalmen|V0033|2047|2|10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||730||730|2088||1 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6300|9092|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||6300||6300|9092||2 040313|N02AB0306|Instanyl|nefúđi|200|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9534|14131|lyfalmen|||1|6|0|2,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9534||9534|14131||1 040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|1278|2033|lyfalmen|V0366|1903|2|30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||690||690|2033||1 040475|C09DA0603|Candesartan/Hydrochlorothiazide Aspen|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3682|5104|lyfalmen|V0095|5104|2|100|0|100,0000|Artasan ehf|Navamedic ASA|Candesartan og ţvagrćsilyf||2935||2935|5104||1 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|0|0|0|0|G|0|SAC|0|0|0|100|IKR|||lyfalmen|||0|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1834||1 040708|G02AD0601|Misodel|sk-innl|200|mcg|5|stk|1|askja||G02AD06|01.09.2014||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|87516|111715|lyfsjukr|||1|5|0||Vistor hf|Ferring Lćgemidler A/S|Misóprostól||||87516|111715||1 040735|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|3|stk|1|ţpakki||J01FA10|01.12.2012||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|1537|2935|lyfalmen|||2|3|0|5,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Azitrómýcín||1349||1349|2935||1 041086|C01EB1701|Procoralan|filmhtfl|5|mg|56|stk|1|ţpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|10220|15070|lyfalmen|||1|56|0|28,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||10220||10220|15070||2 041105|C01EB1701|Procoralan|filmhtfl|7,5|mg|56|stk|1|ţpakki||C01EB17|01.04.2014||R|1|0|0|1|0|0|LLS|0|0|0|100|DKK|10220|15070|lyfalmen|||1|56|0|42,0000|Icepharma hf|Les Laboratoires Servier|Ivabradín||10220||10220|15070||2 041490|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2521|1910|lyfalmen|V0318|1910|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||600||600|1910||2 041704|QG03XA9101|Improvac|stl|300|mcg|20|ml|12|fl||QG03XA91|01.08.2010||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|27404|47805|vetorma|||0|240|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||||27404|47805||2 041716|QG03XA9101|Improvac|stl|300|mcg|100|ml|10|glös||QG03XA91|01.10.2014||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|100779|175804|vetorma|||0|1000|0||Icepharma hf|Zoetis Belgium S.A.|gonadotropin releasing factor analogue, conjugated||100779||100779|175804||2 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4292|7487|vetorma|||0|100|0||Vistor hf|Intervet International BV|||4292||4292|7487||1 041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1123|2626|lyfalmen|||2|90|0|15,0000|Icepharma hf|Mylan AB|Míanserín||||1123|2626||2 041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|IKR|2903|2464|lyfalmen|V0005|2457|2|28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1005||1005|2464||1 041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||0|20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||||1 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1444|3065|lyfalmen|||1|25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1444||1444|3065||1 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|12153|17135|lyfsjukr|||1|500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||12153||12153|17135||1 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2478|3576|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2478||2478|3576||2 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2995|4323|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2995||2995|4323||2 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4240|6119|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4240||4240|6119||2 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4346|6272|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4346||4346|6272||2 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5537|7991|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5537||5537|7991||2 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6833|9862|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6833||6833|9862||2 042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3703|5344|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3703||3703|5344||2 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2834|4090|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2834||2834|4090||2 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2166|3126|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2166||2166|3126||2 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2711|3913|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2711||2711|3913||2 042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3558|5135|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3558||3558|5135||2 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2430|3507|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2430||2430|3507||2 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2053|2963|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2053||2053|2963||2 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5941|8574|lyfsjukr|||2|4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||5941||5941|8574||2 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2325|3356|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2325||2325|3356||2 042549|J07BF0301|Imovax Polio|stl|||0,5|ml|1|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2474|4474|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||2474||2474|4474||2 042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3208|4630|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||3208||3208|4630||2 042556|J07BF0301|Imovax Polio|stl|||0,5|ml|20|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|14428|20937|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||14428||14428|20937||2 042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1310|2606|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1310||1310|2606||2 042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1952|3883|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||1952||1952|3883||2 042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2617|5198|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||2617||2617|5198||2 042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|5236|10226|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||5236||5236|10226||2 042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|6020|11732|vetalmen|||0|2|0||Icepharma hf|Zoetis Belgium S.A.|Mavakoxíb||6020||6020|11732||2 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2363|3410|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2363||2363|3410||2 042669|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 042775|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|3870|6383|lyfalmen|||3|500|0||Icepharma hf|Icepharma hf|Senna||3870||3870|6383||2 043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|543|1832|lyfalmen|||2|30|0|30,0000|Icepharma hf|Mylan AB|Flúnítrazepam||543||543|1832||2 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|3010|4344|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3010||3010|4344||1 043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|18412|5624|lyfalmen|V0516|5624|2|100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||3315||3315|5624||1 043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|skammtar|1|stauk|HFA 134a|R03AC12|01.04.2007||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|4158|6777|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||4158||4158|6777||1 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|0|0|0|0|0|1|AZD|0|0|0|100|SEK|5566|8033|lyfsjukr|||1|100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||5566||5566|8033||1 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|550|1842|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||550||550|1842||1 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1196|2725|lyfalmen|||1|30|0|30,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1196||1196|2725||1 043919|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 043935|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat|||||||1 044360|B03AC0004|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC|01.05.2006||R|0|0|0|0|G|0|LVR|0|0|1|100|CHF|12721|18795|lyfalmen|V0637|18795|3|25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járn, stungulyf||12721||12721|18795||3 044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|371952|468682|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||371952|468682||1 044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|524890|660619|lyfsjukr|||1|30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||524890|660619||1 044732|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.06.2014||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5838|9075|lyfalmen|V0156|9075|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||5838||5838|9075||2 044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|16727|23822|lyfalmen|V0635|20651|1|100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||16727||16727|23822||1 044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|48794|64066|lyfalmen|V0636|60560|1|100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||48794||48794|64066||1 044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|2614|4665|lyfalmen|||1|10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2614||2614|4665||1 044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|0|0|0|0|0|0|OCO|0|0|0|100|DKK|2036|4050|vetalmen|||0|3|0||Icepharma hf|Orion Corporation (I)|||2036||2036|4050||2 045332|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|600|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 045385|J07BF0301|Imovax Polio|stl|||0,5|ml|10|áf.spr|međ nál|J07BF03|01.01.1996||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|7213|10956|lyfalmen|||1|5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7213||7213|10956||2 045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|1050|1803|lyfalmen|V0109|1767|2|98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||522||522|1803||1 045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|868|1675|lyfalmen|V0108|1642|2|98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||428||428|1675||1 045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VAS|0|0|0|100|NOK|2634|3802|lyfsjukr|||1|10|0|2,5000|FarmaPlus AS|Villerton Invest AS|Cefúroxím||2634||2634|3802||0 045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|0|0|0|0|0|1|VAS|0|0|0|100|NOK|5269|7604|lyfsjukr|||1|10|0|5,0000|FarmaPlus AS|Villerton Invest AS|Cefúroxím||5269||5269|7604||0 045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|0|0|0|0|0|0|AGT|0|0|1|100|XEU|404|1642|lyfalmen|||2|10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||404||404|1642||1 045765|C03CA0110|Impugan|dropar|10|mg/ml|30|ml|1|glas||C03CA01|01.06.2013||R|0|0|0|0|G|0|AGT|0|0|0|100|SEK|1544|3201|lyfalmen|||2|30|0|7,5000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||1544||1544|3201||1 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|20643|39810|vetalmen|||0|10|0||Icepharma hf|Zoetis Belgium S.A.|||20643||20643|39810||2 046248|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|30|sk-hyl|30 (6x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1554|3215|lyfalmen|||1|6|0|30,0000|Vistor hf|Laboratories THEA|Latanóprost||1554||1554|3215||1 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1004|2357|lyfalmen|V0648|1910|2|100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||927||927|2357||1 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|3838|6340|lyfalmen|V0382|6340|1|10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||3838||3838|6340||2 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|661|1887|lyfalmen|V0021|1829|2|90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||583||583|1887||1 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|782|2159|lyfalmen|V0022|2159|2|90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||782||782|2159||1 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1001|2459|lyfalmen|V0023|2459|2|90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1001||1001|2459||1 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|0|0|0|0|G|0|VIS|0|0|1|100|DKK|6392|9833|lyfalmen|||1|20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6392||6392|9833||2 046724|R01AD0802|Nasofan|nefúđi|50|mcg/sk|150|skammtar|1|glas||R01AD08|01.12.2013||R|0|0|0|0|G|0|TSB|0|0|1|100|IKR|1350|2184|lyfalmen|V0625|2184|2|150|0|37,5000|Medical ehf|Teva Sweden AB|Flútíkasón||800||800|2184||2 046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|10558|5877|lyfalmen|V0283|2526|2|28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||3500||3500|5877||1 046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|5525|3766|lyfalmen|V0205|3766|2|3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||1957||1957|3766||1 046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|3407|3141|lyfalmen|V0279|1765|2|28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1500||1500|3141||1 046845|N06AB0605|Sertraline Portfarma|filmhtfl|50|mg|100|stk|1|ţpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|2240|2348|lyfalmen|V0322|2348|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Sertralín||920||920|2348||1 046867|N06AB0605|Sertraline Portfarma|filmhtfl|100|mg|100|stk|1|ţpakki||N06AB06|01.08.2014||R|1|0|0|0|G|0|PEH|0|0|0|100|IKR|4495|3620|lyfalmen|V0323|3620|2|100|0|200,0000|Portfarma ehf|Portfarma ehf|Sertralín||1850||1850|3620||1 047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|963|2407|lyfalmen|||2|100|0|25,0000|Icepharma hf|Mylan AB|Sótalól||963||963|2407||2 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr|||1|10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684||5 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr|||1|50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564||5 047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|12311|4578|lyfalmen|V0420|4281|2|30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||2550||2550|4578||1 047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|14784|8344|lyfalmen|V0421|8344|2|30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||5303||5303|8344||1 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|4867|7024|lyfsjukr|||1|250|0||Icepharma hf|Baxter Medical AB|Albúmín||4867||4867|7024||2 048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8540|12325|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8540||8540|12325||2 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|7896|11396|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Albúmín||7896||7896|11396||2 048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2637|2858|lyfalmen|V0324|2858|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1293||1293|2858||1 048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|2449|4439|lyfalmen|||2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2449||2449|4439||1 048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7603|2542|lyfalmen|V0325|2311|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1062||1062|2542||1 048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|7469|4426|lyfalmen|V0326|3894|2|100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2439||2439|4426||1 048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|3831|6330|lyfalmen|||2|28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3831||3831|6330||1 048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14936|3936|lyfalmen|V0327|3483|2|100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2081||2081|3936||1 048183|C09CA0603|Candesartan Aspen|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3737|5190|lyfalmen|V0080|5190|2|100|0|200,0000|Artasan ehf|Navamedic ASA|Candesartan||2998||2998|5190||1 048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|1|0|0|0|G|0|MAB|0|0|0|100|SEK|1183|2708|lyfalmen|||1|100|0||Vistor hf|Meda AB|Klídín og geđlyf||1183||1183|2708||1 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|13579|19872|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||13579||13579|19872||1 048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki|150/30 mcg|G03AA09|01.07.1986||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1752|3486|lyfalmen|||1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1752||1752|3486||1 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|60211|75084|lyfalmen|V0187|13882|1|150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||57573||57573|75084||2 048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|0|0|0|1|0|1|GZE|0|1|0|100|NOK|896214|1126631|lyfsjukr|||1|1,2|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||896214||896214|1126631||1 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|470|1732|lyfalmen|V0230|1645|1|100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||470||470|1732||1 048770|B05ZB0001|Hemosol BO|blóđ.sk|||5000|ml|2|pokar||B05ZB|01.04.2013||R|0|0|0|1|0|1|GBL|0|0|0|100|SEK|4573|6600|lyfsjukr|||1|10000|0||Vistor hf|Gambro Lundia AB|Blóđsölt og stuđpúđalausn||4573||4573|6600||1 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2388|4356|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2388||2388|4356||1 049033|C08DB0108|Cardil|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.05.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|4680|6199|lyfalmen|V0599|5758|2|60|0|30,0000|Vistor hf|Orion Corporation|Diltíazem||3735||3735|6199||1 049091|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|6074|9398|lyfalmen|V0376|5073|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||||6074|9398||1 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|0|0|0|0|0|0|RRL|0|0|0|100|DKK|16262|23239|lyfalmen|||1|3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||16262||16262|23239||2 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2341|4292|lyfalmen|V0122|4292|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2341||2341|4292||1 049549|N03AX2201|Fycompa|filmhtfl|2|mg|7|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|5820|9051|lyfalmen|||1|7|0|1,7500|Vistor hf|Eisai Europe Ltd.|Perampanel||5820||5820|9051||1 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|0|0|0|0|0|0|GAN|0|0|1|100|CHF|6494|9973|lyfalmen|V0655|4646|1|5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6494||6494|9973||2 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1154|1979|lyfalmen|V0109|1767|2|98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||650||650|1979||1 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1827|2389|lyfalmen|V0110|2134|2|100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||950||950|2389||1 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|1|0|0|0|0|0|HES|0|0|0|100|IKR|8006|5110|lyfalmen|V0123|3345|1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Terbínafín||2939||2939|5110||1 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1168|2472|lyfalmen|V0496|1910|2|100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1011||1011|2472||1 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa|||0|30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2406|3401|lyfalmen|V0649|2868|2|100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1690||1690|3401||1 049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1 049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||0|10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól|||||||1 049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|0|0|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||0|10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1527||1 049894|N02BG1001|Sativex|munnhúđi|52|mg|10|ml|3|úđagl|27 mg + 25 mg|N02BG10|01.07.2013||R|0|0|1|1|0|0|GWP|0|0|0|100|DKK|79546|102660|lyfalmen|||1|30|0|37,1400|Vistor hf|GW Pharma Ltd.|Cannabinoids||79546||79546|102660||1 049902|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|147489|186981|lyfsjukr|||1|200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||147489||147489|186981||2 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|0|0|0|1|G|0|ROC|0|0|0|100|DKK|60211|78395|lyfalmen|V0470|74796|1|300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||60211||60211|78395||2 049913|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|7939|11458|lyfsjukr|||1|10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||7939||7939|11458||2 049925|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|19849|26793|lyfsjukr|||1|25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||19849||19849|26793||2 049936|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|36873|48158|lyfsjukr|||1|50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||36873||36873|48158||2 049947|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|73744|94431|lyfsjukr|||1|100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||73744||73744|94431||2 050010|G04CB0104|Finasterid LYFIS|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.12.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3219|5493|lyfalmen|V0445|4491|2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Fínasteríđ||3219||3219|5493||2 050292|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0150|2647|0|100|0|20,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2647||1 050306|G04CA0104|Alfuzosin hydrochlorid ratiopharm|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.12.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|XEU|4193|6825|lyfalmen|||2|90|0|120,0000|LYFIS ehf|ratiopharm GmbH|Alfúzósín||4193||4193|6825||2 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|0|0|0|1|0|1|BAP|0|1|0|100|DKK|561296|706309|lyfsjukr|||1|112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||561296||561296|706309||2 050346|L04AD0104|Ciqorin|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|25500|29813|lyfalmen|||2|50|0|20,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||21500||21500|29813||2 050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|70107|89867|lyfsjukr|||1|7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||70107|89867||1 050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3081|5304|lyfalmen|||1|14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3081||3081|5304||1 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|12995|19139|lyfalmen|||1|56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||12995||12995|19139||1 050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|5377|5174|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||2986||2986|5174||1 050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4615|5357|lyfalmen|V0002|5357|2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3120||3120|5357||1 050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|4435|3962|lyfalmen|V0006|3825|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2100||2100|3962||1 050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|10567|4408|lyfalmen|V0001|3291|2|100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2426||2426|4408||1 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1663|3364|lyfalmen|||1|100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1663||1663|3364||1 051109|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|50|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|1694|3407|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1694||1694|3407||1 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1348|2601|lyfalmen|V0363|2601|2|30|0|45,0000|Icepharma hf|Mylan AB|Fexófenadín||1105||1105|2601|| 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3665|5318|lyfalmen|V0365|5318|2|100|0|150,0000|Icepharma hf|Mylan AB|Fexófenadín||3091||3091|5318||2 051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|0|0|0|0|0|1|UCB|0|0|0|100|DKK|29635|39074|lyfsjukr|||1|50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||29635||29635|39074||1 051686|N05AE0402|Zeldox (Lyf og heilsa)|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|26476|26543|lyfalmen|V0611|26528||56|0|56,0000|Lyf og heilsa|Lyf og heilsa|Ziprasidon||18895||18895|26543|| 051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|1546|2046|lyfalmen|||2|100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||699||699|2046|30.9.2014|1 051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2583|2500|lyfalmen|V0057|1999|2|100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||1031||1031|2500||1 051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|skammtar|1|stauk||R03AC03|01.07.2012||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|873|2284|lyfalmen|||1|100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||873||873|2284||1 052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|202|1366|lyfalmen|V0047|1366|2|20|0|5,0000|Icepharma hf|Mylan AB|Alprazólam||202||202|1366||2 052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|476|1740|lyfalmen|V0305|1020|2|50|0|12,5000|Icepharma hf|Mylan AB|Alprazólam||476||476|1740||2 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|335362|422762|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||335362||335362|422762||1 052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|337|1535|lyfalmen|V0439|1535|2|20|0|10,0000|Icepharma hf|Mylan AB|Alprazólam||326||326|1535||2 052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|832|2206|lyfalmen|||2|50|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||816||816|2206||2 052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|694|2039|lyfalmen|V0305|2039|2|100|0|25,0000|Icepharma hf|Mylan AB|Alprazólam||694||694|2039||2 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|700572|881100|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||700572||700572|881100||1 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|566679|713065|lyfsjukr|||1|60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||566679||566679|713065||1 052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|0|0|0|0|G|0|ALL|0|0|0|100|SEK|3567|5969|lyfalmen|||1|3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3567||3567|5969||1 052478|D06BB0305|Zovirax (Lyf og heilsa)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|2|0||Lyf og heilsa|Lyf og heilsa|Acíklóvír|||||||2 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|36270|47401|lyfsjukr|||1|8212|0||Icepharma hf|Fresenius Kabi|Blöndur||36270||36270|47401||2 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29485|38886|lyfsjukr|||1|7698|0||Icepharma hf|Fresenius Kabi|Blöndur||29485||29485|38886||2 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|31127|40947|lyfsjukr|||1|7680|0||Icepharma hf|Fresenius Kabi|Blöndur||31127||31127|40947||2 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26042|34565|lyfsjukr|||1|7200|0||Icepharma hf|Fresenius Kabi|Blöndur||26042||26042|34565||2 052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|0|0|0|0|0|0|NAS|0|0|0|100|DKK|14654|21221|lyfalmen|||1|6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||14654||14654|21221||1 052997|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|30|stk|1|ţpakki||N05CF02|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|1|100|SEK|460|1557|lyfalmen|V0060|1557|2|30|0|30,0000|Icepharma hf|Mylan AB|Zolpidem||342||342|1557||2 053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|2|0|0|0|0|0|MYL|0|0|0|100|SEK|2252|3814|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Zolpidem||1992||1992|3814|| 053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|0|0|0|0|0|0|BAP|0|0|0|100|DKK|2140|4017|lyfalmen|V0134|3174|1|63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2140||2140|4017||2 053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|5062|8014|lyfalmen|||1|100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5062||5062|8014||1 053155|N02AA5501|Targin|forđatfl|60|mg|28|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|11862|17316|lyfalmen|||1|28|0|14,9400|Icepharma hf|Norpharma|Oxycodonum í blöndum||11862||11862|17316||2 053166|N02AA5501|Targin|forđatfl|60|mg|98|stk|1|ţpakki|40+20 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|35328|47167|lyfalmen|||1|98|0|52,2700|Icepharma hf|Norpharma|Oxycodonum í blöndum||35328||35328|47167||2 053200|N02AA5501|Targin|forđatfl|7,5|mg|98|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|5914|9179|lyfalmen|||1|98|0|6,5400|Icepharma hf|Norpharma|Oxycodonum í blöndum||5914||5914|9179||2 053211|N02AA5501|Targin|forđatfl|7,5|mg|28|stk|1|ţpakki|5+2,5 mg|N02AA55|01.10.2012||R|1|0|1|0|0|0|NOP|0|0|0|100|DKK|1734|3455|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxycodonum í blöndum||1729||1729|3455||2 053231|J07BB0201|Fluarix|stl|||0,5|ml|10|áf.spr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|6275|9673|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||6275||6275|9673||1 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|0|1|0|1|G|0|SDE|0|0|0|100|NOK|35724|47664|lyfalmen|V0453|42860|1|100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||35724||35724|47664||1 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|0|0|1|0|0|0|MAP|0|0|0|100|GBP|16033|22951|lyfalmen|||2|10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16033||16033|22951||2 053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|0|0|0|0|0|0|OTS|0|0|0|100|DKK|1517|3165|lyfalmen|||1|1,33|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1517||1517|3165||1 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1131|2636|lyfalmen|||1|30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1131||1131|2636||1 054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7656|3862|lyfalmen|V0490|2483|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||2027||2027|3862||1 054213|J07AG0101|Act-Hib|sts|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|4111|6713|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Haemophilus influenzae B||4111||4111|6713||2 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|2673|4746|lyfalmen|||1|15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2673||2673|4746||1 054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|3687|6133|lyfalmen|||1|20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3687||3687|6133||1 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|0|0|0|1|0|1|ROA|0|0|0|100|DKK|52801|68148|lyfsjukr|||1|56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||52801||52801|68148||2 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 054524|N05BB0101|Atarax|filmhtfl|25|mg|100|stk|1|ţpakki||N05BB01|01.06.2014||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1473|3104|lyfalmen|V0137|3104|1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1473||1473|3104||1 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|0|0|0|0|0|0|UCN|0|0|0|100|SEK|1035|2505|lyfalmen|||1|200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1035||1035|2505||1 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|1667|3370|lyfalmen|V0061|3370|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1667||1667|3370||1 054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|0|0|1|0|0|0|ALS|1|0|0|100|DKK|4704|9205|vetalmen|||0|10|0||Icepharma hf|Alstoe Limited|Buprenorphinhýdróklóríđ||||4704|9205||2 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|7617|13287|vetorma|||0|20|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||7617||7617|13287||2 054974|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|1|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|XEU|5438|8528|lyfalmen|||1|60|0|30,0000|Vistor hf|Almirall S.A.|Aclídínumbrómíđ||5438||5438|8528||1 055073|L04AA0606|Myfenax|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|20048|24932|lyfalmen|V0470|24932|2|100|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||17611||17611|24932||2 055084|L04AA0606|Myfenax|filmhtfl|500|mg|50|stk|1|ţpakki||L04AA06|01.11.2013||R|1|0|0|1|G|0|TEV|0|0|0|100|XEU|19662|4723|lyfalmen|V0187|4627|2|50|0|12,5000|Medical ehf|Teva Pharma B.V.|Mýcófenólsýra||2656||2656|4723||2 055164|S01AE0701|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AE07|01.08.2010||R|0|0|0|0|0|0|CLA|0|0|1|100|USD|1696|3409|lyfalmen|||1|5|0||Vistor hf|Alcon Nordic A/S|Moxífloxacín||||1696|3409||1 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|738|2099|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||738||738|2099||1 055257|G03AA0903|Benidette|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.04.2013||R|0|0|0|0|0|0|AAB|0|0|0|100|XEU|1314|2245|lyfalmen|V0065|1912|2|63|0|84,0000|Actavis Group PTC ehf|Actavis BV|Desógestrel og ethinylestradíól||845||845|2245||1 055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|9125|13572|lyfalmen|||1|100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9125||9125|13572||1 055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|2064|2457|lyfalmen|V0467|2457|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2457||1 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|4539|3887|lyfalmen|V0112|3483|2|100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||2045||2045|3887||1 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|6185|3896|lyfalmen|V0113|3483|2|100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||2052||2052|3896||1 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|7867|3899|lyfalmen|V0114|3483|2|100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||2054||2054|3899||1 056308|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|31750|42676|lyfalmen|||1|28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||31750||31750|42676||2 056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|0|0|0|0|0|0|CES|1|0|0|100|XEU|26709|46593|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||26709||26709|46593||2 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|1202|2734|lyfalmen|||1|40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1202||1202|2734||1 056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3682|5381|lyfalmen|||2|100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3137||3137|5381||1 056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|Til vélskömmtunar|N06AX16|01.10.2011||R|2|0|0|0|G|0|AGP|0|0|0|100|XEU|3682|5381|lyfalmen|||2|100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3137||3137|5381||1 056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|0|1|0|1|0|1|BIB|0|1|0|100|XEU|221023|279266|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Biogen Idec Ltd|Natalizumab||221023||221023|279266||2 057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|3391|5728|lyfalmen|||1|28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3391||3391|5728||1 057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|10263|15129|lyfalmen|V0095|5002|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||10263||10263|15129||1 057304|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN05|01.08.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|4|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|11635|16484|lyfsjukr|||1|5|0|1,4300|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||11635||11635|16484||1 057335|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3771|5442|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||3771||3771|5442||2 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|6690|9655|lyfsjukr|||1|5|0|0,7100|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||6690||6690|9655||1 057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|22050|30503|lyfalmen|||2|84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||22050||22050|30503||1 057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|4840|6985|lyfsjukr|||1|200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||4840||4840|6985||2 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|3689|5324|lyfsjukr|||1|5|0|0,3600|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||3689||3689|5324||1 057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|358068|451258|lyfsjukr|||1|50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||358068||358068|451258||1 057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|0|0|0|1|0|1|JAS|0|1|0|100|SEK|457110|575556|lyfsjukr|||1|120|0|30,0000|Vistor hf|Janssen-Cilag AB|Abírateron||457110||457110|575556||1 057867|N06DX0107|Zalatine|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|23027|19048|lyfalmen|V0607|18984|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||12923||12923|19048||2 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|19962|27882|lyfalmen|||1|112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||19962|27882||1 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|422|1667|lyfalmen|||1|5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||422||422|1667||1 058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|1|0|0|1|0|1|GGL|0|1|0|100|GBP|132280|167894|lyfsjukr|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||132280||132280|167894||1 058283|QI01AD040|Avipro Thymovac|frţlyf|||500|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|160468|279928|vetorma|||0|5000|0||Icepharma hf|Lohmann Animal Health|||||160468|279928||2 058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|skammtar|10|pakkar||QI01AD04|01.07.2009||R|0|0|0|0|0|0|LOH|0|0|0|100|XEU|243766|425238|vetorma|||0|10000|0||Icepharma hf|Lohmann Animal Health|||||243766|425238||2 058300|N02AA0506|Oxikodon Depot Actavis|forđatfl|40|mg|98|stk|1|glas||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|9903|14636|lyfalmen|V0587|14636|2|98|0|52,2700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||9903||9903|14636||1 058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|972|2419|lyfalmen|||1|100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||972||972|2419||1 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|99272|126469|lyfsjukr|||1|210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||99272||99272|126469||1 058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|39457|52349|lyfalmen|||1|1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||39457||39457|52349||1 058622|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|5543|8000|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5543||5543|8000||2 058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1143|2653|lyfalmen|||1|100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1143||1143|2653||1 058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2132|4006|lyfalmen|||1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2132||2132|4006||1 059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|IKR|2374|2850|lyfalmen|V0006|2142|2|56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1287||1287|2850||1 059224|A04AA0501|Aloxi|stl|250|mcg|5|ml|1|hgl|lausn|A04AA05|01.04.2013||R|0|0|0|0|0|0|HBP|0|0|1|100|DKK|11705|17101|lyfalmen|||1|5|0|1,0000|Swedish Orphan Biovitrum AB|Helsinn Birex Pharmaceuticals Ltd.|Palonosetrón||11705||11705|17101||3 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|97996|125815|lyfalmen|||1|2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||97996||97996|125815||1 059659|J07CA0601|Infanrix-Polio + Hib|sts|||0,5|ml|10|spr||J07CA06|01.01.2007||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|33890|45362|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||33890||33890|45362||1 059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|1|0|0|0|G|0|BPC|0|0|0|100|SEK|38534|44883|lyfalmen|||1|30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||33508||33508|44883||1 059795|C10AA0506|Atorvaratio|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|5500|3483|lyfalmen|V0114|3483|2|100|0|200,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1750||1750|3483||2 059803|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.04.2013||R|1|0|0|0|G|0|BAP|0|0|0|100|DKK|5603|8754|lyfalmen|||1|98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||||5603|8754||2 059882|L04AD0203|Modigraf|mixt.kyr|0,2|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|8848|13193|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||8848||8848|13193||1 059938|L04AD0203|Modigraf|mixt.kyr|1|mg|50|sk-pokar|1|pakki||L04AD02|01.04.2014||R|0|0|0|1|0|0|ASP|0|0|0|100|XEU|44242|58354|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||44242||44242|58354||1 060114|N02AB0305|Fentanyl ratiopharm|forđapl|25|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2685|3455|lyfalmen|V0219|3455|2|5|0|7,5000|Medical ehf|ratiopharm GmbH|Fentanýl||1729||1729|3455||2 060123|N02AB0305|Fentanyl ratiopharm|forđapl|50|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|4264|5836|lyfalmen|V0220|5836|2|5|0|15,0000|Medical ehf|ratiopharm GmbH|Fentanýl||3470||3470|5836||2 060132|N02AB0305|Fentanyl ratiopharm|forđapl|75|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|5528|7509|lyfalmen|V0221|7509|2|5|0|22,5000|Medical ehf|ratiopharm GmbH|Fentanýl||4693||4693|7509||2 060141|N02AB0305|Fentanyl ratiopharm|forđapl|100|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|6446|8156|lyfalmen|V0223|8156|2|5|0|30,0000|Medical ehf|ratiopharm GmbH|Fentanýl||5166||5166|8156||2 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|336684|425368|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||336684||336684|425368||1 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|0|1|0|1|0|0|NEL|0|0|0|100|DKK|186447|236821|lyfalmen|||1|84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||186447||186447|236821||1 061112|L04AA31|AUBAGIO|filmhtfl|14|mg|28|stk|1|ţpakki||L04AA31|01.09.2014||R|1|1|0|1|0|1|SGA|0|0|0|100|NOK|158263|200503|lyfsjukr|||1|28|0|28,0000|Vistor hf|Sanofi-aventis groupe|Teriflúnomíđ||||158263|200503||1 061227|L01XE0103|Mylaukim|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|104652|133221|lyfsjukr|||2|60|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||104652||104652|133221||2 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|2719|5393|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||2719|5393||2 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1425|2835|vetalmen|||0|4|0||Icepharma hf|Zoetis Belgium S.A.|||||1425|2835||2 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|8415|16331|vetalmen|||0|20|0||Icepharma hf|Zoetis Belgium S.A.|||||8415|16331||2 061460|G03CX0102|Livial (Lyf og heilsa)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|0|0|0|0|G|0|HOL|0|0|0|100|DKK|6911|10543|lyfalmen|V0133|10543|3|84|0|84,0000|Lyf og heilsa|Lyf og heilsa|Tíbólón||6911||6911|10543||2 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|0|0|0|0|G|0|ORG|0|0|0|100|DKK|6912|10545|lyfalmen|V0133|10543|1|84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||6912||6912|10545||1 061580|QP52AF0201|Banminth, vet.|pasta|439|mg/g|26|g|1|spr||QP52AF02|01.04.1992||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|1684|2938|vetorma|||0|26|0||Icepharma hf|Zoetis Finland OY|||1684||1684|2938||2 061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|4392|6339|lyfsjukr|||1|10|0|2,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||4392||4392|6339||1 061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|15684|21566|lyfsjukr|||1|1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||15684||15684|21566||1 061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|22081|29594|lyfsjukr|||1|1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||22081||22081|29594||1 062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|454|1710|lyfalmen|V0307|1574|1|30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||454||454|1710||1 062202|N06DX0102|Memantine Merz|filmhtfl|10|mg|30|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6625|4212|lyfalmen|V0604|4061|2|30|0|15,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||2283||2283|4212||1 062250|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|30|ml|1|túpa||A01AA01|01.03.2014|31.07.2014|R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|5091|8054|lyfalmen|||1|30|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||5091||5091|8054||2 062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|0|0|0|1|G|0|AGP|0|0|0|100|XEU|9352|13882|lyfalmen|V0187|13882|2|150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||9352||9352|13882||1 062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1631|3320|lyfalmen|V0634|1685|1|10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1631||1631|3320||1 062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|916|2342|lyfalmen|V0308|2063|1|60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||916||916|2342||1 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|1|0|0|0|G|0|AGT|0|0|1|100|XEU|1985|3805|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1985||1985|3805||1 062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|17810|31069|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||17810||17810|31069||2 062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|15011|16714|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11422||11422|16714||1 062996|J07BM0201|Cervarix|stl|||0,5|ml|10|áf.spr|dreifa|J07BM02|01.03.2014||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|150110|191218|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||150110||150110|191218||1 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|4164|6785|lyfalmen|||1|10|0|1,6667|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||4164||4164|6785||1 063255|N05AH0205|Clozapine Actavis|töflur|100|mg|100|stk|1|ţpakki||N05AH02|01.07.2014||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|7147|10866|lyfalmen|V0277|10866|2|100|0|33,3333|Actavis Group hf|Actavis Group hf|Klózapín||7147||7147|10866||1 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|0|0|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||0|500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3036||1 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|1|0|0|0|0|0|ACA|0|0|0|100|XEU|2509|3403|lyfalmen|V0123|3345|2|28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||1691||1691|3403||1 063715|R06AX2702|Aerius (Lyf og heilsa)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|XEU|4112|6292|lyfalmen|V0458|2725|3|100|0|100,0000|Lyf og heilsa|Lyf og heilsa|Deslóratadín||3803||3803|6292||2 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|0|0|0|0|0|1|OCT|0|0|0|100|DKK|7696|11107|lyfsjukr|||1|2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||7696||7696|11107||1 063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|0|0|0|0|0|0|ZFO|0|0|0|100|XEU|2507|4373|vetorma|||0|11,8|0||Vistor hf|Zoetis Finland Oy|||2507||2507|4373||2 063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|962|2405|lyfalmen|V0309|1995|1|30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||962||962|2405||1 063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2016|3847|lyfalmen|V0310|2991|1|60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2016||2016|3847||1 064023|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|86704|110696|lyfsjukr|||1|1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||86704|110696||3 064034|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.07.2014||R|0|0|0|1|0|1|BAL|0|1|0|100|SEK|132645|168352|lyfsjukr|||1|1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||132645|168352||3 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|1073044|1348553|lyfsjukr|||1|20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1073044|1348553||2 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|429217|540550|lyfsjukr|||1|20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||429217|540550||2 064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2117|3985|lyfalmen|V0311|2991|1|30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2117||2117|3985||1 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|4292178|5388566|lyfsjukr|||1|20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4292178|5388566||2 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|0|0|0|1|0|1|UTE|0|0|0|100|XEU|2146090|2695225|lyfsjukr|||1|20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2146090|2695225||2 064270|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3425|3771|lyfalmen|V0009|3562|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||1960||1960|3771||2 064281|B01AC0406|Clopidogrel Krka|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|8128|6851|lyfalmen|V0029|6851|2|100|0|100,0000|LYFIS ehf|Krka d.d. Novo mesto|Klópídógrel||4212||4212|6851||2 064402|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.06.2013||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1170|2327|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1170||1170|2327||1 064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2078|3932|lyfalmen|||1|100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2078||2078|3932||1 064733|J07BB0203|Vaxigrip|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1985||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|1031|2148|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir mótefnavakar||774||774|2148||2 064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|0|0|0|1|0|1|OCT|0|0|0|100|DKK|57894|74539|lyfsjukr|||1|1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||57894||57894|74539||1 064840|A03FA0102|Afipran|töflur|10|mg|50|stk|1|glas||A03FA01|01.03.2013||R|1|0|0|0|G|0|TAS|0|0|1|100|DKK|822|2214|lyfalmen|||2|50|0|6,6700|Vistor hf|Takeda Nycomed AS|Metóklópramíđ||822||822|2214||1 064956|A03FA0102|Afipran|stl|5|mg/ml|2|ml|10|lykjur|lausn|A03FA01|01.03.2013||R|0|0|0|0|G|0|TAS|0|0|1|100|DKK|472|1735|lyfalmen|||2|20|0|3,3300|Vistor hf|Takeda Nycomed AS|Metóklópramíđ||472||472|1735||1 065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|0|0|0|0|0|0|SLL|0|0|0|100|DKK|1931|3731|lyfalmen|||1|25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||1931||1931|3731||1 065076|QM01AE0302|Ketodine vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.01.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5803|11315|vetalmen|||0|100|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5803||5803|11315||2 065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|14043|19506|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||14043||14043|19506||2 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2476|3805|lyfalmen|V0376|1691|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1985||1985|3805||1 065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|áf.spr|1|pakki||L02AE03|01.06.2011||R|0|0|0|1|G|0|LVR|0|0|0|100|SEK|55442|68125|lyfalmen|V0451|68125|3|1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||52028||52028|68125||3 065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|6074|9398|lyfalmen|V0376|5073|1|7,5|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||6074||6074|9398||1 065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065751|J01CR0204|Amoxin comp|mixtduft|80|mg/ml|70|ml|1|glas|80+11,4 mg|J01CR02|01.02.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|XEU|987|1906|lyfalmen|V0163|1906|2|70|0|5,6000|Medical ehf|ratiopharm GmbH|Amoxicillín og ensímblokkar||597||597|1906||2 065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|4355|6285|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4355||4355|6285||2 065934|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|28|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|599|1909|lyfalmen|||2|28|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||599||599|1909||1 065945|C08CA1301|Lerkanidipin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|1809|3564|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||1809||1809|3564||1 065956|C08CA1301|Lerkanidipin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C08CA13|01.04.2014||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|3362|5688|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis Group PTC ehf|Lerkanidipín||3362||3362|5688||1 066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|0|0|0|0|0|0|DOR|1|0|0|100|DKK|4443|8704|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|||4443||4443|8704||2 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|6180|9543|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6180||6180|9543||1 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32756|42991|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||32756||32756|42991||2 066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|0|0|0|0|0|0|GOG|0|0|1|100|DKK|838|2236|lyfalmen|||1|51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||838||838|2236||2 066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 066593|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|100|stk|1|glas|2x50 stk|A02BC01|01.12.2012||R|1|0|0|0|G|0|PEN|0|0|0|100|IKR|2100|3825|lyfalmen|V0006|3825|2|100|0|100,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól||2000||2000|3825||3 066751|C01BD0103|Cordarone (Lyf og heilsa)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|1|0|0|0|G|0|HOL|0|0|0|100|NOK|1097|2590|lyfalmen|V0036|2590|3|30|0|15,0000|Lyf og heilsa|Lyf og heilsa|Amíódarón||1097||1097|2590||2 066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól|||||||1 066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|15123|20862|lyfsjukr|||2|50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15123||15123|20862||1 067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|8541|12327|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8541||8541|12327||2 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|1|0|0|0|0|0|UCN|0|0|1|100|DKK|1473|3104|lyfalmen|V0137|3104|1|100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1473||1473|3104||1 067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|1011|2472|lyfalmen|V0376|1691|2|2,5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1011||1011|2472||1 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|612|1859|lyfalmen|V0555|1859|2|2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1859||1 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|14199|13547|lyfalmen|V0419|13547|2|30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9107||9107|13547||1 068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|109695|139550|lyfsjukr|||1|15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||109695||109695|139550||1 068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|1|1|0|1|0|1|GTS|0|1|0|100|GBP|80693|103152|lyfsjukr|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||80693||80693|103152||1 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|1689|3400|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1689||1689|3400||1 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|1|0|0|1|G|0|MEB|0|0|0|100|SEK|5316|8361|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||5316||5316|8361||1 068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|18255|10468|lyfalmen|V0342|7716|2|98|0|130,6700|Medical ehf|Medical ehf|Dónepezíl||6856||6856|10468||2 068776|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|30|stk|1|ţpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Deslóratadín|||||||2 068811|L01BA0109|Metoject|stl|50|mg/ml|0,55|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3425|5775|lyfalmen|||1|0,55|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3425||3425|5775||2 068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|2486|3588|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Natríumklóríđ||2486||2486|3588||1 068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|3094|4465|lyfsjukr|||2|400|0||Actavis Group hf|Braun|Kalíumklóríđ||3094||3094|4465||1 068923|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 068933|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 068951|V07AB0009|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 068960|V07AB0009|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 069106|H01BA0201|Minirin|frţ.tfl|240|mcg|30|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|13993|20391|lyfalmen|||1|30|0|18,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13993||13993|20391||1 069115|H01BA0201|Minirin|frţ.tfl|240|mcg|100|stk|1|ţpakki||H01BA02|01.08.2012||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|44169|58262|lyfalmen|||1|100|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||44169||44169|58262||1 069707|G04BD0705|Tolterodine Sandoz|forđahlk|4|mg|98|stk|1|ţpakki||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|10188|15026|lyfalmen|V0589|13169|2|98|0|98,0000|Artasan ehf|Sandoz A/S|Tólteródín||10188||10188|15026||1 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín|||||||1 069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|426|1672|lyfalmen|||2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||426||426|1672|31.7.2014|2 070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|16292|23276|lyfalmen|V0645|23276|1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||16292|23276||1 070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|23494|32315|lyfalmen|V0646|32315|1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||23494|32315||1 070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|30235|40775|lyfalmen|V0647|40775|1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||30235|40775||1 070113|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.10.2012||L|1|0|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|Actavis Group hf|Actavis Group hf|Asetýlsalicýlsýra|||||||1 070142|G04BD0704|Tolterodin Actavis|forđahlk|4|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|9027|13438|lyfalmen|V0589|13438|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||9027||9027|13438||1 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|11835|17279|lyfalmen|||1|100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||11835||11835|17279||1 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|62793|80688|lyfsjukr|||1|1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||62793||62793|80688||1 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|313965|395909|lyfsjukr|||1|5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||313965||313965|395909||1 071458|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 071468|N03AX1108|Topiramat Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2037|2178|lyfalmen|V0247|2178|2|60|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||796||796|2178||2 071479|N03AX1108|Topiramat Bluefish|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.08.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3143|4764|lyfalmen|V0248|4764|2|60|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||2686||2686|4764||2 071490|N03AX1108|Topiramat Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|6166|5444|lyfalmen|V0249|5444|2|60|0|20,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||3183||3183|5444||2 071501|N03AX1108|Topiramat Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N03AX11|01.12.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|13284|19501|lyfalmen|V0252|19501|2|60|0|40,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Tópíramat||13284||13284|19501||2 071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|8162|12255|lyfalmen|||1|30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8162|12255||1 071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10746|5950|lyfalmen|V0144|5814|3|12|0|24,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3553||3553|5950||2 071844|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|50|stk|1|ţpakki||M01AE01|01.03.2013||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Portfarma|Íbúprófen|||||||1 071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|0|0|0|1|0|1|GZE|0|0|0|100|NOK|85859|109636|lyfsjukr|||1|20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||85859||85859|109636||1 072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|3116|3816|lyfalmen|V0009|3816|2|30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||1993||1993|3816||1 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|0|0|0|0|0|0|ORF|1|0|0|100|DKK|6942|13502|vetalmen|||0|5|0||Vistor hf|Orion-Farmos|||6942||6942|13502||1 072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|1|0|0|0|G|0|PSA|0|0|0|100|XEU|8129|6851|lyfalmen|V0029|6851|2|100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||4212||4212|6851||1 072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5 072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr|||1|20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946||5 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|616|889|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||616||616|889||1 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|XEU|16328|23322|lyfalmen|||1|1,2|0|20,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||16328||16328|23322||1 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|0|0|0|0|0|0|BRI|0|0|0|100|XEU|16328|23322|lyfalmen|||1|2,4|0|40,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Exenatíđ||16328||16328|23322||1 073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|70559|90434|lyfsjukr|||1|60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||70559||70559|90434||1 073030|N05AH0410|Quetiapin Actavis|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8766|10391|lyfalmen|V0286|9639|2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||6800||6800|10391||1 073276|C02KX0401|Opsumit|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX04|01.09.2014||R|1|1|0|1|0|1|ACV|0|0|0|100|SEK|425471|535849|lyfsjukr|||1|30|0||Vistor hf|Actelion Registration Ltd.|Macitentan||||425471|535849||1 073313|L01XE1601|Xalkori|hylki|200|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|731059|919362|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||731059||731059|919362||2 073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|1|0|0|0|G|0|GSK|0|0|0|100|GBP|3875|6390|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||3875||3875|6390||1 073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|18388|15871|lyfalmen|V0185|15648|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||10806||10806|15871||1 073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|710|2061|lyfalmen|||2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||710||710|2061|31.7.2014|2 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|301|1501|lyfalmen|V0047|1366|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||301||301|1501||1 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|947|2385|lyfalmen|V0305|2039|1|100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||947||947|2385||1 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|510|1787|lyfalmen|V0439|1535|1|20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||510||510|1787||1 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|1385|2984|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1385||1385|2984||1 073933|C09AA0211|Enalapril Krka|töflur|2,5|mg|100|stk|1|ţpakki||C09AA02|01.04.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1479|3113|lyfalmen|||2|100|0|25,0000|LYFIS ehf|Krka Sverige AB|Enalapríl||1479||1479|3113||2 073935|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|3678|6416|vetorma|||0|1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||3678||3678|6416||2 073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|0|0|0|0|G|0|APT|0|0|0|100|GBP|1377|2973|lyfalmen|||1|50|0|8,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||1377||1377|2973||1 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|1|0|0|0|0|0|NEL|0|0|0|100|DKK|3547|5941|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3547||3547|5941||1 074083|B03BB0106|Folic Acid (Lyf og heilsa)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|1|0|0|0|G|0|HOL|0|0|1|100|GBP|415|1657|lyfalmen|V0391|1657|3|28|0|350,0000|Lyf og heilsa|Lyf og heilsa|Fólínsýra||415||415|1657||2 074348|N03AX2201|Fycompa|filmhtfl|8|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|23279|32045|lyfalmen|||1|28|0|28,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||23279||23279|32045||1 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|473|1736|lyfalmen|||2|25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||473||473|1736||1 074477|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.10.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|30|0|5,0000|Medical ehf|ratiopharm GmbH|Paracetamól|||||||2 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|655|1985|lyfalmen|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||655||655|1985||1 074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|1064|2545|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1064||1064|2545||1 074617|QI06AA0402|Fel-O-Vax PCT vet.|stl|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|22249|38812|vetorma|||0|25|0||Icepharma hf|Pfizer Oy Animal Health|||22249||22249|38812||2 074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|422|1650|lyfalmen|||2|98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||410||410|1650||1 074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|729|2087|lyfalmen|||2|98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||729||729|2087||1 074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|982|2433|lyfalmen|||1|60|0|12,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||982||982|2433||1 074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|524|1806|lyfalmen|||1|100|0|100,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||524||524|1806||1 075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|0|0|0|0|G|0|APT|0|0|0|100|GBP|2422|4403|lyfalmen|||1|100|0|33,3333|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Azatíóprín||2422||2422|4403||1 075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4830|7697|lyfalmen|||1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4830||4830|7697||1 075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|14490|21015|lyfalmen|||1|90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14490||14490|21015||1 075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|4830|7697|lyfalmen|||1|30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||4830||4830|7697||1 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1716|2727|lyfalmen|V0363|2601|1|30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1197||1197|2727||1 075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|0|1|0|0|G|0|NEL|0|0|1|100|DKK|14490|21015|lyfalmen|||1|90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||14490||14490|21015||1 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|IKR|3144|5390|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||3144||3144|5390||1 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|2|0|1|0|0|0|ACA|0|0|1|100|IKR|4555|7320|lyfalmen|||2|300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||4555||4555|7320||1 075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|0|0|0|0|0|0|NBV|0|0|0|100|DKK|2578|4616|lyfalmen|||1|4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2578|4616||1 075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|4053|4491|lyfalmen|V0445|4491|2|98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||2487||2487|4491||1 075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|28451|37589|lyfsjukr|||1|1|0||Vistor hf|Aventis Pharma SA|Docetaxel||28451||28451|37589||1 075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|77563|99224|lyfsjukr|||1|4|0||Vistor hf|Aventis Pharma SA|Docetaxel||77563||77563|99224||1 075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|1042|2073|vetalmen|||0|20|0||Vistor hf|Dechra Veterinary Products A/S|Medroxyprogesteronum||1042||1042|2073||1 075865|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|12626|18676|lyfalmen|V0440|18676|2|90|0|90,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||12626||12626|18676|| 075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5687|8208|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5687||5687|8208||2 075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5687|8208|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5687||5687|8208||2 075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|0|0|0|0|0|1|FMC|0|0|0|100|XEU|5987|8641|lyfsjukr|||1|10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||5987||5987|8641||2 075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|1|0|0|0|0|0|AUK|0|0|0|100|GBP|454|1710|lyfalmen|||2|28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||454||454|1710||1 075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|0|0|0|0|0|0|AEA|0|0|1|100|XEU|444|1697|lyfalmen|||2|20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||444||444|1697||1 075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|887|2303|lyfalmen|||2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||887||887|2303|30.9.2014|2 076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|6473|9944|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6473||6473|9944||1 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|21592|29928|lyfalmen|||1|98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||||21592|29928||1 076043|A10BH0101|Januvia|filmhtfl|25|mg|98|stk|1|ţpakki||A10BH01|01.02.2013||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|22551|31132|lyfalmen|||1|98|0|24,5000|Vistor hf|M.S.D.|Sítagliptín||22551||22551|31132||1 076052|A10BH0101|Januvia|filmhtfl|50|mg|98|stk|1|ţpakki||A10BH01|01.10.2012||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|22564|31148|lyfalmen|||1|98|0|49,0000|Vistor hf|M.S.D.|Sítagliptín||22564||22564|31148||1 076361|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.12.2009||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|445|1698|lyfalmen|V0045|1698|2|20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1698||1 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1691|3210|lyfalmen|V0290|2457|2|60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3210||1 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|1946|2662|lyfalmen|V0291|2320|2|60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1150||1150|2662||1 076403|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.06.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|1660|3360|lyfalmen|V0075|3360|1|5|0||Vistor hf|Laboratories THEA|Ketotifen||1660||1660|3360||1 076628|N05AX0806|Risperidon Krka|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.08.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2457|lyfalmen|V0290|2457|2|60|0|6,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1000||1000|2457||2 076871|G01AF0202|Canesten (Lyf og heilsa)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|0|100|IKR|||lyflausa|||0|1|0|5,0000|Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 076876|M01AE0219|Alpoxen|töflur|500|mg|25|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|474|1738|lyfalmen|||2|25|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||474||474|1738||1 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|367|1591|lyfalmen|||2|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||367||367|1591||1 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1042|2515|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1042||1042|2515||1 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|812|2200|lyfalmen|||1|10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||812||812|2200||1 078193|D01AC0102|Canesten (Lyf og heilsa)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|0|0|0|0|0|0|HOL|0|0|1|100|IKR|||lyflausa|||0|20|0||Lyf og heilsa|Lyf og heilsa|Klótrímazól|||||||2 078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|11524|12717|lyfalmen|V0419|12644|2|28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||8500||8500|12717||1 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|501|1775|lyfalmen|||1|20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||501||501|1775||1 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|764|2134|lyfalmen|||1|40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||764||764|2134||1 078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1376|2972|lyfalmen|V0560|2972|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1376||1376|2972||2 078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|0|0|0|0|0|0|FPL|0|0|1|100|XEU|1968|3781|lyfalmen|V0561|3781|2|100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1968||1968|3781||2 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|123285|156605|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||123285||123285|156605||2 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|8778|6130|lyfalmen|V0069|2944|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3685||3685|6130||1 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3597|6010|lyfalmen|||1|10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3597||3597|6010||2 079269|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|18172|25636|lyfalmen|V0639|25636|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||18172||18172|25636||1 079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3528|5915|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3528||3528|5915|31.8.2014|1 079597|L02BG0305|Anastrozole Teva|filmhtfl|1|mg|100|stk|1|ţpakki||L02BG03|01.05.2014||R|0|0|0|0|G|0|TSB|0|0|0|100|IKR|9500|6465|lyfalmen|V0184|6465|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Anastrózól||3930||3930|6465||2 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|0|0|0|0|0|1|BRS|0|0|0|100|DKK|2040|2944|lyfsjukr|||1|5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2040||2040|2944||1 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|393|1627|lyfalmen|V0176|1627|2|10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1627||1 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|638|1962|lyfalmen|V0418|1962|2|20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1962||1 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|647|1974|lyfalmen|V0177|1974|2|10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1974||1 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1168|2687|lyfalmen|V0411|2687|2|20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2687||1 080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745||2 080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|3950|7757|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||3950|7757||2 080256|A10BB0903|Gliclazide LYFIS|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4000|6288|lyfalmen|V0020|5743|2|90|0|45,0000|LYFIS ehf|LYFIS ehf|Glíklazíđ||3800||3800|6288||2 080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|14784|8344|lyfalmen|V0421|8344|2|30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||5303||5303|8344||2 080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|10721|18702|vetorma|||0|24|0||Icepharma hf|Bayer Animal Health GmbH|||10721||10721|18702||2 080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|16326|7619|lyfalmen|V0170|7619|2|30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||4773||4773|7619||2 080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|0|0|0|0|G|0|RAT|0|0|0|100|XEU|18388|15832|lyfalmen|V0185|15648|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||10777||10777|15832||2 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2213|4117|lyfalmen|||1|100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2213||2213|4117||1 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|6092|9423|lyfalmen|||1|30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6092||6092|9423||1 080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2612|2385|lyfalmen|V0143|1726|2|4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||947||947|2385||1 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|glas|m/br. losunarhrađa|N06AX12|01.07.2007||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|3163|5416|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3163||3163|5416||1 080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7383|5888|lyfalmen|V0143|5178|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||3508||3508|5888||1 080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|2884|2664|lyfalmen|V0144|1938|2|4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1151||1151|2664||1 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|14728|20366|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||14728||14728|20366||1 080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|10747|6435|lyfalmen|V0144|5814|2|12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||3908||3908|6435||1 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|29036|38323|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||29036||29036|38323||1 081305|L01XE1601|Xalkori|hylki|250|mg|60|stk|1|ţpakki||L01XE16|01.05.2013||R|1|1|0|1|0|1|IPI|0|0|0|100|SEK|731059|919362|lyfsjukr|||1|60|0||Icepharma hf|Pfizer Limited|Crizotiníb||731059||731059|919362||2 081490|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.07.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081501|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.10.2013||L|0|0|0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa|||0|300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín|||||||1 081525|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081534|V03AN0101|Conoxia|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|20|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081543|V03AN0101|Conoxia|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|50|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081552|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081561|V03AN0101|Conoxia|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|600|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081589|V03AN0101|Conoxia|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|1|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081625|V03AN0101|Conoxia|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|2|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081634|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|7913|4208|lyfalmen|V0515|4208|2|100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||2280||2280|4208||1 081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|4538|7297|lyfalmen|||1|21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4538||4538|7297||1 081671|V03AN0101|Conoxia|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|4|0||Ísaga ehf|AGA AB|Súrefni|||||||5 081708|G03AC0903|Desogestrel ratiopharm|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.02.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1715|2731|lyfalmen|V0590|2731|2|84|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel||1200||1200|2731||2 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1798|2595|lyfsjukr|||1|10|0|3,3333|Icepharma hf|Roche|Mídazólam||1798||1798|2595||2 081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|0|0|0|0|G|0|SAA|0|0|0|100|NOK|5350|8408|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5350||5350|8408||1 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|0|0|0|0|G|0|SDE|0|0|0|100|NOK|7534|11395|lyfalmen|||1|15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||7534||7534|11395||1 082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|16784|9142|lyfalmen|V0184|6336|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||5887||5887|9142||1 082040|D07XC0101|Diprosalic|húđlausn|||100|ml|1|glas||D07XC01|01.01.1987||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2208|4110|lyfalmen|V0640|4110|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2208||2208|4110||1 082233|V03AN0101|Conoxia|lyfjagas|100|%|36|l|1|hylki|kćlt|V03AN01|01.04.2007||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|36|0||Ísaga ehf|AGA AB|Súrefni|||||||5 082512|QI06AH0701|Leucofeligen FeLV/RCP|stl|||10|hgl|1|pakki|frostţurrkađ stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|8483|14798|vetorma|||0|10|0||Vistor hf|Virbac S.A|.||8483||8483|14798||1 082523|QI06AH0701|Leucofeligen FeLV/RCP|stl|||50|hgl|1|pakki|frostţurrkađ stungulyf|QI06AH07|01.05.2014||R|0|0|0|0|0|0|VIR|1|0|0|100|XEU|39048|68117|vetorma|||0|50|0||Vistor hf|Virbac S.A|.||39048||39048|68117||1 082548|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|836|2233|lyfalmen|V0629|2233|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||836||836|2233||1 082675|N02BE0118|Paracetamol-ratiopharm|töflur|1000|mg|100|stk|1|ţpakki||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|728|2069|lyfalmen|V0229|2069|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Paracetamól||716||716|2069||2 082685|R03BA0502|Flixotide Diskus|innönddu|250|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|3047|5257|lyfalmen|||1|60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3047||3047|5257||1 082719|R03BA0502|Flixotide Diskus|innönddu|500|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|5393|8467|lyfalmen|||1|60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5393||5393|8467||1 082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|0|0|0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól|||||||1 082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3729|6190|lyfalmen|||1|40|0|3,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3729||3729|6190||1 082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4060|6643|lyfalmen|||1|40|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4060||4060|6643||1 082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|8837|5190|lyfalmen|V0080|5190|2|100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||2998||2998|5190||1 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|12901|19021|lyfalmen|V0354|16564|1|56|0|9,3350|Vistor hf|Novartis Healthcare A/S|Rívastigmín||12901||12901|19021||1 083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|17835|25213|lyfalmen|V0186|2368|1|28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||17835||17835|25213||1 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|13473|19739|lyfalmen|V0344|15713|1|56|0|18,6700|Vistor hf|Novartis Healthcare A/S|Rívastigmín||13473||13473|19739||1 083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|5510|8627|lyfalmen|||1|40|0|13,3400|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5510||5510|8627||1 083413|QN05CM9102|Narcostart|stl|1|mg/ml|10|mg|1|hgl|fyrir hunda og ketti|QN05CM91|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|6067|11822|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Metetomidinum||6067||6067|11822||2 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|29237|39522|lyfalmen|V0346|33539|1|112|0|74,6667|Vistor hf|Novartis Healthcare A/S|Rívastigmín||29237||29237|39522||1 083644|N02BE0101|Panodil|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.02.2013||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|1286|2849|lyfalmen|||1|300|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||1286||1286|2849||1 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|263|1449|lyfalmen|V0642|1449|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||263||263|1449||1 084192|N05BA1206|Alprazolam Krka|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|1994|2991|lyfalmen|V0311|2991|2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1390||1390|2991||2 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|508|1784|lyfalmen|V0643|1784|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||508||508|1784||1 084456|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|68049|87284|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||68049||68049|87284||1 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|60018|77205|lyfsjukr|||1|0,3|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||60018||60018|77205||2 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|78242|100076|lyfsjukr|||1|0,3|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||78242||78242|100076||2 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|96796|123361|lyfsjukr|||1|0,3|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||96796||96796|123361||2 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|20006|26990|lyfsjukr|||1|0,3|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||20006||20006|26990||2 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|31247|41097|lyfsjukr|||1|0,3|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||31247||31247|41097||2 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|40012|52098|lyfsjukr|||1|0,3|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||40012||40012|52098||2 084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|12391|17433|lyfsjukr|||1|0,3|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||12391|17433||2 084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|47235|61162|lyfsjukr|||1|0,3|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||47235|61162||2 084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|145481|184461|lyfsjukr|||1|0,6|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||145481|184461||2 084807|L01XE2301|Tafinlar|hylki|75|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|272955|344441|lyfsjukr|||1|28|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||272955||272955|344441||1 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|889|2305|lyfalmen|||1|10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||889||889|2305||1 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|10548|15518|lyfalmen|||1|60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||10548||10548|15518||1 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|34326|45909|lyfalmen|||1|100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||34326||34326|45909||1 084924|J05AG0301|Stocrin|filmhtfl|200|mg|90|stk|1|glas||J05AG03|01.10.2013||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|49850|64444|lyfsjukr|||1|90|0|30,0000|Vistor hf|M.S.D.|Efavirenz||49850||49850|64444||1 085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|12479|18491|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||12479||12479|18491||1 085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|0|0|0|1|G|0|GAN|0|0|0|100|NOK|39712|52669|lyfalmen|||1|2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||39712||39712|52669||2 085205|S01AE0501|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AE05|01.03.2008||R|0|0|0|0|0|0|SAO|0|0|1|100|XEU|2571|4606|lyfalmen|||1|15|0||Icepharma hf|Santen Oy|Levófloxacín||2571||2571|4606||2 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|29237|39522|lyfalmen|V0345|33539|1|112|0|56,0000|Vistor hf|Novartis Healthcare A/S|Rívastigmín||29237||29237|39522||1 085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|756|2124|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||756||756|2124||1 085488|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6111|8820|lyfsjukr|||1|7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6111||6111|8820||2 085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|17579|24892|lyfalmen|V0412|22605|1|375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||17579|24892||1 085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|33768|45209|lyfalmen|V0412|45209|1|750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||33768|45209||1 085574|B01AF0201|Eliquis|filmhtfl|5|mg|100|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|17043|24219|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||17043|24219||1 085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|0|0|0|1|0|1|ELD|0|0|0|100|XEU|92224|117624|lyfsjukr|||1|56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||92224||92224|117624||2 085771|N07XX0202|Riluzol Actavis|filmhtfl|50|mg|56|stk|1|ţpakki||N07XX02|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|SEK|20470|28520|lyfalmen|V0579|28520|2|56|0|28,0000|Actavis Group hf|Actavis Group PTC ehf|Rílúzól||20470||20470|28520||1 085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|0|0|0|0|0|0|AEB|0|0|0|100|DKK|39059|51849|lyfalmen|||1|1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||39059||39059|51849||1 085830|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|5315|7671|lyfsjukr|||2|60|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||5315||5315|7671||1 085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|2782|4895|lyfalmen|V0465|4112|1|3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2782||2782|4895||1 085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|0|0|0|0|G|0|API|0|0|0|100|SEK|8221|12335|lyfalmen|V0465|12335|1|9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8221||8221|12335||1 085860|N05CF0101|Imovane|filmhtfl|5|mg|30|stk|1|ţpakki||N05CF01|01.12.2013||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|425|1671|lyfalmen|||1|30|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||425||425|1671||1 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1988|3809|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1988||1988|3809||1 086018|N02CC0404|Rizatriptan Actavis|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3704|1899|lyfalmen|V0621|1764|2|6|0|6,0000|Actavis Group hf|Actavis Group PTC ehf|Rizatriptan||592||592|1899||1 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|5052|5665|lyfalmen|V0365|5318|1|100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3345||3345|5665||1 086142|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|ţpakki||N07XX07|01.03.2013||R|0|0|0|1|0|0|BIB|0|0|0|100|XEU|63500|82523|lyfalmen|||1|56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||63500||63500|82523||2 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|8448|12193|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8448||8448|12193||1 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|9170|13235|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||9170||9170|13235||1 086324|A02BC0501|Nexium|sţ-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13802|20152|lyfalmen|V0012|5466|1|100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13802||13802|20152||1 086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|28838|39022|lyfalmen|||1|600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||28838|39022||1 086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|0|0|0|1|G|0|FEL|0|0|0|100|DKK|57846|75427|lyfalmen|||1|1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||||57846|75427||1 086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|0|0|0|1|0|1|BSP|0|1|0|100|DKK|51400|66390|lyfsjukr|||1|1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||51400||51400|66390||1 086530|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.08.2012||R|0|0|0|0|0|0|BOY|0|0|0|100|DKK|17831|25208|lyfalmen|||1|1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||||17831|25208||2 086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|49205|63635|lyfsjukr|||1|100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||49205||49205|63635||2 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd|||||||1 087233|N05CF0201|Stilnoct|töflur|10|mg|30|stk|1|ţpakki||N05CF02|01.08.2012||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|394|1628|lyfalmen|V0060|1557|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||394||394|1628||1 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|157524|199575|lyfsjukr|||1|60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||157524||157524|199575||1 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|267|1455|lyfalmen|V0312|427|1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||267||267|1455||1 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|235|1411|lyfalmen|V0312|1281|1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||235||235|1411||1 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|1977|3794|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||1977||1977|3794||1 087332|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|48773|19464|lyfalmen|||2|250|0|166,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||13254||13254|19464||1 087354|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|250|stk|1|glas||N06DA02|01.01.2014||R|2|0|0|0|G|0|APC|0|0|0|100|XEU|48773|19464|lyfalmen|||2|250|0|333,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Dónepezíl||13254||13254|19464||1 087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|0|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3697||1 087727|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2561|4593|lyfalmen|V0628|4593|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2561||2561|4593||1 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|0|0|0|0|G|0|MEC|0|0|0|100|SEK|828|2222|lyfalmen|||1|5|0|27,7778|Icepharma hf|Merck AB|Klómífen||828||828|2222||2 087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3426|3636|lyfalmen|V0009|3562|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||1862||1862|3636||1 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|6568|5528|lyfalmen|V0420|4281|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||3245||3245|5528||1 087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|30790|53712|vetorma|||0|104|0||Icepharma hf|Chanelle Pharmaceuticals|||30790||30790|53712||2 087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||0|20|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||||1 087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|3701|7279|vetalmen|||0|76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||3701||3701|7279||1 088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|0|0|0|0|0|0|CES|1|0|0|100|SEK|26451|46142|vetorma|||0|10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||26451||26451|46142||2 088235|G03AA1204|Yasmin 28|filmhtfl|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2013||R|0|0|0|0|0|0|BYP|0|0|0|100|DKK|3239|5520|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3239||3239|5520||2 088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|skammtar|1|glas||R01AD12|01.04.2008||R|0|0|0|0|G|0|GGL|0|0|1|100|GBP|1280|2840|lyfalmen|||1|120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1280||1280|2840||1 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1442|3062|lyfalmen|||1|20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1442||1442|3062||1 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|5566|8703|lyfalmen|||1|100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5566||5566|8703||1 088558|N06AX2601|Brintellix|filmhtfl|15|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|9414|13967|lyfalmen|||1|28|0||Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||9414||9414|13967||1 088612|N06DA0207|Donepezil Bluefish|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12701|7716|lyfalmen|V0342|7716|2|98|0|130,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4844||4844|7716||2 088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|4958|7872|lyfalmen|||1|30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||4958||4958|7872||1 088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|9578|14192|lyfalmen|||1|60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9578||9578|14192||1 088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|0|0|0|0|G|0|LEP|0|0|0|100|DKK|14695|21272|lyfalmen|||1|120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14695||14695|21272||1 088737|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.06.2014||R|0|0|0|1|0|1|ABV|0|0|0|100|DKK|5951|8589|lyfsjukr|||1|30|0|2,5000|Vistor hf|AbbVie Ltd.|Ritonavír||5951||5951|8589||1 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|14784|10762|lyfalmen|V0421|8344|2|30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||7071||7071|10762||1 088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2912|5073|lyfalmen|V0376|5073|2|7,5|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||2912||2912|5073||1 088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1445|3066|lyfalmen|||1|63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og ethinylestradíól||1445||1445|3066||1 089077|J07BD5204|M-M-RVAXPRO|sts|||10|hgl|1|pakki|+ lausn í áf.sp|J07BD52|01.02.2013||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|22920|31595|lyfalmen|||1|10|0||Icepharma hf|Sanofi Pasteur MSD|Mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||22920||22920|31595||2 089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|1|0|0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen|||0|120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5784||1 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|1|0|0|1|0|1|VII|0|0|0|100|DKK|157524|199575|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||157524||157524|199575||1 089156|A03AA0406|Mebeverin Mylan|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3782|6263|lyfalmen|||2|100|0|45,0000|Icepharma hf|Mylan AB|Mebeverín||3782||3782|6263||2 089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||||2 089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||L|1|0|0|0|G|0|LYF|0|0|1|100|XEU|||lyfalmen|V0362|2091|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín|||||2091||2 089533|V03AE0401|OsvaRen|filmhtfl|||180|stk|1|glas|435 mg / 235 mg|V03AE04|01.10.2012||R|1|0|0|0|0|0|FMC|0|0|0|100|XEU|6531|10023|lyfalmen|||1|180|0|30,0000|Icepharma hf|Fresenius Medical Care Deutschland GmbH|Kalsíum asetat og ţungt magnesíum karbón||6531||6531|10023||2 089801|B03AC0001|Monofer|irl|100|mg/ml|1|ml|5|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|24226|33234|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||24226||24226|33234||1 089936|B03AC0001|Monofer|irl|100|mg/ml|10|ml|2|hgl||B03AC|01.10.2012||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|96902|124442|lyfalmen|||1|20|0|20,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||96902||96902|124442||1 090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|2051|3895|lyfalmen|||1|20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||2051||2051|3895||2 090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|4102|6701|lyfalmen|||1|40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||4102||4102|6701||2 090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|0|0|0|0|0|0|PAD|0|0|1|100|DKK|927|2357|lyfalmen|||1|100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||927||927|2357||2 090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|5681|8199|lyfsjukr|||1|10|0|3,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||5681||5681|8199||2 090547|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.10.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|127326|162624|lyfalmen|V0140|162624|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||127326||127326|162624||3 090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1627|3315|lyfalmen|||1|16,5|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1627||1627|3315||1 090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|0|0|0|1|0|1|CLA|0|0|0|100|USD|15962|21915|lyfsjukr|||1|60|0||Vistor hf|Alcon Nordic A/S|Flúorescein||||15962|21915||1 091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2788|4024|lyfsjukr|||1|2,5|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2788||2788|4024||1 091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4819|6955|lyfsjukr|||1|5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||4819||4819|6955||1 091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|14140|19628|lyfsjukr|||1|17,5|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14140||14140|19628||1 091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|3868|6381|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||3868||3868|6381||1 091493|A10BH0501|Trajenta|filmhtfl|5|mg|30|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|6408|9855|lyfalmen|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||6408||6408|9855||1 091627|J01CR0501|Piperacillin/Tazobactam Actavis|irs|2,5|g|1|hgl|1|pakki|2 g/ 0,5 g|J01CR05|01.08.2014||R|0|1|0|0|0|1|APC|0|0|0|100|SEK|1182|1706|lyfsjukr|||1|1|0|0,1400|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||1182||1182|1706||1 091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|7174|10354|lyfsjukr|||2|1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7174|10354||1 091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|0|0|0|0|G|0|CHA|0|0|1|100|DKK|3873|6387|lyfalmen|||1|30|0||Vistor hf|CCS Healthcare AB|Dexametasón||3873||3873|6387||1 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1153|1829|lyfalmen|V0021|1829|1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||541||541|1829||1 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1993|2210|lyfalmen|V0022|2159|1|90|0|90,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||819||819|2210||1 091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|609|1922|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||609||609|1922||1 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8943|17344|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||8943||8943|17344||2 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|1|0|0|0|G|0|SBM|0|0|0|100|NOK|7246|10052|lyfalmen|V0009|3562|1|28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||6552||6552|10052||1 092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092554|N06DX0105|Memantine Mylan|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|11592|7495|lyfalmen|V0606|6743|2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Memantín||4683||4683|7495||2 092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2216|4121|lyfalmen|||1|18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2216||2216|4121||1 092750|N05AH0203|Leponex (Lyf og heilsa)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|1|0|0|0|G|0|HOL|0|0|0|100|DKK|9029|13441|lyfalmen|V0277|10866|3|100|0|33,3333|Lyf og heilsa|Lyf og heilsa|Klózapín||9029||9029|13441||2 092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|509|1786|lyfalmen|||2|28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||509||509|1786||1 092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|900|2320|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||900||900|2320||1 092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|3269|3149|lyfalmen|V0203|2995|2|12|0|84,0000|Williams & Halls efh|Williams & Halls ehf|Alendrónsýra||1506||1506|3149||2 092989|C03DA0403|Eplerenon Bluefish|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7800|10665|lyfalmen|V0107|10650|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||7000||7000|10665||2 093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|972|2419|lyfalmen|||1|28|0|1,8700|Icepharma hf|Norpharma|Oxýcódon||972||972|2419||2 093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|2231|4141|lyfalmen|||1|28|0|3,7300|Icepharma hf|Norpharma|Oxýcódon||2231||2231|4141||2 093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|0|0|1|0|0|0|NOP|0|0|0|100|DKK|4338|7024|lyfalmen|||1|28|0|7,4700|Icepharma hf|Norpharma|Oxýcódon||4338||4338|7024||2 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6447|9909|lyfalmen|||1|1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||6447||6447|9909||1 093284|G04BD1201|Betmiga|forđatfl|50|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5977|9266|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5977||5977|9266||1 093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1430|3046|lyfalmen|||1|160|0|6,0000|Vistor hf|Novartis Healthcare A/S|Valsartan||1430||1430|3046||1 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|25773|44960|vetorma|||0|100|0||Icepharma hf|Zoetis Finland OY|Medroxyprogesteronum||25773||25773|44960||2 093668|N01BB0203|Xylocain|húđúđi|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.2014||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2509|4522|lyfalmen|V0656|4522|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2509||2509|4522||1 093725|C03BA0802|Metolazon Abcur|töflur|5|mg|100|stk|1|ţpakki||C03BA08|01.01.2014||R|0|0|0|0|G|0|ABC|0|0|0|100|SEK|36899|49138|lyfalmen|||2|100|0|100,0000|Icepharma hf|Abcur AB|Metólazón||36899||36899|49138||2 093736|L02AE0305|Zoladex LA (Lyf og heilsa)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|0|0|0|1|G|0|HOL|0|0|0|100|SEK|55442|68268|lyfalmen|V0451|68125|3|1|0|83,7209|Lyf og heilsa|Lyf og heilsa|Góserelín||52142||52142|68268||2 093747|C09AA0503|Ramipril Actavis (Lyf og heilsa)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|1|0|0|0|G|0|HOL|0|0|0|100|XEU|1157|2669|lyfalmen|V0496|1910|3|100|0|200,0000|Lyf og heilsa|Lyf og heilsa|Ramipríl||1155||1155|2669||2 093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|9326|13847|lyfalmen|||1|28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||9326||9326|13847||2 093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|24173|33167|lyfalmen|V0588|22453|1|98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||24173||24173|33167||2 093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|391494|493207|lyfsjukr|||1|0,5|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||391494||391494|493207||1 093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|441980|556567|lyfsjukr|||1|1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||441980||441980|556567||1 094099|N02CC0501|Almogran|filmhtfl|12,5|mg|3|stk|1|ţpakki||N02CC05|01.06.2013||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|2364|4323|lyfalmen|V0236|3616|1|3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2364||2364|4323||1 094111|N02CC0501|Almogran|filmhtfl|12,5|mg|6|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|4813|7673|lyfalmen|V0236|7231|1|6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||4813||4813|7673||1 094122|N02CC0501|Almogran|filmhtfl|12,5|mg|9|stk|1|ţpakki||N02CC05|01.07.2010||R|1|0|0|0|G|0|AAA|0|0|0|100|SEK|7133|10847|lyfalmen|V0236|10847|1|9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7133||7133|10847||1 094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|1736|3453|vetalmen|||0|15|0||Vistor hf|Boehringer Ingelheim|||1736||1736|3453||1 094441|J05AB0103|Aclovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|1031|2352|lyfalmen|V0044|2352|2|25|0|1,2500|Medical ehf|ratiopharm GmbH|Acíklóvír||923||923|2352||2 094652|B01AC0602|Hjarta-Aspirín|sţ-tfl|75|mg|500|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|500|0|500,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 094757|N04BC0406|Ropinirole Portfarma|forđatfl|8|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|30369|21501|lyfalmen|||2|84|0|112,0000|Portfarma ehf|Portfarma|Rópíníról||14877||14877|21501|30.9.2014|1 094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|82352|105234|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||82352||82352|105234||1 094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|0|1|0|0|0|0|APE|0|0|1|100|XEU|46160|60761|lyfalmen|||1|1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||46160|60761||1 094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|6298|10987|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6298||6298|10987||2 095005|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.01.2014||R|0|0|0|1|0|1|TAG|0|0|0|100|DKK|50451|65199|lyfsjukr|||2|1|0||Vistor hf|Takeda Austria GmbH|Blöndur||50451||50451|65199||1 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|1577|3247|lyfalmen|||0|100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3247||1 095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|4921|3816|lyfalmen|V0143|3452|3|8|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1993||1993|3816||2 095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|0|0|0|0|G|0|AGT|0|0|0|100|DKK|5939|9214|lyfalmen|||1|50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5939||5939|9214||1 095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|16823|23943|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16823||16823|23943||1 095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|16823|23943|lyfalmen|||1|28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16823||16823|23943||1 095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|1869|2697|lyfsjukr|||2|100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1869||1869|2697||1 095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2927|4224|lyfsjukr|||2|200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||2927||2927|4224||1 095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|0|0|0|0|G|0|JCI|0|0|0|100|SEK|16823|23943|lyfalmen|||1|28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||16823||16823|23943||1 095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|2453|3540|lyfsjukr|||2|50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2453|3540||1 095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|0|0|0|0|0|1|POF|0|0|0|100|XEU|3394|4898|lyfsjukr|||2|100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3394|4898||1 095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|972|1600|lyfalmen|V0225|1597|2|100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||373||373|1600||1 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|4156|8153|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4156||4156|8153||2 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|5733|11181|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||5733||5733|11181||2 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|0|0|0|0|0|0|CHD|0|0|0|100|IKR|9534|18479|vetalmen|||0|100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||9534||9534|18479||2 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|30624|40316|lyfsjukr|||1|60|0||Icepharma hf|Baxter Medical AB|Mesna||30624||30624|40316||2 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|12456|17515|lyfsjukr|||1|10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||12456||12456|17515||1 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl||J06BA01|01.10.2008||R|0|0|0|1|0|1|OCT|0|1|0|100|DKK|92757|118293|lyfsjukr|||1|100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||92757||92757|118293||1 096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2333|2442|lyfalmen|V0088|2419|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||989||989|2442||2 096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2428|2751|lyfalmen|V0089|2728|2|98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1215||1215|2751||2 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|0|0|0|0|0|0|GGL|0|0|1|100|GBP|2074|3926|lyfalmen|||1|5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2074||2074|3926||1 096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|14680|21253|lyfalmen|V0347|18604|1|30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||14680||14680|21253||1 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|667951|840161|lyfsjukr|||1|21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||667951||667951|840161||2 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|708063|890502|lyfsjukr|||1|21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||708063||708063|890502||2 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|744709|936492|lyfsjukr|||1|21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||744709||744709|936492||2 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|1|1|0|1|0|1|CEE|0|1|0|100|XEU|777382|977497|lyfsjukr|||1|21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||777382||777382|977497||2 096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|15662|22486|lyfalmen|V0349|19770|1|30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||15662||15662|22486||1 096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|1444|3065|lyfalmen|||1|30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1444||1444|3065||2 096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|31325|42143|lyfalmen|||1|60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||31325||31325|42143||1 096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|0|0|0|1|G|0|SNO|0|0|0|100|NOK|16935|24083|lyfalmen|||1|20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||16935||16935|24083||1 097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|26231|34802|lyfsjukr|||2|10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||26231||26231|34802||1 097061|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.10.2012||R|0|0|0|0|0|0|ELA|0|0|0|100|DKK|71417|124583|vetorma|||1|1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||71417||71417|124583||2 097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|0|0|0|0|0|0|AUW|1|0|0|100|XEU|7869|15282|vetalmen|||0|10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||7869|15282||2 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|1|0|0|0|0|0|DAC|0|0|1|100|DKK|2119|3988|lyfalmen|V0461|3988|3|20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2119||2119|3988||2 097498|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.12.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|561|1857|lyfalmen|V0333|784|1|7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||561||561|1857||1 097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10801|15865|lyfalmen|V0334|3078|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10801||10801|15865||1 097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|20506|28565|lyfalmen|V0335|3078|1|98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||20506|28565||1 097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|2359|4316|lyfalmen|||0|100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2359||2359|4316||1 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|2860|2520|lyfalmen|V0023|2459|1|90|0|135,0000|Vistor hf|Sanofi-aventis Norge AS|Glímepíríđ||1046||1046|2520||1 097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|2738|2248|lyfalmen|V0233|2244|2|12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||847||847|2248|| 097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|IKR|1917|1957|lyfalmen|V0234|1954|2|6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||634||634|1957|| 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1069|2206|lyfalmen|V0329|1773|2|30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||816||816|2206||1 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4460|3560|lyfalmen|||2|98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1806||1806|3560||1 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|5988|3835|lyfalmen|||2|98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||2007||2007|3835||1 098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|643|1969|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||643||643|1969||2 098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|0|0|0|0|G|0|BIG|0|0|1|100|SEK|643|1969|lyfalmen|||1|30|0||Icepharma hf|Bioglan AB|Flúócínólón||643||643|1969||2 098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|250|0||Icepharma hf|Bioglan AB|Klórhexidín|||||||2 098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1063|1637|lyfalmen|V0243|1637|2|50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||400||400|1637||2 098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|1812|1910|lyfalmen|V0244|1705|2|50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||600||600|1910||2 098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|5116|3552|lyfalmen|V0245|3552|2|100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1800||1800|3552||2 098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|0|0|0|0|G|0|RGM|0|0|0|100|IKR|9166|7929|lyfalmen|V0232|7929|2|100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||5000||5000|7929||2 098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|18144|24653|lyfsjukr|||2|25|0||Actavis Group hf|Braun|Flúmazeníl||18144||18144|24653||1 098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|16116|23056|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||16116||16116|23056||2 099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|0|0|0|1|0|1|ASZ|0|0|0|100|SEK|74938|95930|lyfsjukr|||1|10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||74938||74938|95930||1 099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3089|2487|lyfalmen|V0284|2184|2|100|0|6,2500|Icepharma hf|Mylan AB|Quetíapín||1022||1022|2487||2 099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|6440|4959|lyfalmen|V0285|4509|2|100|0|25,0000|Icepharma hf|Mylan AB|Quetíapín||2829||2829|4959||2 099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|10010|10625|lyfalmen|V0286|9639|2|100|0|50,0000|Icepharma hf|Mylan AB|Quetíapín||6971||6971|10625||2 099705|D08AG0201|Betadine|húđlausn|100|mg/ml|500|ml|1|brusar|vatnslausn|D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2854|2314|lyfalmen|V0247|2178|2|60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||895||895|2314||1 099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3947|5036|lyfalmen|V0248|4764|2|60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2885||2885|5036||1 099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|8017|5851|lyfalmen|V0249|5444|2|60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3481||3481|5851||1 099863|L01XE0401|Sutent|hylki|12,5|mg|28|stk|1|ţpakki||L01XE04|01.12.2012||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|180159|227982|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||180159||180159|227982||1 099872|L01XE0401|Sutent|hylki|25|mg|28|stk|1|ţpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|327704|413151|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||327704||327704|413151||1 099881|L01XE0401|Sutent|hylki|50|mg|28|stk|1|ţpakki||L01XE04|01.03.2014||R|1|0|0|1|0|1|IPI|0|1|0|100|DKK|655385|824391|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Limited|Sunitíníb||655385||655385|824391||1 099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|717|2070|lyfalmen|V0414|2070|2|98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||717||717|2070||1 100211|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|25|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|6074|9910|veteldis|||0|25|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||6074||6074|9910||1 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|12778|18866|lyfalmen|||1|28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12778|18866||2 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|0|0|0|0|0|0|LIL|0|0|0|100|XEU|11431|16726|lyfalmen|||1|28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||11431|16726||2 100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1953|3755|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1949||1949|3755||1 100482|J01DH0202|Merinfec|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.08.2013||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|10143|14612|lyfsjukr|||2|5000|0|2,5000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||10143|14612||1 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11144|13064|lyfalmen|V0254|11349|1|100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||8754||8754|13064||1 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16861|23991|lyfalmen|V0256|20400|1|100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||16861||16861|23991||1 101148|QI10AB0301|Alpha Ject 5-3|stl|||500|ml|1|poki||QI10AB03|01.09.2013||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|74325|121261|veteldis|||0|500|0||Vistor hf|Pharmaq AS|Aeromónas + moritella + vibrio||74325||74325|121261||1 101195|N06DX0105|Memantine Mylan|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|6207|4025|lyfalmen|V0604|3790|2|28|0|14,0000|Icepharma hf|Generics UK Ltd|Memantín||2146||2146|4025||2 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|1317|2221|lyfalmen|V0330|1773|2|30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||827||827|2221||1 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|2706|3082|lyfalmen|V0331|2594|2|96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1457||1457|3082||1 101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|2870|2468|lyfalmen|V0088|2468|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1008||1008|2468||1 101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|3942|2784|lyfalmen|V0089|2784|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1239||1239|2784||1 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|0|0|0|0|0|0|BOI|0|0|0|100|DKK|12099|23404|vetalmen|||0|250|0||Vistor hf|Boehringer Ingelheim|||12099||12099|23404||1 101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|6902|10531|lyfalmen|||1|28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6902||6902|10531||2 101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|20704|28814|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||20704||20704|28814||2 102051|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1041|2513|lyfalmen|||1|100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1041||1041|2513||1 102062|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.03.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1622|3308|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1622||1622|3308||1 102121|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|6300|9092|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||6300||6300|9092||2 102173|N02BE0107|Paratabs|filmhtfl|500|mg|100|stk|1|ţpakki||N02BE01|01.03.2013||R|1|0|0|0|0|0|APC|0|0|1|100|XEU|406|1645|lyfalmen|V0230|1645|2|100|0|16,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||406||406|1645||1 102404|R03DX0701|Daxas|filmhtfl|500|mcg|30|stk|1|ţpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|7062|10750|lyfalmen|||1|30|0|30,0000|Vistor hf|Takeda GmbH|Roflumílast||7062||7062|10750||1 102743|L01XA0303|Oxaliplatin Actavis|irţ|5|mg/ml|40|ml|1|hgl||L01XA03|01.05.2013|31.08.2014|R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|10044|14488|lyfsjukr|||2|40|0||Actavis Group hf|Actavis Group PTC ehf|Oxalíplatín||10044||10044|14488||1 102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3505|5884|lyfalmen|V0041|2768|1|98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3505||3505|5884||1 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994|30.09.2014|R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|1763|2544|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||1763||1763|2544||1 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988|30.09.2014|R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|2866|4136|lyfsjukr|||1|50|0||Vistor hf|AstraZeneca AB|Própófól||2866||2866|4136||1 102952|G04BD0803|Solifenacin Portfarma|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|15517|22304|lyfalmen|V0441|22304|2|90|0|180,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||15517||15517|22304||1 103610|L01DB0105|Doxorubicin Actavis|irţ|2|mg/ml|25|ml|1|hgl|lausn|L01DB01|01.03.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|8917|12869|lyfsjukr|||2|25|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||8917||8917|12869||1 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2997|2742|lyfalmen|V0088|2419|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1208||1208|2742||1 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4280|3325|lyfalmen|V0089|2728|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1634||1634|3325||1 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|2992|3511|lyfalmen|V0069|2944|2|98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1770||1770|3511||1 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|2590|2088|lyfalmen|V0033|2047|2|10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||730||730|2088||1 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|1|0|0|0|G|0|POF|0|0|1|100|GBP|7464|5497|lyfalmen|V0182|5207|2|40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||3222||3222|5497||1 103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|4454|4044|lyfalmen|V0334|3141|2|100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||2160||2160|4044||1 103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|7148|4372|lyfalmen|V0335|3141|2|100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||2400||2400|4372||1 103806|N02AB0305|Fentanyl ratiopharm|forđapl|12|mcg/klst|5|stk|1|skpoki||N02AB03|01.12.2012||R|0|0|1|0|G|0|RGM|0|0|0|100|XEU|2034|3872|lyfalmen|V0222|3872|2|5|0|3,6000|Medical ehf|ratiopharm GmbH|Fentanýl||2034||2034|3872||2 103813|B02BC3002|TISSEEL|vefjalím|||4|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|323544|407930|lyfsjukr|||1|40|0||Icepharma hf|Baxter AG|Blöndur||323544||323544|407930||2 103854|L01XE1701|INLYTA|filmhtfl|1|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|119714|152124|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||119714||119714|152124||1 103906|QD08AC5201|Malaseb vet.|hársápa|2|%|250|ml|1|glas|w/v|QD08AC52|01.10.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|3867|7598|vetalmen|||1|250|0||Vistor hf|Dechra Veterinary Products A/S|Bígvaníđ og amídín-Klórhexidín í blöndum||3867||3867|7598||1 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|0|0|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||0|25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1994||1 103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|12401|17446|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Jódixanól||12401||12401|17446||2 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|3055|5268|lyfalmen|||1|2,5|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3055||3055|5268||1 104489|H01BA0201|Minirin|nefúđi|0,1|mg/ml|5|ml|1|úđagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|6612|10134|lyfalmen|||1|5|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||6612||6612|10134||1 104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|8055|12108|lyfalmen|||1|28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8055||8055|12108||1 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|4523|7277|lyfalmen|V0017|7277|1|700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4523||4523|7277||1 104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|1|0|0|0|G|0|FER|0|0|0|100|DKK|5119|8092|lyfalmen|||1|100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5119||5119|8092||1 104856|R03AK1101|Flutiform|innúđal|55|mcg/sk|120|skammtar|1|pakki|50+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|4426|7144|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||4426||4426|7144||2 104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|107334|136587|lyfsjukr|||1|2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||107334|136587||1 105315|G03AA0705|Microgynon (Lyf og heilsa)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|0|0|0|0|0|0|HOL|0|0|0|100|DKK|1257|2803|lyfalmen|V0545|2065|3|63|0|84,0000|Lyf og heilsa|Lyf og heilsa|Levónorgestrel og ethinylestradíól||1253||1253|2803||2 105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|13353|19588|lyfalmen|||1|98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||13353||13353|19588||1 105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|15402|22160|lyfalmen|||1|98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||15402||15402|22160||1 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2279|4207|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2279||2279|4207||1 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2694|4775|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2694||2694|4775||1 106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|1792|3541|lyfalmen|||1|10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1792||1792|3541||2 106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|1|0|0|0|0|0|RRL|0|0|0|100|DKK|3585|5993|lyfalmen|||1|10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3585||3585|5993||2 106182|G03AA1203|Yasminelle|filmhtfl|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.04.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3429|5780|lyfalmen|V0191|4998|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||3429||3429|5780||2 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|19033|25769|lyfsjukr|||1|5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19033||19033|25769||1 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|10526|15093|lyfsjukr|||1|5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10526||10526|15093||1 106932|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|9024|4820|lyfalmen|V0572|4820|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||2727||2727|4820||2 107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|1|0|0|0|G|0|RAN|0|0|0|100|XEU|1972|1797|lyfalmen|V0278|1699|2|28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||517||517|1797||1 107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1529|3181|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1529||1529|3181||1 107265|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|9000|12443|lyfalmen|V0197|12443|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||8300||8300|12443||2 107464|G04BD0803|Solifenacin Portfarma|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.06.2013||R|1|0|0|0|G|0|PEH|0|0|0|100|XEU|||lyfalmen|||2|30|0|30,0000|Portfarma ehf|Portfarma ehf|Sólífenacín||4506||||30.9.2014| 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||R|0|0|0|0|0|0|CRO|0|0|0|100|XEU|1500|2617|vetorma|||0|6,42|0||Portfarma ehf|Cross Vetpharm Group Ltd.|Ivermectinum||1500||1500|2617||1 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|900|2320|lyfalmen|||2|60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||900||900|2320||1 108103|M05BA0804|Zoledronic acid medac|irl|4|mg/glasi|100|ml|1|glas|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|48934|63295|lyfsjukr|||2|100|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||48934||48934|63295||2 108126|G04BD0402|Oxybutynin Mylan|töflur|5|mg|100|stk|1|ţpakki||G04BD04|01.05.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|2589|4631|lyfalmen|||2|100|0|33,3300|Icepharma hf|Mylan AB|Oxýbútýnín||2589||2589|4631||2 108433|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.10.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|53261|68725|lyfsjukr|||1|4|0|26,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||53261||53261|68725||1 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|3207|5476|lyfalmen|||1|30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3207||3207|5476||1 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|9519|14111|lyfalmen|||1|90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||9519||9519|14111||1 108697|A16AA0601|Cystadane|duft|1|g|180|g|1|glas||A16AA06|01.07.2013||R|0|0|0|1|0|0|OEU|0|0|0|100|XEU|84676|109098|lyfalmen|||1|180|0|30,0000|Orphan Europe S.a.r.l.|Orphan Europe S.a.r.l.|Betain anhydrous||84676||84676|109098||3 108741|QP52AC1304|Panacur PetPaste|pasta|187,5|mg|4,8|g|1|sk-dćl||QP52AC13|01.05.2014||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|805|1404|vetorma|||0|4,8|0||Vistor hf|Intervet International BV|||805||805|1404||1 108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|skammtar|1|fl||R01AD05|01.10.1988||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1529|3181|lyfalmen|V0443|3180|1|120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1529||1529|3181||1 109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|1|0|0|0|0|0|APC|0|0|0|100|IKR|2382|2457|lyfalmen|V0004|2215|2|28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||1000||1000|2457||1 109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23598|32446|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|rykmaurar||23598||23598|32446||1 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|18892|26539|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|rykmaurar||18892||18892|26539||1 109569|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|2931|4606|lyfalmen|V0584|3449|2|28|0|7,4700|Medical ehf|ratiopharm GmbH|Oxýcódon||2571||2571|4606||2 109578|N02AA0505|Oxycodone ratiopharm|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|7288|10159|lyfalmen|V0585|8523|2|98|0|26,1300|Medical ehf|ratiopharm GmbH|Oxýcódon||6630||6630|10159||2 109588|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|4931|6501|lyfalmen|V0586|6501|2|28|0|14,9300|Medical ehf|ratiopharm GmbH|Oxýcódon||3956||3956|6501||2 109597|N02AA0505|Oxycodone ratiopharm|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|14238|18342|lyfalmen|V0587|14636|2|98|0|52,2700|Medical ehf|ratiopharm GmbH|Oxýcódon||12360||12360|18342||2 109615|N02AA0505|Oxycodone ratiopharm|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.01.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|21858|29086|lyfalmen|V0588|22453|2|98|0|104,5300|Medical ehf|ratiopharm GmbH|Oxýcódon||20921||20921|29086||2 110033|R06AE0705|Cetirizin ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||R06AE07|01.09.2012||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Medical ehf|ratiopharm GmbH|Cetirizín|||||||2 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|504|1779|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||504||504|1779||2 110094|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|12|stk|1|ţpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|10746|5814|lyfalmen|V0144|5814|2|12|0|24,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||3454||3454|5814||1 110242|V03AN0101|Conoxia|lyfjagas|100|%|3|l|1|hylki|undir ţrýstingi/LIV|V03AN01|01.04.2008||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|3|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110287|N05AX0806|Risperidon Krka|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|1500|2320|lyfalmen|V0291|2320|2|60|0|12,0000|LYFIS ehf|Krka Sverige AB|Risperídón||900||900|2320||2 110306|N05AX0806|Risperidon Krka|filmhtfl|2|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|2700|3757|lyfalmen|V0292|3757|2|60|0|24,0000|LYFIS ehf|Krka Sverige AB|Risperídón||1950||1950|3757||2 110324|N05AX0806|Risperidon Krka|filmhtfl|3|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|4210|5330|lyfalmen|V0296|5330|2|60|0|36,0000|LYFIS ehf|Krka Sverige AB|Risperídón||3100||3100|5330||2 110342|N05AX0806|Risperidon Krka|filmhtfl|4|mg|60|stk|1|ţpakki||N05AX08|01.05.2014||R|1|0|0|0|G|0|KRK|0|0|0|100|IKR|5000|6698|lyfalmen|V0297|6698|2|60|0|48,0000|LYFIS ehf|Krka Sverige AB|Risperídón||4100||4100|6698||2 110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.07.1990||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|1496|3136|lyfalmen|V0065|1912|1|63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og ethinylestradíól||1496||1496|3136||1 110397|V03AN0101|Conoxia|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|5|0||Ísaga ehf|AGA AB|Súrefni|||||||5 110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|3826|6323|lyfalmen|||1|100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||3826||3826|6323||1 110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|94048|119913|lyfsjukr|||1|60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||94048||94048|119913||1 111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|5125|7257|lyfalmen|V0373|7257|2|15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4509||4509|7257||1 111678|A06AB5802|CitraFleet|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.12.2013||L|0|0|0|0|0|0|SLU|0|0|0|100|IKR|||lyflausa|||0|2|0||Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumpicosúlfat|||||||1 111795|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.09.2014||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1 111889|C07AB1201|Nebivolol Portfarma|töflur|5|mg|98|stk|1|ţpakki||C07AB12|01.08.2013|31.07.2014|R|1|0|0|0|0|0|POF|0|0|0|100|XEU|3608|6025|lyfalmen|||2|98|0|98,0000|Portfarma ehf|Portfarma|Nebivolól||||3608|6025||1 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|1|0|0|0|0|0|GSH|0|0|1|100|DKK|729|2087|lyfalmen|V0229|2069|1|100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||729||729|2087||1 112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|21143|29364|lyfalmen|||1|1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||21143||21143|29364||1 112056|R03BB0501|Eklira Genuair|innönddu|322|mcg|60|skammtar|3|innö.t||R03BB05|01.01.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|XEU|16316|23307|lyfalmen|||1|180|0|90,0000|Vistor hf|Almirall S.A.|Aclídínumbrómíđ||16316||16316|23307||1 113058|N07BA0148|Nicovel Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 113247|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.03.2014||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|127326|162624|lyfalmen|V0140|162624|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||127326||127326|162624||3 113251|D01AE1602|Amorolfin ratiopharm|lakk|5|%|5|ml|1|glas||D01AE16|01.09.2014||L|0|0|0|0|0|0|RPO|0|0|1|100|IKR|||lyfalmen|V0655|4646|2|5|0||LYFIS ehf|ratiopharm Oy|Amorolfín|||||4646||2 113331|H02AB0205|Dexametason Abcur|töflur|1|mg|20|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|1846|3615|lyfalmen|||2|20|0|13,3300|Icepharma hf|Abcur AB|Dexametasón||1846||1846|3615||2 113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8270|12402|lyfalmen|V0024|11227|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8270||8270|12402||1 113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|24583|33682|lyfalmen|V0024|33682|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||24583||24583|33682||1 113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|8378|12550|lyfalmen|V0025|9858|1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8378||8378|12550||1 113414|B05AA0114|Albuman|irl|40|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|2253|3252|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||2253||2253|3252||2 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|3206|5475|lyfalmen|||1|2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3206||3206|5475||1 113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|0|0|0|0|G|0|NEL|0|0|0|100|DKK|21311|29575|lyfalmen|V0025|29575|1|180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||21311||21311|29575||1 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|áf.spr|einnota dćla|B01AB05|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|5505|8620|lyfalmen|||1|4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5505||5505|8620||1 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|492079|619442|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||492079||492079|619442||1 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|627|1947|lyfalmen|||1|20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||627||627|1947||1 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|794|2175|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||794||794|2175||1 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1306|2876|lyfalmen|||1|40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1306||1306|2876||1 114033|R03AC0210|Ventolin Diskus|innönddu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|732|2091|lyfalmen|||1|60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||732||732|2091||1 114072|A07DA0301|Imodium|filmhtfl|2|mg|16|stk|1|ţpakki||A07DA03|01.02.2014||L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1 114134|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|22500|30120|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||22500|30120||2 114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|34370|45017|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||||34370|45017||2 114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|1|0|0|0|G|0|MSD|0|0|1|100|DKK|4016|6583|lyfalmen|||1|28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4016||4016|6583||1 114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslunar|D06BB04|01.11.2010||R|0|0|0|0|0|0|GAN|0|0|1|100|XEU|2152|4033|lyfalmen|||1|3,5|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2152||2152|4033||2 114531|L01AA0201|Leukeran|filmhtfl|2|mg|25|stk|1|glas||L01AA02|01.04.2013||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10546|15516|lyfalmen|V0594|15516|1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10546||10546|15516||1 114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|0|0|0|0|0|0|GAN|0|0|0|100|SEK|5841|9080|lyfalmen|||1|60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||5841||5841|9080||2 114941|N05AH0312|Zalasta|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|2417|1699|lyfalmen|V0278|1699|2|28|0|7,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||446||446|1699||2 114952|N05AH0312|Zalasta|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|3161|1765|lyfalmen|V0279|1765|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||494||494|1765||2 114963|N05AH0312|Zalasta|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|10970|3118|lyfalmen|V0280|3118|2|56|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1483||1483|3118||2 114985|N05AH0312|Zalasta|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|11544|3118|lyfalmen|V0282|2397|2|56|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1483||1483|3118||2 114996|N05AH0312|Zalasta|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|7255|7883|lyfalmen|V0457|7883|2|28|0|14,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||4966||4966|7883||2 115007|N05AH0312|Zalasta|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|14207|15580|lyfalmen|V0456|15580|2|28|0|28,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10593||10593|15580||2 115018|N05AH0312|Zalasta|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|23237|15386|lyfalmen|V0475|15386|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||10451||10451|15386||2 115029|N05AH0312|Zalasta|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|35825|20065|lyfalmen|V0540|20065|2|28|0|56,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||13733||13733|20065||2 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1851|3621|lyfalmen|||1|10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1851||1851|3621||1 115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|8613|12431|lyfsjukr|||2|10|0||Actavis Group hf|Braun|Naloxón||8613||8613|12431||1 115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1472|2550|lyfalmen|V0158|2457|2|20|0|15,0000|Icepharma hf|Mylan AB|Amoxicillín||1068||1068|2550||2 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11105|16280|lyfalmen|||1|60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11105||11105|16280||1 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|1851|3621|lyfalmen|||1|10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1851||1851|3621||1 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11105|16280|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11105||11105|16280||1 115554|B03AC0001|Monofer|irl|100|mg/ml|10|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|54350|71039|lyfalmen|||1|10|0|10,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||54350||54350|71039||1 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|1844|3612|lyfalmen|V0369|3035|1|5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1844||1844|3612||1 115931|R03AC1202|Serevent Diskus|innönddu|50|mcg/sk|60|skammtar|1|pakki||R03AC12|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|3781|6262|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3781||3781|6262||1 115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|55|0||Icepharma hf|Norpharma |Malatíón|||||||2 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|3797|5480|lyfsjukr|||1|5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3797||3797|5480||1 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|0|0|0|0|0|1|GSK|0|0|0|100|GBP|1985|2865|lyfsjukr|||1|5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1985||1985|2865||1 116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1153|1999|lyfalmen|V0056|1999|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1999||2 116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1826|1999|lyfalmen|V0057|1999|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||665||665|1999||2 116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|0|0|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||0|10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum|||||||2 116449|N05AH0313|Olanzapin Sandoz|filmhtfl|5|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|19201|13390|lyfalmen|||2|250|0|125,0000|Artasan ehf|Sandoz A/S|Olanzapín||8992||8992|13390||1 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen|||||||1 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.08.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|737|1970|lyfalmen|V0562|1485|2|100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||644||644|1970||1 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|367|1576|lyfalmen|V0563|1575|2|30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||356||356|1576||1 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|glas||M01AE01|01.05.2008||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|883|2277|lyfalmen|V0564|1751|2|100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||868||868|2277||1 116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|17214|24434|lyfalmen|||1|84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||17214||17214|24434||1 116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|7344|4493|lyfalmen|V0081|4493|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||2488||2488|4493||1 116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|5866|9114|lyfalmen|||1|28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||5866||5866|9114||1 116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|6299|9706|lyfalmen|||1|28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6299||6299|9706||1 116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|1|0|0|0|G|0|IPI|0|0|0|100|DKK|18596|26168|lyfalmen|||1|84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18596||18596|26168||1 116769|N06DX0108|Memantine Alvogen|munndr.t|20|mg|56|stk|1|ţpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|12028|13125|lyfalmen|||2|56|0|56,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||8798||8798|13125||1 116841|D07AC1302|Ovixan|húđlausn|0,1|%|30|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|955|2396|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||||955|2396||1 117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX|01.04.2004||R|0|0|0|0|0|0|KEL|1|0|0|100|NOK|10026|19424|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum í blöndum međ D-vítamíni/eđa öđrum efnum||10026||10026|19424||2 117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|2945|5118|lyfalmen|||1|100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||2945||2945|5118||1 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4407|7118|lyfalmen|V0435|7017|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4407||4407|7118||2 117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|13888|17993|lyfalmen|V0275|16687|1|100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||12082||12082|17993||1 117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|G|0|ASZ|0|0|0|100|SEK|24546|29632|lyfalmen|V0273|28120|1|100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||21356||21356|29632||1 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1562|3226|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1562||1562|3226||2 117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|4244|6895|lyfalmen|||1|10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4244|6895||1 117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|39394|45843|lyfalmen|V0272|43418|1|100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||34273||34273|45843||1 117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|1|0|0|0|0|0|ASZ|0|0|0|100|SEK|49092|64440|lyfalmen|||1|100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||49092|64440||1 117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|0|0|0|1|0|1|JCI|0|1|0|100|SEK|55916|72057|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||55916||55916|72057||1 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|9449|16483|vetorma|||0|250|0||Icepharma hf|Bayer Animal Health GmbH|||9449||9449|16483||2 117929|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|6706|13049|vetalmen|||0|1200|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||6706||6706|13049||2 117937|QA12AA0301|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA03|01.04.2004||R|0|0|0|0|0|0|KEL|0|0|0|100|NOK|11762|22757|vetalmen|||0|6000|0||Icepharma hf|Kela Laboratoria NV|Kalsíum glúkónat||11762||11762|22757||2 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1760|1699|lyfalmen|V0278|1699|2|28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||446||446|1699||1 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2886|1765|lyfalmen|V0279|1765|2|28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||494||494|1765||1 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|10366|2858|lyfalmen|V0282|2397|2|56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1293||1293|2858||1 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1702|2526|lyfalmen|V0283|2526|2|28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1050||1050|2526||1 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2261|4182|lyfalmen|||1|100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2261||2261|4182||1 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr|||1|4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728||5 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|16836|3118|lyfalmen|V0280|3118|2|56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1483||1483|3118||1 118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|0|0|0|0|G|0|FER|0|0|0|100|DKK|22481|31044|lyfalmen|||1|150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||22481||22481|31044||1 118658|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|3158|4558|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3158||3158|4558||2 118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|1|0|0|0|G|0|APP|0|0|0|100|XEU|475|1739|lyfalmen|||1|120|0|30,0000|Artasan ehf|Aspen Pharma Trading Limited|Digoxín||475||475|1739||1 119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|75211|96272|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||75211||75211|96272||1 119394|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.04.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|1393|2995|lyfalmen|||1|50|0|8,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||1393||1393|2995||1 119825|N05BA1206|Alprazolam Krka|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|937|1995|lyfalmen|V0309|1995|2|30|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||662||662|1995||2 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|1|0|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen|||||||1 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|414959|522656|lyfsjukr|||1|30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||414959||414959|522656||1 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|1|1|0|1|0|1|GGL|0|1|0|100|GBP|414959|522656|lyfsjukr|||1|30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||414959||414959|522656||1 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|948|2386|lyfalmen|||1|10|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Cýklópentólat||948||948|2386||1 120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|0|0|0|1|0|1|LIL|0|1|0|100|XEU|46816|60637|lyfsjukr|||1|1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||46816||46816|60637||2 120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|30383|40013|lyfsjukr|||1|1,5|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||30383||30383|40013||1 121104|L01XC1401|Kadcyla|irţ|160|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|440410|554597|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||440410||440410|554597||2 121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|0|0|0|0|0|0|AZD|0|0|0|100|SEK|5283|8316|lyfalmen|||1|28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5283||5283|8316||1 121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|0|0|0|0|0|1|ORG|0|0|0|100|DKK|7989|11530|lyfsjukr|||1|50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||7989||7989|11530||1 121302|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|60|0|10,0000|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|skammtar|1|stauk||R03AC02|01.12.1972||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|439|1690|lyfalmen|||1|200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||439||439|1690||1 121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|8128|5266|lyfalmen|V0011|5266|2|98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3053||3053|5266||1 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|478|1743|lyfalmen|V0391|1657|2|28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||478||478|1743||1 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1713|3433|lyfalmen|V0314|2940|1|100|0|25,0000|Vistor hf|Novartis Healthcare A/S|Klómípramín||1713||1713|3433||1 121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|277|1468|lyfalmen|||2|28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||277||277|1468||1 122301|R01AD0802|Nasofan|nefúđi|50|mcg/sk|60|skammtar|1|glas||R01AD08|01.05.2014||L|0|0|0|0|0|0|TSB|0|0|1|100|IKR|||lyflausa|||2|60|0|15,0000|Medical ehf|Teva Sweden AB|Flútíkasón|||||||2 122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9871|17219|vetorma|||0|50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9871||9871|17219||1 122547|N07BC0202|Metadon Abcur|töflur|5|mg|20|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|658|1989|lyfalmen|||1|20|0|5,0000|Icepharma hf|Abcur AB|Metadón||658||658|1989||2 122577|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|3035|3914|lyfalmen|V0381|3914|2|10|0|2,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||2065||2065|3914||2 122588|A04AA0107|Ondansetron Bluefish|filmhtfl|4|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|14974|12421|lyfalmen|||2|50|0|12,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||8284||8284|12421||2 122610|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|3466|3491|lyfalmen|V0384|3491|2|10|0|5,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||1756||1756|3491||2 122643|A04AA0107|Ondansetron Bluefish|filmhtfl|8|mg|50|stk|1|ţpakki||A04AA01|01.11.2012||R|1|0|0|0|G|0|BLP|0|0|1|100|XEU|14974|12421|lyfalmen|||2|50|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Ondansetrón||8284||8284|12421||2 123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|815|2204|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||815||815|2204||1 123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1100|2594|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1100||1100|2594||1 123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|26003|45361|vetorma|||0|100|0||Icepharma hf|Icepharma hf|||26003||26003|45361||2 123456|R03DX0701|Daxas|filmhtfl|500|mcg|90|stk|1|ţpakki||R03DX07|01.10.2013||R|0|1|0|0|0|0|TAK|0|0|0|100|DKK|20795|28928|lyfalmen|||1|90|0|90,0000|Vistor hf|Takeda GmbH|Roflumílast||20795||20795|28928||1 123493|C10AA0506|Atorvaratio|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|0|0|TSB|0|0|0|100|IKR|9000|13401|lyfalmen|V0115|13401|2|100|0|400,0000|Medical ehf|Teva Sweden AB|Atorvastatín||9000||9000|13401||2 123641|QP51AJ0102|Baycox Sheep vet.|mixtúra|50|mg/ml|1000|ml|1|glas||QP51AJ01|01.03.2014||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|30996|54071|vetorma|||0|1000|0||Icepharma hf|Bayer Animal Health GmbH|||30996||30996|54071||2 123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|238|1415|lyfalmen|||2|100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||238|1415||1 123954|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2324|1773|lyfalmen|V0317|1773|2|100|0|50,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||500||500|1773||2 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|1|0|0|0|G|0|AVS|0|0|0|100|NOK|26217|35732|lyfalmen|V0579|28520|1|56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||26217||26217|35732||1 124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|1771|3523|vetalmen|||0|42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1771|3523||2 124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|1|0|0|0|0|0|SBM|0|0|0|100|NOK|34746|46436|lyfalmen|||1|30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||34746|46436||1 124168|N07BC0202|Metadon Abcur|töflur|20|mg|100|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|9868|14588|lyfalmen|||1|100|0|100,0000|Icepharma hf|Abcur AB|Metadón||9868||9868|14588||2 124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1857|1954|lyfalmen|V0234|1954|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||632||632|1954||2 124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2653|2244|lyfalmen|V0233|2244|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||844||844|2244||2 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|972|2419|lyfalmen|||1|30|0|18,7500|Vistor hf|Novartis Healthcare A/S|Metýlergómetrín||972||972|2419||1 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|497|1769|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||497||497|1769||1 124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|9269|13769|lyfalmen|V0464|13769|0|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||9269||9269|13769||1 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1011|2208|lyfalmen|V0066|2208|2|100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||818||818|2208||1 125125|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|12655|18712|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Melphalan||12655||12655|18712||1 125457|N05AH0411|Quetiapin Teva|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4400|4509|lyfalmen|V0285|4509|2|100|0|25,0000|Medical ehf|Teva Sweden AB|Quetíapín||2500||2500|4509||2 125973|D01BA0206|Terbinafin Bluefish|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.08.2012||R|1|0|0|0|0|0|BLP|0|0|0|100|XEU|2412|3430|lyfalmen|V0123|3345|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Terbínafín||1711||1711|3430||2 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991|31.08.2014|L|1|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ|||||||1 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|115449|146771|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||115449|146771||1 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|29628|39066|lyfsjukr|||1|10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||29628|39066||1 126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|24655|32825|lyfsjukr|||1|1|0|0,5417|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||24655||24655|32825||2 126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|0|0|0|0|0|1|EUS|0|0|0|100|XEU|8218|11861|lyfsjukr|||1|1|0|0,1354|EUSA Pharma (Europe) Ltd.|EUSA Pharma (Europe) Ltd|Gentamícín||8218||8218|11861||2 126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|33716|44196|lyfsjukr|||1|50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||33716||33716|44196||2 126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|67432|86510|lyfsjukr|||1|100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||67432||67432|86510||2 126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|134864|171137|lyfsjukr|||1|200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||134864||134864|171137||2 126803|S01LA0501|Eylea|stl|40|mg/ml|1|hgl|1|pakki|lausn|S01LA05|01.10.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|131905|167423|lyfsjukr|||1|1|0||Icepharma hf|Bayer Pharma AG|Aflibercept||131905||131905|167423||2 126926|B01AF0101|Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38305|50903|lyfalmen|||1|100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||38305|50903||2 126949|S01BC1001|Nevanac|augndr|3|mg/ml|3|ml|1|glas||S01BC10|01.02.2014||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3063|5279|lyfalmen|||1|3|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3063|5279||1 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991|31.08.2014|R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|971|2418|lyfalmen|||1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||971||971|2418||1 127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 127542|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|4|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1765|2449|lyfalmen|V0144|1938|2|4|0|8,0000|Icepharma hf|Mylan AB|Síldenafíl||994||994|2449||2 127881|N07BA0149|Nicovel Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.02.2013||L|0|0|0|0|0|0|ORI|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Orifarm Generics A/S|Nikótín|||||||1 128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|8475|6166|lyfalmen|V0279|1765|1|28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3711||3711|6166||2 128131|QG51AG0101|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51AG01|01.03.2009||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|14052|27155|vetalmen|||0|30|0||Vistor hf|Boehringer Ingelheim Danmark|Súlfónamíđar í blöndu međ öđrum lyfjum||14052||14052|27155||1 128146|N06DX0108|Memantine Alvogen|munndr.t|10|mg|56|stk|1|ţpakki||N06DX01|01.05.2014||R|0|0|0|0|G|0|IPC|0|0|0|100|DKK|4861|6553|lyfalmen|||2|56|0|28,0000|Portfarma ehf|Alvogen IPco S.á.r.l.|Memantín||3994||3994|6553||1 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1198|2728|lyfalmen|||1|100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1198||1198|2728||1 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3733|5388|lyfsjukr|||1|100|0||Icepharma hf|Baxter Medical AB|Mesna||3733||3733|5388||2 129024|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|2500|2184|lyfalmen|V0003|1679|2|28|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2184||2 129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|30554|29585|lyfalmen|V0280|3118|1|56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21319||21319|29585||2 129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|1|0|0|0|G|0|ELD|0|0|0|100|XEU|33208|22892|lyfalmen|V0282|2397|1|56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||15986||15986|22892||2 129124|N02AA0506|Oxikodon Depot Actavis|forđatfl|80|mg|98|stk|1|glas||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|15636|22453|lyfalmen|V0588|22453|2|98|0|104,5300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||15636||15636|22453||1 129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|1|0|0|0|G|0|AUK|0|0|1|100|GBP|233|1408|lyfalmen|||2|28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||233||233|1408||1 129483|J01DH0202|Merinfec|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.08.2013||R|0|0|0|0|0|1|AGP|0|0|0|100|XEU|17906|24355|lyfsjukr|||1|10|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Meropenem||||17906|24355||1 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH|01.08.2005||L|1|0|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||0|100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3182||1 129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|0|0|0|0|G|0|BOI|0|0|0|100|DKK|3254|5541|lyfalmen|||1|60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||3254||3254|5541||1 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|17374|21857|lyfalmen|V0285|4509|1|100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||15161||15161|21857||1 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|27600|33054|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||24083||24083|33054|30.9.2014|1 130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|2184|4077|lyfalmen|||2|10|0|20,0000|Icepharma hf|Mylan AB|Adrenalín tartrat||2184||2184|4077||2 130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|13589|26265|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||13589||13589|26265||1 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3885|6404|lyfalmen|V0644|6404|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||3885||3885|6404||1 130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|1|100|SEK|1707|3424|lyfalmen|||2|10|0|3,3400|Icepharma hf|Mylan AB|Atrópínsúlfat||1707||1707|3424||2 130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|1|0|0|0|0|0|IPI|0|0|1|100|DKK|11056|16213|lyfalmen|||1|53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11056|16213||1 130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|0|0|0|0|0|0|PHA|0|0|0|100|NOK|58774|95890|veteldis|||0|500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||58774|95890||1 131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|3130|5371|lyfalmen|||2|10|0|10,0000|Icepharma hf|Mylan AB|Efedrínhýdróklóríđ||||3130|5371||2 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|441|1693|lyfalmen|||2|100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||441||441|1693||1 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|695|2040|lyfalmen|||2|100|0|15,0000|Vistor hf|Recip AB|Fenemal||695||695|2040||1 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|927|2357|lyfalmen|||2|100|0|50,0000|Vistor hf|Recip AB|Fenemal||927||927|2357||1 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|1|0|0|0|G|0|REP|0|0|0|100|SEK|1026|2493|lyfalmen|||2|100|0|100,0000|Vistor hf|Recip AB|Fenemal||1026||1026|2493||1 131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|5285|8319|lyfalmen|V0132|8319|1|26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5285||5285|8319||1 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 131817|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|3820|6315|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||3820||3820|6315||2 131828|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|11460|16766|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||11460||11460|16766||2 131840|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.05.2009||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38050|50583|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||38050||38050|50583||2 132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|1|0|0|0|G|0|POF|0|0|0|100|SEK|7472|11311|lyfalmen|||2|28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7472||7472|11311||1 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|7082|3842|lyfalmen|V0581|3552|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2012||2012|3842||1 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4073|3832|lyfalmen|V0580|3552|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2005||2005|3832||1 132546|A06AX0401|Constella|hylki|290|mcg|28|stk|1|glas||A06AX04|01.05.2013||R|0|0|0|0|G|0|ALM|0|0|0|100|DKK|9787|14477|lyfalmen|||1|28|0||Vistor hf|Almirall S.A.|Linaclotídum||9787||9787|14477||1 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|1|0|1|0|G|0|REP|0|0|1|100|SEK|1387|2987|lyfalmen|||2|100|0|25,0000|Vistor hf|Recip AB|Kódein||1387||1387|2987||1 132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|1|0|1|0|0|0|JAS|0|0|0|100|SEK|6516|10003|lyfalmen|||1|30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6516||6516|10003||1 132717|QN05CM9204|Nerfasin vet.|stl|100|mg/ml|50|ml|1|hgl|fyrir nautgripi og hesta|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|9357|18139|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet B.V.|||9357||9357|18139||2 132761|D08AG0201|Betadine|húđlausn|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|0|0|0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa|||0|8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón|||||||2 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|1080|2567|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1080||1080|2567||1 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|0|0|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||0|100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol|||||||1 132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1292|2857|lyfalmen|||1|84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1292||1292|2857||1 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|26408|35025|lyfsjukr|||1|0,5|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||26408||26408|35025||1 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|35128|45968|lyfsjukr|||1|1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||35128||35128|45968||1 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|0|0|0|1|0|1|EIS|0|0|0|100|SEK|45900|59487|lyfsjukr|||1|2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||45900|59487||1 133411|B06AC0101|Cinryze|sts|500|ae|2|hgl|1|pakki|+ leysir, lausn|B06AC01|01.03.2013||R|0|1|0|1|0|1|VIO|0|0|0|100|DKK|265909|335598|lyfsjukr|||1|2|0||Williams & Halls efh|ViroPharma SPRL|C1 hemill||265909||265909|335598||2 133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa|||0|20|0|10,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||||1 133551|J05AG0101|Viramune|töflur|200|mg|14|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|8364|12071|lyfsjukr|||1|14|0|7,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||8364||8364|12071||1 133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|0|0|0|0|0|0|MEB|0|0|0|100|SEK|||lyfalmen|V0592|6435|0|50|0|25,0000|Vistor hf|Meda AB (V)|Makrógól 3350|||||6435||1 133919|N06AX1105|Mirtazapine Bluefish|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|998|1773|lyfalmen|V0329|1773|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1773||2 133974|N06AX1610|Venlafaxine Bluefish|forđahlk|37,5|mg|30|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|1661|3362|lyfalmen|V0333|3362|2|30|0|11,2500|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1661||1661|3362||2 134019|N06AX1610|Venlafaxine Bluefish|forđahlk|75|mg|100|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0334|3141|2|100|0|75,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134085|N06AX1610|Venlafaxine Bluefish|forđahlk|150|mg|100|stk|1|ţpakki|hart|N06AX16|01.04.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|3700|3141|lyfalmen|V0335|3141|2|100|0|150,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Venlafaxín||1500||1500|3141||2 134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3884|6402|lyfalmen|V0378|5672|1|9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||3884||3884|6402||2 134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|11642|17015|lyfalmen|V0378|17015|1|27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||11642||11642|17015||2 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|4587|6620|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4587||4587|6620||1 134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|1|0|0|1|0|1|BRS|0|0|0|100|DKK|58283|75028|lyfsjukr|||1|30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||58283||58283|75028||1 134844|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.04.2014||L|1|0|0|0|G|0|MBV|0|0|1|100|DKK|||lyfalmen|V0362|2091|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||8970||1 134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|116994|148710|lyfsjukr|||1|30|0|30,0000|Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||116994||116994|148710||2 134906|A02BC0307|Gasterix|sţ-hylki|30|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4200|3415|lyfalmen|V0007|3415|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||1700||1700|3415||2 134939|A02BC0307|Gasterix|sţ-hylki|15|mg|100|stk|1|glas||A02BC03|01.02.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3100|3825|lyfalmen|||2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Lansóprazól||2000||2000|3825||2 135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|0|0|0|1|0|1|PER|0|1|0|100|DKK|51371|66353|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||51371||51371|66353||1 135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|2561|4593|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2561||2561|4593||1 135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|944|2381|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Verapamíl||944||944|2381||2 135434|R03BA0502|Flixotide Diskus|innönddu|100|mcg/sk|60|skammtar|1|pakki|í diskus-t|R03BA05|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1380|2977|lyfalmen|||1|60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1380||1380|2977||1 135559|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|4|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|5200|7505|lyfsjukr|||2|4|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||5200||5200|7505||1 136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|1555|3217|lyfalmen|||1|63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og ethinylestradíól||1555||1555|3217||1 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|6478|9951|lyfalmen|||1|100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||6478||6478|9951||1 136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|68049|87284|lyfsjukr|||1|4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||68049||68049|87284||1 136653|N06AX2601|Brintellix|filmhtfl|5|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|3137|5381|lyfalmen|||1|28|0||Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||3137||3137|5381||1 136658|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|1|100|XEU|445|1574|lyfalmen|V0307|1574|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||354||354|1574||2 136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|2275|3283|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2275||2275|3283||2 136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|7124|10282|lyfsjukr|||2|16,7|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7124||7124|10282||2 136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5250|7577|lyfsjukr|||2|25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5250||5250|7577||2 136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|8184|11812|lyfsjukr|||2|50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8184||8184|11812||2 137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5753|8303|lyfsjukr|||2|20|0||Icepharma hf|Hospira UK Ltd|Oxalíplatín||5753||5753|8303||2 137218|G03AC0902|Gestrina|filmhtfl|75|mcg|168|stk|1|ţpakki|6x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|3251|4048|lyfalmen|||2|168|0|168,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||2163||2163|4048||1 137340|N04BC0506|Pramipexole Accord|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.04.2014||R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|9584|14200|lyfalmen|||2|100|0|28,0000|Portfarma ehf|Accord Healthcare Limited|Pramipexól||9584||9584|14200|31.7.2014|1 137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|20937|28158|lyfsjukr|||2|25|0|1,2500|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||20937||20937|28158||2 137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|6087|8785|lyfsjukr|||2|10|0|0,5000|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||6087||6087|8785||2 137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|5316|7672|lyfsjukr|||2|10|0|1,0000|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||5316||5316|7672||2 137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|0|0|0|0|0|1|HUK|0|0|0|100|XEU|6008|8671|lyfsjukr|||2|10|0|1,5000|Icepharma hf|Hospira UK Ltd|Pamídrónsýra||6008||6008|8671||2 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|721|1041|lyfsjukr|||2|1|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||721||721|1041||2 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.1997||R|0|0|0|0|0|1|HOS|0|0|0|100|XEU|1016|1466|lyfsjukr|||2|1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1016||1016|1466||2 138318|L01BA0109|Metoject|stl|50|mg/ml|0,35|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3035|5241|lyfalmen|||1|0,35|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3035||3035|5241||2 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1662|3363|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1662||1662|3363||2 138603|N07BB0501|Selincro|filmhtfl|18|mg|28|stk|1|ţpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|16654|23731|lyfalmen|||1|28|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||16654||16654|23731||1 139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|4573|7257|lyfalmen|V0373|7257|2|15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4509||4509|7257||1 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|1|0|0|0|0|0|NEH|0|0|1|100|DKK|||lyfalmen|||0|100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín|||||5048||1 140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|331593|418032|lyfsjukr|||1|50|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||331593||331593|418032||1 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|1405|3011|lyfalmen|V0266|2152|1|30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1405||1405|3011||1 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|0|0|0|0|0|1|LBK|0|0|0|100|DKK|11367|16148|lyfsjukr|||1|10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11367||11367|16148||1 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|0|0|0|0|0|1|SIG|0|0|0|100|DKK|616|889|lyfsjukr|||1|5|0|3,3333|Swedish Orphan Biovitrum A/S|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||616||616|889||3 140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|0|0|0|0|0|0|SRR|0|0|0|100|NOK|85141|163656|vetalmen|||0|1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||85141||85141|163656||1 140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|áfspr||H02AB04|01.04.1994||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1200|2731|lyfalmen|V0413|2459|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1200||1200|2731||1 141063|S01BC1001|Nevanac|augndr|1|mg/ml|5|ml|1|dropaí||S01BC10|01.08.2013||R|0|0|0|0|G|0|ALA|0|0|1|100|USD|3063|5279|lyfalmen|||1|5|0||Vistor hf|Alcon Laboratories Ltd.|Nepafenak||||3063|5279||1 141129|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.06.2014||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|1260|1818|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1260||1260|1818||2 141153|R01AB0601|Otrivin Comp|nefúđi|1,1|mg/ml|10|ml|1|glas|0,5+0,6 mg/ml|R01AB06|01.05.2013||L|0|0|0|0|0|0|NAA|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S|Xýlómetazóín og Ípratrópíum|||||||1 141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3727|5379|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3727||3727|5379||2 141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|16239|23210|lyfalmen|||1|0,5|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||16239|23210||2 141569|H02AB0908|Plenadren|töflur|5|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|VIO|0|0|1|100|DKK|50769|66545|lyfalmen|||1|50|0|8,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||50769||50769|66545||2 141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|4047|6625|lyfalmen|V0193|6084|1|84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og ethinylestradíól||||4047|6625||2 141872|R03DC0304|Montelukast Teva|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.02.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12977|5471|lyfalmen|V0492|5471|2|98|0|39,2000|Medical ehf|Teva Pharma B.V.|Montelúkast||3203||3203|5471||2 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|8325|12478|lyfalmen|V0267|5144|1|100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8325||8325|12478||1 142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|1841|3515|lyfalmen|V0127|3271|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||1773||1773|3515||2 142123|R07AX0101|INOmax|innö.gas|800|ppm|2|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|22536|30165|lyfsjukr|||1|2|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||||22536|30165||5 142203|QS02QA0301|Otimectin vet.|eyrnahl|1|mg/g|10|g|1|túpa|fyrir ketti|QS02QA03|01.10.2012||R|0|0|0|0|0|0|LEV|0|0|0|100|XEU|1606|2802|vetorma|||0|10|0||Le Vet B.V.|Le Vet B.V.|Ivermectinum||1606||1606|2802||2 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|900|2320|lyfalmen|||1|30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||900||900|2320||1 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|2690|4769|lyfalmen|||1|100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2690||2690|4769||1 143139|V07AB0013|Sterilt vatten/vann/vand Fresenius Kabi|leysir|||100|ml|50|hgl|fyrir stungulyf|V07AB|01.11.2012||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1396|2999|lyfalmen|||1|1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1396||1396|2999||1 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2193|3165|lyfsjukr|||1|1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2193||2193|3165||1 143511|J07BC2002|Twinrix Paediatric|stl|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|3879|6396|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||3879||3879|6396||1 143526|C07AB0309|Atenolol Actavis|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|567|1543|lyfalmen|V0542|1543|2|100|0|66,6700|Actavis Group hf|Actavis Group PTC ehf|Atenólól||332||332|1543||1 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|0|0|0|0|0|0|SAC|0|0|0|100|USD|892|2310|lyfalmen|||1|15|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||892||892|2310||1 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1425|3039|lyfalmen|V0173|2545|1|2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1425||1425|3039||1 143609|A10BD0701|Janumet|filmhtfl|900|mg|56|stk|1|ţpakki|50/850 mg|A10BD07|01.03.2013||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|6391|9832|lyfalmen|V0387|8765|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||6391||6391|9832||1 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|1284|2846|lyfalmen|||1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1284||1284|2846||1 143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|1|0|0|0|G|0|MLD|0|0|0|100|DKK|8149|12237|lyfalmen|V0386|8882|1|56|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Metforminum og sitagliptinum||8149||8149|12237||1 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|586|1891|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||586||586|1891||1 143800|N05AN0101|Litarex|forđatfl|6|mmól|100|stk|1|glas||N05AN01|01.04.1974||R|1|0|0|0|G|0|AGT|0|0|0|100|DKK|2194|4091|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||2194||2194|4091||1 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|1669|3372|lyfalmen|V0174|3372|1|3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1669||1669|3372||1 144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|1|0|0|0|G|0|MSD|0|0|0|100|DKK|2020|3853|lyfalmen|||1|100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2020||2020|3853||1 144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|22209|30702|lyfalmen|||1|60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22209||22209|30702||1 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|77995|99766|lyfsjukr|||1|1,5|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||77995||77995|99766||1 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|58294|75041|lyfsjukr|||1|1,5|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||58294||58294|75041||1 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|0|0|0|1|0|1|NAS|0|1|0|100|DKK|36220|47339|lyfsjukr|||1|1,5|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||36220||36220|47339||1 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|632|1954|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||632||632|1954||1 145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|76568|97975|lyfsjukr|||1|1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||76568||76568|97975||1 145440|QG04CX9001|Ypozane|töflur|1,875|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|1737|3455|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||1737||1737|3455||1 145451|QG04CX9001|Ypozane|töflur|3,75|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|2635|5232|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||2635||2635|5232||1 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|1|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|8|0|1,1400|Vistor hf|Recip AB|Pýrvín|||||||1 145616|QG04CX9001|Ypozane|töflur|7,5|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|4055|7959|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||4055||4055|7959||1 145627|QG04CX9001|Ypozane|töflur|15|mg|7|stk|1|ţpakki|handa hundum|QG04CX90|01.05.2014||R|0|0|0|0|0|0|VIR|0|0|0|100|XEU|5654|11029|vetalmen|||0|7|0||Vistor hf|Virbac S.A|Osasterón||5654||5654|11029||1 145784|B03AC0005|Ferinject|irl|50|mg/ml|2|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|5036|7978|lyfalmen|||1|2|0|1,0000|Vistor hf|Vifor France SA|Járn, stungulyf||5036||5036|7978||1 145806|B03AC0005|Ferinject|irl|50|mg/ml|10|ml|1|hgl||B03AC|01.06.2014||R|0|0|0|0|G|0|VIF|0|0|1|100|CHF|26605|36219|lyfalmen|||1|10|0|5,0000|Vistor hf|Vifor France SA|Járn, stungulyf||26605||26605|36219||1 146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|31011|40801|lyfsjukr|||1|1|0|4,8000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||||31011|40801||1 146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|2939|4242|lyfsjukr|||2|2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||2939||2939|4242||2 146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|0|0|0|1|0|1|HUK|0|0|0|100|XEU|5971|8618|lyfsjukr|||2|5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||5971||5971|8618||2 146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|ţpakki|hart|N06BA09|01.01.2010||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|17092|24280|lyfalmen|||1|28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||17092||17092|24280||2 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|796|2178|lyfalmen|||1|10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||796||796|2178||1 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2437|3517|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2437||2437|3517||2 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1510|2179|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1510||1510|2179||2 148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|0|0|0|0|0|0|ROA|0|0|1|100|DKK|109334|140044|lyfalmen|||1|75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||109334||109334|140044||2 148263|J01CA0802|Penomax|filmhtfl|200|mg|20|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1169|2378|lyfalmen|V0577|2378|2|20|0|6,6667|Portfarma ehf|Orion Corporation|Pívmecillínam||942||942|2378||1 148274|J01CA0802|Penomax|filmhtfl|200|mg|30|stk|1|ţpakki||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|1740|3470|lyfalmen|||2|30|0|10,0000|Portfarma ehf|Orion Corporation|Pívmecillínam||1740||1740|3470||1 148285|J01CA0802|Penomax|filmhtfl|200|mg|100|stk|1|glas||J01CA08|01.09.2012||R|0|0|0|0|0|0|OPF|0|0|1|100|DKK|6234|8876|lyfalmen|||2|100|0|33,3300|Portfarma ehf|Orion Corporation|Pívmecillínam||5692||5692|8876||1 148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|80691|104097|lyfalmen|||1|30|0|15,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||80691||80691|104097||1 148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|0|1|0|1|0|0|SLI|0|0|0|100|DKK|80691|104097|lyfalmen|||1|30|0|45,0000|GlaxoSmithKline ehf|Stiefel Laboratories (Ireland) Ltd.|Alítretínóín||80691||80691|104097||1 148411|C03CA0110|Impugan|töflur|40|mg|100|stk|1|glas||C03CA01|01.08.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|431|1572|lyfalmen|V0601|1572|2|100|0|100,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||353||353|1572||1 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|1|0|0|0|G|0|LFS|0|0|0|100|DKK|826|2219|lyfalmen|||1|100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||826||826|2219||1 148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|0|0|0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr|||1|5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814||5 148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6341|9152|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6341||6341|9152||2 148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|13293|18565|lyfsjukr|||2|10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13293||13293|18565||2 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|0|0|0|1|0|1|HOS|0|0|0|100|XEU|28436|37570|lyfsjukr|||1|1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28436||28436|37570||2 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|0|0|0|0|0|0|BAN|1|0|0|100|DKK|3521|6933|vetalmen|||0|25|0||Icepharma hf|Bayer Animal Health GmbH|||3521||3521|6933||2 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|0|0|0|0|0|0|PCO|0|0|0|100|XEU|3264|5554|lyfalmen|||0|75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||3264||3264|5554||1 149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|1011|2472|lyfalmen|V0376|1691|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1011||1011|2472||1 150162|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.01.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4928|7831|lyfalmen|||1|24|0||Vistor hf|Laboratories THEA|Ketotifen||4928||4928|7831||1 150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|42932|55762|lyfsjukr|||1|1,6|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||42932|55762||1 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|6365|9796|lyfalmen|||1|10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6365||6365|9796||1 151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1073|2557|lyfalmen|||1|10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1073||1073|2557||1 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|15457|22229|lyfalmen|V0606|6743|1|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||15457|22229||1 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|47727|59875|lyfalmen|V0607|18984|1|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||45454||45454|59875||1 151532|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|411|1652|lyfalmen|V0633|1583|2|100|0|50,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||411||411|1652||1 151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|4692|7508|lyfalmen|||1|0,5|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||||4692|7508||2 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|5020|3729|lyfalmen|V0148|3189|2|90|0|90,0000|Icepharma hf|Mylan AB|Tamsúlósín||1930||1930|3729||2 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1527|3178|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1527||1527|3178||1 151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|1|0|0|0|G|0|RAT|0|0|0|100|IKR|4359|3962|lyfalmen|V0006|3825|2|100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2100||2100|3962||2 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|1947|2810|lyfsjukr|||1|5|0|0,4500|Vistor hf|Novartis Healthcare A/S|Baklófen||1947||1947|2810||1 152318|D01BA0204|Terbinafine (Lyf og heilsa)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|1|0|0|0|0|0|HOL|0|0|0|100|XEU|2509|3345|lyfalmen|V0123|3345|3|28|0|28,0000|Lyf og heilsa|Lyf og heilsa|Terbínafín||1649||1649|3345||2 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|túpa||M02AA07|01.04.1996||L|0|0|0|0|0|0|PER|0|0|1|100|IKR|||lyflausa|||0|25|0||Icepharma hf|Pfizer ApS|Píroxíkam|||||||1 152397|R03BA0202|Pulmicort Turbuhaler|innönddu|100|mcg/sk|200|skammtar|1|stauk||R03BA02|01.04.1991||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|3044|5253|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3044||3044|5253||1 152413|R03BA0202|Pulmicort Turbuhaler|innönddu|200|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|4885|7772|lyfalmen|||1|200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4885||4885|7772||1 152421|R03BA0202|Pulmicort Turbuhaler|innönddu|400|mcg/sk|200|skammtar|1|stauk||R03BA02|01.10.1989||R|0|0|0|0|G|0|ASZ|0|0|0|100|SEK|8931|13307|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||8931||8931|13307||1 152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|1|0|0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra|||||||1 152653|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|1427|2047|lyfalmen|V0033|2047|2|10|0|1,6667|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||700||700|2047||2 152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|18265|14155|lyfalmen|V0269|14155|3|100|0|28,0000|LYFIS ehf|LYFIS ehf|Pramipexól||9551||9551|14155||2 152675|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|5140|5467|lyfalmen|V0182|5467|2|42|0|7,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||3200||3200|5467||2 152687|J05AB1105|Valaciclovir Bluefish|filmhtfl|500|mg|90|stk|1|ţpakki||J05AB11|01.06.2014||R|1|0|0|0|G|0|BLP|0|0|1|100|IKR|12712|10665|lyfalmen|||2|90|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Valacíklóvír||7000||7000|10665||2 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|1169|2688|lyfalmen|||1|4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1169||1169|2688||1 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1675|3381|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1675||1675|3381||1 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín|||||||1 153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|32200|42294|lyfsjukr|||1|1,2|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||32200|42294||1 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2115|3983|lyfalmen|V0561|3781|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2115||2115|3983||1 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|1480|3114|lyfalmen|V0560|2972|1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1480||1480|3114||1 153288|R06AE0704|Histasin|filmhtfl|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||L|1|0|0|0|G|0|ACA|0|0|1|100|XEU|||lyfalmen|V0575|2292|2|100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín|||||3824||1 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|0|0|0|0|0|1|GSL|0|0|0|100|DKK|222097|280614|lyfsjukr|||1|10|0|14,2857|Gilead Nordic|Gilead Science International Ltd|Amfóterícín||222097||222097|280614||2 153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|1|0|0|0|G|0|AGT|0|0|0|100|XEU|529|1813|lyfalmen|||2|100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||529|1813||1 153507|L02BG0602|Exemestan- Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|31528|42398|lyfalmen|V0452|42398|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||31528||31528|42398||1 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|4038|6613|lyfalmen|||1|15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4038||4038|6613||1 153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|311|1515|lyfalmen|||2|24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||311||311|1515||1 153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|516|1795|lyfalmen|||2|24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||516||516|1795||1 154014|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|TEV|0|0|1|100|XEU|1182|1903|lyfalmen|V0366|1903|2|30|0|30,0000|Medical ehf|Teva Pharma B.V.|Deslóratadín||595||595|1903||2 154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|9145|13599|lyfalmen|||1|100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9145||9145|13599||1 154558|N03AX2201|Fycompa|filmhtfl|12|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|23279|32045|lyfalmen|||1|28|0|42,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||23279||23279|32045||1 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1026|2493|lyfalmen|||1|20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1026||1026|2493||1 154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|25829|34298|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||25829||25829|34298||2 154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|32188|42278|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||32188||32188|42278||2 154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|40743|53015|lyfsjukr|||1|7880|0||Icepharma hf|Fresenius Kabi|Blöndur||40743||40743|53015||2 154651|B05BA1021|SmofKabiven|irl|2700|kcal|2463|ml|3|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|29144|38458|lyfsjukr|||1|7389|0||Icepharma hf|Fresenius Kabi|Blöndur||29144||29144|38458||2 154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|30156|39728|lyfsjukr|||1|3944|0||Icepharma hf|Fresenius Kabi|Blöndur||30156||30156|39728||2 154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|37095|48437|lyfsjukr|||1|5908|0||Icepharma hf|Fresenius Kabi|Blöndur||37095||37095|48437||2 154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|26575|35234|lyfsjukr|||1|4824|0||Icepharma hf|Fresenius Kabi|Blöndur||26575||26575|35234||2 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|3199|5465|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3199||3199|5465||1 154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|34650|45368|lyfsjukr|||1|7616|0||Icepharma hf|Fresenius Kabi|Blöndur||34650||34650|45368||2 154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|1480|3114|lyfalmen|||2|28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1480||1480|3114||1 154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4206|3538|lyfalmen|V0334|3078|2|98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1790||1790|3538||1 154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|6751|3538|lyfalmen|V0335|3078|2|98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1790||1790|3538||1 154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|436819|551038|lyfalmen|||1|252|0|28,0300|Vistor hf|InterMune Europe Ltd.|Pírfenidon||436819||436819|551038||1 155033|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|30|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|5537|4061|lyfalmen|V0604|4061|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Memantín||2172||2172|4061||2 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|10546|15516|lyfalmen|V0594|15516|1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Chlorambucíl||10546||10546|15516||1 155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|2150|2229|lyfalmen|V0247|2178|2|60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||833||833|2229||1 155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|3624|5688|lyfalmen|V0248|4764|2|60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3362||3362|5688||1 155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|6516|5512|lyfalmen|V0249|5444|2|60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||3233||3233|5512||1 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1477|3110|lyfalmen|||1|100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1477||1477|3110||1 155410|A02BC0403|Rabeprazol Krka|sţ-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|0|0|KRK|0|0|0|100|IKR|1500|2184|lyfalmen|V0466|1821|2|28|0|14,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||800||800|2184||2 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|633|1955|lyfalmen|||1|100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||633||633|1955||1 155478|G03AC0902|Gestrina|filmhtfl|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2013||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|1626|3314|lyfalmen|V0590|2731|2|84|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Desógestrel||1626||1626|3314||1 155494|M01AE0113|Ibuxin|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2014||L|1|0|0|0|0|0|ROY|0|0|1|100|IKR|||lyflausa|||2|30|0|10,0000|Medical ehf|ratiopharm Oy|Íbúprófen|||||||2 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|1|0|0|0|0|0|JAS|0|0|1|100|SEK|6305|9714|lyfalmen|||1|28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6305||6305|9714||1 156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5496|8608|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5496||5496|8608||2 156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|0|0|0|0|G|0|ELD|0|0|0|100|XEU|5741|8943|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5741||5741|8943||2 156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|1|0|0|0|0|0|REP|0|0|1|100|SEK|406|1645|lyfalmen|||2|15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||406||406|1645||1 156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|2284|3296|lyfsjukr|||2|15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2284||2284|3296||2 156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|1339|1933|lyfsjukr|||2|5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1339||1339|1933||2 156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|6257|9030|lyfsjukr|||2|45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6257||6257|9030||2 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|1|0|0|0|0|0|ROC|0|0|0|100|DKK|9640|14276|lyfalmen|||1|84|0|28,0000|Icepharma hf|Roche|Orlístat||9640||9640|14276||2 156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|0|0|0|1|0|1|HOP|0|0|0|100|XEU|8380|12094|lyfsjukr|||2|60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8380||8380|12094||2 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|1|0|0|0|0|0|JAS|0|0|0|100|SEK|815|2204|lyfalmen|||1|6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||815||815|2204||1 156723|QN01AX0303|Ketador vet.|stl|100|mg/ml|50|ml|1|hgl|lausn|QN01AX03|01.04.2013||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|11421|22103|vetalmen|||0|50|0||Icepharma hf|Richter Pharma AG|||11421||11421|22103||2 156861|QJ01MA9002|Enrotron Flavour|töflur|50|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|1898|3775|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||1898||1898|3775||2 157015|QP54AB5207|Equest Pramox vet|hlaup|||14,4|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.08.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|2764|4822|vetorma|||0|14,4|0||Icepharma hf|Zoetis Finland OY|||2764||2764|4822||2 157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|1480|3114|lyfalmen|V0239|3114|1|100|0|20,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1480||1480|3114||1 157869|D11AX1601|Vaniqa|krem|11,5|%|30|g|1|túpa||D11AX16|01.01.2013||R|0|0|0|0|0|0|ALM|0|0|0|100|DKK|6851|10461|lyfalmen|||1|30|0||Vistor hf|Almirall S.A.|Eflórníthin||6851||6851|10461||1 158098|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|6|lykjur||C01BD01|01.08.2013||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|1132|1634|lyfsjukr|||1|18|0|4,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||||1132|1634||1 158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|1477|3110|lyfalmen|||1|10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1477|3110||1 158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|1|0|0|0|0|0|ASA|0|0|0|100|SEK|27208|36976|lyfalmen|||1|100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||27208|36976||1 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|923|2352|lyfalmen|V0239|1557|1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||923||923|2352||1 158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|100446|127942|lyfsjukr|||1|1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||100446|127942||1 158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|184217|233075|lyfsjukr|||1|1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||184217|233075||1 158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|0|1|0|1|0|1|NAS|0|0|0|100|DKK|569628|716766|lyfsjukr|||1|1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||569628|716766||1 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|51350|66327|lyfsjukr|||1|1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||51350|66327||1 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|0|1|0|1|0|1|APG|0|0|0|100|XEU|73253|93815|lyfsjukr|||1|1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||73253||73253|93815||1 158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|0|0|0|0|G|0|SIG|0|0|0|100|DKK|796|2178|lyfalmen|||1|5|0|13,3333|Swedish Orphan Biovitrum A/S|Sigma-Tau Industrie Farmaceutiche|Oxýtócín||796||796|2178||3 158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|965|1966|lyfalmen|V0469|1910|2|100|0|50,0000|Icepharma hf|Mylan AB|Díklófenak||641||641|1966||2 159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|2049|3455|lyfalmen|V0219|3455|2|5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||1729||1729|3455||1 159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|3513|5836|lyfalmen|V0220|5836|2|5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3470||3470|5836||1 159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5044|7512|lyfalmen|V0221|7509|2|5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||4695||4695|7512||1 159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|0|0|1|0|G|0|AGP|0|0|0|100|XEU|5637|8156|lyfalmen|V0223|8156|2|5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5166||5166|8156||1 159295|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|172,5|mg|98|stk|1|ţpakki|160/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|3552|lyfalmen|V0581|3552|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1800||1800|3552||2 159565|J01CR0501|Piperacillin/Tazobactam Actavis|irs|4,5|g|12|hgl|1|pakki|4 g/ 0,5 g|J01CR05|01.10.2013||R|0|1|0|0|0|1|APC|0|0|0|100|XEU|16943|23146|lyfsjukr|||1|12|0|3,4300|Actavis Group PTC ehf|Actavis Group PTC ehf|Piperacillín og ensimblokkar||16943||16943|23146||1 159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|494|1765|lyfalmen|||2|25|0|10,0000|Icepharma hf|Mylan AB|Acetýlcýstein||494||494|1765||2 159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|0|0|0|0|G|0|MYL|0|0|1|100|SEK|1499|3140|lyfalmen|||2|100|0|40,0000|Icepharma hf|Mylan AB|Acetýlcýstein||1499||1499|3140||2 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|0|0|0|0|0|1|APC|0|0|0|100|DKK|97913|124763|lyfsjukr|||1|2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||97913||97913|124763||1 159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|4086|8018|vetalmen|||0|50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4086||4086|8018||2 160164|M01AE0219|Alpoxen|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.05.2014||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||2|20|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen|||||||1 160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|5305|2457|lyfalmen|V0010|2107|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1000||1000|2457||1 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|7320|4461|lyfsjukr|||2|50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||3091||3091|4461||1 160343|G03AA1206|Cleodette|filmhtfl|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2857|4998|lyfalmen|V0191|4998|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2857||2857|4998||1 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|908|2331|lyfalmen|||1|100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||908||908|2331||1 160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|0|0|0|0|G|0|BOI|0|0|1|100|DKK|1168|2687|lyfalmen|||1|15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1168||1168|2687||1 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|577|1879|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||577||577|1879||1 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|896|1293|lyfsjukr|||1|1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||896||896|1293||1 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|813|1173|lyfsjukr|||1|5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||813||813|1173||1 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|590|1896|lyfalmen|||1|1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||590||590|1896||1 161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|4696|7513|lyfalmen|V0131|7513|1|26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||4696||4696|7513||1 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|58636|76418|lyfalmen|V0452|42398|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||58636||58636|76418||1 161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|11949|16878|lyfsjukr|||1|28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||11949||11949|16878||1 162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|151917|192538|lyfsjukr|||1|7,5|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||151917||151917|192538||1 162261|H01CB0501|Signifor|stl|0,6|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|530779|668958|lyfalmen|||1|60|0|30,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||530779||530779|668958||1 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1867|3643|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1867||1867|3643||1 162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|0|0|0|0|0|0|LEV|1|0|0|100|XEU|5291|10332|vetalmen|||0|5|0||Le Vet B.V.|Le Vet B.V.|||||5291|10332||2 162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.10.2013||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2701|2824|lyfalmen|V0041|2824|2|100|0|150,0000|Icepharma hf|Mylan AB|Ísósorbíđ mónónítrat||1268||1268|2824||2 162841|A10BA0203|Metformin Bluefish|filmhtfl|500|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|459|1691|lyfalmen|V0500|1691|2|100|0|25,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||440||440|1691||2 162852|A10BA0203|Metformin Bluefish|filmhtfl|850|mg|100|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|745|2108|lyfalmen|||2|100|0|42,5000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||745||745|2108||2 162863|A10BA0203|Metformin Bluefish|filmhtfl|1000|mg|60|stk|1|ţpakki||A10BA02|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|918|2175|lyfalmen|V0502|2175|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Metformín||794||794|2175||2 162874|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1675|lyfalmen|V0108|1675|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1675||2 162885|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1803|lyfalmen|V0109|1803|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1803||2 162896|C10AA0106|Simvastatin Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.08.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1347|2134|lyfalmen|V0110|2134|2|100|0|133,3333|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||764||764|2134||2 162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|XEU|1595|3204|lyfalmen|V0373|2419|2|5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1546||1546|3204||1 162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|1506|3149|lyfalmen|||1|120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1506||1506|3149||1 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|1|0|1|0|0|0|HES|0|0|0|100|DKK|1234|2777|lyfalmen|||1|30|0|10,0000|Vistor hf|Novartis Healthcare A/S|Metýlfenídat||1234||1234|2777||1 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|1|0|0|0|0|0|SNO|0|0|1|100|NOK|1530|3182|lyfalmen|||1|30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1530||1530|3182||1 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|1|0|0|0|G|0|AEA|0|0|0|100|XEU|197|1359|lyfalmen|||2|20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||197|1359||1 163429|C01CA0601|Fenylefrin Abcur|stl|0,1|mg/ml|5|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12521|17596|lyfsjukr|||2|50|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||12521||12521|17596||2 163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|skammtar|1|stauk||R03BA05|01.07.1994||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|2627|4683|lyfalmen|||1|120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2627||2627|4683||1 163494|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.06.2013||R|0|0|0|1|0|1|BYP|0|1|0|100|DKK|561296|706309|lyfsjukr|||1|112|0||Icepharma hf|Bayer Pharma AG|Sorafeníb||561296||561296|706309||2 163667|M01AE0113|Ibuxin|filmhtfl|800|mg|30|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|680|1751|lyfalmen|||2|30|0|20,0000|Medical ehf|ratiopharm Oy|Íbúprófen||484||484|1751||2 163675|M01AE0113|Ibuxin|filmhtfl|800|mg|100|stk|1|ţpakki||M01AE01|01.03.2013||R|1|0|0|0|G|0|ROY|0|0|1|100|XEU|1633|2683|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Íbúprófen||1165||1165|2683||2 163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|8140|12224|lyfalmen|||0|454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12224||1 164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|306461|386491|lyfsjukr|||1|42|0|7,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||306461||306461|386491||1 164125|R01AA0707|Otrivin Junior ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas||R01AA07|01.02.2014||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3779|5454|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3779||3779|5454||2 164592|QN03AX9001|Pexion|töflur|400|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|9351|18128|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||9351||9351|18128||1 164724|QA07XA9101|VetZin|forbl|1000|mg/g|25|kg|1|poki|forblanda f, lyfjabl. fóđur|QA07XA91|01.03.2014||R|0|0|0|0|0|0|VEP|0|0|0|100|DKK|42857|82464|vetalmen|||0|25|0||Orion Pharma A/S Animal Health|Vepidan Aps|Zink Oxide||42857||42857|82464||2 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|2815|4940|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Selegilín||||2815|4940||2 164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|9280|13784|lyfalmen|||2|100|0|200,0000|Icepharma hf|Mylan AB|Selegilín||9280||9280|13784||2 164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1145|2656|lyfalmen|||2|100|0|10,0000|Icepharma hf|Mylan AB|Klómípramín||1145||1145|2656||2 164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1353|2940|lyfalmen|V0314|2940|2|100|0|25,0000|Icepharma hf|Mylan AB|Klómípramín||1353||1353|2940||2 164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|6876|10495|lyfalmen|V0014|10301|1|60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||6876|10495||2 165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|0|0|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||0|30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón|||||||1 165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|1|0|0|0|0|0|AGT|0|0|0|100|XEU|815|2204|lyfalmen|||2|100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||815||815|2204||1 165179|N03AX2201|Fycompa|filmhtfl|10|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|23279|32045|lyfalmen|||1|28|0|35,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||23279||23279|32045||1 165306|QN05CM9101|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM91|01.05.2009||R|0|0|0|0|0|0|LAS|1|0|0|100|XEU|6731|13097|vetalmen|||0|10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|Metetomidinum||6731||6731|13097||2 165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4763|7605|lyfalmen|V0059|6308|1|98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4763||4763|7605||1 165507|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|25|ml|1|hgl|lausn|L01XX19|01.04.2013||R|0|0|0|1|0|1|AGT|0|0|0|100|XEU|23302|31127|lyfsjukr|||2|25|0||Actavis Group hf|Actavis Group hf|Írinótekan||23302||23302|31127||1 165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3074|5294|lyfalmen|V0058|4849|1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3074||3074|5294||1 165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|175093|221624|lyfsjukr|||1|7,5|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||175093||175093|221624||2 165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|33099|43422|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||33099||33099|43422||2 165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|48194|62366|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||48194||48194|62366||2 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|659|1991|lyfalmen|||1|100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||659||659|1991||1 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|1|0|0|0|G|0|UCN|0|0|1|100|SEK|191|1351|lyfalmen|||1|25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||191||191|1351||1 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|1|0|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||0|10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín|||||||1 165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3993|5763|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3993||3993|5763||2 165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|64293|82570|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||64293||64293|82570||2 166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4557|8923|vetalmen|||0|60|0||Vistor hf|Intervet International BV|||||4557|8923||1 166120|A16AX0701|Kuvan|lausnart|100|mg|120|stk|1|glas||A16AX07|01.04.2013||R|0|0|0|1|0|0|MSE|0|0|0|100|SEK|449234|566619|lyfalmen|||1|120|0||Icepharma hf|Merck Serono Europe Ltd|Saprópterín||449234||449234|566619||2 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1688|3398|lyfalmen|||1|100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1688||1688|3398||1 166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|0|0|0|1|G|0|PER|0|0|0|100|DKK|14797|21400|lyfalmen|||1|8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||14797||14797|21400||1 166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|2086|3943|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Naproxen||2086||2086|3943||2 166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3949|6491|lyfalmen|V0428|6491|2|100|0|100,0000|Icepharma hf|Mylan AB|Naproxen||3949||3949|6491|| 166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|0|1|0|1|G|0|BIO|0|0|0|100|DKK|127326|162624|lyfalmen|V0140|162624|1|1|0|1,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Clostridíum||127326||127326|162624||3 166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|1|0|0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa|||0|100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra|||||||1 167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|437|1687|lyfalmen|V0333|784|2|7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||437||437|1687||1 168038|J05AR0901|Stribild|filmhtfl|745|mg|30|stk|1|glas|150+150+200+245 mg|J05AR09|01.11.2013||R|0|1|0|1|0|1|GSL|0|0|0|100|DKK|173122|219151|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín,tenófóvír disóproxíl,elvítegravír og cobícístat||173122||173122|219151||2 168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|1|0|0|0|G|0|AUK|0|0|0|100|GBP|542|1831|lyfalmen|V0119|1637|2|100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||542|1831||1 168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|IKR|4452|3880|lyfalmen|V0007|3347|2|98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||2040||2040|3880||1 168589|N02CC0402|Maxalt Smelt|frţ.tfl|10|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|4362|7056|lyfalmen|V0621|1764|1|6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||4362||4362|7056||1 168618|L01BA0109|Metoject|stl|50|mg/ml|0,15|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2324|4268|lyfalmen|||1|0,15|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2324||2324|4268||2 168629|L01BA0109|Metoject|stl|50|mg/ml|0,2|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2489|4494|lyfalmen|||1|0,2|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2489||2489|4494||2 168640|L01BA0109|Metoject|stl|50|mg/ml|0,3|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|2734|4829|lyfalmen|||1|0,3|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||2734||2734|4829||2 168651|L01BA0109|Metoject|stl|50|mg/ml|0,4|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3091|5318|lyfalmen|||1|0,4|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3091||3091|5318||2 168662|L01BA0109|Metoject|stl|50|mg/ml|0,5|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3256|5543|lyfalmen|||1|0,5|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3256||3256|5543||2 168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2972|5155|lyfalmen|V0240|5155|1|200|0|40,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||2972||2972|5155||1 168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5486|8594|lyfalmen|V0433|8593|1|200|0|80,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||5486||5486|8594||1 168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|50712|65526|lyfsjukr|||1|10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||50712||50712|65526||1 169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|0|0|0|1|0|1|PFP|0|0|0|100|SEK|220487|278594|lyfsjukr|||1|50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||220487||220487|278594||1 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|0|0|0|0|0|1|ROA|0|0|0|100|DKK|21133|28404|lyfsjukr|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||21133||21133|28404||2 169664|J07BK0101|Varilrix|sts|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|5445|8538|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5445||5445|8538|| 169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|1407|2937|lyfalmen|V0124|2937|2|30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2937||1 169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|0|1|0|1|G|0|POF|0|0|0|30|IKR|2450|3620|lyfalmen|V0125|3144|2|30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||1850||1850|3620||1 169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|1168|2687|lyfalmen|V0411|2687|2|20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2687||1 169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|647|1974|lyfalmen|V0177|1974|2|10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1974||1 169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|638|1962|lyfalmen|V0418|1962|2|20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1962||1 169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|1|0|0|0|0|0|POF|0|0|1|100|IKR|393|1627|lyfalmen|V0176|1627|2|10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1627||1 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2774|4884|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2774||2774|4884||1 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2986|5174|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2986||2986|5174||1 170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|19481|26331|lyfsjukr|||1|4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||19481|26331||2 170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|48240|62424|lyfsjukr|||1|10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||48240|62424||2 170092|J07BC2001|Twinrix Adult|stl|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|0|0|0|0|0|0|GLB|0|0|0|100|GBP|5853|9096|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||5853||5853|9096||1 170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|96482|122967|lyfsjukr|||1|20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||96482||96482|122967||2 170489|G04BD0705|Tolterodine Sandoz|forđahlk|4|mg|28|stk|1|plglas||G04BD07|01.08.2013||R|1|0|0|0|G|0|SHS|0|0|0|100|DKK|3365|5692|lyfalmen|V0618|5692|1|28|0|28,0000|Artasan ehf|Sandoz A/S|Tólteródín||||3365|5692||1 170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|ţpakki||J04AB02|01.07.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|15626|22441|lyfalmen|||1|100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||15626||15626|22441||2 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2270|4195|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2270||2270|4195||1 170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|11132|15853|lyfsjukr|||2|1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11132||11132|15853||1 170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|26779|35490|lyfsjukr|||2|1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||26779||26779|35490||1 170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|40168|52293|lyfsjukr|||2|2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||40168||40168|52293||1 170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|3269|3917|lyfalmen|V0203|2995|2|12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2067||2067|3917||1 170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|POF|0|0|0|100|IKR|12363|2315|lyfalmen|V0207|2315|2|12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||896||896|2315||1 170997|L01BC0701|Vidaza|sts|25|mg/ml|4|ml|1|hgl|dreifa|L01BC07|01.09.2009||R|0|0|0|1|0|1|CEE|0|1|0|100|XEU|56027|72196|lyfsjukr|||1|4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||56027||56027|72196||2 171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|0|0|0|0|0|0|DEC|0|0|0|100|DKK|2667|5294|vetalmen|||0|25|0||Vistor hf|Dechra Veterinary Products A/S|||2667||2667|5294||1 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3439|5794|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3439||3439|5794||1 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3473|5840|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3473||3473|5840||1 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|2875|5022|lyfalmen|V0247|2178|1|60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||2875||2875|5022||1 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|5024|7962|lyfalmen|V0248|4764|1|60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||5024||5024|7962||1 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|43624|56631|lyfsjukr|||1|75|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||43624||43624|56631||2 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|29083|38382|lyfsjukr|||1|50|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||29083||29083|38382||2 172249|QJ01MA9002|Enrotron Flavour|töflur|150|mg|10|stk|1|ţpakki|handa hundum|QJ01MA90|01.09.2012||R|0|0|0|0|0|0|ANI|0|0|0|100|IKR|3289|6488|vetalmen|||0|10|0||Dýraheilsa ehf|aniMedica GmbH|Enrofloxacinum||3289||3289|6488||2 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|9168|13631|lyfalmen|V0249|5444|1|60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||9168||9168|13631||1 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|16733|23830|lyfalmen|V0252|19501|1|60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||16733||16733|23830||1 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|66891|85831|lyfsjukr|||1|100|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||66891||66891|85831||2 172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33539|lyfalmen|V0346|33539|3|112|0|74,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33539||2 172592|N06AX2601|Brintellix|filmhtfl|10|mg|98|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|21904|30320|lyfalmen|||1|98|0||Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||21904||21904|30320||1 172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|47326|62224|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||47326||47326|62224|30.9.2014|1 172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|10927|16037|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||10927||10927|16037||1 172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|6197|9567|lyfalmen|||1|56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6197||6197|9567||2 172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|11512|16837|lyfalmen|||1|56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||11512||11512|16837||2 172723|N05AH0410|Quetiapin Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.07.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|2965|2538|lyfalmen|V0284|2184|2|100|0|6,2500|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||1059||1059|2538||1 172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|19972|27895|lyfalmen|||1|56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||19972||19972|27895||2 172895|H01CB0501|Signifor|stl|0,9|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|596210|751074|lyfalmen|||1|60|0|45,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||596210||596210|751074||1 172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|26045|35517|lyfalmen|||1|56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||26045||26045|35517||2 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|1|0|0|0|0|0|MAB|0|0|1|100|SEK|394|1628|lyfalmen|||1|50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||394||394|1628||1 173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3268|5560|lyfalmen|||2|100|0|16,6667|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||3268||3268|5560||2 173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|0|0|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||0|60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3617||1 173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|5781|8997|lyfalmen|||2|100|0|33,3333|Icepharma hf|Mylan AB|Búspírón hýdróklóríđ||5781||5781|8997||2 173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|16183|22069|lyfsjukr|||1|1,6|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16085||16085|22069||1 173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|15453|21276|lyfsjukr|||1|1,5|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||15453||15453|21276||1 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2466|3559|lyfsjukr|||2|20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||2466||2466|3559||1 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|634|1957|lyfalmen|||1|14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||634||634|1957||1 174354|J01CA0414|Amoxicilline Actavis Disper|töflur|500|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1336|2917|lyfalmen|||2|20|0|10,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1336||1336|2917||1 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|648|1976|lyfalmen|||1|14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||648||648|1976||1 174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|1674|3379|lyfalmen|V0368|2602|1|5|0|25,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||1674||1674|3379||1 174522|N04BC0505|Oprymea|forđatfl|0,26|mg|30|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|2900|5056|lyfalmen|V0634|5056|2|30|0|3,1200|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||2900||2900|5056||2 174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|0|0|0|0|G|0|API|0|0|0|100|SEK|4911|7807|lyfalmen|V0368|7807|1|15|0|75,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Brímónidín||4911||4911|7807||1 175333|QM01AC0603|Rheumocam|mixtúra|15|mg/ml|100|ml|1|glas|handa hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|0|0|0|100|XEU|5203|10163|vetalmen|||0|100|0||Icepharma hf|Chanelle Pharmaceuticals|||5203||5203|10163||2 175600|G03AA0904|Denise|töflur|||63|stk|1|ţpakki|150/20 mcg|G03AA09|01.04.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|1477|2252|lyfalmen|V0065|1912|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||850||850|2252||2 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|2589|2352|lyfalmen|V0033|2047|1|10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||923||923|2352||1 175868|V03AN0101|Conoxia|lyfjagas|100|%|37|l|1|gashyl|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|37|0||Ísaga ehf|AGA AB|Súrefni|||||||5 176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|1|0|0|0|0|0|ELD|0|0|0|100|XEU|6456|4966|lyfalmen|V0278|1699|1|28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2834||2834|4966||2 176520|M01AH0105|Cloxabix|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|5750|8955|lyfalmen|V0429|8955|2|100|0|50,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||5750||5750|8955||2 176616|N05CH0101|Circadin|forđatfl|2|mg|30|stk|1|ţpakki||N05CH01|01.10.2012||R|1|0|0|0|0|0|RAD|0|0|1|100|DKK|2687|4765|lyfalmen|||2|30|0|30,0000|Vistor hf|RAD Neurim Pharmaceuticals EEC Ltd.|Melatonin||2687||2687|4765||1 177176|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8524|12302|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||8524||8524|12302||2 177454|N02BE0107|Paratabs|filmhtfl|500|mg|300|stk|1|glas||N02BE01|01.05.2013||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1123|2626|lyfalmen|||2|300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1123||1123|2626|30.9.2014|1 177627|QH02AB0201|Dexaject|stl|2|mg/ml|100|ml|1|hgl||QH02AB02|01.06.2013||R|0|0|0|0|0|0|DOR|1|0|0|100|XEU|4466|8748|vetalmen|||0|100|0||Icepharma hf|Dopharma Reserch B.V|Dexamethasón||4466||4466|8748||2 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|723|2078|lyfalmen|||0|1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|2078||1 178223|B01AF0101|Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|38050|50583|lyfalmen|||1|100|0|100,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||38050||38050|50583||2 178722|N06AB0404|Citalopram Bluefish|filmhtfl|40|mg|100|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|5438|4783|lyfalmen|V0320|4783|2|100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||2700||2700|4783||2 179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|138115|175217|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||138115||138115|175217||1 179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|10274|7225|lyfalmen|V0253|6913|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||4485||4485|7225||2 179552|B01AF0101|Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|10766|15817|lyfalmen|||1|28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||10766|15817||2 180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|0|0|0|1|0|1|WIL|0|1|0|100|XEU|126741|160942|lyfsjukr|||2|5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||126741||126741|160942||2 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|5458|8556|lyfalmen|||1|100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5458||5458|8556||1 180500|G04CA0207|Tamsulosin Medical|hylki|0,4|mg|100|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.12.2012||R|1|0|0|0|G|0|MED|0|0|0|100|XEU|2534|3543|lyfalmen|V0148|3543|2|100|0|100,0000|Medical ehf|Medical ehf|Tamsúlósín||1794||1794|3543||2 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|777|2152|lyfalmen|||1|5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||777||777|2152||1 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa|||0|50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól|||||||2 181552|QJ51DD1201|Pathozone vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DD12|01.10.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|7839|15225|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|Cefoperazone||7839||7839|15225||2 181750|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|9529|13753|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Metótrexat||9529||9529|13753||1 181980|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5964|9248|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||5964||5964|9248||1 182086|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|3|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||6156||2 182307|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.11.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|12595|18637|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||12595||12595|18637||1 182435|A10BB0903|Gliclazide LYFIS|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.10.2014||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8700|11486|lyfalmen|V0020|11486|2|180|0|90,0000|LYFIS ehf|LYFIS ehf|Glíklazíđ||7600||7600|11486||2 182502|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|5|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|16880|23067|lyfsjukr|||2|50|0|8,3300|Icepharma hf|Abcur AB|Noradrenalín||16880||16880|23067||2 182831|QN51AA0102|Exagon vet.|stl|400|mg/ml|100|ml|5|hgl||QN51AA01|01.09.2014||R|0|0|1|0|0|0|RPG|1|0|0|100|XEU|20130|38825|vetalmen|||0|500|0||Icepharma hf|Richter Pharma AG|Pentobarbital||||20130|38825||2 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|5255|10263|vetalmen|||0|50|0||Vistor hf|Intervet International BV|||5255||5255|10263||1 183516|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.03.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|1857|1954|lyfalmen|V0234|1954|2|6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||632||632|1954||2 183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5642|8807|lyfalmen|||1|1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5642|8807||1 183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|0|1|0|1|0|1|JCI|0|1|0|100|SEK|1225844|1540317|lyfsjukr|||1|168|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1225844||1225844|1540317||1 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|0|0|0|0|G|0|BRS|0|0|0|100|DKK|1158|2673|lyfalmen|||1|100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1158||1158|2673||1 184014|A10BX0901|Forxiga|filmhtfl|10|mg|28|stk|1|ţpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|6412|9861|lyfalmen|||1|28|0|28,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||6412||6412|9861||1 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|476|1740|lyfalmen|||2|100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||476||476|1740||1 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|IKR|1603|2232|lyfalmen|||2|100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2232||1 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|0|0|0|0|G|0|TIL|0|0|0|100|SEK|4628|7420|lyfalmen|V0017|7277|1|700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||||4628|7420||2 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|21178|29408|lyfalmen|V0170|7619|1|30|0|30,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||21178||21178|29408||1 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|53822|70377|lyfalmen|V0185|15648|1|100|0|100,0000|Vistor hf|Novartis Healthcare A/S|Letrózól||53822||53822|70377||1 184341|J01CR0201|Amoksiklav|filmhtfl|625|mg|16|stk|1|ţpakki|500+125 mg|J01CR02|01.01.1996||R|0|0|0|0|0|0|LPM|0|0|1|100|XEU|1150|2662|lyfalmen|||2|16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1150||1150|2662||1 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|5005|7936|lyfalmen|V0235|6309|1|6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5005||5005|7936||1 186713|N02AA0506|Oxikodon Depot Actavis|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|939|2374|lyfalmen|V0597|2374|2|28|0|3,7300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||939||939|2374||1 186790|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|35325|19371|lyfalmen|V0607|19371|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Memantín||13180||13180|19371||2 187191|A10BX0204|Repaglinide Krka|töflur|0,5|mg|120|stk|1|ţpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3192|3825|lyfalmen|V0462|3825|2|120|0|15,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníđ||2000||2000|3825||2 187595|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|4319|6998|lyfalmen|||1|30|0||Vistor hf|Meda AB|Pímekrólímus||4319||4319|6998||1 188338|S01XA2020|Hyprosan|augndr|3,2|mg|10|ml|1|dropaí||S01XA20|01.09.2014||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2779||2 188364|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.08.2012||R|0|0|0|0|0|1|WTE|0|0|0|100|DKK|75219|96282|lyfsjukr|||1|10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||75219||75219|96282||2 188405|N02CC0403|Rizatriptan Portfarma|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.09.2013||R|0|0|0|0|G|0|PEH|0|0|0|100|XEU|3280|1764|lyfalmen|V0621|1764|2|6|0|6,0000|Portfarma ehf|Portfarma ehf|Rizatriptan||493||493|1764||1 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|0|0|0|0|G|0|DEA|0|0|0|100|XEU|2855|4995|lyfalmen|||1|250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2855||2855|4995||1 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2908|5067|lyfalmen|V0146|5067|1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíđ||2908||2908|5067||2 189052|M05BA0604|Iasibon|irţ|1|mg/ml|2|ml|1|lykja||M05BA06|01.10.2012||R|0|0|0|0|0|1|PSA|0|0|0|100|DKK|9408|13578|lyfsjukr|||2|2|0|0,3400|Portfarma ehf|Pharmathen S.A.|Íbandrónsýra||9408||9408|13578||1 189148|J05AG0501|EDURANT|filmhtfl|25|mg|30|stk|1|glas||J05AG05|01.04.2013||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|45371|58823|lyfsjukr|||1|30|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Rilpívírin||45371||45371|58823||1 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|6978|10071|lyfsjukr|||1|10|0||Vistor hf|Novartis Healthcare A/S|Deferoxamín||6978||6978|10071||1 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|2431|4415|lyfalmen|||1|5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2431||2431|4415||1 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|1001|2459|lyfalmen|V0413|2459|1|2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1001||1001|2459||1 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|484|1751|lyfalmen|||1|1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||484||484|1751||1 189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|449|648|lyfsjukr|||1|1|0||Icepharma hf|Pfizer ApS|Metótrexat||449||449|648||1 190320|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|263|1449|lyfalmen|V0642|1449|2|10|0|2,5000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||263||263|1449||1 190425|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|7795|11753|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Pharma AG|Nífedipín||||7795|11753||2 190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|972|2419|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||972||972|2419||1 190728|M01AB0101|Confortid|eţ-stíll|50|mg|10|stk|1|ţpakki||M01AB01|01.08.2012||R|0|0|0|0|G|0|AGT|0|0|1|100|DKK|859|2264|lyfalmen|||2|10|0|5,0000|Actavis Group hf|Actavis Group hf|Indómetacín||859||859|2264||1 191045|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.06.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0149|2635|0|100|0|10,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||2635||1 191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3764|5432|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3764||3764|5432||2 191079|C10AA0702|Rosuvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.12.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|6822|10421|lyfalmen|V0117|10264|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rósuvastatín||6822||6822|10421||1 191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3586|5175|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3586||3586|5175||2 191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3700|5340|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Vítamín||3700||3700|5340||2 191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 191742|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.08.2012||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|4217|6858|lyfalmen|||1|98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4217||4217|6858||1 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|508|1784|lyfalmen|||1|4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||508||508|1784|| 192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|0|0|0|0|G|0|AGP|0|0|0|100|XEU|3732|6195|lyfalmen|||2|96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3732||3732|6195||1 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|1566|3232|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1566||1566|3232||1 192699|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|8513|12286|lyfsjukr|||1|5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||8513||8513|12286||2 192867|S01BA0103|Ozurdex|vefjalyf|700|mcg|1|stk|1|pakki|til ísetningar, vefjalyf|S01BA01|01.10.2012||R|0|1|0|1|0|1|API|0|1|0|100|SEK|175374|221977|lyfsjukr|||2|1|0||Vistor hf|Allergan Pharmaceuticals Ireland|Dexametasón||175374||175374|221977||1 193122|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.07.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|2653|2244|lyfalmen|V0233|2244|2|12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||844||844|2244||2 193242|A07DA0301|Imodium|filmhtfl|2|mg|100|stk|1|ţpakki||A07DA03|01.02.2014||R|1|0|0|0|G|0|MCS|0|0|0|100|SEK|970|2416|lyfalmen|V0447|2211|1|100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||970||970|2416||1 193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|0|0|0|0|0|0|SHS|0|0|0|100|IKR|||lyfalmen|||0|20|0|7,5500|Artasan ehf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2344||1 193999|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|250|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|44302|72279|veteldis|||0|250|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||44302||44302|72279||1 194356|J02AC0102|Candizol|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|2031|1910|lyfalmen|V0556|1906|2|4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||600||600|1910||1 194404|QM01AC0606|Meloxidolor|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5331|10409|vetalmen|||0|50|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5331||5331|10409||2 195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|1723|3446|lyfalmen|||2|250|0|83,3300|Icepharma hf|Mylan AB|Atenólól||1723||1723|3446||2 195445|N05AE0403|Ziprasidon Actavis|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|13941|20326|lyfalmen|V0609|20326|2|56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13941||13941|20326||1 195455|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB|01.07.2013||L|0|0|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||0|5000|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|9142|5982|lyfalmen|V0012|5357|2|98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||3577||3577|5982||1 195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|58365|75131|lyfsjukr|||1|2,5|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||58365||58365|75131||2 195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|0|1|0|1|0|1|CEO|0|1|0|100|DKK|138115|175217|lyfsjukr|||1|1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||138115||138115|175217||1 195618|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|982|2433|lyfalmen|||1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||982||982|2433||1 195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|710|2061|lyfalmen|||1|15|0||Vistor hf|Janssen-Cilag AB|Blöndur||710||710|2061||1 195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|364|1587|lyfalmen|||1|30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||364||364|1587||1 195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|1|0|0|0|G|0|REP|0|0|1|100|SEK|770|2143|lyfalmen|||1|100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||770||770|2143||1 196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|2|0|0|0|G|0|MYL|0|0|0|100|SEK|2202|4102|lyfalmen|||2|250|0|166,6700|Icepharma hf|Mylan AB|Atenólól||2202||2202|4102||2 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1499|3140|lyfalmen|||1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||1499||1499|3140||2 196444|M04AA0105|Allonol|töflur|300|mg|100|stk|1|ţpakki||M04AA01|01.06.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1681|3389|lyfalmen|||2|100|0|75,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||1681||1681|3389||2 196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|0|0|0|0|G|0|APP|0|0|0|100|GBP|8090|12151|lyfalmen|||1|100|0|0,8333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||8086||8086|12151||1 196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|21466|28822|lyfsjukr|||1|2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||21466|28822||1 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|2491|4955|vetalmen|||0|10|0||Vistor hf|Intervet International BV|||2491||2491|4955||1 197160|M04AA0105|Allonol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.05.2014||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|575|1637|lyfalmen|V0119|1637|2|100|0|25,0000|Medical ehf|ratiopharm GmbH|Allópúrinol||400||400|1637||2 197554|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|150|skammtar|1|fl|1 x 150 úđaskammtar|N07BA01|01.01.2013||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|150|0|0,4400|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|829|2223|lyfalmen|||1|20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||829||829|2223||1 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2715|4803|lyfalmen|||1|100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2715||2715|4803||1 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2000|3825|lyfalmen|||1|100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2000||2000|3825||1 198582|C09CA0106|Losatrix|filmhtfl|50|mg|100|stk|1|ţpakki||C09CA01|01.01.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2212|3004|lyfalmen|V0069|3004|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Lósartan||1400||1400|3004||2 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|6950|10031|lyfsjukr|||1|200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||6950||6950|10031||1 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|34925|46661|lyfalmen|||1|100|0||Icepharma hf|Pfizer ApS|Estramústín||34925||34925|46661||1 199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|8253|4208|lyfalmen|V0515|4208|2|100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||2280||2280|4208||1 199319|A10BG0304|Pioglitazone Accord|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|7091|4820|lyfalmen|V0572|4820|2|98|0|49,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||2727||2727|4820||1 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|613|1928|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||613||613|1928||1 199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|91207|116347|lyfsjukr|||1|0,6|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||91207|116347||1 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|4522|7275|lyfalmen|V0126|7275|1|8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4522||4522|7275||1 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|0|0|0|0|0|1|JAB|0|0|0|100|XEU|54511|70294|lyfsjukr|||1|5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||54511||54511|70294||0 199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|2649609|3327142|lyfsjukr|||1|40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2649609||2649609|3327142||1 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|ţpakki||A05AA02|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|5463|8383|lyfalmen|||0|60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5332||5332|8383||1 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|653|942|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||653||653|942||2 370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|0|0|0|0|0|0|VIR|1|0|0|100|DKK|30013|57802|vetalmen|||0|2|0||Vistor hf|Virbac S.A|Deslorelín||30013||30013|57802||1 370395|J01CA0413|Amoxin|filmhtfl|375|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1425|2746|lyfalmen|||2|20|0|7,5000|Medical ehf|ratiopharm GmbH|Amoxicillín||1211||1211|2746||2 370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012|30.09.2014|R|1|0|0|0|G|0|APC|0|0|0|100|IKR|11531|5231|lyfalmen|||2|98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3028||3028|5231||1 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|0|0|0|0|0|1|PAD|0|0|0|100|DKK|568|820|lyfsjukr|||1|1|0|0,3333|Icepharma hf|PharmaCoDane ApS|Cefazólín||568||568|820||2 371284|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.09.2012||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|9411|13963|lyfalmen|||1|60|0||Vistor hf|Meda AB|Pímekrólímus||9411||9411|13963|30.9.2014|1 371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1 371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||0|120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||||1 371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|0|0|0|0|0|0|FEL|0|0|0|100|DKK|||lyfalmen|||0|1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||9746||1 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|1|0|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||0|10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín|||||||1 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|4285|6951|lyfalmen|||1|90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||4285||4285|6951||1 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|3543|5936|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3543||3543|5936||2 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|0|0|0|0|0|0|PTL|0|0|0|100|DKK|2430|4413|lyfalmen|||1|66|0|66,0000|Navamedic AB|Aspen Pharma Trading Limited|Desógestrel og ethinylestradíól||2430||2430|4413||1 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|14365|20858|lyfalmen|||1|90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||14365||14365|20858||1 373324|R03AK0602|Seretide Diskus|innönddu|150|mcg/sk|60|skammtar|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4184|6813|lyfalmen|||1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||4184||4184|6813||1 373340|R03AK0602|Seretide Diskus|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|6494|9973|lyfalmen|V0436|9973|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||6494||6494|9973||1 373365|R03AK0602|Seretide Diskus|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|8515|12737|lyfalmen|V0437|12737|1|60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og fluticason||8515||8515|12737||1 373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|0|0|0|0|G|0|MED|0|0|0|100|XEU|7207|4281|lyfalmen|V0420|4281|2|30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||2333||2333|4281||2 373857|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|ţpakki||C07AB03|01.10.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|452|1609|lyfalmen|V0541|1497|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Atenólól||380||380|1609||1 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1531|3184|lyfalmen|V0126|1819|1|2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1531||1531|3184||1 374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|365076|460053|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||365076||365076|460053||1 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|1|0|0|0|G|0|MCK|0|0|0|100|SEK|530|1814|lyfalmen|V0500|1691|1|100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||530||530|1814||2 374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5553|8014|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5553||5553|8014||2 374279|L04AD0104|Ciqorin|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|6800|6835|lyfalmen|||2|50|0|5,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||4200||4200|6835||2 374319|H02AB0205|Dexametason Abcur|töflur|4|mg|100|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|20687|28792|lyfalmen|||2|100|0|266,6600|Icepharma hf|Abcur AB|Dexametasón||20687||20687|28792||2 374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|1|0|0|0|G|0|ASP|0|0|0|100|XEU|4457|7186|lyfalmen|||1|30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4457||4457|7186||1 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|11672|17056|lyfalmen|||1|60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||11672||11672|17056||1 374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|7717|11646|lyfalmen|||1|6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7717||7717|11646||1 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|áf.spr|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|9107|13547|lyfalmen|||1|8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9107||9107|13547||1 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|10666|15680|lyfalmen|||1|10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||10666||10666|15680||1 376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|29113|39367|lyfalmen|V0459|39367|1|168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||29113||29113|39367||1 376387|R03AK1001|Relvar Ellipta|innönddu|206|mcg/sk|30|skammtar|1|pakki|184+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|7800|11759|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||7800||7800|11759||1 376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|19198|26924|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||19198||19198|26924||1 376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|90248|116091|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||90248||90248|116091||1 376974|L01XX4301|Erivedge|hylki|150|mg|28|stk|1|glas||L01XX43|01.10.2014||R|1|1|0|1|0|1|RRL|0|0|0|100|DKK|964884|1212812|lyfsjukr|||1|28|0||Icepharma hf|Roche Registration Limited|Vismodegibum||964884||964884|1212812||2 377134|QP54AA0105|Noromectin|stl|1|% w/v|250|ml|1|hgl|lausn|QP54AA01|01.03.2014||R|0|0|0|0|0|0|NOB|1|0|0|100|XEU|12341|21528|vetorma|||0|250|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||12341||12341|21528||2 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|1|0|0|0|0|0|ABS|0|0|1|100|DKK|4154|6772|lyfalmen|V0116|4783|1|14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4154||4154|6772||1 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|11305|8127|lyfalmen|V0182|5467|1|42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||5145||5145|8127||1 378535|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2470|4468|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2470||2470|4468||1 378686|D11AX1801|Solaraze|hlaup|3|%|100|g|1|túpa||D11AX18|01.08.2012||R|0|0|0|0|0|0|ALM|0|0|0|100|XEU|15863|22738|lyfalmen|||1|100|0||Vistor hf|Almirall S.A.|Önnur húđlyf-Diclofenacum||15863||15863|22738||1 379521|QP54AB5208|Cydectin TriclaMox|mixtúra|51|mg/ml|1|l|1|glas|1 mg/ml + 50 mg/ml|QP54AB52|01.03.2014||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|8071|14079|vetorma|||0|1|0||Icepharma hf|Zoetis Finland OY|||8071||8071|14079||2 379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|152773|193613|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||152773|193613||1 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|97118|123766|lyfsjukr|||1|2|0|14,2900|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||97118||97118|123766||1 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|136653|173382|lyfsjukr|||1|2|0|28,5700|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||136653||136653|173382||1 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|176213|223030|lyfsjukr|||1|2|0|42,8600|Vistor hf|Novartis Healthcare A/S|Oktreótíđ||176213||176213|223030||1 379760|L03AB1001|PegIntron|sts|150|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|147512|187010|lyfsjukr|||1|4|0|80,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||147512||147512|187010||1 379796|N04BC0406|Ropinirole Portfarma|forđatfl|2|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|8895|6307|lyfalmen|V0532|6307|2|84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||3814||3814|6307||1 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1462|3089|lyfalmen|||2|12,5|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1462||1462|3089||1 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|0|0|0|0|0|0|AGT|0|0|1|100|DKK|1808|3563|lyfalmen|||2|12,5|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1808||1808|3563||1 380162|H01BA0201|Minirin|nefúđi|0,1|mg/ml|5|ml|3|úđagl||H01BA02|01.09.2013||R|0|0|0|0|G|0|FEL|0|0|0|100|DKK|20253|28248|lyfalmen|||1|15|0|60,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||20253||20253|28248||1 380466|B01AF0201|Eliquis|filmhtfl|2,5|mg|168|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|28633|38764|lyfalmen|V0653|38764|1|168|0|84,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||28633|38764||1 380732|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|20000|25420|lyfalmen|V0195|25420|2|100|0|400,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||18000||18000|25420||2 380833|N06DX0106|Memantine ratiopharm|filmhtfl|20|mg|30|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|10979|7225|lyfalmen|V0606|7225|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Memantín||4485||4485|7225||2 381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|7382|5452|lyfalmen|V0143|5178|3|12|0|12,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||3189||3189|5452||2 382162|N04BC0406|Ropinirole Portfarma|forđatfl|4|mg|84|stk|1|glas||N04BC04|01.12.2012||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|15720|10668|lyfalmen|V0533|10668|2|84|0|56,0000|Portfarma ehf|Portfarma|Rópíníról||7002||7002|10668||1 382190|G04BE0307|Sildenafil Mylan|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.03.2014||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|3877|5043|lyfalmen|V0141|5043|2|4|0|2,0000|Icepharma hf|Mylan AB|Síldenafíl||2890||2890|5043||2 382383|V03AN0101|Conoxia|lyfjagas|100|%|10|l|1|hylki|kćlt|V03AN01|01.10.2012||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||0|10|0||Ísaga ehf|AGA AB|Súrefni|||||||5 382474|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|20|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|6554|10055|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||6554||6554|10055||1 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|1246|2174|vetorma|||0|2|0||Icepharma hf|Bayer Animal Health GmbH|||1246||1246|2174||2 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|7507|13096|vetorma|||0|20|0||Icepharma hf|Bayer Animal Health GmbH|||7507||7507|13096||2 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|60|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|120|0||Actavis Group hf|Actavis hf|Ketókónazól|||||||1 383428|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2146|4025|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2146||2146|4025||1 383445|J05AG0101|Viramune|forđatfl|400|mg|30|stk|1|ţpakki||J05AG01|01.03.2013||R|1|0|0|1|0|1|BII|0|0|0|100|DKK|41278|53686|lyfsjukr|||1|30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Nevírapín||41278||41278|53686||1 385214|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|25|lykja||H02AB01|01.07.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|10876|15967|lyfalmen|||1|25|0|116,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||10876||10876|15967||1 385238|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8182|12282|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8182||8182|12282||1 386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|5970|4361|lyfalmen|V0144|3876|3|8|0|16,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||2392||2392|4361||2 386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|54121|70752|lyfalmen|V0184|6336|1|98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||54121||54121|70752||1 386959|C03DA0402|Eplerenone Portfarma|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|30490|37268|lyfalmen|V0111|37268|2|100|0|100,0000|Portfarma ehf|Portfarma ehf|Eplerenón||27441||27441|37268|| 387579|N05BA1206|Alprazolam Krka|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|900|2063|lyfalmen|V0308|2063|2|60|0|30,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||712||712|2063||2 387759|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.04.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|125574|159478|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||125574||125574|159478||1 387854|QM01AE9103|Carprofelican|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|5589|10904|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||5589||5589|10904||2 387991|R03DC0304|Montelukast Teva|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|12977|7174|lyfalmen|V0491|7144|2|98|0|49,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||4448||4448|7174||2 388198|L01XE0901|Torisel|irţ|30|mg|1|hgl|1|pakki||L01XE09|01.09.2012||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|158209|200435|lyfsjukr|||1|1|0||Icepharma hf|Pfizer Limited|Temsirolímus||158209||158209|200435||1 388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3116|5352|lyfalmen|||1|25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3116||3116|5352||1 388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|3927|6461|lyfalmen|||1|30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3927||3927|6461||1 388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|2|0||Vistor hf|AstraZeneca A/S DK|Blöndur|||||||1 388278|N01AH0601|Remifentanil Actavis|sts/irs|5|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.04.2013||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|12961|18149|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||12961||12961|18149||1 388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|7621|11514|lyfalmen|||1|20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||7621||7621|11514||1 388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2357|1821|lyfalmen|V0466|1821|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||535||535|1821||1 389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|2640|4701|lyfalmen|V0410|4701|1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2640||2640|4701||1 389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|1983|3802|lyfalmen|||1|84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||1983||1983|3802||1 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|779|2155|lyfalmen|V0128|2155|1|84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||779||779|2155||1 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|0|0|0|0|G|0|BIP|0|0|0|100|SEK|583|1887|lyfalmen|||1|84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||583||583|1887||1 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|0|0|0|0|G|0|NOC|0|0|1|100|SEK|881|2295|lyfalmen|V0367|1693|1|3|0||Vistor hf|Novartis Healthcare A/S|Díklófenak||881||881|2295||1 389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2611|2385|lyfalmen|V0143|1726|3|4|0|4,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||947||947|2385||2 389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|3771|5144|lyfalmen|V0267|5144|3|100|0|7,2000|LYFIS ehf|LYFIS ehf|Pramipexól||2964||2964|5144||2 389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|46729|61475|lyfalmen|||1|1,5|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||46729|61475||2 389939|N05CF0106|Zopiclone Actavis|filmhtfl|7,5|mg|30|stk|1|ţpakki||N05CF01|01.05.2013||R|1|0|0|0|0|0|AGT|0|0|0|100|SEK|356|1281|lyfalmen|V0312|1281|2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Zópíklón||140||140|1281||1 389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|17952|25360|lyfalmen|||1|50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||17952||17952|25360||1 390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|79788|102016|lyfsjukr|||1|50|0|5,0000|Vistor hf|Orion Corporation|Dexmedetómid||79788||79788|102016||1 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|0|0|0|0|G|0|BRS|0|0|1|100|DKK|2841|4976|lyfalmen|||1|100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2841||2841|4976||1 390784|A10BG0303|Pioglitazone Teva Pharma|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.11.2012||R|1|1|0|0|G|0|TEV|0|0|0|100|XEU|2953|1995|lyfalmen|||2|28|0|14,0000|Medical ehf|Teva Pharma B.V.|Píóglítazón||662||662|1995||2 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|6808|10402|lyfalmen|V0429|8955|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||6808||6808|10402||1 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|2689|4768|lyfalmen|V0037|3947|1|20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2689||2689|4768||1 391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|0|0|0|1|G|0|MSE|0|0|0|100|SEK|24334|33369|lyfalmen|||1|0,75|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||||24334|33369||2 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|13120|19296|lyfalmen|V0196|16246|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13120||13120|19296||1 391376|J05AE1401|Olysio|hylki|150|mg|28|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|1455415|1828428|lyfsjukr|||1|28|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||1455415|1828428||1 391653|L01XE0102|Imatinib Accord|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|336605|269904|lyfsjukr|||2|30|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||213563||213563|269904||1 391730|N01BB0203|Xylocain|húđúđi|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|0|0|0|0|0|0|AZD|0|0|1|100|SEK|2509|4522|lyfalmen|V0656|4522|1|50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2509||2509|4522||1 391954|N07BC0202|Metadon Abcur|töflur|20|mg|20|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2392|4361|lyfalmen|||1|20|0|20,0000|Icepharma hf|Abcur AB|Metadón||2392||2392|4361||2 392000|G03AA0706|Erlibelle|töflur|||63|stk|1|ţpakki||G03AA07|01.08.2014||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|713|2065|lyfalmen|V0545|2065|2|63|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Levónorgestrel og ethinylestradíól||713||713|2065||1 392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|217944|275402|lyfsjukr|||1|500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||217944||217944|275402||2 392402|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|4434|5836|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3470||3470|5836||1 392563|A04AA0101|Zofran|mixtúra|0,8|mg/ml|50|ml|1|glas||A04AA01|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|10298|15176|lyfalmen|||1|50|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||10298||10298|15176||1 393192|N05AH0409|Quetiapin Orion|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|20927|9639|lyfalmen|V0286|9639|2|100|0|50,0000|Portfarma ehf|Orion Corporation|Quetíapín||6250||6250|9639||1 393735|H02AB0908|Plenadren|töflur|20|mg|50|stk|1|glas|međ breyttan losunarhrađa|H02AB09|01.01.2013||R|1|0|0|0|G|0|VIO|0|0|1|100|DKK|83508|107633|lyfalmen|||1|50|0|33,3300|Williams & Halls efh|ViroPharma SPRL|Hýdrókortisón||83508||83508|107633||2 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5468|10672|vetalmen|||0|24|0||Icepharma hf|Zoetis Finland OY|||5468||5468|10672||2 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|3483|lyfalmen|V0327|3483|2|100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1750||1750|3483||2 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín|||||||1 394357|A10BX0205|Repaglinide Accord|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.04.2014||R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|1456|3081|lyfalmen|||2|90|0|22,5000|Portfarma ehf|Accord Healthcare Limited|Repaglíníđ||1456||1456|3081|30.9.2014|1 395372|L01XA0303|Oxaliplatin Actavis|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.05.2013|31.08.2014|R|0|0|0|1|0|1|AGP|0|0|0|100|XEU|26082|8346|lyfsjukr|||2|20|0||Actavis Group hf|Actavis Group PTC ehf|Oxalíplatín||5783||5783|8346||1 395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|144649|182286|lyfsjukr|||1|1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||143748||143748|182286||1 395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|360|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|24617|33724|lyfalmen|V0356|32349|3|360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||24617||24617|33724|| 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|0|0|0|0|0|1|BGB|0|0|0|100|DKK|174499|220879|lyfsjukr|||1|300|0||Icepharma hf|Bayer Pharma AG|Gadópentetat||174499||174499|220879||2 396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|1|0|0|0|G|0|APS|0|0|1|100|DKK|3941|6480|lyfalmen|||1|100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3941||3941|6480||1 396319|QN01BA0201|Procamidor vet.|stl|20|mg/ml|100|ml|10|hgl||QN01BA02|01.03.2014||R|0|0|0|0|0|0|RPG|1|0|0|100|DKK|20721|39960|vetalmen|||0|1000|0||Icepharma hf|Richter Pharma AG|Procaine Hydrochlorid||20721||20721|39960||2 396865|QN03AX9001|Pexion|töflur|100|mg|100|stk|1|glas|handa hundum|QN03AX90|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|5473|10682|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Imepitoin||5473||5473|10682||1 397161|J01CA0414|Amoxicilline Actavis Disper|töflur|375|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1229|2771|lyfalmen|||2|20|0|7,5000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1229||1229|2771||1 397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|0|0|0|1|0|1|MKA|0|1|0|100|SEK|28139|37197|lyfsjukr|||1|20|0||Icepharma hf|Merck KgaA|Cetúxímab||28139||28139|37197||2 397567|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|0|0|1|RBP|0|0|0|100|DKK|1238|1787|lyfsjukr|||1|7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1238||1238|1787||1 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|9631|13900|lyfsjukr|||1|60|0||Icepharma hf|Roche|Capecitabín||9631||9631|13900||2 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|50838|65684|lyfsjukr|||1|120|0||Icepharma hf|Roche|Capecitabín||50838||50838|65684||2 397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|0|0|0|0|0|0|FEL|0|0|0|100|IKR|||lyfalmen|||0|2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat|||||5393||1 398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|7175|3825|lyfalmen|V0012|3061|3|56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3825||2 399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3425|3771|lyfalmen|V0009|3562|3|28|0|28,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||1960||1960|3771||2 399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|371|1597|lyfalmen|V0225|1597|1|100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||371||371|1597||1 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|1|0|0|0|G|0|GSK|0|0|0|100|IKR|2049|2315|lyfalmen|V0244|1910|1|56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||896||896|2315||1 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8778|13097|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8778||8778|13097||1 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír|||||||1 399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|110962|141140|lyfsjukr|||1|2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||110962||110962|141140||2 400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|0|0|0|0|G|0|SNO|0|0|1|100|NOK|1363|2954|lyfalmen|||1|8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1363||1363|2954||1 400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|0|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|150|0||Actavis Group hf|Actavis hf|Blöndur|||||||1 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5013|7947|lyfalmen|||1|100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5013||5013|7947||1 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|217|1386|lyfalmen|||1|25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||217||217|1386||1 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|395|1630|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||395||395|1630||1 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|188|1347|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||188||188|1347||1 400573|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|5245|8264|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||5245||5245|8264||1 401084|M01AH0105|Cloxabix|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2271|3947|lyfalmen|V0037|3947|2|20|0|20,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2089||2089|3947||2 401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|1|0|0|0|G|0|AZA|0|0|0|100|SEK|10058|14848|lyfalmen|V0459|13122|1|56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||10058||10058|14848||1 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|738|2099|lyfalmen|||1|100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||738||738|2099||1 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|1181|2705|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1181||1181|2705||1 402203|D07AC1302|Ovixan|húđlausn|0,1|%|100|ml|1|dropaí||D07AC13|01.08.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2646|4709|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||||2646|4709||1 402395|N06DX0103|Nemdatine|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|38801|19048|lyfalmen|V0607|18984|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||12923||12923|19048||1 402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1934|3847|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1934||1934|3847||1 402873|N06DA0302|Exelon (Lyfjaver)|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|14687|19770|lyfalmen|V0349|19770|3|30|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||13498||13498|19770||3 402988|J02AC0102|Candizol|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|5748|3278|lyfalmen|V0552|3270|2|30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||1600||1600|3278||1 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|0|0|0|0|0|0|IBV|1|0|0|100|DKK|4999|9771|vetalmen|||0|20|0||Vistor hf|Intervet International BV|||4999||4999|9771||1 403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|5709|8899|lyfalmen|||1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Ísradipín||5709||5709|8899||1 403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|35970|47025|lyfsjukr|||1|50|0||Icepharma hf|Pfizer ApS|Metótrexat||||35970|47025||1 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|1300|2868|lyfalmen|||1|13,5|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1300||1300|2868||1 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|0|0|0|0|G|0|SAO|0|0|0|100|XEU|||lyfalmen|||0|10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1943||2 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|63355|81393|lyfsjukr|||1|1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||63355||63355|81393||1 404818|C03AA0305|Hydromed|töflur|25|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1160|2676|lyfalmen|||2|100|0|100,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||1160||1160|2676||1 404832|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||36|stk|1|ţpakki||R02AA03|01.03.2014||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|665|960|lyfsjukr|||1|5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||665||665|960||2 404997|A10BX1001|Lyxumia|stl|||2|áf-penni|1|pakki|10 og 20 mcg|A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|11537|16871|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Lixisenatíd||11537||11537|16871||1 405019|C03CA0110|Impugan|töflur|40|mg|250|stk|1|glas||C03CA01|01.11.2013||R|1|0|0|0|G|0|AGT|0|0|0|100|SEK|978|2427|lyfalmen|||2|250|0|250,0000|Actavis Group hf|Actavis Group hf|Fúrósemíđ||978||978|2427||1 405076|C03EA0114|Diuramin mite|töflur|27,5|mg|100|stk|1|ţpakki|2,5+25 mg|C03EA01|01.05.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1398|2252|lyfalmen|V0559|2252|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Hýdróklórtíazíđ og kalíumsparandi lyf||850||850|2252||2 405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|0|0|0|0|0|0|AEL|1|0|0|100|XEU|7905|15351|vetalmen|||0|10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||7905||7905|15351||2 405589|J07BD5203|Priorix|sts|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|1817|3575|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1817||1817|3575||1 405597|J07BD5203|Priorix|sts|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|19370|27139|lyfalmen|||1|5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||19370||19370|27139||1 405677|J01DD0401|Rocephalin|irţ|2|g|1|hgl|1|pakki|lausn|J01DD04|01.03.2013||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4109|5930|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Roche|Ceftríaxón||4109||4109|5930||2 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|19889|27791|lyfalmen|||1|100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||19889||19889|27791||1 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|59969|78091|lyfalmen|||1|100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||59969||59969|78091||1 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|70397|91178|lyfalmen|||1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||70397||70397|91178||1 406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|0|0|0|1|0|1|SDG|0|1|0|100|DKK|75959|97211|lyfsjukr|||1|7,5|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||75959||75959|97211||1 407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|3264|3088|lyfalmen|||2|98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||1461||1461|3088|30.9.2014|2 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|163|1312|lyfalmen|||1|25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||163||163|1312||1 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|354|1574|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||354||354|1574||1 408266|N05BA1206|Alprazolam Krka|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.08.2012||R|1|0|0|0|0|0|KRK|0|0|0|100|XEU|1901|2991|lyfalmen|V0310|2991|2|60|0|60,0000|LYFIS ehf|Krka Sverige AB|Alprazólam||1390||1390|2991||2 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2793|4910|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2793||2793|4910||1 408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2190|4085|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2190||2190|4085||1 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|0|0|0|0|0|0|PER|0|0|1|100|DKK|4156|6775|lyfalmen|||1|35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4156||4156|6775||1 409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|skammtar|1|stauk||R01AD05|01.01.1992||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3979|6532|lyfalmen|||1|200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3979||3979|6532||1 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|12103|18019|lyfalmen|||1|98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12103||12103|18019||1 409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|73098|94568|lyfalmen|||1|1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||73098||73098|94568||1 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|0|0|0|0|0|0|BII|0|0|0|100|DKK|9807|14505|lyfalmen|||1|98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||9807||9807|14505||1 409927|G04BD1201|Betmiga|forđatfl|50|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16843|23968|lyfalmen|V0651|23968|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16843||16843|23968||1 409975|M01AH0105|Cloxabix|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|11080|16246|lyfalmen|V0196|16246|2|100|0|100,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||11080||11080|16246||2 410077|N02CC0402|Maxalt Smelt|frţ.tfl|5|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5311|8355|lyfalmen|V0620|8355|1|6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5311||5311|8355||1 410173|N02AA0506|Oxikodon Depot Actavis|forđatfl|10|mg|98|stk|1|glas||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|3014|5073|lyfalmen|V0598|5073|2|98|0|13,0700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||2912||2912|5073||1 410382|C03DA0103|Spiron|töflur|100|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|3807|5340|lyfalmen|V0093|5340|2|100|0|133,3300|Portfarma ehf|Orion Corporation|Spírónólaktón||3107||3107|5340||1 410469|L04AB0202|Remsima|irţ|100|mg|1|hgl|1|pakki||L04AB02|01.01.2014||R|0|1|0|1|0|1|CHH|0|1|0|100|DKK|61848|79502|lyfsjukr|||2|1|0|26,6700|Portfarma ehf|Celltrion Healthcare Hungary Kft.|Infliximab||61848||61848|79502||2 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|1|0|0|0|0|0|REP|0|0|0|100|SEK|1067|2549|lyfalmen|||1|20|0|6,2000|Vistor hf|Recip AB|Klórókín||1067||1067|2549||1 411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|638|1962|lyfalmen|||2|50|0|10,0000|Icepharma hf|Mylan AB|Baklófen||638||638|1962||2 411184|N02BE0118|Paracetamol-ratiopharm|töflur|500|mg|100|stk|1|glas||N02BE01|01.10.2013||R|1|0|0|0|0|0|RGM|0|0|1|100|XEU|470|1656|lyfalmen|V0230|1645|2|100|0|16,6667|Medical ehf|ratiopharm GmbH|Paracetamól||414||414|1656||2 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|4741|6842|lyfsjukr|||1|50|0|16,6667|Icepharma hf|Roche|Mídazólam||4741||4741|6842||2 411616|N06BA0404|Methylphenidate Sandoz|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.11.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|8330|9463|lyfalmen|V0624|9463|2|30|0|36,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||6121||6121|9463||1 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|25746|34194|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||25746||25746|34194||1 411859|J02AC0102|Candizol|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.02.2014||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|V0554|1879|2|1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól|||||1879||1 411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|skammtar|1|pakki||N02CC01|01.07.2000||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|7532|11393|lyfalmen|||1|6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7532||7532|11393||1 412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|áf.spr|1|pakki||L02AE03|01.01.1990||R|0|0|0|1|G|0|AZA|0|0|0|100|SEK|20531|28596|lyfalmen|||1|1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||20531||20531|28596||1 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|3418|4933|lyfsjukr|||1|3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3418||3418|4933||1 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|0|0|0|0|0|0|MER|1|0|0|100|XEU|6047|11784|vetalmen|||0|100|0||Vistor hf|Merial|||6047||6047|11784||1 412468|QM01AC0606|Meloxidolor|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.07.2014||R|0|0|0|0|0|0|VEB|1|0|0|100|XEU|4798|9385|vetalmen|||0|20|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||4798||4798|9385||2 412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|0|0|0|1|0|1|BIB|0|0|0|100|XEU|119305|151610|lyfsjukr|||1|2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||119305||119305|151610||2 412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|56852|74179|lyfalmen|||1|1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||56852||56852|74179||1 412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|3204|5472|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Tamoxífen||3204||3204|5472||2 412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|3306|5612|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Tamoxífen||3306||3306|5612||2 413988|N02BE0107|Paratabs|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.03.2013||L|1|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 414006|N06AB0404|Citalopram Bluefish|filmhtfl|10|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|890|1842|lyfalmen|V0062|1842|2|30|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||550||550|1842||2 414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|18255|7716|lyfalmen|V0342|7716|2|98|0|130,6700|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4844||4844|7716||2 414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|1|0|0|0|G|0|SEV|0|0|0|100|DKK|4184|6813|lyfalmen|||1|90|0|54,0000|Icepharma hf|Servier|Indapamíđ||4184||4184|6813||2 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|1285|2847|lyfalmen|||1|300|0|6,0000|Vistor hf|Novartis Healthcare A/S|Karbamazepín||1285||1285|2847||1 415338|N05AA0201|Nozinan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AA02|01.11.2012||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1879|3660|lyfalmen|||1|100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1879||1879|3660||1 415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|1|0|0|0|0|0|PSA|0|0|0|100|XEU|10274|6913|lyfalmen|V0253|6913|2|100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||4257||4257|6913||1 416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|9235|9420|lyfalmen|V0088|2419|1|98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6090||6090|9420||1 416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|4213|2576|lyfalmen|V0005|2457|2|28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||1087||1087|2576||1 416630|N06BA0702|Modafinil Bluefish|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|7200|9023|lyfalmen|V0657|9023|2|30|0|10,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Modafinil||5800||5800|9023||2 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.03.2013||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4706|7527|lyfalmen|||1|300|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||4706||4706|7527||1 416859|A01AA0101|Duraphat|tanndrei|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|0|0|0|0|G|0|GOG|0|0|1|100|XEU|2812|4936|lyfalmen|||1|10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2812||2812|4936||2 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1262|2816|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Azelainsýra||1262||1262|2816||2 417266|N05AH0409|Quetiapin Orion|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.10.2012||R|1|0|0|0|G|0|OPF|0|0|0|100|IKR|10510|4966|lyfalmen|V0285|4509|2|100|0|25,0000|Portfarma ehf|Orion Corporation|Quetíapín||2834||2834|4966||1 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|42140|54768|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||42140||42140|54768||1 417880|B02BD0901|BeneFIX|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD09|01.07.2012||R|0|0|0|1|0|1|IPI|0|1|0|100|DKK|96666|123198|lyfsjukr|||1|1|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||96666||96666|123198||1 418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|33316|44642|lyfalmen|V0460|44642|1|180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||33316|44642||1 418122|H02AB0205|Dexametason Abcur|töflur|4|mg|20|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|4137|6749|lyfalmen|||2|20|0|53,3300|Icepharma hf|Abcur AB|Dexametasón||4137||4137|6749||2 418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|0|0|0|1|0|1|BIO|0|0|0|100|DKK|130995|166281|lyfsjukr|||1|18,76|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||130995||130995|166281||3 418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|0|0|0|0|G|0|SNO|0|0|0|100|NOK|6734|10301|lyfalmen|V0014|10301|1|60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||6734||6734|10301||1 418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|1|0|0|0|G|0|APC|0|0|1|100|XEU|2282|2988|lyfalmen|V0458|2725|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1388||1388|2988||1 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|2685|4762|lyfalmen|||1|100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||2685||2685|4762||1 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|1|0|0|0|G|0|LEP|0|0|0|100|DKK|6919|10554|lyfalmen|||1|100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||6919||6919|10554||1 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|1|0|0|1|0|1|MSD|0|0|0|100|DKK|50805|65643|lyfsjukr|||1|180|0|30,0000|Vistor hf|M.S.D.|Indínavír||50805||50805|65643||1 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|1|0|0|1|0|1|ORP|0|0|0|100|DKK|38551|50264|lyfsjukr|||1|100|0|7,5000|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||38551||38551|50264||3 419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|851|2253|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||851||851|2253||1 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|11729|17134|lyfalmen|||1|10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||11729||11729|17134||1 420678|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.01.2013||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4768|6881|lyfsjukr|||1|7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||4768||4768|6881||1 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1098|2591|lyfalmen|V0036|2590|1|30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1098||1098|2591||1 421816|QN04BC0201|Prascend|töflur|1|mg|160|stk|1|ţpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|32918|63380|vetalmen|||0|160|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||32918||32918|63380||1 421938|R06AX2705|Desloratadine Teva|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.09.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|XEU|2283|2725|lyfalmen|V0458|2725|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Deslóratadín||1196||1196|2725||2 422115|N02AA0506|Oxikodon Depot Actavis|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|590|1896|lyfalmen|V0596|1896|2|28|0|1,8600|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||590||590|1896||1 422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1421|3033|lyfalmen|V0051|2184|1|100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1421||1421|3033||1 422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|3191|5454|lyfalmen|V0049|4198|1|98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3191||3191|5454||1 422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|5247|8267|lyfalmen|V0054|7269|1|98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||5247||5247|8267||1 422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|0|0|0|1|0|1|CSB|0|0|0|100|SEK|66849|85778|lyfsjukr|||1|1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||66849||66849|85778||2 423361|G03AA1201|Yasmin|filmhtfl|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.01.2014||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|3239|5520|lyfalmen|V0192|4450|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og ethinylestradíól||||3239|5520||2 423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4596|3825|lyfalmen|V0011|3009|3|56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2000||2000|3825||2 423703|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.05.2014||R|0|0|0|0|G|0|TEA|0|0|0|100|DKK|742|2104|lyfalmen|||1|10|0||Vistor hf|Laboratories THEA|Nafazólín í blöndum međ öđrum efnum||742||742|2104||1 423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|21278|28586|lyfsjukr|||2|1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||21278||21278|28586||1 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1577|2751|vetorma|||0|24|0||Vistor hf|Intervet International BV|||1577||1577|2751||1 425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|1|0|1|0|0|0|MYL|0|0|0|100|SEK|1011|2472|lyfalmen|||2|100|0|100,0000|Icepharma hf|Mylan AB|Flúnítrazepam||1011||1011|2472||2 425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|0|0|1|1|0|1|RBP|0|0|0|100|DKK|4643|6656|lyfsjukr|||1|28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4612||4612|6656||1 425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|1|0|0|0|G|0|AHF|0|0|0|100|IKR|2248|3995|lyfalmen|||2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group hf|Lósartan||2124||2124|3995||1 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|634|1957|lyfalmen|||1|20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||634||634|1957||1 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|828|2222|lyfalmen|||1|30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||828||828|2222||1 427075|M01AE0115|Alvofen Express|hylki|400|mg|50|stk|1|ţpakki||M01AE01|01.04.2014||L|1|0|0|0|0|0|IPC|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Portfarma ehf|Alvogen IPco S.á.r.l.|Íbúprófen|||||||2 427186|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|8725|13025|lyfalmen|||1|28|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||8725||8725|13025||1 427321|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|3|glös||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|6738|10307|lyfalmen|V0658|10307|0|7,5|0|75,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||6738||6738|10307||1 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|0|0|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||0|30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2849||1 427803|R03AK0604|Relanio|innönddu|300|mcg/sk|180|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|19495|21028|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||14500||14500|21028||2 428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 428089|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0136|1814|0|25|0|5,0000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1814||1 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|836|2233|lyfalmen|V0629|2233|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||836||836|2233||1 428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|28356|31426|lyfalmen|V0344|31426|3|112|0|37,3300|LYFIS ehf|LYFIS ehf|Rívastigmín||22786||22786|31426||2 429098|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|3709|5353|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3709||3709|5353||2 429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|glas||J02AC04|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|93939|119776|lyfsjukr|||1|105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||93939||93939|119776||1 429703|A02BC0508|Esomeprazol Actavis|sţ-tfl|40|mg|100|stk|1|glas||A02BC05|01.04.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|6361|5467|lyfalmen|||2|100|0|133,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3200||3200|5467|30.9.2014|1 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3974|6526|lyfalmen|V0093|5340|1|100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||3974||3974|6526||1 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|1598|2306|lyfsjukr|||1|50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1598||1598|2306||1 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|0|0|0|0|0|1|ROC|0|0|0|100|DKK|1403|2025|lyfsjukr|||1|50|0|3,3333|Icepharma hf|Roche|Mídazólam||1403||1403|2025||2 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|4352|8529|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||4352||4352|8529||1 430232|L03AB1001|PegIntron|sts|100|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|106522|135568|lyfsjukr|||1|4|0|53,3300|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||106522||106522|135568||1 430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|0|0|0|0|G|0|WEH|0|0|0|100|XEU|28489|6532|lyfalmen|V0184|6336|2|98|0|98,0000|Williams & Halls efh|Williams & Halls ehf|Anastrózól||3979||3979|6532||2 430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|2883|2520|lyfalmen|V0144|1938|3|4|0|8,0000|LYFIS ehf|LYFIS ehf|Síldenafíl||1046||1046|2520||2 430710|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áfspr||J07AP03|01.07.1994||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2384|4351|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir mótefnavakar||2384||2384|4351||2 430862|J01FA1005|Azithromycin Actavis|filmhtfl|500|mg|2|stk|1|ţpakki||J01FA10|01.05.2013||R|1|0|0|0|0|0|AHF|0|0|1|100|XEU|1064|2545|lyfalmen|V0173|2545|2|2|0|3,3300|Actavis Group PTC ehf|Actavis Group hf|Azitrómýcín||1064||1064|2545||1 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|740|2102|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||740||740|2102||1 431154|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.11.2013||L|0|0|0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa|||0|4|0||Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 431193|N02AB0306|Instanyl|nefúđi|100|mcg|6|sk-ílát|1|pakki||N02AB03|01.08.2014||R|0|1|1|1|0|0|TPA|0|0|0|100|DKK|9534|14131|lyfalmen|||1|6|0|1,0000|Vistor hf|Takeda Pharma A/S|Fentanýl||9534||9534|14131||1 431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|0|0|0|1|0|1|AVS|0|0|0|100|NOK|153529|194561|lyfsjukr|||1|8|0||Vistor hf|Aventis Pharma SA|Docetaxel||153529||153529|194561||1 431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|1375|2970|lyfalmen|||1|20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1375|2970||1 431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|1|0|0|0|G|0|PER|0|0|1|100|DKK|4265|6924|lyfalmen|||1|100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4265||4265|6924||1 431985|D07XC0101|Diprosalic|húđlausn|||100|ml|1|glas||D07XC01|01.04.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2208|4110|lyfalmen|V0640|4110|1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||2208||2208|4110||1 432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|0|0|0|0|G|0|NDR|0|0|0|100|SEK|31247|42045|lyfalmen|||1|12,5|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||31247|42045||1 432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|3606|7097|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3606||3606|7097||2 433126|N02BE0102|Panodil Brus|freyđit|500|mg|20|stk|1|ţpakki||N02BE01|01.05.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen|||0|20|0|3,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1764||1 433194|N05AD0301|Buronil|húđuđtfl|25|mg|100|stk|1|glas||N05AD03|01.01.2013||R|1|0|0|0|G|0|MEV|0|0|0|100|DKK|1722|3445|lyfalmen|||1|100|0|8,3333|Vistor hf|MediLink A/S|Melperón||1722||1722|3445||1 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|10757|15804|lyfalmen|||1|100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||10757||10757|15804||1 433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2516|4531|lyfalmen|||1|28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2516||2516|4531||1 433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|5507|8623|lyfalmen|||1|28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5507||5507|8623||1 434088|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.03.2013||R|0|0|0|0|0|1|BYP|0|0|0|100|DKK|192529|243506|lyfsjukr|||1|150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||192529||192529|243506||2 434091|N06DX0102|Memantine Merz|filmhtfl|10|mg|100|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|17896|9831|lyfalmen|V0605|9185|2|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||6390||6390|9831||1 434169|R03DC0304|Montelukast Teva|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.01.2013||R|1|0|0|0|G|0|TEV|0|0|0|100|XEU|6788|3862|lyfalmen|V0490|2433|2|98|0|98,0000|Medical ehf|Teva Pharma B.V.|Montelúkast||2027||2027|3862||2 434261|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|1000|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|NOK|87013|134773|veteldis|||0|1000|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||82607||82607|134773||1 434461|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|8796|13122|lyfalmen|V0139|13122|1|56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||8796||8796|13122||1 434576|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|4021|3688|lyfalmen|V0010|3688|2|98|0|98,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1900||1900|3688||2 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1105|1928|vetorma|||0|10|0||Vistor hf|Intervet International BV|||1105||1105|1928||1 434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|MCS|0|0|1|100|SEK|842|2241|lyfalmen|||1|50|0||Vistor hf|McNeil Sweden AB|Blöndur||842||842|2241||1 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5310|8353|lyfalmen|||1|1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5310||5310|8353||1 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|5310|8353|lyfalmen|||1|1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5310||5310|8353||1 434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|XEU|9995|14762|lyfalmen|||1|100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||9995||9995|14762||2 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|1|0|0|0|0|0|AZA|0|0|0|100|SEK|7809|10405|lyfalmen|||1|100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||6810||6810|10405|30.9.2014|1 435728|N06AX1105|Mirtazapine Bluefish|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|0|0|BLP|0|0|0|100|IKR|5573|8713|lyfalmen|V0304|8713|2|96|0|144,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||5573||5573|8713||2 436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|226731|286430|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||226731||226731|286430||2 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|1|0|0|0|0|0|HES|0|0|0|100|DKK|3440|5795|lyfalmen|||1|28|0|28,0000|Vistor hf|Novartis Healthcare A/S|Valsartan og ţvagrćsilyf||3440||3440|5795||1 436042|R03DC0305|Montelukast Navamedic|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6922|7174|lyfalmen|V0491|7144|2|98|0|49,0000|Artasan ehf|Navamedic ASA|Montelúkast||4448||4448|7174||1 436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 436394|H01BA0202|Octostim|nefúđi|0,15|mg/sk|2,5|ml|1|úđagl||H01BA02|01.01.2013||R|0|0|0|1|0|1|FEL|0|0|0|100|DKK|41956|54537|lyfsjukr|||1|2,5|0|150,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||41956||41956|54537||1 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|721|2076|lyfalmen|||1|15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||721||721|2076||1 436471|N06DX0105|Memantine Mylan|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|16778|9632|lyfalmen|V0605|9001|2|98|0|49,0000|Icepharma hf|Generics UK Ltd|Memantín||6245||6245|9632||2 436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|235524|297465|lyfsjukr|||1|500|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||235524||235524|297465||2 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|899|2319|lyfalmen|||1|100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||899||899|2319||1 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3289|5589|lyfalmen|||1|100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3289||3289|5589||1 437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|8128|6851|lyfalmen|V0029|6851|3|100|0|100,0000|LYFIS ehf|LYFIS ehf|Klópídógrel||4212||4212|6851||2 437427|R06AX2704|Desloratadine ratiopharm|munndr.t|5|mg|10|stk|1|ţpakki||R06AX27|01.04.2014||L|0|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyflausa|||2|10|0|10,0000|Medical ehf|ratiopharm GmbH|Deslóratadín|||||||2 437774|N06DX0103|Nemdatine|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18144|9077|lyfalmen|V0605|9001|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||5839||5839|9077||1 437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|0|0|0|1|0|1|AST|0|1|0|100|DKK|66015|84731|lyfsjukr|||1|125|0||Icepharma hf|Astellas Pharma GmbH|Bendamústín||66015||66015|84731||2 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|dropaí|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|0|0|0|0|G|0|CLA|0|0|1|100|USD|1194|2723|lyfalmen|||1|10|0||Vistor hf|Alcon Nordic A/S|Hýdrókortisón og sýkingalyf||1194||1194|2723||1 438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10801|15865|lyfalmen|V0334|3078|1|98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||10801||10801|15865||1 438639|N06DX0107|Zalatine|filmhtfl|10|mg|98|stk|1|ţpakki||N06DX01|01.03.2014||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|10527|9077|lyfalmen|V0605|9001|2|98|0|49,0000|Williams & Halls efh|Williams & Halls ehf|Memantín||5839||5839|9077||2 438759|L01XE1501|Zelboraf|filmhtfl|240|mg|56|stk|1|ţpakki||L01XE15|01.08.2012||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|323600|408001|lyfsjukr|||1|56|0||Icepharma hf|Roche Registration Limited|Vemurafeníb||323600||323600|408001||2 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||1|10|0|10,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|0|0|MBV|0|0|1|100|IKR|||lyflausa|||1|30|0|30,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||||1 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||L|1|0|0|0|G|0|MBV|0|0|1|100|DKK|||lyfalmen|V0362|2091|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme B.V.|Lóratadín|||||8970||1 438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|160062|202760|lyfsjukr|||1|2,6|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||160062||160062|202760||1 439198|N04BC0505|Oprymea|forđatfl|0,26|mg|10|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|1300|2868|lyfalmen|V0634|1685|2|10|0|1,0400|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||1300||1300|2868||2 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|2675|4749|lyfalmen|||1|14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2675||2675|4749||1 439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|8039|12086|lyfalmen|||1|98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8039||8039|12086||1 439594|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|21492|29802|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb og simvastatín||21492||21492|29802||1 439719|S01EE0402|IZBA|augndr|30|mcg/ml|2,5|ml|1|glas||S01EE04|01.10.2014||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|2246|4162|lyfalmen|V0658|3436|0|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Travóprost||2246||2246|4162||1 439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|0|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín|||||||1 439908|G03AA0904|Denise|töflur|||126|stk|1|ţpakki|150/20 mcg|G03AA09|01.05.2014||R|0|0|0|0|0|0|RGM|0|0|0|100|IKR|2900|3825|lyfalmen|V0065|3825|2|126|0|168,0000|Medical ehf|ratiopharm GmbH|Desógestrel og ethinylestradíól||2000||2000|3825||2 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1066|2319|lyfalmen|V0163|1906|1|70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2319||1 440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|1525|2201|lyfsjukr|||2|10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1525||1525|2201||1 440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|2407|3474|lyfsjukr|||2|10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2407||2407|3474||1 440713|A02BC0508|Esomeprazol Actavis|sţ-tfl|20|mg|100|stk|1|ţpakki||A02BC05|01.06.2014||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|4046|5397|lyfalmen|V0011|5373|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3149||3149|5397||1 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|900|2320|lyfalmen|V0046|2032|1|100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||900||900|2320||1 441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|0|0|0|0|0|0|JAS|0|0|1|100|SEK|1150|2662|lyfalmen|||1|30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1150||1150|2662||1 441341|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|1023|2489|lyfalmen|V0046|2032|2|100|0|33,3333|Vistor hf|Takeda Pharma A/S|Spírónólaktón||1023||1023|2489||1 441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|0|0|0|1|0|1|GSL|0|0|0|100|DKK|121901|154868|lyfsjukr|||1|30|0||Gilead Nordic|Gilead Science International Ltd|Emtrícítabín, rilpívírin og tenófóvír||121901||121901|154868||2 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|ţpakki||G03DC02|01.12.1972||R|0|0|0|0|G|0|BAP|0|0|0|100|DKK|1024|2490|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1024||1024|2490||2 442407|N05AH0312|Zalasta|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.01.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|XEU|14050|3118|lyfalmen|V0283|2526|2|28|0|42,0000|LYFIS ehf|Krka d.d. Novo mesto|Olanzapín||1483||1483|3118||2 442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|0|1|0|0|G|0|BII|0|0|0|100|DKK|11105|16280|lyfalmen|V0460|14881|1|60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11105|16280||1 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|0|0|0|0|G|0|NAS|0|0|1|100|DKK|3354|5677|lyfalmen|||1|1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3354||3354|5677||1 443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|25568|34918|lyfalmen|||1|90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||25568||25568|34918||1 443500|L01XA0211|Carboplatin Actavis|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.05.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|4504|6500|lyfsjukr|||2|45|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Karbóplatín||4504||4504|6500||1 443904|J01FA0902|Clarithromycin ratiopharm|filmhtfl|500|mg|14|stk|1|ţpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|2700|4783|lyfalmen|V0116|4783|2|14|0|14,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||2700||2700|4783||2 444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7403|11216|lyfalmen|||1|20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7403||7403|11216||1 444102|A06AB0603|Senokot (Icepharma)|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.2012||R|1|0|0|0|0|0|FMV|0|0|0|100|GBP|1014|2476|lyfalmen|||3|60|0||Icepharma hf|Icepharma hf|Senna||1014||1014|2476||2 444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|1|0|0|0|0|0|ELI|0|0|0|100|DKK|3039|5247|lyfalmen|V0061|3370|1|30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3039||3039|5247||2 444362|N01AF0302|Pentocur|sts|1|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|23938|31925|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||23938||23938|31925||2 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|0|0|0|0|G|0|ROC|0|0|0|100|DKK|2425|4407|lyfalmen|||1|100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2425||2425|4407||2 444574|N07CA0102|Betahistin ratiopharm|töflur|8|mg|100|stk|1|ţpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|2250|4167|lyfalmen|||2|100|0|33,3300|Medical ehf|ratiopharm Oy|Betahistín||2250||2250|4167||2 445149|R03AK1001|Relvar Ellipta|innönddu|114|mcg/sk|30|skammtar|1|pakki|92+22 mcg|R03AK10|01.04.2014||R|0|0|0|0|G|0|GGL|0|0|0|100|GBP|6095|9427|lyfalmen|||1|30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Vilanterol og flútícason||6095||6095|9427||1 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|0|0|0|0|G|0|LEO|0|0|1|100|DKK|1544|3201|lyfalmen|||1|30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1544||1544|3201||1 445479|N04BC0407|Ropinirol Actavis|forđatfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8381|6307|lyfalmen|V0532|6307|2|84|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||3814||3814|6307||1 446268|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|6589|10103|lyfalmen|||1|98|0|65,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||6589|10103||2 446618|N03AF0301|Inovelon|mixtúra|40|mg/ml|460|ml|1|fl||N03AF03|01.09.2012||R|0|0|0|1|G|0|EIS|0|0|0|100|SEK|18297|25793|lyfalmen|||1|460|0|13,1400|Vistor hf|Eisai Ltd|Rúfínamíđ||18297||18297|25793||1 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|10296|15174|lyfalmen|||1|3,6|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10296||10296|15174||1 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|5868|9116|lyfalmen|||1|2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||5868||5868|9116||1 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|7263|11025|lyfalmen|||1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7263||7263|11025||1 447145|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.09.2014||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1044|2517|lyfalmen|V0654|2517|1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||||1044|2517|| 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|0|0|0|0|G|0|PER|0|0|1|100|DKK|8643|12913|lyfalmen|||1|3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||8643||8643|12913||1 447753|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|1262|1773|lyfalmen|V0330|1773|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||500||500|1773||2 447785|C10AA0703|Rosuvastatin Krka|filmhtfl|5|mg|30|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|3300|5604|lyfalmen|V0171|5604|2|30|0|15,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3300||3300|5604||2 448125|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|2912|5073|lyfalmen|||1|100|0|33,3333|Icepharma hf|Bayer Pharma AG|Nífedipín||||2912|5073||2 448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|725|2081|lyfalmen|||1|10|0||Icepharma hf|Bayer AB|Flúókortólón||725||725|2081||2 448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|0|0|0|0|0|0|BAB|0|0|0|100|DKK|1329|2907|lyfalmen|||1|30|0||Icepharma hf|Bayer AB|Flúókortólón||1329||1329|2907||2 448245|N07BA0150|Nicotinell Spearmint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|24|0|3,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|2058|3905|lyfalmen|V0202|3520|1|50|0|25,0000|Vistor hf|Novartis Healthcare A/S|Baklófen||2058||2058|3905||1 449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|0|0|0|0|0|1|BRU|0|0|0|100|XEU|1115|1609|lyfsjukr|||2|0,25|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1115||1115|1609||1 449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1310|2881|lyfalmen|||2|98|0|130,6667|Icepharma hf|Mylan AB|Atenólól||1310||1310|2881||2 449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|0|0|0|0|0|1|AGT|0|0|0|100|DKK|5706|8235|lyfsjukr|||2|10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5706||5706|8235||1 449868|B01AF0101|Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|3820|6315|lyfalmen|||1|10|0|10,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||3820||3820|6315||2 449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|0|0|0|0|G|0|ELI|0|0|0|100|XEU|5236|8252|lyfalmen|||1|15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5236||5236|8252||2 450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|0|0|1|0|0|0|LEV|1|0|0|100|XEU|4540|8890|vetalmen|||0|100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4540||4540|8890||2 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|ţpakki|875+125 mg|J01CR02|01.01.1997||R|0|0|0|0|0|0|GSK|0|0|1|100|IKR|1115|2319|lyfalmen|V0169|1719|1|12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||899||899|2319||1 450201|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.07.2014||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|132680|168396|lyfsjukr|||1|20|0||Vistor hf|Merck Sharp & Dohme Limited|Sugammadex||132680||132680|168396||1 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|2781|3932|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2078||2078|3932||1 450979|QP54AA0107|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|7246|12640|vetorma|||0|2,5|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||7246||7246|12640||2 450993|R07AX0101|INOmax|innö.gas|800|ppm|10|l|1|gashyl||R07AX01|01.09.2014||R|0|1|0|1|0|1|LIN|0|0|0|100|XEU|20795|27980|lyfsjukr|||1|10|0||Ísaga ehf - Linde Heathcare|Linde Healthcare AB|Nituroxíđ||||20795|27980||5 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|50127|64792|lyfsjukr|||1|100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||50127||50127|64792||2 451293|N05AX1204|ABILIFY MAINTENA|sts|400|mg|1|hgl|1|pakki||N05AX12|01.07.2014||R|0|0|0|0|0|0|UKA|0|0|0|100|DKK|46609|61324|lyfalmen|||1|1|0|26,6700|Lundbeck Export A/S|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||46609||46609|61324||1 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|48462|62702|lyfsjukr|||1|150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||48462||48462|62702||2 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|64617|82977|lyfsjukr|||1|200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||64617||64617|82977||2 451761|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2013||R|0|0|0|1|G|0|APP|0|0|0|100|XEU|47074|61908|lyfalmen|||1|100|0||Artasan ehf|Aspen Pharma Trading Limited|Búsúlfan||47074||47074|61908||1 452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|120|0||Vistor hf|McNeil Sweden AB|Ketókónazól|||||||1 452258|R03AK1101|Flutiform|innúđal|260|mcg/sk|120|skammtar|1|pakki|250+10 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|8005|12040|lyfalmen|||1|120|0|60,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||8005||8005|12040||2 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|0|0|0|0|G|0|ROA|0|0|1|100|DKK|1425|3039|lyfalmen|||1|5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1425||1425|3039||2 452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|0|0|0|0|0|0|LHS|0|0|0|100|XEU|10856|18938|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||10856||10856|18938||2 452482|V07AB0009|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 452594|A02BC0403|Rabeprazol Krka|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|3500|2457|lyfalmen|V0010|2107|2|56|0|56,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2457||2 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|0|0|0|0|0|0|LAB|0|0|1|100|SEK|11182|16386|lyfalmen|||1|3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||11182||11182|16386||1 452866|B05AA0114|Albuman|irl|200|g/líter|100|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|8389|12107|lyfsjukr|||1|100|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||8389||8389|12107||2 452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|0|0|0|0|0|0|LCC|0|0|0|100|DKK|2280|4208|lyfalmen|||1|90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2280||2280|4208||1 452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|1503|3145|lyfalmen|V0597|2374|1|28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||1503||1503|3145||2 452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|4053|6634|lyfalmen|V0598|5073|1|98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||4053||4053|6634||2 452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|2858|4999|lyfalmen|V0584|3449|1|28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||2858||2858|4999||2 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||R|0|0|0|0|0|0|MEF|0|0|0|100|XEU|1434|2502|vetorma|||0|6,4|0||Vistor hf|Merial (MSD)|Ivermectinum||1434||1434|2502||1 453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|7779|11731|lyfalmen|V0585|8523|1|98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||7779||7779|11731||2 453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|5508|8624|lyfalmen|V0586|6501|1|28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||5508||5508|8624||2 453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|1|0|1|0|G|0|NOP|0|0|0|100|DKK|15351|22096|lyfalmen|V0587|14636|1|98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||15351||15351|22096||2 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2678|3865|lyfsjukr|||1|1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2678||2678|3865||1 454036|A09AA0206|Creon 10.000|sh-hylki|||100|stk|1|plglas||A09AA02|01.07.2013||R|1|0|0|0|G|0|APR|0|0|0|100|DKK|3111|5345|lyfalmen|||1|100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3111||3111|5345||1 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|14922|21557|lyfalmen|||1|28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||14922||14922|21557||1 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|42334|38274|lyfalmen|V0341|7716|1|98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||28242||28242|38274||1 454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|1|0|0|0|0|0|POF|0|0|0|100|IKR|2138|2215|lyfalmen|V0004|2215|2|28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||823||823|2215||1 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|16750|23851|lyfalmen|||1|28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||16750||16750|23851||1 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|46641|42609|lyfalmen|V0342|7716|1|98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||31696||31696|42609||1 454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|0|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól|||||||1 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|0|0|0|1|0|1|SKB|0|0|0|100|GBP|54298|70026|lyfsjukr|||1|1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||54298||54298|70026||1 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|1117|2222|vetalmen|||0|100|0||Vistor hf|Boehringer Ingelheim Danmark|||1117||1117|2222||1 454955|J01CA0414|Amoxicilline Actavis Disper|töflur|750|mg|20|stk|1|ţpakki|hrćra vel í vatni og drekka|J01CA04|01.03.2013||R|0|0|0|0|0|0|AVB|0|0|1|100|XEU|1678|3385|lyfalmen|||2|20|0|15,0000|Actavis Group PTC ehf|Actavis BV|Amoxicillín||1678||1678|3385||1 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|1|0|0|0|G|0|BGB|0|0|0|100|DKK|1044|2517|lyfalmen|V0654|2517|1|30|0|5,0000|Icepharma hf|Bayer Pharma AG|Acarbósa||1044||1044|2517||2 455406|L01XA0101|Cisplatin Strides|irţ|1|mg/ml|100|ml|1|hgl||L01XA01|01.11.2013||R|0|0|0|1|0|1|SAI|0|0|0|100|IKR|8350|12051|lyfsjukr|||2|100|0||LYFIS ehf|Strides Arcolab International Limited|Cisplatín||8350||8350|12051||2 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|1|0|0|0|G|0|HES|0|0|1|100|DKK|21333|29603|lyfalmen|||1|21|0|14,0000|Vistor hf|Novartis Healthcare A/S|Famcíclóvír||21333||21333|29603||1 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|535|1821|lyfalmen|||2|10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||535||535|1821||1 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|992|2446|lyfalmen|||2|15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||992||992|2446||1 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki||J01AA02|01.10.2008||R|1|0|0|0|0|0|AGT|0|0|1|100|XEU|1943|3747|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1943||1943|3747||1 456989|R03AK0604|Relanio|innönddu|550|mcg/sk|180|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|26905|26688|lyfalmen|||2|180|0|90,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||19010||19010|26688||2 457508|J07AH0801|Nimenrix|sts|5|mcg|0,5|ml|1|hgl|+áfyllt sprauta|J07AH08|01.07.2013||R|0|0|0|0|0|0|GSB|0|0|0|100|GBP|7672|11584|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals|Hreinsađir fjórgildi A,C,Y,W-135 og fl.||7672||7672|11584||1 457692|L01BA0109|Metoject|stl|50|mg/ml|0,45|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3307|5613|lyfalmen|||1|0,45|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3307||3307|5613||2 457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|0|0|0|0|0|0|APC|0|0|0|100|XEU|2647|1679|lyfalmen|V0003|1679|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||431||431|1679||1 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|1|0|0|0|0|0|CHE|0|0|1|100|DKK|1113|2612|lyfalmen|||1|25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1113||1113|2612||1 458149|L01XE2101|Stivarga|filmhtfl|40|mg|84|stk|1|glas|3 x 28|L01XE21|01.06.2014||R|0|0|0|1|0|1|BGB|0|0|0|100|DKK|669188|841713|lyfsjukr|||1|84|0||Icepharma hf|Bayer Pharma AG|Regorafenib||669188||669188|841713||2 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|1403|3009|lyfalmen|V0577|2378|1|20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1403||1403|3009||1 458805|B01AF0201|Eliquis|filmhtfl|2,5|mg|60|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|10248|15108|lyfalmen|V0653|13844|1|60|0|30,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||10248|15108||1 459037|L01XE2301|Tafinlar|hylki|75|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|1170858|1471309|lyfsjukr|||1|120|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||1170858||1170858|1471309||1 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|833|1202|lyfsjukr|||1|2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||833||833|1202||1 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|1526|2202|lyfsjukr|||1|4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1526||1526|2202||1 459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|7403|11216|lyfalmen|||1|20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7403||7403|11216||1 459812|N05AH0411|Quetiapin Teva|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.09.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|2500|2184|lyfalmen|V0284|2184|2|100|0|6,2500|Medical ehf|Teva Sweden AB|Quetíapín||800||800|2184||2 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|1|0|0|0|G|0|MAS|0|0|1|100|SEK|2060|3907|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2060||2060|3907||1 460170|J07BC0202|Avaxim|stl|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|3911|6439|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3911||3911|6439||2 460293|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|ţpakki||J04AB02|01.09.2012||R|1|0|0|0|G|0|SAD|0|0|0|100|DKK|8009|12045|lyfalmen|||1|100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8009||8009|12045||2 460339|L01XC0301|Herceptin|stl|600|mg/hgl|5|ml|1|hgl||L01XC03|01.12.2013||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|237050|299380|lyfsjukr|||1|5|0||Icepharma hf|Roche|Trastuzumab||237050||237050|299380||2 460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|6931|13481|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||6931||6931|13481||2 461006|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.06.2014||R|0|0|0|0|G|0|AML|0|0|1|100|DKK|1086|2575|lyfalmen|||1|2,4|0||Vistor hf|Amdipharm Limited|Fúsidínsýra||1086||1086|2575||1 461107|L03AB1001|PegIntron|sts|80|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|84886|108414|lyfsjukr|||1|4|0|42,6700|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||84886||84886|108414||1 461113|L01XE1801|Jakavi|töflur|20|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|543803|684355|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||543803||543803|684355||1 461206|J02AC0104|Fluconazol ratiopharm|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.08.2013||L|1|0|0|0|0|0|RGM|0|0|1|100|IKR|||lyfalmen|V0554|1879|2|1|0|0,7500|Medical ehf|ratiopharm GmbH|Flúkónazól|||||1879||2 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|202|1366|lyfalmen|||2|10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||202||202|1366||1 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|533|1818|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||533||533|1818||1 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|589|1895|lyfalmen|||1|25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||589||589|1895||1 462049|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.03.2013||R|1|0|0|0|G|0|BYP|0|0|0|100|DKK|3658|6093|lyfalmen|||1|100|0|66,6667|Icepharma hf|Bayer Pharma AG|Nífedipín||||3658|6093||2 462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|6493|9971|lyfalmen|||1|7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||6493||6493|9971||1 462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|1|0|0|0|G|0|XEL|0|0|1|100|DKK|16199|23160|lyfalmen|||2|28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||16199||16199|23160||1 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|1|0|0|100|DKK|6523|12698|vetalmen|||0|20|0||Icepharma hf|Zoetis Finland OY|||||6523|12698||2 463197|C10AA0106|Simvastatin Bluefish|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA01|01.10.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|743|1675|lyfalmen|V0108|1675|2|100|0|33,3400|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||428||428|1675||2 463251|N06DX0106|Memantine ratiopharm|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.10.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|XEU|17376|9185|lyfalmen|V0605|9185|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Memantín||5918||5918|9185||2 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|5204|10165|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||5204||5204|10165||2 463642|J01XA0107|Vancomycin Xellia|irs|1|g/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|779|1124|lyfsjukr|||2|1|0|0,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||779||779|1124||1 463654|J05AE1001|Prezista|filmhtfl|800|mg|30|stk|1|plglas||J05AE10|01.08.2013||R|1|0|0|1|0|1|JCI|0|0|0|100|SEK|60701|78062|lyfsjukr|||1|30|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||||60701|78062||1 463861|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|2902|5059|lyfalmen|||1|100|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||2902||2902|5059||1 463941|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.11.2012||L|1|0|0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa|||0|60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín|||||||2 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|1|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 464591|J01FA0902|Clarithromycin ratiopharm|filmhtfl|250|mg|14|stk|1|ţpakki||J01FA09|01.06.2014||R|1|0|0|0|0|0|TSB|0|0|1|100|IKR|1821|3580|lyfalmen|||2|14|0|7,0000|Medical ehf|Teva Sweden AB|Klaritrómýcín||1821||1821|3580||2 465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|0|0|0|0|G|0|APC|0|0|0|100|DKK|2912|5073|lyfalmen|V0376|5073|2|7,5|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||2912||2912|5073||1 465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1156|2299|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1156||1156|2299||1 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|1170|2327|vetalmen|||0|100|0||Vistor hf|Intervet International BV|||1170||1170|2327||1 465333|L01BA0109|Metoject|stl|50|mg/ml|0,6|ml|1|áfspr||L01BA01|01.12.2012||R|0|0|0|1|G|0|WIL|0|0|0|100|SEK|3628|6052|lyfalmen|||1|0,6|0||Williams & Halls efh|medac Gesellschaft|Metótrexat||3628||3628|6052||2 465472|M05BA0803|Zoledronic acid Actavis|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.06.2013||R|0|0|0|1|0|1|APC|0|0|0|100|XEU|32541|42721|lyfsjukr|||2|5|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Zoledronsýra||32541||32541|42721||1 465932|L04AA1303|Leflunomide ratiopharm|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.05.2013||R|0|1|0|1|G|0|RGM|0|0|0|100|XEU|26858|20425|lyfalmen|V0454|20425|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Leflúnómíđ||14020||14020|20425||2 466003|N06AB0310|Seromex|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|1601|2184|lyfalmen|V0038|2184|2|30|0|30,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||800||800|2184||2 466029|N06AB0310|Seromex|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.02.2013||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4767|3825|lyfalmen|V0039|3825|2|100|0|100,0000|Medical ehf|ratiopharm GmbH|Flúoxetín||2000||2000|3825||2 466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|649|1977|lyfalmen|||1|25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||649||649|1977||1 466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2385|4352|lyfalmen|||1|100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2385||2385|4352||1 466122|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.08.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|1257|2809|lyfalmen|V0545|2065|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Levónorgestrel og ethinylestradíól||||1257|2809||2 466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1438|3056|lyfalmen|||1|25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1438||1438|3056||1 466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4984|7907|lyfalmen|||1|100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||4984||4984|7907||1 466278|L01XC1401|Kadcyla|irţ|100|mg|1|hgl|1|pakki||L01XC14|01.06.2014||R|0|1|0|1|0|1|RRL|0|0|0|100|DKK|275256|347329|lyfsjukr|||1|1|0||Icepharma hf|Roche Registration Limited|Trastuzumab emtansine||275256||275256|347329||2 466394|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2014||R|1|0|0|0|G|0|EIS|0|0|0|100|SEK|20628|28718|lyfalmen|V0138|28718|1|98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||20628||20628|28718||1 466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|2674|4747|lyfalmen|||1|25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2674||2674|4747||1 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|7702|11625|lyfalmen|||1|50|0|5,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||7702||7702|11625||1 466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|4399|7107|lyfalmen|||1|25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4399||4399|7107||1 466723|V03AN0501|Lyfjaloft AGA 100%|lyfjagas|100|%|2,5|l|1|hylki|undir ţrýstingi|V03AN05|01.10.2013||L|0|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||2|2,5|0||Ísaga ehf|AGA AB|Lyfjagös|||||||5 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|3913|6442|lyfalmen|V0063|5007|1|100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||3913||3913|6442||1 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|14858|20529|lyfsjukr|||1|0,5|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||14858||14858|20529||1 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|22770|30459|lyfsjukr|||1|0,5|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||22770||22770|30459||1 467459|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|6754|9748|lyfsjukr|||1|2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6754||6754|9748||2 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|17984|23708|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||17391||17391|23708||1 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|15026|21688|lyfalmen|||1|50|0|10,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||15026||15026|21688||1 467699|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.10.2012||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|7295|11069|lyfalmen|||1|84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7295||7295|11069||2 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|28611|38737|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||28611||28611|38737||1 467756|A10BX1001|Lyxumia|stl|20|mcg|2|áf-penni|1|pakki||A10BX10|01.10.2013||R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|11537|16871|lyfalmen|||1|2|0||Vistor hf|Sanofi-aventis groupe|Lixisenatíd||11537||11537|16871||1 467810|J01DI0201|Zinforo|irţ|600|mg|10|hgl|1|pakki|lausn|J01DI02|01.04.2013||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|88462|112902|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Ceftarólin||88462||88462|112902||1 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|0|0|0|0|0|1|JAS|0|0|0|100|SEK|475|686|lyfsjukr|||1|5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||475||475|686||1 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|6236|6616|lyfalmen|V0317|1773|1|100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4040||4040|6616||1 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|0|0|1|0|0|1|JAS|0|0|0|100|SEK|361|521|lyfsjukr|||1|10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||361||361|521||1 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|9079|6311|lyfalmen|V0318|1910|1|100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||3817||3817|6311||1 468568|J01XA0107|Vancomycin Xellia|irs|500|mg/hgl|1|hgl|1|pakki||J01XA01|01.04.2013||R|0|0|0|0|0|1|XEL|0|0|0|100|XEU|390|563|lyfsjukr|||2|1|0|0,2500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||390||390|563||1 468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|4530|2315|lyfalmen|V0207|2315|2|12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||896||896|2315||1 468825|QM01AC0603|Rheumocam|stl|20|mg/ml|50|ml|1|hgl|handa nautg, svínum og hestum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|6064|11816|vetalmen|||0|50|0||Icepharma hf|Chanelle Pharmaceuticals|||6064||6064|11816||2 468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4172|5188|lyfalmen|V0467|4388|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2996||2996|5188||1 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5482|8588|lyfalmen|||1|98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5482||5482|8588||1 469375|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|glas||N03AX14|01.11.2012||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11767|7225|lyfalmen|V0253|6913|2|100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4485||4485|7225||1 469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|7382|10654|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7382||7382|10654||2 469794|N07BA0150|Nicotinell Spearmint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.09.2013||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|6139|9487|lyfalmen|V0228|9055|1|100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6139||6139|9487||2 469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|4992|7918|lyfalmen|V0227|7130|1|100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||4992||4992|7918||2 469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|1|0|1|0|G|0|GRU|0|0|1|100|DKK|3259|5547|lyfalmen|V0226|4892|1|100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3259||3259|5547||2 470148|N06BA0404|Methylphenidate Sandoz|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.09.2013||R|1|0|1|0|0|0|SHS|0|0|0|100|DKK|10534|10858|lyfalmen|V0622|10858|2|30|0|54,0000|Artasan ehf|Sandoz A/S|Metýlfenídat||7141||7141|10858||1 470352|M05BA0804|Zoledronic acid medac|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.12.2013||R|0|0|0|1|0|1|WIL|0|0|0|100|XEU|28096|37143|lyfsjukr|||2|5|0|1,0000|Williams & Halls efh|medac Gesellschaft|Zoledronsýra||28096||28096|37143||2 470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|skammtar|1|stauk||R03BA05|01.04.1995||R|0|0|0|0|G|0|GSK|0|0|0|100|GBP|4784|7634|lyfalmen|||1|120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||4784||4784|7634||1 470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|30075|39627|lyfsjukr|||1|16|0|1,6000|Vistor hf|Orion Corporation|Dexmedetómid||30075||30075|39627||1 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|1185|2710|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1185||1185|2710||1 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|2068|3608|vetorma|||0|20|0||Vistor hf|Intervet International BV|||2068||2068|3608||1 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|0|0|0|0|G|0|BAM|0|0|0|100|SEK|5838|9075|lyfalmen|V0156|9075|1|100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||5838||5838|9075||2 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|0|0|0|0|0|0|ORC|1|0|0|100|DKK|4632|9067|vetalmen|||0|10|0||Vistor hf|Orion Corporation|Atipamesól||4632||4632|9067||1 472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1967|3780|lyfalmen|V0048|2819|1|98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1967||1967|3780||1 472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 472332|J07BC0201|Havrix|stl|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|3195|5460|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3195||3195|5460||1 472338|S01AA2701|APROKAM|sts|50|mg|10|hgl|1|pakki|lausn|S01AA27|01.04.2013||R|0|0|0|1|0|1|TEA|0|0|0|100|SEK|12360|17394|lyfsjukr|||1|10|0||Vistor hf|Laboratories THEA|Cefuroxím||12360||12360|17394||1 472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|9141|5357|lyfalmen|V0012|5357|3|98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5357||2 472759|R06AX2701|Aerius|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|4469|7203|lyfalmen|V0458|2725|1|100|0|100,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||4469||4469|7203||1 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|14562|20158|lyfsjukr|||1|400|0||Vistor hf|Meda AB|Dextran||14562||14562|20158||1 474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|0|0|1|0|0|1|AGP|0|0|0|100|XEU|5132|7407|lyfsjukr|||2|5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5132||5132|7407||1 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|0|0|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||0|15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen|||||||2 474252|A10BX1001|Lyxumia|stl|10|mcg|1|áf-penni|1|pakki||A10BX10|01.10.2013|31.08.2014|R|0|0|0|0|0|0|SGA|0|0|0|100|NOK|5631|8792|lyfalmen|||1|1|0||Vistor hf|Sanofi-aventis groupe|Lixisenatíd||5631||5631|8792||1 474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1716|3437|lyfalmen|||1|140|0|35,0000|Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1716||1716|3437||1 474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|0|0|0|0|0|0|PHM|0|0|0|100|DKK|29580|56971|vetalmen|||0|1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||29580||29580|56971||2 474628|N05AH0313|Olanzapin Sandoz|filmhtfl|10|mg|250|stk|1|glas||N05AH03|01.05.2013||R|2|0|0|0|G|0|SHS|0|0|0|100|DKK|31287|12391|lyfalmen|||2|250|0|250,0000|Artasan ehf|Sandoz A/S|Olanzapín||8262||8262|12391||1 474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|0|0|0|0|G|0|LYF|0|0|0|100|XEU|777|2152|lyfalmen|V0266|2152|3|30|0|1,0600|LYFIS ehf|LYFIS ehf|Pramipexól||777||777|2152||2 475338|QI09AL0101|Eryseng Parvo|stl|||50|ml|1|hgl|dreifa|QI09AL01|01.10.2014||R|0|0|0|0|0|0|LHS|0|0|0|100|IKR|9978|17406|vetorma|||0|50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Porcine parvovirus + erysipelothrix||9978||9978|17406||2 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|1|0|0|0|G|0|APC|0|0|0|100|IKR|1100|2594|lyfalmen|||2|100|0|26,6667|Actavis Group PTC ehf|Actavis Group PTC ehf|Warfarín||1100||1100|2594||1 475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2885|5036|lyfalmen|V0130|5036|1|26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||2885||2885|5036||1 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|497|1769|lyfalmen|||2|20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||497||497|1769||1 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|627|1947|lyfalmen|||2|30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||627||627|1947||1 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|1|0|1|0|0|0|ACA|0|0|1|100|IKR|1486|3122|lyfalmen|||2|100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1486||1486|3122||1 475798|R03AC1302|Oxis Turbuhaler|innönddu|4,5|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|2871|5017|lyfalmen|||1|60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||2871||2871|5017||1 475822|R03AC1302|Oxis Turbuhaler|innönddu|9|mcg/sk|60|skammtar|1|stauk||R03AC13|01.10.1997||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|3745|6212|lyfalmen|||1|60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||3745||3745|6212||1 476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|64401|82706|lyfsjukr|||1|1,2|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||64401|82706||1 476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|0|0|0|0|G|0|GSK|0|0|1|100|IKR|1146|2657|lyfalmen|||1|20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1146||1146|2657||1 477017|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.07.2013||R|1|0|0|0|0|0|MLD|0|0|0|100|DKK|17859|25243|lyfalmen|||1|98|0|98,0000|Vistor hf|Merck Sharp & Dohme Limited|Ezetimíb||17859||17859|25243||1 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|ţpakki|250 + 100 mg|P01BB51|01.02.2006||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|5261|8286|lyfalmen|||1|12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5261||5261|8286||1 477382|N05AH0410|Quetiapin Actavis|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|35287|43418|lyfalmen|V0272|43418|2|100|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||32341||32341|43418||1 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB|01.02.2007||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477631|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.10.2013||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|934|2367|lyfalmen|||1|1|0|4,6700|Vistor hf|Merck Sharp & Dohme B.V.|Betametasón||934||934|2367||1 477752|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477760|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477786|V07AB0014|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|0|0|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||0|1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||2 477941|L01XX4401|Zaltrap|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|52014|67160|lyfsjukr|||1|4|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||52014||52014|67160||1 478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|466|1727|lyfalmen|V0500|1691|2|100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||466||466|1727||1 478360|QM01AC0603|Rheumocam|stl|5|mg/ml|20|ml|1|hgl|handa hundum og köttum|QM01AC06|01.09.2013||R|0|0|0|0|0|0|CHP|1|0|0|100|XEU|7384|14351|vetalmen|||0|20|0||Icepharma hf|Chanelle Pharmaceuticals|||7384||7384|14351||2 479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|26858|36537|lyfalmen|V0454|20425|2|100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||26858||26858|36537||2 479564|N01AB0701|Suprane|innönd.l|||240|ml|1|glas||N01AB07|01.01.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|12824|17977|lyfsjukr|||1|240|0||Icepharma hf|Baxter Medical AB|Desflúran||12824||12824|17977||2 479904|L01XE1401|Bosulif|filmhtfl|100|mg|28|stk|1|ţpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|119064|151308|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||119064||119064|151308||1 480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|1|0|0|0|G|0|WEH|0|0|0|100|XEU|15901|7716|lyfalmen|V0341|7716|2|98|0|65,3333|Williams & Halls efh|Williams & Halls ehf|Dónepezíl||4844||4844|7716||2 480932|A10BX0901|Forxiga|filmhtfl|10|mg|98|stk|1|ţpakki||A10BX09|01.10.2013||R|1|0|0|0|G|0|BRI|0|0|0|100|SEK|20718|28831|lyfalmen|||1|98|0|98,0000|Vistor hf|Bristol-Myers Squibb/AstraZeneca EEIG|Dapagliflozín||20718||20718|28831||1 481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|1|0|0|0|0|0|GSK|0|0|0|100|GBP|14184|20631|lyfalmen|||1|100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14184||14184|20631||1 481208|D07AC1302|Ovixan|krem|0,1|%|30|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|778|2154|lyfalmen|||2|30|0||Vistor hf|Galenica AB|Mómetasón||778||778|2154||1 481375|R03AC1901|Striverdi Respimat|innöndl|2,5|mcg|60|skammtar|1|rörlyk||R03AC19|01.08.2014||R|0|0|0|0|G|0|BII|0|0|1|100|DKK|4758|7598|lyfalmen|||1|60|0||Vistor hf|Boehringer Ingelheim International|Olodaterol||4758||4758|7598||1 481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|1|0|1|0|G|0|GLP|0|0|1|100|SEK|312|1516|lyfalmen|V0055|1371|1|20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||312||312|1516||1 482183|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|hgl||G03BA03|01.05.2014||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|15850|22722|lyfalmen|V0641|22722|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||15850||15850|22722||2 482457|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.12.2012||L|0|0|0|0|0|0|MAB|0|0|1|100|IKR|||lyflausa|||0|20|0|3,3333|Vistor hf|Meda AB|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole|||||||1 483104|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.03.2013||R|0|1|0|1|0|1|AEB|0|0|0|100|DKK|75211|96272|lyfsjukr|||1|5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||75211||75211|96272||1 483217|B01AF0101|Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|37540|49943|lyfalmen|||1|98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||37540|49943||2 483371|B05AA0114|Albuman|irl|40|g/líter|400|ml|1|hgl|lausn|B05AA01|01.03.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|6712|9687|lyfsjukr|||1|400|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||6712||6712|9687||2 483477|A02BC0403|Rabeprazol Krka|sţ-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.03.2014||R|0|0|0|0|G|0|KRK|0|0|0|100|IKR|1800|2457|lyfalmen|V0467|2457|2|56|0|28,0000|LYFIS ehf|Krka Sverige AB|Rabeprazól||1000||1000|2457||2 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|2697|3892|lyfsjukr|||1|50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2697||2697|3892||1 483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|0|0|0|0|G|0|SHS|0|0|1|100|DKK|5988|9281|lyfalmen|||1|3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||5988||5988|9281||1 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|4655|6718|lyfsjukr|||1|100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4655||4655|6718||1 483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|0|0|0|0|G|0|POF|0|0|0|100|DKK|2358|4315|lyfalmen|V0374|4315|2|2,5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2358||2358|4315||1 483968|C03AA0305|Hydromed|töflur|12,5|mg|100|stk|1|ţpakki||C03AA03|01.06.2013||R|0|0|0|0|G|0|MEV|0|0|0|100|DKK|932|2364|lyfalmen|||2|100|0|50,0000|Vistor hf|MediLink A/S|hýdróklórtíazíđ||932||932|2364||1 483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|1|0|1|0|G|0|AGP|0|0|1|100|XEU|283|1371|lyfalmen|V0055|1371|2|20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||206||206|1371||1 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|55636|71706|lyfsjukr|||1|3|0|112,5000|Vistor hf|Ferring|Triptórelín||55636||55636|71706||1 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|1|0|0|0|0|0|MSD|0|0|0|100|DKK|5781|8997|lyfalmen|||1|28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||5781||5781|8997||1 484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|0|0|0|1|0|1|AEB|0|0|0|100|DKK|141399|179338|lyfsjukr|||1|0,6|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||141399||141399|179338||1 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|0|0|0|0|G|0|MEB|0|0|1|100|SEK|1294|2859|lyfalmen|||1|300|0||Vistor hf|Meda AB (V)|Benzýdamín||1294||1294|2859||1 484658|B01AF0101|Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AF01|01.01.2014||R|1|1|0|0|G|0|BYP|0|0|0|100|DKK|11460|16766|lyfalmen|||1|30|0|30,0000|Icepharma hf|Bayer Pharma AG|Rivaoxaban||11460||11460|16766||2 484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|53281|69698|lyfalmen|||1|50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||53281||53281|69698||1 485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|0|0|0|0|G|0|ANS|0|0|1|100|XEU|1209|2743|lyfalmen|||1|5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1209||1209|2743||1 485252|L01CD0202|Docetaxel Actavis|irţ|20|mg/ml|7|ml|1|hgl|lausn|L01CD02|01.04.2013||R|0|0|0|1|0|1|AVB|0|0|0|100|XEU|8668|12510|lyfsjukr|||2|7|0||Actavis Group PTC ehf|Actavis BV|Docetaxel||8668||8668|12510||1 485764|J05AX1201|Tivicay|filmhtfl|50|mg|30|stk|1|glas||J05AX12|01.04.2014||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|88715|113220|lyfsjukr|||1|30|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Dolutegravír||88715||88715|113220||1 486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|1|0|0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa|||0|20|0|10,0000|Icepharma hf|Mylan AB|Naproxen|||||||2 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|456|1713|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||456||456|1713||1 486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|0|0|0|0|G|0|SAC|0|0|1|100|USD|651|1980|lyfalmen|||1|5|0||Vistor hf|S.A. Alcon - Couvreur N.V.|Dexametasón||651||651|1980||1 487341|A10BG0302|Pioglitazone Actavis|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|19135|17295|lyfalmen|V0573|16810|2|98|0|98,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||11847||11847|17295||1 487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|3894|lyfalmen|V0326|3894|2|100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||2050||2050|3894||2 487692|L04AB0101|Enbrel|sts|10|mg|4|hgl|1|pakki|+ leysir, lausn|L04AB01|01.12.2012||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|32410|42557|lyfsjukr|||1|4|0|5,7200|Icepharma hf|Pfizer Limited|Etanercept||32410||32410|42557||1 487725|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|53948|69587|lyfsjukr|||1|1,2|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||53948||53948|69587||1 487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|0|1|0|1|G|0|WIL|0|0|0|100|XEU|31896|42860|lyfalmen|V0453|42860|2|100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||31896||31896|42860||2 487827|M01AB0517|Diclomex|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.04.2013||R|1|0|0|0|G|0|RGM|0|0|1|100|IKR|1033|1910|lyfalmen|V0469|1910|2|100|0|50,0000|Medical ehf|ratiopharm GmbH|Díklófenak||600||600|1910||2 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|895|2314|lyfalmen|||1|20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||895||895|2314||1 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2487|4491|lyfalmen|V0198|2910|1|60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2487||2487|4491||1 488468|L01XE1801|Jakavi|töflur|5|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|273445|345056|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||273445||273445|345056||1 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|5743|8945|lyfalmen|||1|50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||5743||5743|8945||1 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|1|0|0|1|G|0|APC|0|0|0|100|DKK|10992|16126|lyfalmen|||1|50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||10992||10992|16126||1 489050|N06AX1105|Mirtazapine Bluefish|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.04.2014||R|0|0|0|0|G|0|BLP|0|0|0|100|IKR|2700|2594|lyfalmen|V0331|2594|2|96|0|96,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Mirtazapín||1100||1100|2594||2 489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|100477|127981|lyfsjukr|||1|1,6|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||100477|127981||1 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|0|0|HES|0|0|1|100|IKR|338|1352|lyfalmen|V0188|507|1|10|0|5,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||192||192|1352||1 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|IKR|882|1728|lyfalmen|V0188|1520|1|30|0|15,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||467||467|1728||1 490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2238|4151|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2238||2238|4151||1 490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|2223|4130|lyfalmen|||1|8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2223||2223|4130||1 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|3848|6353|lyfalmen|||1|30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||3848||3848|6353||1 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|10533|10431|lyfalmen|V0112|3483|1|100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6829||6829|10431||1 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5117|8089|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5117||5117|8089||1 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|13901|14093|lyfalmen|V0113|3483|1|100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9506||9506|14093||1 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15876|17499|lyfalmen|V0114|3483|1|100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||11996||11996|17499||1 491213|N03AX2201|Fycompa|filmhtfl|6|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|23279|32045|lyfalmen|||1|28|0|21,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||23279||23279|32045||1 491313|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.12.2012||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|37286|48676|lyfsjukr|||1|2,5|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||37286|48676||1 491321|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.08.2013||R|0|1|0|1|0|1|IPI|0|1|0|100|DKK|132846|168604|lyfsjukr|||1|4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||||132846|168604||1 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|0|0|0|1|0|1|ORG|0|0|0|100|DKK|48032|62163|lyfsjukr|||1|3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||48032||48032|62163||1 492377|L01XE1401|Bosulif|filmhtfl|500|mg|28|stk|1|ţpakki||L01XE14|01.09.2014||R|1|0|0|1|0|1|PZE|0|0|0|100|DKK|535785|674293|lyfsjukr|||1|28|0||Icepharma hf|Pfizer Ltd.|Bósútíníb||535785||535785|674293||1 492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|3193|5457|lyfalmen|||1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3193||3193|5457||2 492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11826|17267|lyfalmen|V0002|5357|1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||11826||11826|17267||1 492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|1|0|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||0|14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól|||||||1 493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 493218|B03AC0001|Monofer|irl|100|mg/ml|5|ml|1|hgl||B03AC|01.07.2013||R|0|0|0|0|G|0|PAC|0|0|1|100|DKK|27174|36933|lyfalmen|||1|5|0|5,0000|Vistor hf|Pharmacosmos A/S|Járn, stungulyf||27174||27174|36933||1 493313|G04BD0704|Tolterodin Actavis|forđahlk|2|mg|100|stk|1|ţpakki||G04BD07|01.01.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11638|17010|lyfalmen|||2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tólteródín||11638||11638|17010||1 493401|R03DC0305|Montelukast Navamedic|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|6880|5958|lyfalmen|V0492|5471|2|98|0|39,2000|Artasan ehf|Navamedic ASA|Montelúkast||3559||3559|5958||1 493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|18412|5861|lyfalmen|V0516|5624|2|100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||3488||3488|5861||1 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|1243|2790|lyfalmen|||1|100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1243||1243|2790||1 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2400|4372|lyfalmen|||1|100|0|33,3333|Vistor hf|Novartis Healthcare A/S|Pízótífen||2400||2400|4372||1 494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|73079|93597|lyfsjukr|||1|20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||73079||73079|93597||2 494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|0|0|0|1|0|1|RRL|0|1|0|100|DKK|182696|231166|lyfsjukr|||1|50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||182696||182696|231166||2 494466|J05AE1401|Olysio|hylki|150|mg|7|stk|1|pakki||J05AE14|01.09.2014||R|0|0|0|1|0|1|JCI|0|0|0|100|SEK|363850|458514|lyfsjukr|||1|7|0||Vistor hf|Janssen-Cilag International N.V.|Simeprevír||||363850|458514||1 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|0|0|0|0|0|0|PER|0|0|0|100|DKK|1959|3769|lyfalmen|||1|60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1959||1959|3769||1 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2197|4095|lyfalmen|V0128|2155|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2197||2197|4095||1 494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3193|5457|lyfalmen|V0410|4701|1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3193||3193|5457||1 494740|QA12CC0203|Sedaman vet|irl|200|mg/ml|100|ml|1|hgl||QA12CC02|01.04.2014||R|0|0|0|0|0|0|OOR|0|0|0|100|DKK|2148|4273|vetalmen|||0|100|0||Icepharma hf|Orion Corporation|||2148||2148|4273||2 494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|1776|3519|lyfalmen|||1|60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1776||1776|3519||1 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|18909|6502|lyfalmen|V0384|5237|1|15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||3957||3957|6502||1 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|7354|6616|lyfalmen|V0382|6340|1|10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||4040||4040|6616||1 495757|N06AX2601|Brintellix|filmhtfl|10|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|6275|9673|lyfalmen|||1|28|0||Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||6275||6275|9673||1 495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|skammtar|1|stauk|+diskhaler|J05AH01|01.02.2000||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2885|5036|lyfalmen|||1|20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2885||2885|5036||1 496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|30803|33539|lyfalmen|V0345|33539|3|112|0|56,0000|LYFIS ehf|LYFIS ehf|Rívastigmín||24469||24469|33539||2 496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4452|8721|vetalmen|||0|10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4452||4452|8721||2 496468|A10BG0302|Pioglitazone Actavis|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.09.2012||R|1|1|0|0|G|0|APC|0|0|0|100|XEU|12371|4937|lyfalmen|V0572|4820|2|98|0|49,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Píóglítazón||2813||2813|4937||1 496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|0|0|0|1|0|1|SOI|0|1|0|100|DKK|83618|106823|lyfsjukr|||1|3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||83618||83618|106823||3 496648|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|508|1784|lyfalmen|V0643|1784|2|20|0|5,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||508||508|1784||1 496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|0|0|1|0|G|0|PER|0|0|0|100|DKK|456|1713|lyfalmen|||1|10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||456||456|1713||1 496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|823|2215|lyfalmen|||1|20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||823||823|2215||1 497003|L01XE0103|Mylaukim|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.09.2014||R|0|0|0|1|0|1|WEH|0|1|0|100|XEU|191862|242669|lyfsjukr|||2|30|0||Williams & Halls efh|Williams & Halls ehf|Imatiníb||191862||191862|242669||2 497012|A07AA1201|Dificlir|filmhtfl|200|mg|20|stk|1|ţpakki||A07AA12|01.08.2012||R|1|0|0|0|0|1|APE|0|0|0|100|XEU|240860|304162|lyfsjukr|||1|20|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Fidaxomicin||240860||240860|304162||1 497065|M01AE0219|Alpoxen|töflur|500|mg|100|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|1760|3271|lyfalmen|V0127|3271|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||1595||1595|3271||1 497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|3140|5385|lyfalmen|||1|100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3140||3140|5385||1 497107|M01AE0219|Alpoxen|töflur|250|mg|100|stk|1|ţpakki||M01AE02|01.05.2014||R|0|0|0|0|G|0|AGP|0|0|1|100|SEK|873|2284|lyfalmen|||2|100|0|50,0000|Actavis Group hf|Actavis Group PTC ehf|Naproxen||873||873|2284||1 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|331|1542|lyfalmen|||2|30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||331||331|1542||1 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|634|1758|lyfalmen|V0448|1758|2|100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||489||489|1758||1 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|1366|2483|lyfalmen|V0449|2483|2|100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||1019||1019|2483||1 497983|N04BC0407|Ropinirol Actavis|forđatfl|4|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|14646|10668|lyfalmen|V0533|10668|2|84|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||7002||7002|10668||1 497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|1464|3035|lyfalmen|V0369|3035|2|5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1422||1422|3035||1 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|16494|23530|lyfalmen|V0608|16540|1|56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||16494||16494|23530||1 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|17594|24910|lyfalmen|V0609|20326|1|56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17594||17594|24910||1 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|21917|30336|lyfalmen|V0610|20118|1|56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||21917||21917|30336||1 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|26477|36059|lyfalmen|V0611|26528|1|56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||26477||26477|36059||1 499070|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|skammtar|1|fl||R01AD05|01.03.2013||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1102|2597|lyfalmen|||1|120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1102||1102|2597||1 499109|N05AH0410|Quetiapin Actavis|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.07.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|12441|16687|lyfalmen|V0275|16687|2|100|0|12,5000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||11402||11402|16687||1 499142|C09CA0603|Candesartan Aspen|töflur|4|mg|100|stk|1|ţpakki||C09CA06|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|1556|3218|lyfalmen|V0102|3218|2|100|0|50,0000|Artasan ehf|Navamedic ASA|Candesartan||1556||1556|3218||1 499189|N03AX2201|Fycompa|filmhtfl|4|mg|28|stk|1|ţpakki||N03AX22|01.07.2013||R|1|0|0|0|G|0|EUR|0|0|0|100|SEK|23279|32045|lyfalmen|||1|28|0|14,0000|Vistor hf|Eisai Europe Ltd.|Perampanel||23279||23279|32045||1 499273|B01AF0101|Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|10766|15817|lyfalmen|||1|28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||10766|15817||2 499436|R03AK1101|Flutiform|innúđal|130|mcg/sk|120|skammtar|1|pakki|125+5 mcg/sk|R03AK11|01.01.2014||R|0|0|0|0|G|0|HAR|0|0|0|100|DKK|6102|9437|lyfalmen|||1|120|0|30,0000|Icepharma hf|Norpharma a/s (N)|Formóteról og flútikasón||6102||6102|9437||2 499920|N06AX2601|Brintellix|filmhtfl|20|mg|28|stk|1|ţpakki||N06AX26|01.10.2014||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|12552|18583|lyfalmen|||1|28|0||Lundbeck Export A/S|H. Lundbeck A/S|Vortioxetín||12552||12552|18583||1 501225|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|185|mg|98|stk|1|ţpakki|160/25 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|4880|3857|lyfalmen|||2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||2023||2023|3857||2 501278|G04BD1201|Betmiga|forđatfl|25|mg|30|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|5977|9266|lyfalmen|||1|30|0|15,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||5977||5977|9266||1 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|2977|5162|lyfalmen|V0434|4887|1|100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2977||2977|5162||2 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|1|0|0|0|G|0|AML|0|0|0|100|DKK|2903|5060|lyfalmen|||1|100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||2903||2903|5060||1 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|0|0|0|1|0|1|FER|0|0|0|100|DKK|20361|27436|lyfsjukr|||1|1|0|37,5000|Vistor hf|Ferring|Triptórelín||20361||20361|27436||1 503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|6799|8282|lyfalmen|V0354|8282|3|28|0|4,6700|LYFIS ehf|LYFIS ehf|Rívastigmín||5258||5258|8282||2 503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|1|0|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak|||||||1 504014|N04BC0407|Ropinirol Actavis|forđatfl|8|mg|84|stk|1|ţpakki||N04BC04|01.12.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|28688|21402|lyfalmen|V0534|21402|2|84|0|112,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rópíníról||14798||14798|21402||1 504020|B05AA0114|Albuman|irl|40|g/líter|250|ml|1|hgl|lausn|B05AA01|01.04.2013||R|0|0|0|0|0|1|SSB|0|0|0|100|XEU|4182|6036|lyfsjukr|||1|250|0||Williams & Halls efh|Stichting Sanquin Bloedvoorziening|Albúmín||4182||4182|6036||2 504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|1617|2751|lyfalmen|||2|90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1215||1215|2751|30.9.2014|1 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|0|0|0|0|G|0|PTL|0|0|0|100|DKK|1986|3806|lyfalmen|||1|90|0|45,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól||1986||1986|3806||1 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|ţpakki||N05BA08|01.01.1987||R|1|0|0|0|0|0|ROC|0|0|1|100|DKK|1129|2634|lyfalmen|||1|100|0|30,0000|Icepharma hf|Roche|Brómazepam||1129||1129|2634||2 504923|QN04BC0201|Prascend|töflur|1|mg|60|stk|1|ţpakki|handa hestum|QN04BC02|01.05.2014||R|0|0|0|0|0|0|BIV|0|0|0|100|DKK|13620|26325|vetalmen|||0|60|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Pergolide||13620||13620|26325||1 505647|N07BA0147|Nicorette QuickMist|munnhúđi|1|mg/sk|300|skammtar|1|fl|2 x 150 úđaskammtar|N07BA01|01.11.2012||L|0|0|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||0|300|0|0,8800|Vistor hf|McNeil Denmark ApS|Nikótín|||||||1 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|1|0|0|0|G|0|AML|0|0|0|100|DKK|7986|12014|lyfalmen|||1|100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||7986||7986|12014||1 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|1755|2533|lyfsjukr|||1|5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1755||1755|2533||1 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|3505|5059|lyfsjukr|||1|10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3505||3505|5059||1 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|0|0|0|1|0|1|PER|0|0|0|100|DKK|8000|11546|lyfsjukr|||1|25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8000||8000|11546||1 506176|N07BC0202|Metadon Abcur|töflur|5|mg|100|stk|1|ţpakki||N07BC02|01.10.2013||R|1|0|1|0|G|0|ABC|0|0|0|100|SEK|2467|4464|lyfalmen|||1|100|0|25,0000|Icepharma hf|Abcur AB|Metadón||2467||2467|4464||2 506806|C10AA0703|Rosuvastatin Krka|filmhtfl|20|mg|30|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|5250|5877|lyfalmen|||2|30|0|60,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||3500||3500|5877||2 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|2397|4368|lyfalmen|||1|100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2397||2397|4368||1 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|1|0|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||0|25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl|||||||1 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|1|0|0|0|0|0|ERC|0|0|0|100|DKK|389|1621|lyfalmen|||1|100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||389||389|1621||1 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|641|1118|vetorma|||0|24|0||Icepharma hf|Zoetis Finland OY|||641||641|1118||2 507315|L03AB1001|PegIntron|sts|120|mcg|4|áf-penni|1|pakki|fjölskammta pennar|L03AB10|01.11.2013||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|125574|159478|lyfsjukr|||1|4|0|64,0000|Vistor hf|Merck Sharp & Dohme Limited|Peginterferón alfa 2b||125574||125574|159478||1 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|0|0|0|0|0|0|IBV|0|0|0|100|DKK|15641|27285|vetorma|||0|1000|0||Vistor hf|Intervet International BV|||15641||15641|27285||1 507367|A10BX0205|Repaglinide Accord|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.04.2014||R|1|0|0|0|G|0|AHL|0|0|0|100|DKK|1456|3081|lyfalmen|||2|90|0|11,2500|Portfarma ehf|Accord Healthcare Limited|Repaglíníđ||1456||1456|3081|30.9.2014|1 507758|R03AK0604|Relanio|innönddu|550|mcg/sk|60|skammtar|1|pakki|50+500 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|9000|9707|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||6300||6300|9707||2 507834|N07CA0102|Betahistin ratiopharm|töflur|16|mg|100|stk|1|ţpakki||N07CA01|01.12.2013||R|1|0|0|0|0|0|ROY|0|0|0|100|IKR|3105|5337|lyfalmen|||2|100|0|66,6700|Medical ehf|ratiopharm Oy|Betahistín||3105||3105|5337||2 507915|C03DA0103|Spiron|töflur|50|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1963|3775|lyfalmen|V0092|3775|2|100|0|66,6600|Portfarma ehf|Orion Corporation|Spírónólaktón||1963||1963|3775||1 508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|2487|4491|lyfalmen|||1|98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2487||2487|4491||1 508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4970|9716|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4970|9716||2 508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|4477|8769|vetalmen|||0|50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4477||4477|8769||2 508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|0|0|0|0|0|0|BAN|0|0|0|100|DKK|13266|25645|vetalmen|||0|100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||13266||13266|25645||2 508921|L01CD0401|Jevtana|irţ|60|mg|1|hgl|1|pakki|+ leysir|L01CD04|01.08.2011||R|0|0|0|1|0|1|SAA|0|1|0|100|NOK|656429|825701|lyfsjukr|||1|1|0||Vistor hf|Sanofi - Aventis|Cabazitaxel||656429||656429|825701||1 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|0|0|0|0|G|0|LBK|0|0|0|100|DKK|8845|13189|lyfalmen|||1|10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||8845||8845|13189||1 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|75,0000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2880||1 509577|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.06.2013||R|0|0|0|0|0|0|BGB|0|0|0|100|DKK|2140|4017|lyfalmen|V0134|3174|1|63|0|84,0000|Icepharma hf|Bayer Pharma AG|Cýpróterón og östrógen||2140||2140|4017||2 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|1|0|0|1|0|1|VII|0|0|0|100|GBP|48906|63260|lyfsjukr|||1|60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||48906||48906|63260||1 509696|N05AH0314|Olanzapine Mylan|filmhtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|1906|1798|lyfalmen|||2|28|0|28,0000|Icepharma hf|Generics UK Ltd|Olanzapín||518||518|1798||2 510200|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|86703|110695|lyfsjukr|||1|1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||86703|110695||2 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|16184|22193|lyfsjukr|||1|1,8|0|12,0000|Icepharma hf|Roche|Epóetín||16184||16184|22193||2 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|24225|32285|lyfsjukr|||1|1,8|0|18,0000|Icepharma hf|Roche|Epóetín||24225||24225|32285||2 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|39737|51752|lyfsjukr|||1|1,8|0|30,0000|Icepharma hf|Roche|Epóetín||39737||39737|51752||2 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|0|0|0|1|0|1|ROC|0|0|0|100|DKK|70689|90597|lyfsjukr|||1|3,6|0|60,0000|Icepharma hf|Roche|Epóetín||70689||70689|90597||2 510553|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.04.2014||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|468|1730|lyfalmen|V0601|1572|2|100|0|100,0000|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||468||468|1730||1 510608|L01XX4401|Zaltrap|irţ|25|mg/ml|8|ml|1|hgl|lausn|L01XX44|01.06.2013||R|0|0|0|1|0|1|SGA|0|0|0|100|NOK|104028|132438|lyfsjukr|||1|8|0||Vistor hf|Sanofi-aventis groupe|Afliberceptum||104028||104028|132438||1 510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|160503|203314|lyfsjukr|||1|1,2|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||160503|203314||1 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|4053|4491|lyfalmen|V0445|4491|2|98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||2487||2487|4491||1 511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2618|4671|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2618||2618|4671||1 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|21906|29375|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||21906||21906|29375||1 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|0|0|0|0|0|1|MAB|0|0|0|100|SEK|13704|19081|lyfsjukr|||1|6000|0||Vistor hf|Meda AB|Dextran||13704||13704|19081||1 511932|G02BA0303|Jaydess|leginnle|13,5|mg|1|stk|1|ţpakki||G02BA03|01.01.2014||R|0|1|0|0|0|0|BAB|0|0|0|100|DKK|16646|23721|lyfalmen|||1|1|0||Icepharma hf|Bayer AB|Plast lyfjalykkja (IUD) međ prógestógen||16646||16646|23721||2 512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|4775|2311|lyfalmen|V0325|2311|2|100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||893||893|2311||2 512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5111|7376|lyfsjukr|||1|100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5111||5111|7376||2 513195|C10AA0106|Simvastatin Bluefish|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA01|01.02.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|836|1803|lyfalmen|V0109|1803|2|100|0|66,6700|LYFIS ehf|Bluefish Pharmaceuticals AB|Simvastatín||522||522|1803||2 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|0|0|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||0|35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín|||||||1 513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|0|0|0|0|0|0|ORR|0|0|0|100|DKK|22209|30702|lyfalmen|||1|60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||22209||22209|30702||1 513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|2061|4100|vetalmen|||0|100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2061||2061|4100||2 514265|R03AC0302|Bricanyl Turbuhaler|innönddu|0,25|mg/sk|200|skammtar|1|stauk||R03AC03|01.07.1993||R|0|0|0|0|G|0|AZD|0|0|1|100|SEK|1719|3441|lyfalmen|||1|200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1719||1719|3441||1 514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|1|0|0|0|G|0|ADG|0|0|0|100|XEU|3775|6253|lyfalmen|||2|100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||3775||3775|6253||1 514840|N06BA0901|Strattera|hylki|100|mg|28|stk|1|ţpakki|hart|N06BA09|01.07.2013||R|1|0|0|1|0|0|ELI|0|0|0|100|XEU|19921|27831|lyfalmen|||1|28|0|35,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||||19921|27831||2 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|1|0|0|0|G|0|PER|0|0|0|100|IKR|4026|4333|lyfalmen|||1|60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2371||2371|4333||1 515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0149|2635|0|100|0|10,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2635||1 515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0150|2647|0|100|0|20,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2647||1 516219|J01FA1006|Azithromycin Eberth|irs|500|mg|10|ml|1|hgl||J01FA10|01.12.2012||R|0|0|0|0|0|1|FRI|0|0|0|100|DKK|5226|6493|lyfsjukr|||1|10|0|1,0000|Portfarma ehf|Dr. Friedrich Eberth Arzneimittel GmbH|Azitrómýcín||4499||4499|6493||1 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2873|5019|lyfalmen|V0462|2869|1|90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||2873||2873|5019||1 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3128|5368|lyfalmen|V0471|2869|1|90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3128||3128|5368||1 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|3364|5691|lyfalmen|V0472|3305|1|90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3364||3364|5691||1 517824|C01CA0302|Noradrenalin Abcur|irţ|1|mg/ml|10|ml|10|lykjur||C01CA03|01.05.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|33759|44250|lyfsjukr|||2|100|0|16,6600|Icepharma hf|Abcur AB|Noradrenalín||33759||33759|44250||2 517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|1|0|0|0|0|0|APS|0|0|1|100|IKR|||lyflausa|||0|10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín|||||||1 518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|1058|2537|lyfalmen|||1|20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||1058||1058|2537||1 518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|1|0|0|0|G|0|AGT|0|0|1|100|DKK|3360|5686|lyfalmen|||1|100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3360||3360|5686||1 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|0|0|0|0|0|0|ORG|0|0|0|100|DKK|2027|3862|lyfalmen|V0590|2731|1|84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2027||2027|3862||1 518897|A10BH0501|Trajenta|filmhtfl|5|mg|90|stk|1|ţpakki||A10BH05|01.12.2012||R|1|0|0|0|G|0|BII|0|0|0|100|DKK|18730|26336|lyfalmen|||1|90|0|90,0000|Vistor hf|Boehringer Ingelheim International|Línaglíptín||18730||18730|26336||1 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|0|0|0|0|0|0|REP|0|0|1|100|SEK|1038|2509|lyfalmen|||1|125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1038||1038|2509||1 519450|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.05.2014||R|0|0|0|0|G|0|TPA|0|0|0|100|DKK|3885|6404|lyfalmen|V0644|6404|2|125|0|31,2500|Vistor hf|Takeda Pharma A/S|Fúrósemíđ||3885||3885|6404||1 519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|0|0|0|0|0|0|APP|0|0|1|100|SEK|1554|3215|lyfalmen|||1|100|0|2,5000|Artasan ehf|Aspen Pharma Trading Limited|Súlfametoxazól og trímetóprím||1554||1554|3215||1 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|7061|10748|lyfalmen|||2|2|0|5,7222|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||7061||7061|10748||1 520186|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|23494|32315|lyfalmen|V0646|32315|1|1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||23494|32315||1 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4681|7493|lyfalmen|V0141|5043|1|4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4681||4681|7493||1 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5287|8322|lyfalmen|V0143|1726|1|4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5287||5287|8322||1 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|14896|21525|lyfalmen|V0143|5178|1|12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||14896||14896|21525||1 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|5670|8846|lyfalmen|V0144|1938|1|4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5670||5670|8846||1 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|15687|22517|lyfalmen|V0144|5814|1|12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15687||15687|22517||1 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1355|2047|lyfalmen|V0056|1999|2|100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2047||1 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|2163|2047|lyfalmen|V0057|1999|2|100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||700||700|2047||1 520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|334|1546|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||334||334|1546||1 520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0135|1805|0|25|0|2,5000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1805||1 520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|0|0|0|0|G|0|NYC|0|0|0|100|DKK|||lyfalmen|V0136|1814|0|25|0|5,0000|Vistor hf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1814||1 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|0|0|0|0|G|0|BII|0|0|0|100|DKK|31181|41962|lyfalmen|V0269|14155|1|100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||31181||31181|41962||1 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ51RC23|01.12.1982||R|0|0|0|0|0|0|BID|0|0|0|100|DKK|8158|15837|vetalmen|||0|320|0||Vistor hf|Boehringer Ingelheim Danmark|||8158||8158|15837||1 522399|N05AE0403|Ziprasidon Actavis|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|0|0|APC|0|0|0|100|XEU|11295|16540|lyfalmen|V0608|16540|2|56|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||11295||11295|16540||1 522599|J07CA0202|Tetravac|stl|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|0|0|0|0|0|0|SPM|0|0|0|100|XEU|2222|4129|lyfalmen|||1|0,5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2222||2222|4129||2 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|0|0|0|1|0|1|NEL|0|0|0|100|DKK|180864|228867|lyfsjukr|||1|1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||180864||180864|228867||1 522797|N02AX0204|Tradolan|filmhtfl|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|1|0|1|0|G|0|GLP|0|0|1|100|DKK|2692|4772|lyfalmen|||1|250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2692||2692|4772||1 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|0|0|1|0|G|0|GLP|0|0|1|100|DKK|383|1613|lyfalmen|||1|10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||383||383|1613||1 523008|G03AA1208|Cleosensa|filmhtfl|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|2457|4450|lyfalmen|V0192|4450|2|63|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||2457||2457|4450||1 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|982|2433|lyfalmen|||2|40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||982||982|2433||1 523151|N05AH0410|Quetiapin Actavis|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.08.2013||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|5663|4946|lyfalmen|V0285|4509|2|100|0|25,0000|Actavis Group hf|Actavis Group PTC ehf|Quetíapín||2819||2819|4946||1 523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|0|0|0|0|G|0|GEM|0|0|0|100|IKR|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1505||1 523758|L01XE0801|Tasigna|hylki|150|mg|112|stk|1|ţpakki||L01XE08|01.03.2013||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|381733|480957|lyfsjukr|||1|112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||381733||381733|480957||1 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|1|0|0|0|G|0|SNO|0|0|1|100|NOK|1151|2664|lyfalmen|||1|100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1151||1151|2664||1 523967|N02AA0506|Oxikodon Depot Actavis|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|1725|3449|lyfalmen|V0584|3449|2|28|0|7,4700|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||1725||1725|3449||1 524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|418|1661|lyfalmen|||1|28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||418||418|1661||1 524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2407|4382|lyfalmen|||1|98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2407||2407|4382||1 524257|L02BB0001|Xtandi|hylki|40|mg|112|stk|1|ţpakki||L02BB|01.07.2014||R|1|0|0|0|0|1|APE|0|1|0|100|XEU|475240|598309|lyfsjukr|||1|112|0||Vistor hf|Astellas Phama Europe B.V.|Enzalutamid||475240||475240|598309||1 524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|8619|6062|lyfalmen|V0010|3688|1|98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|6062||1 524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|0|0|0|0|0|0|ZBE|0|0|0|100|DKK|1847|3674|vetalmen|||0|1|0||Icepharma hf|Zoetis Belgium S.A.|Vedaprófen||1847||1847|3674||2 525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|1|0|0|0|G|0|MEB|0|0|1|100|SEK|690|2033|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||690||690|2033||1 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|0|0|0|0|0|0|HES|0|0|1|100|DKK|752|2118|lyfalmen|||1|15|0|3,7500|Vistor hf|Novartis Healthcare A/S|Díklófenak||752||752|2118||1 525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|1669|3372|lyfalmen|||2|30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1669||1669|3372||1 525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|1|0|0|0|G|0|ACA|0|0|1|100|XEU|4834|7702|lyfalmen|||2|100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||4834||4834|7702||1 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|1|0|0|0|0|0|TBP|0|0|0|100|DKK|7269|11033|lyfalmen|V0657|9023|1|30|0|10,0000|Vistor hf|Teva Pharma B.V.|Modafinil||7269||7269|11033||1 525593|N06DX0103|Nemdatine|filmhtfl|10|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18431|9240|lyfalmen|V0605|9185|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||5958||5958|9240||1 525720|B01AF0101|Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|38305|50903|lyfalmen|||1|100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||38305|50903||2 525757|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|glas||C10AA07|01.03.2014||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|13826|20182|lyfalmen|V0117|10473|1|100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13826||13826|20182||1 525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5272|7609|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5272||5272|7609||1 525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|4800|6928|lyfsjukr|||2|1000|0||Actavis Group hf|Braun|Natríumklóríđ||4800||4800|6928||1 525998|V07AB0004|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 526004|V07AB0009|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|0|0|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||||1 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|4333|7017|lyfalmen|V0435|7017|1|100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4333||4333|7017||2 526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|4037|6612|lyfalmen|||1|100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4037||4037|6612||1 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|1|0|0|0|G|0|DEA|0|0|0|100|XEU|3453|5813|lyfalmen|||1|100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3453||3453|5813||1 527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|0|0|0|0|0|0|APC|0|0|1|100|IKR|||lyflausa|||0|20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól|||||||1 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|0|0|0|0|0|1|SNO|0|0|0|100|NOK|13914|19345|lyfsjukr|||1|2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||13914||13914|19345||1 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1205|2738|lyfalmen|||0|5|0||Vistor hf|Alcon Laboratories Ltd.|Emedastín||1205||1205|2738||1 528055|C03DA0103|Spiron|töflur|25|mg|100|stk|1|glas||C03DA01|01.09.2013||R|1|0|0|0|G|0|OPF|0|0|0|100|DKK|1031|2032|lyfalmen|V0046|2032|2|100|0|33,3333|Portfarma ehf|Orion Corporation|Spírónólaktón||689||689|2032||1 528214|N04BC0505|Oprymea|forđatfl|0,52|mg|100|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|16800|20651|lyfalmen|V0635|20651|2|100|0|20,8000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||14200||14200|20651||2 528267|A02BC0501|Nexium|sţ-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2013||R|1|0|0|0|0|0|AZD|0|0|0|100|SEK|11320|6833|lyfalmen|V0011|5373|1|100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4199||4199|6833||1 528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|0|0|0|0|G|0|BGB|0|0|0|100|DKK|16475|23506|lyfalmen|V0641|22722|1|4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||16475||16475|23506||2 528418|D07AC1302|Ovixan|krem|0,1|%|100|g|1|túpa||D07AC13|01.06.2013||R|0|0|0|0|G|0|GAB|0|0|1|100|SEK|2234|4145|lyfalmen|||2|100|0||Vistor hf|Galenica AB|Mómetasón||2234||2234|4145||1 528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innönddu|164,5|mcg/sk|120|skammtar|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|0|0|0|0|G|0|LVR|0|0|0|100|SEK|8205|12313|lyfalmen|V0356|10783|3|120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og budesonide||8205||8205|12313||3 528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|1|0|0|0|G|0|FEL|0|0|0|100|DKK|6681|10229|lyfalmen|||1|60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||6681||6681|10229||1 528874|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|18|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|9205|5444|lyfalmen|V0621|5292|2|18|0|18,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||3183||3183|5444||2 529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4366|8556|vetalmen|||0|72|0||Icepharma hf|Zoetis Finland OY|||4366||4366|8556||2 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|4642|9086|vetalmen|||0|100|0||Icepharma hf|Zoetis Finland OY|||4642||4642|9086||2 529449|A02BC0112|Omezolmyl|sţ-hylki|40|mg|98|stk|1|ţpakki||A02BC01|01.09.2013||R|0|0|0|0|G|0|MYL|0|0|0|100|SEK|9756|3225|lyfalmen|V0001|3225|2|98|0|196,0000|Icepharma hf|Mylan AB|Ómeprazól||1561||1561|3225||2 529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|0|0|0|0|0|1|PER|0|0|0|100|DKK|66647|85524|lyfsjukr|||1|100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||66647||66647|85524||1 530109|C10AA0703|Rosuvastatin Krka|filmhtfl|40|mg|30|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|6500|9981|lyfalmen|V0194|9981|2|30|0|120,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6500||6500|9981||2 530162|A06AD6502|Movicol|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.07.2014||L|0|0|0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa|||0|8|0||Artasan ehf|Norgine A/S|Makrógól 3350|||||||1 530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|0|0|0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen|V0592|6435|0|50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6794||1 530322|B01AC0602|Hjarta-Aspirín|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.02.2014||L|1|0|0|0|0|0|LYF|0|0|0|100|IKR|||lyflausa|||0|100|0|100,0000|LYFIS ehf|LYFIS ehf|Asetýlsalicýlsýra|||||||2 530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|11419|2368|lyfalmen|V0186|2368|2|28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||935||935|2368||2 530701|QN05CM9204|Nerfasin vet.|stl|20|mg/ml|25|ml|1|hgl|nautg. hestar,hundar og kettir|QN05CM92|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|1585|3153|vetalmen|||0|25|0||Dýraheilsa ehf|Le Vet B.V.|||1585||1585|3153||2 530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|0|0|0|0|G|0|NAS|0|0|0|100|DKK|2927|5093|lyfalmen|||1|84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2927||2927|5093||1 530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|5794|8362|lyfsjukr|||2|10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||5794||5794|8362||2 531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|2789|4905|lyfalmen|||1|100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2789||2789|4905||1 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|0|0|0|0|0|0|JAS|0|0|0|100|SEK|617|1933|lyfalmen|||1|30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||617||617|1933||1 532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|326|1535|lyfalmen|||1|30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||326||326|1535||1 532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|947|2385|lyfalmen|||1|100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||947||947|2385||1 532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|262|1448|lyfalmen|||1|14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||262||262|1448||1 532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|1|0|0|0|0|0|MEB|0|0|1|100|SEK|1668|3371|lyfalmen|||1|100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1668||1668|3371||1 532983|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|2162|3120|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2162||2162|3120||2 533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|1|0|0|0|G|0|AZD|0|0|0|100|SEK|1891|3676|lyfalmen|||1|100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||1891||1891|3676||1 533779|A02BC0111|Omeprazol Pensa|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.12.2012||L|1|0|0|0|0|0|PEN|0|0|0|100|IKR|||lyflausa|||0|28|0|28,0000|Lyfjaver ehf|Pensa Pharma AB|Ómeprazól|||||||3 534166|N05AB0302|Trilafon Dekanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.04.2014||R|0|0|0|0|G|0|COR|0|0|0|100|DKK|18172|25636|lyfalmen|V0639|25636|1|10|0|154,5714|Vistor hf|Orion Corporation|Perfenazín||18172||18172|25636||1 534183|N05AH0308|Lazapix|filmhtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2013||R|1|0|0|0|G|0|POF|0|0|0|100|XEU|14760|21354|lyfalmen|||2|28|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||14760||14760|21354||1 534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|0|0|0|1|G|0|IPI|0|0|0|100|DKK|57046|74423|lyfalmen|||1|100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||57046||57046|74423||1 534512|C10AA0703|Rosuvastatin Krka|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.07.2014||R|1|0|0|0|0|0|KRK|0|0|0|100|IKR|7700|10473|lyfalmen|V0117|10473|2|100|0|100,0000|LYFIS ehf|Krka Sverige AB|Rósuvastatín||6860||6860|10473||2 534652|G03XB0101|Mifepristone Linepharma|töflur|200|mg|1|stk|1|ţpakki||G03XB01|01.05.2014||R|0|0|0|1|0|1|LPF|0|0|0|100|XEU|3143|4532|lyfsjukr|||1|1|0|0,3300|Portfarma ehf|Linepharma France|Mifepriston||3140||3140|4532||1 534885|L01AA0601|Holoxan|sts/irs|1000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|5795|8364|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||5795||5795|8364||2 535265|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.11.2013||R|1|0|0|0|G|0|TPA|0|0|0|100|DKK|2621|4675|lyfalmen|V0092|3775|2|100|0|66,6667|Vistor hf|Takeda Pharma A/S|Spírónólaktón||2621||2621|4675||1 535446|N02AA0506|Oxikodon Depot Actavis|forđatfl|20|mg|98|stk|1|glas||N02AA05|01.10.2014||R|1|0|1|0|G|0|APC|0|0|0|100|XEU|5434|8523|lyfalmen|V0585|8523|2|98|0|26,1300|Actavis Group PTC ehf|Actavis Group PTC ehf|Oxýcódon||5434||5434|8523||1 535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|0|0|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum|||||||2 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|425|1671|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||425||425|1671||1 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|0|0|0|0|G|0|SAC|0|0|0|100|USD|542|1831|lyfalmen|||1|10|0|25,0000|Vistor hf|S.A. Alcon - Couvreur N.V.|Pílókarpín||542||542|1831||1 536133|A10BA0202|Metformin Actavis|filmhtfl|1000|mg|30|stk|1|ţpakki||A10BA02|01.11.2012||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|393|1597|lyfalmen|V0502|1088|2|30|0|15,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||371||371|1597||1 536289|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|29007|38286|lyfsjukr|||1|1,2|0|15,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||29007||29007|38286||1 536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|0|0|0|0|0|0|JCI|0|0|0|100|SEK|101368|130047|lyfalmen|||1|1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||101368||101368|130047||1 536745|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|2898|4183|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2898||2898|4183||2 537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|6137|8857|lyfsjukr|||2|7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6137||6137|8857||2 537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|0|0|0|0|G|0|PTL|0|0|0|100|DKK|||lyfalmen|||0|15|0|37,5000|Navamedic AB|Aspen Pharma Trading Limited|Estríól|||||2481||1 537866|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2014||L|0|0|0|0|G|0|TPA|0|0|0|100|DKK|||lyfalmen|V0135|1805|0|25|0|2,5000|Vistor hf|Takeda Pharma A/S|Glýcerýltrínítrat|||||1805||1 538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|0|0|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||0|96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda|||||||2 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|0|0|0|1|0|1|MSE|0|0|0|100|SEK|126648|160826|lyfsjukr|||1|6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||126648||126648|160826||2 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|1|0|0|1|G|0|SNO|0|0|0|100|NOK|7951|11966|lyfalmen|||1|100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||7951||7951|11966||1 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|1|100|DKK|214|1382|lyfalmen|||2|25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||214||214|1382||1 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|1|0|0|0|0|0|AGT|0|0|0|100|DKK|623|1942|lyfalmen|||2|100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||623||623|1942||1 539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0||Vistor hf|McNeil Sweden AB|Blöndur|||||||1 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|1745|3476|lyfalmen|||1|40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1745||1745|3476||1 540009|B05BA1021|SmofKabiven|irl|550|kcal|493|ml|6|pokar|fleyti|B05BA10|01.03.2014||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|22608|30256|lyfsjukr|||1|2958|0||Icepharma hf|Fresenius Kabi|Blöndur||22608||22608|30256||2 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|0|0|0|0|0|0|SON|0|0|1|100|DKK|2710|4796|lyfalmen|||1|250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2710||2710|4796||2 540544|N02CC0405|Rizatriptan ratiopharm|munndr.t|10|mg|6|stk|1|ţpakki||N02CC04|01.11.2013||R|0|0|0|0|G|0|RGM|0|0|0|100|XEU|3317|2041|lyfalmen|V0621|1764|2|6|0|6,0000|Medical ehf|ratiopharm GmbH|Rizatriptan||696||696|2041||2 540970|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2012||R|0|0|0|0|0|0|ZOE|0|0|0|100|XEU|2507|4373|vetorma|||0|11,8|0||Icepharma hf|Zoetis Finland OY|||2507||2507|4373||2 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|0|0|0|0|G|0|MSD|0|0|0|100|DKK|5717|8910|lyfalmen|V0373|7257|1|15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||5717||5717|8910||1 541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|0|0|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||0|24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól|||||||1 541834|N06DA0207|Donepezil Bluefish|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2013||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|12701|7716|lyfalmen|V0341|7716|2|98|0|65,3300|LYFIS ehf|Bluefish Pharmaceuticals AB|Dónepezíl||4844||4844|7716||2 542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|5710|8241|lyfsjukr|||2|800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5710||5710|8241||1 542937|N05AE0403|Ziprasidon Actavis|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|13775|20118|lyfalmen|V0610|20118|2|56|0|42,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||13775||13775|20118||1 543236|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|ţpakki||N05AA02|01.10.2012||R|1|0|0|0|0|0|SNO|0|0|0|100|NOK|641|1966|lyfalmen|||1|100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||641||641|1966||1 543274|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|16292|23276|lyfalmen|V0645|23276|1|1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||16292|23276||1 543320|M05BA0409|Alendronat Bluefish|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.09.2014||R|1|0|0|0|G|0|BLP|0|0|0|100|XEU|3694|2995|lyfalmen|V0203|2995|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Alendrónsýra||1393||1393|2995||2 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|2825|4954|lyfalmen|||1|98|0|65,3333|Vistor hf|Novartis Healthcare A/S|Pindólól||2825||2825|4954||1 543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|0|0|0|0|G|0|POF|0|0|0|100|XEU|2153|3204|lyfalmen|V0373|2419|2|5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1546||1546|3204||1 543592|N01AB0701|Suprane|innönd.l|||240|ml|6|glas||N01AB07|01.09.2014||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|76940|98442|lyfsjukr|||1|1440|0||Icepharma hf|Baxter Medical AB|Desflúran||||76940|98442||2 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|0|0|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||0|250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)|||||||1 543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|0|0|0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa|||0|7,5|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín|||||||1 543755|R03DC0305|Montelukast Navamedic|töflur|10|mg|98|stk|1|ţpakki||R03DC03|01.04.2014||R|1|0|0|0|G|0|ART|0|0|0|100|XEU|7078|2589|lyfalmen|V0490|2433|2|98|0|98,0000|Artasan ehf|Navamedic ASA|Montelúkast||1096||1096|2589||1 543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|0|1|0|1|0|1|MLD|0|1|0|100|DKK|499291|628493|lyfsjukr|||1|336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||499291||499291|628493||1 544186|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|12|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|4321|5178|lyfalmen|V0143|5178|2|12|0|12,0000|Icepharma hf|Mylan AB|Síldenafíl||2989||2989|5178||2 544385|J06BA0208|Privigen|irl|100|mg/ml|400|ml|1|hgl||J06BA02|01.02.2014||R|0|0|0|0|0|1|CSB|0|1|0|100|SEK|267762|337924|lyfsjukr|||1|400|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||267762||267762|337924||2 544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|0|0|0|1|G|0|ASP|0|0|0|100|XEU|12639|18692|lyfalmen|||1|50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||12639||12639|18692||1 545090|N04BC0505|Oprymea|forđatfl|2,1|mg|100|stk|1|ţpakki||N04BC05|01.02.2014||R|0|0|0|0|G|0|KNM|0|0|0|100|IKR|50000|60560|lyfalmen|V0636|60560|2|100|0|84,0000|LYFIS ehf|Krka d.d. Novo mesto|Pramipexól||46000||46000|60560||2 545104|L01XC0201|MabThera|stl|1400|mg|11,7|ml|1|hgl|lausn|L01XC02|01.10.2014||R|0|1|0|1|0|1|RRL|0|1|0|100|DKK|252304|318524|lyfsjukr|||1|11,7|0||Icepharma hf|Roche Registration Limited|Rítúxímab||252304||252304|318524||2 545176|G03HB0103|Cypretyl|töflur|||63|stk|1|ţpakki||G03HB01|01.10.2012||R|0|0|0|0|0|0|RGM|0|0|0|100|XEU|1876|3174|lyfalmen|V0134|3174|2|63|0|84,0000|Medical ehf|ratiopharm GmbH|Cýpróterón og östrógen||1524||1524|3174||2 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|996|2452|lyfalmen|||1|15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||996||996|2452||1 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|880|2293|lyfalmen|||1|100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||880||880|2293||1 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|2171|4059|lyfalmen|||1|100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2171||2171|4059||1 545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|29381|39703|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||29381||29381|39703||1 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|23688|32558|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||23688||23688|32558||1 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|29554|39920|lyfalmen|||1|20|0||Vistor hf|ALK-Abello A/S|grasfrjó||29554||29554|39920||1 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|0|0|0|1|G|0|ALK|0|0|0|100|DKK|25107|34339|lyfalmen|||1|5|0||Vistor hf|ALK-Abello A/S|grasfrjó||25107||25107|34339||1 546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|1|0|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||0|30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól|||||||1 546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|1|0|0|0|0|0|ACA|0|0|1|100|XEU|1335|2916|lyfalmen|||2|100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1335||1335|2916||1 546722|C09DA0310|Valsartan/Hydrochlorothiazide ratiopharm|filmhtfl|92,5|mg|98|stk|1|ţpakki|80/12,5 mg|C09DA03|01.11.2012||R|1|0|0|0|G|0|RGM|0|0|0|100|IKR|3218|3552|lyfalmen|V0580|3552|2|98|0|98,0000|Medical ehf|ratiopharm GmbH|Valsartan og ţvagrćsilyf||1800||1800|3552||2 546844|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|100|stk|1|glas||A02BC04|01.10.2012||R|0|0|0|0|G|0|APC|0|0|0|100|IKR|4021|4160|lyfalmen|V0010|3763|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||2245||2245|4160||1 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|1|0|0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen|||0|60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4902||1 547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|2267|2457|lyfalmen|V0004|2215|3|28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2457||2 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|10443|14988|lyfsjukr|||1|100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10443||10443|14988||1 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|0|0|0|1|0|1|GGL|0|0|0|100|GBP|3441|4966|lyfsjukr|||1|10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3441||3441|4966||1 548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|556|1850|lyfalmen|V0542|1543|2|100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||556||556|1850||2 548121|L03AB0801|Betaferon|sts|250|mcg/ml|15|spr|1|pakki|+leysir|L03AB08|01.07.2013||R|0|0|0|1|0|1|BYP|0|0|0|100|DKK|127308|161654|lyfsjukr|||1|15|0|30,0000|Icepharma hf|Bayer Pharma AG|Interferón beta-1b||127308||127308|161654||2 548154|N06DX0103|Nemdatine|filmhtfl|20|mg|100|stk|1|glas||N06DX01|01.08.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|37595|19380|lyfalmen|V0607|19371|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||13187||13187|19380||1 548326|M01AE0112|ibuxin rapid|filmhtfl|400|mg|10|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|10|0|3,3300|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 548506|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|túpa||D07AC13|01.02.2014||R|0|0|0|0|G|0|MBV|0|0|1|100|DKK|1127|2631|lyfalmen|V0627|2631|1|30|0||Vistor hf|Merck Sharp & Dohme B.V.|Mómetasón||1127||1127|2631||1 548563|S01XA2011|Oculac|augndr|50|mg/ml|10|ml|1|glas|međ rotvörn|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|10|0||Vistor hf|Alcon Nordic A/S|Gervitár og ađrar óvirkar samsetningar|||||1765||1 548894|B02BC3002|TISSEEL|vefjalím|||2|ml|10|áf.spr|+ Duo sett|B02BC30|01.01.2013||R|0|0|0|0|0|1|BAA|0|0|0|100|SEK|166054|210280|lyfsjukr|||1|20|0||Icepharma hf|Baxter AG|Blöndur||166054||166054|210280||2 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|8910|13278|lyfalmen|||1|5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||8910||8910|13278||1 549255|N06DX0102|Memantine Merz|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|12366|7108|lyfalmen|V0606|6743|2|28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||4400||4400|7108||1 549674|B01AF0101|Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AF01|01.05.2012||R|1|1|0|0|G|0|BAP|0|0|0|100|DKK|37540|49943|lyfalmen|||1|98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaoxaban||||37540|49943||2 550020|J07AP0302|Typherix|stl|||0,5|ml|1|spr|m/ ađsk. nál|J07AP03|01.08.2013||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|2381|3896|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir mótefnavakar||2052||2052|3896||1 550256|J02AC0102|Candizol|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.08.2014||R|1|0|0|0|0|0|ACA|0|0|1|100|IKR|1567|1771|lyfalmen|V0551|1761|2|7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||498||498|1771||1 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 550803|A10BX0204|Repaglinide Krka|töflur|1|mg|120|stk|1|ţpakki||A10BX02|01.11.2013||R|1|0|0|0|G|0|KNM|0|0|0|100|IKR|3475|3825|lyfalmen|V0471|3825|2|120|0|30,0000|LYFIS ehf|Krka d.d. Novo mesto|Repaglíníđ||2000||2000|3825||2 551043|B01AC0701|Persantin|húđuđtfl|100|mg|100|stk|1|ţpakki||B01AC07|01.05.2014||R|1|0|0|0|G|0|BOI|0|0|0|100|DKK|2341|4292|lyfalmen|V0122|4292|1|100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2341||2341|4292||1 551328|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.06.2013||L|0|0|0|0|0|0|TEA|0|0|0|100|IKR|||lyflausa|||0|8|0||Vistor hf|Laboratories THEA|Ketotifen|||||||1 551388|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.08.2012||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|9822|14176|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9822||9822|14176||2 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|0|0|0|0|G|0|AZA|0|0|0|100|SEK|8427|12617|lyfalmen|V0235|12617|1|12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||8427||8427|12617||1 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|1717|3438|lyfalmen|||1|1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1717||1717|3438||1 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|1|0|0|0|G|0|MAB|0|0|1|100|SEK|2749|4850|lyfalmen|V0198|4850|1|100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||2749||2749|4850||1 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|738|2099|lyfalmen|||0|20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|2099||2 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|2157|1862|lyfalmen|V0466|1821|1|28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1862||1 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3931|3542|lyfalmen|V0467|2457|1|56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3542||1 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|1510|1118|lyfalmen|V0003|840|1|14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||21||21|1118||1 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|3631|1862|lyfalmen|V0003|1679|1|28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1862||1 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|0|0|0|0|0|0|EIS|0|0|0|100|IKR|7648|3542|lyfalmen|V0010|2107|1|56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3542||1 551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|1|0|0|0|0|0|LYF|0|0|0|100|XEU|18412|5861|lyfalmen|V0516|5624|2|100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||3488||3488|5861||2 552328|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1701|2455|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1701||1701|2455||2 552377|M01AE0102|Ibufen|filmhtfl|400|mg|50|stk|1|glas||M01AE01|01.11.2012||L|1|0|0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa|||0|50|0|16,6600|Actavis Group hf|Actavis Group PTC ehf|Íbúprófen|||||||1 552764|QN01AX9301|Tricaine Pharmaq|duft|1000|mg/g|100|g|1|askja|lausn handa fiskum|QN01AX93|01.07.2013||R|0|0|0|0|0|0|PHL|0|0|0|100|GBP|17864|29145|veteldis|||0|100|0||PHARMAQ Ltd.|PHARMAQ Ltd|Tricaine Methane Sulfónat||17864||17864|29145||1 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|3199|5465|lyfalmen|||1|100|0|15,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||3199||3199|5465||1 553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|11667|17049|lyfalmen|V0237|17049|1|18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||11667|17049||1 553231|C10AA0506|Atorvaratio|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|3300|3483|lyfalmen|V0112|3483|2|100|0|50,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1750||1750|3483||2 553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|3990|6547|lyfalmen|V0237|5683|1|6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||3990||3990|6547||1 553720|L01XE1801|Jakavi|töflur|15|mg|56|stk|1|ţpakki||L01XE18|01.02.2014||R|1|0|0|1|0|1|NEL|0|0|0|100|DKK|543803|684355|lyfsjukr|||1|56|0||Vistor hf|Novartis Europharm Ltd|Ruxolitinib||543803||543803|684355||1 553923|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.11.2013||R|0|0|0|1|0|1|BAY|0|1|0|100|SEK|44195|57347|lyfsjukr|||1|1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||44195|57347||2 554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|0|0|0|0|0|0|BID|1|0|0|100|DKK|10090|19547|vetalmen|||0|500|0||Vistor hf|Boehringer Ingelheim Danmark|||10090||10090|19547||1 554582|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.11.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|8129|6851|lyfalmen|V0029|6851|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||4212||4212|6851||1 555235|N05AB0303|Peratsin|húđuđtfl|4|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2209|4111|lyfalmen|||2|100|0|13,3300|Vistor hf|Orion Corporation|Perfenazín||2209||2209|4111||1 555268|N05AB0303|Peratsin|húđuđtfl|8|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|2517|4532|lyfalmen|||2|100|0|26,6700|Vistor hf|Orion Corporation|Perfenazín||2517||2517|4532||1 555292|N05AB0303|Peratsin|húđuđtfl|2|mg|100|stk|1|glas||N05AB03|01.02.2013||R|1|0|0|0|G|0|ORC|0|0|0|100|DKK|1900|3688|lyfalmen|||2|100|0|6,6700|Vistor hf|Orion Corporation|Perfenazín||1900||1900|3688||1 555836|N05AH0314|Olanzapine Mylan|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.12.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|4253|2827|lyfalmen|||2|56|0|42,0000|Icepharma hf|Generics UK Ltd|Olanzapín||1270||1270|2827|31.7.2014|2 556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|25052|33323|lyfsjukr|||1|1,03|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||25052||25052|33323||2 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|4739|7572|lyfalmen|||1|100|0|30,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||4739||4739|7572||1 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|1|0|0|0|G|0|HES|0|0|0|100|DKK|9239|13728|lyfalmen|||1|100|0|60,0000|Vistor hf|Novartis Healthcare A/S|Oxkarbazepín||9239||9239|13728||1 557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|0|0|0|0|0|0|ASP|0|0|0|100|XEU|1552|3212|lyfalmen|||1|30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1552||1552|3212||1 557907|N02BE0109|Panodil Hot|mixtduft|500|mg|10|skammtar|1|pakki||N02BE01|01.10.2014||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||||1 557980|M01AH0105|Cloxabix|hylki|100|mg|20|stk|1|ţpakki||M01AH01|01.03.2013||R|1|0|0|0|G|0|WEH|0|0|1|100|XEU|2790|4906|lyfalmen|||2|20|0|10,0000|Williams & Halls efh|Williams & Halls ehf|Celekoxíb||2790||2790|4906||2 558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|0|1|0|1|0|1|NEL|0|1|0|100|DKK|242667|306430|lyfsjukr|||1|28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||242667|306430||1 559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|1|0|0|0|G|0|ABS|0|0|0|100|DKK|1889|3673|lyfalmen|||1|98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1889||1889|3673||1 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1519|3167|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1519||1519|3167||2 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|0|0|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||0|100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ|||||||2 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|5564|8701|lyfalmen|||1|1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5564||5564|8701||1 559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|0|0|0|0|G|0|MEB|0|0|0|100|SEK|3281|5578|lyfalmen|||1|30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3281||3281|5578||1 559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|0|0|0|0|0|1|BAX|0|0|0|100|SEK|12824|17977|lyfsjukr|||1|240|0||Icepharma hf|Baxter|Desflúran||12824||12824|17977||2 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|0|0|0|0|G|0|GEM|0|0|0|100|XEU|||lyfalmen|||0|10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1520||1 560244|N06AB0404|Citalopram Bluefish|filmhtfl|20|mg|30|stk|1|ţpakki||N06AB04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|791|1842|lyfalmen|V0067|1842|2|30|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Cítalópram||550||550|1842||2 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|1|0|0|0|G|0|GSK|0|0|1|100|GBP|1474|2765|lyfalmen|V0044|2352|1|25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1225||1225|2765||1 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|0|0|0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa|||0|2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír|||||||1 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|1548|3207|lyfalmen|||1|4,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1548||1548|3207||1 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|5930|9201|lyfalmen|||1|125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5930||5930|9201||1 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|6430|9885|lyfalmen|||1|100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6430||6430|9885||1 560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|97425|124151|lyfsjukr|||1|5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||97425||97425|124151||1 560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|450561|567337|lyfsjukr|||1|20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||450561||450561|567337||1 560695|L01XE0102|Imatinib Accord|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.11.2013||R|0|0|0|1|0|1|AHL|0|1|0|100|DKK|165877|148077|lyfsjukr|||2|60|0||Portfarma ehf|Accord Healthcare Limited|Imatiníb||116490||116490|148077||1 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|1668|3371|lyfalmen|||1|5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1668||1668|3371||2 562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|1914|2706|lyfalmen|V0098|2706|2|100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||1182||1182|2706||1 562176|B02BD0901|BeneFIX|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD09|01.02.2013||R|0|0|0|1|0|1|IPI|0|0|0|100|DKK|48404|62630|lyfsjukr|||1|1|0|1,1100|Icepharma hf|Pfizer Limited|Storkuţáttur IX||48404||48404|62630||1 562254|S01EE0105|Monoprost|augndr|50|mcg/ml|0,2|ml|90|sk-hyl|90 (18x5)|S01EE01|01.03.2013||R|0|0|0|0|G|0|TEA|0|0|0|100|SEK|4663|7468|lyfalmen|||1|18|0|90,0000|Vistor hf|Laboratories THEA|Latanóprost||4663||4663|7468||1 562577|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl||J06BA02|01.05.2013||R|0|0|0|0|0|1|BAA|0|1|0|100|SEK|230369|290996|lyfsjukr|||1|300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||230369||230369|290996||2 562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|0|0|0|1|0|1|GGL|0|1|0|100|GBP|103368|131609|lyfsjukr|||1|1|0|16,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||103368||103368|131609||1 563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|1|1|0|1|0|0|INT|0|0|0|100|DKK|111562|142840|lyfalmen|||1|63|0|7,0000|Vistor hf|InterMune Europe Ltd.|Pírfenidon||111562||111562|142840||1 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|716|2069|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||716||716|2069||1 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|0|0|0|0|G|0|GSK|0|0|1|100|GBP|692|2036|lyfalmen|||1|30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||692||692|2036||1 563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|1|0|1|0|G|0|PER|0|0|0|100|DKK|1343|2926|lyfalmen|||1|100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1343||1343|2926||1 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001|31.08.2014|R|0|0|0|0|G|0|NYC|0|0|0|100|DKK|200954|255027|lyfalmen|||2|60|0|171,6667|Vistor hf|Nycomed Danmark A/S|Natríumhýalúrónat||200954||200954|255027||1 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3480|5850|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3480||3480|5850||2 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|0|0|0|0|G|0|SAO|0|0|0|100|XEU|3608|6025|lyfalmen|||1|15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3608||3608|6025||2 563756|H01CB0501|Signifor|stl|0,3|mg|1|ml|60|lykjur||H01CB05|01.11.2012||R|0|0|0|0|0|0|NEL|0|0|0|100|DKK|451162|569038|lyfalmen|||1|60|0|15,0000|Vistor hf|Novartis Europharm Ltd|PAsireótiđ disapartate||451162||451162|569038||1 563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|2323|2316|lyfalmen|V0207|2315|2|12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||897||897|2316||2 563899|QP54AA0105|Noromectin|áhella|0,5|% w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|0|0|0|0|0|0|NOB|0|0|0|100|XEU|11046|19269|vetorma|||0|1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Ivermectinum||11046||11046|19269||2 563918|N02AA0505|Oxycodone ratiopharm|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.04.2013||R|1|0|1|0|G|0|RGM|0|0|0|100|XEU|1453|2693|lyfalmen|V0596|1896|2|28|0|1,8600|Medical ehf|ratiopharm GmbH|Oxýcódon||1172||1172|2693||2 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|1|0|0|1|0|1|MLD|0|0|0|100|DKK|79583|101759|lyfsjukr|||1|168|0|33,6000|Vistor hf|Merck Sharp & Dohme Limited|Ribavirin||79583||79583|101759||1 564110|A02BX1302|Galieve Cool Mint|mixtúra|||150|ml|1|glas|dreifa|A02BX13|01.10.2014||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|150|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 564441|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|glas||R06AX27|01.11.2012||R|1|0|0|0|G|0|MLD|0|0|1|100|DKK|1073|2557|lyfalmen|||1|120|0|12,0000|Vistor hf|Merck Sharp & Dohme Limited|Deslóratadín||1073||1073|2557||1 565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|1|0|0|0|G|0|UCB|0|0|0|100|DKK|11226|16446|lyfalmen|||1|100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11226||11226|16446||1 565982|H01BA0401|Glypressin|stl|0,1|mg/ml|8,5|ml|5|lykjur|lausn|H01BA04|01.08.2012||R|0|0|0|0|0|1|FEL|0|0|0|100|DKK|35280|46159|lyfsjukr|||1|42,5|0|0,3600|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||35280||35280|46159||1 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|1346|2931|lyfalmen|V0444|2174|0|5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Brinzólamíđ||1346||1346|2931||1 566243|G03AA1207|Cleonita|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.07.2014||R|0|0|0|0|0|0|AGP|0|0|0|100|XEU|3651|6084|lyfalmen|V0193|6084|2|84|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Dróspírenón og ethinylestradíól||3651||3651|6084||1 567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|1|0|0|1|0|1|GGL|0|0|0|100|GBP|210218|265706|lyfsjukr|||1|84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||210218||210218|265706||1 567338|G04BD1201|Betmiga|forđatfl|50|mg|90|stk|1|glas||G04BD12|01.07.2014||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16843|23968|lyfalmen|V0651|23968|1|90|0|90,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16843||16843|23968||1 567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|0|0|0|0|G|0|ALK|0|0|1|100|DKK|5642|8807|lyfalmen|||1|1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5642|8807||1 567503|N05AX0801|Risperdal|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|3151|5400|lyfalmen|V0291|2320|1|60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3151||3151|5400||1 567510|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.06.2013||R|1|0|0|0|G|0|APP|0|0|0|100|GBP|3302|5606|lyfalmen|||1|100|0|33,3333|Artasan ehf|Aspen Pharma Trading Limited|Labetalól||3302||3302|5606||1 567511|N05AX0801|Risperdal|filmhtfl|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|1|0|0|0|G|0|JAS|0|0|0|100|SEK|6377|9813|lyfalmen|V0292|3757|1|60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6377||6377|9813||1 567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín|||||||1 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|1|100|GBP|1112|2611|lyfalmen|||1|3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1112||1112|2611||1 568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2821|4948|lyfalmen|V0058|4948|2|100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||2821||2821|4948||1 568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|3909|6437|lyfalmen|V0059|6437|2|100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||3909||3909|6437||1 569041|C09CA0603|Candesartan Aspen|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.04.2014||R|1|0|0|0|0|0|ART|0|0|0|100|XEU|3105|4493|lyfalmen|V0081|4493|2|100|0|100,0000|Artasan ehf|Navamedic ASA|Candesartan||2488||2488|4493||1 569378|L01AA0601|Holoxan|sts/irs|2000|mg|1|stk|1|hgl||L01AA06|01.07.2013||R|0|0|0|1|0|1|BAM|0|0|0|100|SEK|11627|16474|lyfsjukr|||1|1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||11627||11627|16474||2 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|16708|22851|lyfsjukr|||1|5|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||16708||16708|22851||1 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|0|0|0|1|0|1|HES|0|0|0|100|DKK|19211|25992|lyfsjukr|||1|20|0|18,1800|Vistor hf|Novartis Healthcare A/S|Baklófen||19211||19211|25992||1 571030|QM01AA9001|Danilon equidos|kyrni|1,5|g|10|g|18|pokar||QM01AA90|01.07.2014||R|0|0|0|0|0|0|EST|0|0|0|100|DKK|3296|6501|vetalmen|||0|180|0||Vistor hf|Laboratorios Dr. ESTEVE S.A.|Suxibuzone||3296||3296|6501||1 571217|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|44194|57346|lyfsjukr|||1|1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||44194|57346||3 571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|0|0|0|1|G|0|APE|0|0|0|100|XEU|81687|105347|lyfalmen|||1|50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||81687||81687|105347||1 572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|0|0|0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa|||0|48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra|||||||1 573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|8127|5357|lyfalmen|V0011|5266|3|98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3120||3120|5357||2 573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|5300|3502|lyfalmen|V0245|3481|2|98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||1764||1764|3502||1 573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|0|0|0|0|G|0|ALA|0|0|0|100|USD|3453|5813|lyfalmen|V0464|4590|0|2,5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||3453||3453|5813||1 573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|3039|5247|lyfalmen|V0129|5247|1|26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3039||3039|5247||1 573436|N06DX0102|Memantine Merz|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|LBK|0|0|0|100|DKK|36363|20222|lyfalmen|V0607|18984|2|98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||13858||13858|20222||1 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|0|0|0|1|0|1|ROC|0|1|0|100|DKK|86712|110706|lyfsjukr|||1|1|0||Icepharma hf|Roche|Trastuzumab||86712||86712|110706||2 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|22465|30076|lyfsjukr|||1|5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||22465||22465|30076||1 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|0|0|0|0|0|1|AZA|0|0|0|100|SEK|27402|36272|lyfsjukr|||1|10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||27402||27402|36272||1 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|1|0|0|0|G|0|HES|0|0|1|100|IKR|2477|2769|lyfalmen|V0189|2178|1|100|0|50,0000|Vistor hf|Novartis Healthcare A/S|Díklófenak||1228||1228|2769||1 573999|G04BE0307|Sildenafil Mylan|filmhtfl|100|mg|12|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|5733|6133|lyfalmen|V0144|5814|2|12|0|24,0000|Icepharma hf|Mylan AB|Síldenafíl||3687||3687|6133||2 574377|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.09.2013||R|0|0|0|1|0|1|SAR|0|0|0|100|DKK|41434|53882|lyfsjukr|||1|2,5|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||||41434|53882||1 574423|L01XC1301|Perjeta|irţ|420|mg|14|ml|1|hgl||L01XC13|01.06.2013||R|0|0|0|1|0|1|RRL|0|0|0|100|DKK|406226|511696|lyfsjukr|||1|14|0||Icepharma hf|Roche Registration Limited|Pertuzumab||406226||406226|511696||2 574900|N05AH0410|Quetiapin Actavis|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.09.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|21987|28120|lyfalmen|V0273|28120|2|100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Quetíapín||20151||20151|28120||1 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|2404|2184|lyfalmen|V0151|1655|1|28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||800||800|2184||1 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|7491|6879|lyfalmen|V0322|2301|1|98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4232||4232|6879||1 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|0|0|PER|0|0|0|100|DKK|4434|2184|lyfalmen|V0152|2082|1|28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||800||800|2184||1 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|1|0|0|0|G|0|PER|0|0|0|100|DKK|13500|6879|lyfalmen|V0323|3548|1|98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4232||4232|6879||1 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994|30.09.2014|L|0|0|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||0|40|0||Icepharma hf|Norpharma |Malatíón|||||||2 575571|J01CA0413|Amoxin|filmhtfl|500|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1541|2147|lyfalmen|V0159|2143|2|20|0|10,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||773||773|2147||2 575589|J01CA0413|Amoxin|filmhtfl|500|mg|30|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1648|2553|lyfalmen|V0160|2553|2|30|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1070||1070|2553||2 575621|J01CA0413|Amoxin|filmhtfl|750|mg|20|stk|1|ţpakki||J01CA04|01.03.2013||R|0|0|0|0|0|0|RGM|0|0|1|100|IKR|1556|2457|lyfalmen|V0158|2457|2|20|0|15,0000|Medical ehf|ratiopharm GmbH|Amoxicillín||1000||1000|2457||2 576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|1|0|0|0|G|0|ACA|0|0|0|100|IKR|1150|1549|lyfalmen|V0243|1375|2|42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||336||336|1549||1 576714|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.12.2012||R|0|0|0|0|G|0|APP|0|0|0|100|XEU|12447|18451|lyfalmen|||1|25|0||Artasan ehf|Aspen Pharma Trading Limited|Merkaptópúrín||12447||12447|18451||1 577455|C10AA0506|Atorvaratio|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.07.2014||R|1|0|0|0|G|0|TSB|0|0|0|100|IKR|4000|3483|lyfalmen|V0113|3483|2|100|0|100,0000|Medical ehf|Teva Sweden AB|Atorvastatín||1750||1750|3483||2 577711|C01CA0601|Fenylefrin Abcur|stl|0,05|mg/ml|10|ml|10|lykjur||C01CA06|01.09.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12521|17596|lyfsjukr|||2|100|0|1,2500|Icepharma hf|Abcur AB|Phenylephrin||12521||12521|17596||2 578259|A04AA0106|Ondansetron Mylan|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|1|0|0|0|G|0|MYL|0|0|1|100|SEK|3483|3496|lyfalmen|||2|10|0|5,0000|Icepharma hf|Mylan AB|Ondansetrón||1759||1759|3496|30.9.2014|2 578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|0|0|0|0|0|0|ICE|0|0|0|100|USD|5533|9652|vetorma|||0|20|0||Icepharma hf|Icepharma hf|||5533||5533|9652||2 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|0|0|0|0|G|0|AZD|0|0|0|100|SEK|1210|2745|lyfalmen|||1|10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1210||1210|2745||1 579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|1|0|0|0|0|0|LYF|0|0|0|100|IKR|4212|2457|lyfalmen|V0005|2457|3|28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||1000||1000|2457||2 579854|L04AX0305|Methotrexate Pfizer|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|355|1575|lyfalmen|||1|30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||355||355|1575||1 579932|C03DA0402|Eplerenone Portfarma|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.06.2014||R|1|0|0|0|0|0|PEH|0|0|0|100|DKK|8421|10650|lyfalmen|V0107|10650|2|30|0|15,0000|Portfarma ehf|Portfarma ehf|Eplerenón||6989||6989|10650|| 580104|N07BB0501|Selincro|filmhtfl|18|mg|14|stk|1|ţpakki||N07BB05|01.06.2013||R|1|0|0|0|0|0|LBK|0|0|0|100|DKK|8327|12480|lyfalmen|||1|14|0||Lundbeck Export A/S|H. Lundbeck A/S|Nalmefenum||8327||8327|12480||1 580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2800|2868|lyfalmen|V0324|2858|2|100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1300||1300|2868||2 580960|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.07.2013||R|0|0|0|0|0|1|BAM|0|0|0|100|SEK|1997|2882|lyfsjukr|||1|10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1997||1997|2882||2 581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|1|0|0|0|G|0|LYF|0|0|0|100|IKR|2801|3305|lyfalmen|V0472|3305|3|90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1620||1620|3305||2 581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|0|0|0|0|0|0|ANI|1|0|0|100|XEU|13989|27034|vetalmen|||0|20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||13989||13989|27034||2 581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|0|0|0|0|G|0|ASN|0|0|0|100|USD|2247|4163|lyfalmen|||0|2,5|0|25,0000|Alcon Nordic A/S|Alcon Laboratories Ltd.|Travóprost||2247||2247|4163||1 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|27331|36183|lyfsjukr|||1|1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||27331||27331|36183||2 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|52744|68076|lyfsjukr|||1|1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||52744||52744|68076||2 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|0|0|0|1|0|1|ELI|0|1|0|100|XEU|105488|134270|lyfsjukr|||1|1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||105488||105488|134270||2 582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|60134|77351|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||60134||60134|77351||2 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|4682|8168|vetorma|||0|50|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||4682||4682|8168||2 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|0|0|0|0|0|0|PAL|1|0|0|100|DKK|18191|31733|vetorma|||0|200|0||Icepharma hf|Pfizer Oy Animal Health|Doramectinum||18191||18191|31733||2 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|40435|52628|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||40435||40435|52628||2 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|74643|95559|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||74643||74643|95559||2 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|44575|57824|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||44575||44575|57824||2 582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|0|0|0|1|0|1|EMA|0|1|0|100|SEK|35018|45830|lyfsjukr|||1|1,5|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||35018||35018|45830||2 583105|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.08.2013||R|0|0|0|0|G|0|PER|0|0|0|100|DKK|2476|3805|lyfalmen|V0376|1691|1|2,5|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||1985||1985|3805||1 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|88642|113128|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||88642||88642|113128||2 583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|1|0|0|0|G|0|MYL|0|0|0|100|SEK|1032|2501|lyfalmen|||2|100|0|50,0000|Icepharma hf|Mylan AB|Sótalól||1032||1032|2501||2 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|105801|134663|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||105801||105801|134663||2 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|31850|41854|lyfsjukr|||1|1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||31850||31850|41854||2 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|50960|65837|lyfsjukr|||1|2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||50960||50960|65837||2 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|0|0|0|0|0|1|GEH|0|0|0|100|NOK|95550|121798|lyfsjukr|||1|3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||95550||95550|121798||2 583776|L01XE2301|Tafinlar|hylki|50|mg|28|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|181217|229310|lyfsjukr|||1|28|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||181217||181217|229310||1 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|3696|5334|lyfsjukr|||2|5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3696||3696|5334||2 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|0|0|0|0|0|1|FRP|0|0|0|100|DKK|2238|3230|lyfsjukr|||2|9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2238||2238|3230||2 584133|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.10.2012||R|0|0|0|1|0|1|MLD|0|0|0|100|DKK|17984|24452|lyfsjukr|||1|1,2|0|9,0000|Vistor hf|Merck Sharp & Dohme Limited|Interferón alfa-2b||17984||17984|24452||1 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|1|0|0|0|G|0|MAS|0|0|0|100|SEK|1736|3464|lyfalmen|V0064|2870|1|30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1736||1736|3464||1 584479|G04BE0307|Sildenafil Mylan|filmhtfl|50|mg|4|stk|1|ţpakki||G04BE03|01.08.2013||R|1|0|0|0|0|0|MYL|0|0|0|100|SEK|1700|2424|lyfalmen|V0143|1726|2|4|0|4,0000|Icepharma hf|Mylan AB|Síldenafíl||976||976|2424||2 585130|N06DA0301|Exelon|forđapl|13,3|mg/sólh|60|pokar|1|pakki||N06DA03|01.02.2014||R|0|1|0|0|G|0|NEL|0|0|0|100|DKK|41871|55378|lyfalmen|||1|60|0|84,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||41871||41871|55378||1 585661|B01AB0101|Heparin Leo|stl|100|ae/ml|10|ml|10|hgl||B01AB01|01.03.2014||R|0|0|0|0|0|0|LEP|0|0|1|100|DKK|5897|9156|lyfalmen|||1|100|0|1,0000|Vistor hf|LEO Pharma A/S|Heparín||5897||5897|9156||1 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|0|0|0|0|0|1|LEP|0|0|0|100|DKK|4443|6412|lyfsjukr|||1|25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4443||4443|6412||1 585869|J07BC0201|Havrix|stl|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|4508|7256|lyfalmen|||1|1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4508||4508|7256||1 585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|1|0|0|0|G|0|LYF|0|0|0|100|XEU|455|1497|lyfalmen|V0541|1497|2|100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||298||298|1497||2 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|0|0|0|0|G|0|HES|0|0|0|100|DKK|31579|42462|lyfalmen|||1|50|0|20,0000|Vistor hf|Novartis Healthcare A/S|Ciklospórín||31579||31579|42462||1 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|0|0|0|0|G|0|ASP|0|0|1|100|XEU|1684|3393|lyfalmen|||1|100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1684||1684|3393||1 586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|0|0|0|0|0|1|BRA|0|0|0|100|XEU|13738|19124|lyfsjukr|||2|800|0|10,0000|Actavis Group hf|Braun|Gentamícín||13738||13738|19124||1 586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|0|0|0|1|0|1|NEL|0|1|0|100|DKK|367186|462701|lyfsjukr|||1|224|0|56,0000|Vistor hf|Novartis Europharm Ltd|Tobramýcín||367186||367186|462701||1 586694|N06DX0103|Nemdatine|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|11802|6816|lyfalmen|V0606|6743|2|28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||4186||4186|6816||1 586967|B01AF0201|Eliquis|filmhtfl|5|mg|168|stk|1|ţpakki||B01AF02|01.09.2014||R|1|1|0|0|G|0|BRP|0|0|0|100|DKK|28758|38921|lyfalmen|||1|168|0|168,0000|Icepharma hf|Bristol-Myers Squibb/Pfizer EEIG|Apixaban ||||28758|38921|30.9.2014|1 587141|N05AE0403|Ziprasidon Actavis|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.06.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|18883|26528|lyfalmen|V0611|26528|2|56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Ziprasidon||18883||18883|26528||1 587437|N06DX0103|Nemdatine|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.07.2013||R|1|0|0|0|G|0|APC|0|0|0|100|XEU|5157|3862|lyfalmen|V0604|3790|2|28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Memantín||2027||2027|3862||1 587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|1|0|0|0|0|0|AGP|0|0|0|100|XEU|9805|5999|lyfalmen|V0095|5104|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||3589||3589|5999||1 588457|N06DX0105|Memantine Mylan|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.10.2013||R|1|0|0|0|G|0|GEN|0|0|0|100|SEK|34090|20096|lyfalmen|V0607|18984|2|98|0|98,0000|Icepharma hf|Generics UK Ltd|Memantín||13758||13758|20096||2 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2121|3991|lyfalmen|V0461|3988|1|20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2121||2121|3991||1 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|1|0|0|0|G|0|SNO|0|0|0|100|NOK|8724|13023|lyfalmen|||1|100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||8724||8724|13023||1 588911|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|100|stk|1|glas||N05AH03|01.11.2012||R|1|0|0|0|G|0|AGP|0|0|0|100|XEU|9087|5426|lyfalmen|V0282|4280|2|100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3170||3170|5426||1 588982|R03AK0604|Relanio|innönddu|300|mcg/sk|60|skammtar|1|pakki|50+250 mcg|R03AK06|01.01.2014||R|0|0|0|0|G|0|EPL|0|0|0|100|IKR|6000|7656|lyfalmen|||2|60|0|30,0000|LYFIS ehf|ELPEN Pharmaceutical Co. Inc.|Salmeteról og fluticason||4800||4800|7656||2 589153|L01XE2301|Tafinlar|hylki|50|mg|120|stk|1|glas||L01XE23|01.11.2013||R|1|0|0|1|0|1|GTS|0|1|0|100|GBP|784065|985884|lyfsjukr|||1|120|0||GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Dabrafeníb||784065||784065|985884||1 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5899|10291|vetorma|||0|3|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5899||5899|10291||2 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|2286|3988|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||2286||2286|3988||2 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|5691|9928|vetorma|||0|6|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||5691||5691|9928||2 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3074|5362|vetorma|||0|0,75|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3074||3074|5362||2 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|XEU|3193|5570|vetorma|||0|1,5|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3193||3193|5570||2 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|0|0|0|0|0|0|ZBE|1|0|0|100|DKK|3078|5369|vetorma|||0|2,25|0||Icepharma hf|Zoetis Belgium S.A.|Selamectinum||3078||3078|5369||2 589888|N01AF0302|Pentocur|sts|0,5|g|10|hgl|1|pakki||N01AF03|01.07.2013||R|0|0|0|0|0|1|ABC|0|0|0|100|SEK|12267|17278|lyfsjukr|||2|10|0||Icepharma hf|Abcur AB|Tíópentalnatríum||12267||12267|17278||2 590092|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar|áfylltur penni|L04AB04|01.07.2013||R|0|1|0|1|0|1|ABV|0|1|0|100|DKK|133381|169276|lyfsjukr|||1|1,6|0|27,5900|Vistor hf|AbbVie Ltd.|Adalimumab||133381||133381|169276||1 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|0|0|0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa|||0|20|0||Icepharma hf|Bayer AB|Klótrímazól|||||||2 590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|1|0|0|0|G|0|ACA|0|0|0|100|XEU|2976|3314|lyfalmen|V0041|2768|2|98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||1626||1626|3314||1 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|0|0|0|0|0|1|BOI|0|0|0|100|DKK|174484|220860|lyfsjukr|||1|1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||174484||174484|220860||1 591260|N06DA0302|Exelon (Lyfjaver)|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.10.2012||R|0|0|0|0|G|0|LVR|0|0|0|100|DKK|12569|18604|lyfalmen|V0347|18604|3|30|0|14,5300|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||12569||12569|18604||3 591317|C03DA0403|Eplerenon Bluefish|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.10.2014||R|1|0|0|0|0|0|BLP|0|0|0|100|IKR|30623|37970|lyfalmen|V0111|37268|2|100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Eplerenón||28000||28000|37970||2 591445|H02AB0205|Dexametason Abcur|töflur|1|mg|100|stk|1|ţpakki||H02AB02|01.11.2013||R|1|0|0|0|G|0|ABC|0|0|1|100|SEK|9229|13714|lyfalmen|||2|100|0|66,6700|Icepharma hf|Abcur AB|Dexametasón||9229||9229|13714||2 592534|L04AD0104|Ciqorin|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.04.2014||R|0|0|0|0|G|0|TEV|0|0|0|100|IKR|12500|14085|lyfalmen|||2|50|0|10,0000|Medical ehf|Teva Pharma B.V.|Ciklospórín||9500||9500|14085||2 592687|A02BC0112|Omezolmyl|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC01|01.09.2013||R|0|0|0|0|0|0|MYL|0|0|0|100|SEK|2663|2357|lyfalmen|||2|28|0|56,0000|Icepharma hf|Mylan AB|Ómeprazól||927||927|2357||2 592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|1|1|0|1|0|1|AZA|0|0|0|100|SEK|744915|936751|lyfsjukr|||1|30|0||Vistor hf|AstraZeneca AB|Vandetaníb||744915||744915|936751||1 593200|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2014||R|0|0|0|1|0|1|BER|0|1|0|100|SEK|23336|31169|lyfsjukr|||1|1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||23336|31169||3 593379|A10BG0304|Pioglitazone Accord|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2013||R|1|1|0|0|G|0|AHL|0|0|0|100|XEU|12362|16810|lyfalmen|V0573|16810|2|98|0|98,0000|Portfarma ehf|Accord Healthcare Limited|Píóglítazón||11492||11492|16810||1 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|501|1775|lyfalmen|V0238|800|1|50|0|3,1250|Icepharma hf|Roche|Klónazepam||501||501|1775||2 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|959|2401|lyfalmen|V0238|2401|1|150|0|9,3750|Icepharma hf|Roche|Klónazepam||959||959|2401||2 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|1|0|0|0|G|0|ROC|0|0|0|100|DKK|1309|2880|lyfalmen|||1|100|0|25,0000|Icepharma hf|Roche|Klónazepam||1309||1309|2880||2 593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|0|0|0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa|||0|204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín|||||||1 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|0|0|0|0|G|0|MAB|0|0|1|100|SEK|19363|27131|lyfalmen|||1|12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||19363||19363|27131||1 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||R|0|0|0|0|0|0|ZOE|0|0|0|100|DKK|328|572|vetorma|||0|10|0||Icepharma hf|Zoetis Finland OY|||328||328|572||2 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|0|0|0|0|0|1|HES|0|0|0|100|DKK|5783|8346|lyfsjukr|||1|5|0|5,0000|Vistor hf|Novartis Healthcare A/S|Samtengt laxakalsítónín||5783||5783|8346||1 595198|G04BD1201|Betmiga|forđatfl|25|mg|90|stk|1|ţpakki||G04BD12|01.07.2013||R|1|0|0|0|G|0|APE|0|0|0|100|XEU|16843|23968|lyfalmen|||1|90|0|45,0000|Vistor hf|Astellas Phama Europe B.V.|Mírabegrón||16843||16843|23968||1 595991|J07BB0201|Fluarix|stl|||0,5|ml|1|áfspr||J07BB02|01.10.1994||R|0|0|0|0|0|0|GSK|0|0|0|100|GBP|629|1950|lyfalmen|||1|0,5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir mótefnavakar||629||629|1950||1 596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|0|0|0|1|0|1|RAG|0|0|0|100|DKK|53667|69235|lyfsjukr|||1|2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||53667|69235||1 596196|G04BE0308|Sildenafil Portfarma|tuggutfl|100|mg|4|stk|1|ţpakki||G04BE03|01.09.2013||R|1|0|0|0|0|0|PEH|0|0|0|100|XEU|2883|2357|lyfalmen|V0144|1938|2|4|0|8,0000|Portfarma ehf|Portfarma ehf|Síldenafíl||927||927|2357||1 596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|0|0|0|1|0|1|ORC|0|0|0|100|DKK|18797|25473|lyfsjukr|||1|10|0|1,0000|Vistor hf|Orion Corporation|Dexmedetómid||18797||18797|25473||1 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|1|0|0|0|0|0|PER|0|0|1|100|DKK|2266|4189|lyfalmen|||1|24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2266||2266|4189||1 597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|0|1|0|1|0|1|BMS|0|1|0|100|DKK|662408|833205|lyfsjukr|||1|10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||662408||662408|833205||1 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|0|0|0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa|||0|30|0||Vistor hf|McNeil Sweden AB|Ekónazól|||||||1 598021|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.06.2014||R|1|0|0|0|G|0|MPH|0|0|0|100|SEK|2908|5067|lyfalmen|V0146|5067|1|100|0|33,3333|Icepharma hf|Mercury Pharmaceuticals Ltd.|Acetazólamíđ||2908||2908|5067||2 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|0|0|0|0|0|0|SNO|0|0|1|100|NOK|412|1653|lyfalmen|||1|150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||412||412|1653||1 598499|M01AE0112|ibuxin rapid|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.09.2012||L|0|0|0|0|0|0|RAT|0|0|1|100|IKR|||lyflausa|||0|30|0|10,0000|LYFIS ehf|ratiopharm GmbH|Íbúprófen|||||||2 598925|M01AE0114|Nurofen Apelsin|mixtúra|40|mg/ml|100|ml|1|glas||M01AE01|01.04.2013||L|0|0|0|0|0|0|REC|0|0|1|100|DKK|||lyfalmen|||0|100|0|3,3333|Vistor hf|Reckitt Benckiser Healthcare Ltd|Íbúprófen|||||1829||1 599010|L01XE1701|INLYTA|filmhtfl|5|mg|56|stk|1|ţpakki||L01XE17|01.05.2013||R|1|0|0|1|0|1|PZE|0|1|0|100|DKK|598571|753089|lyfsjukr|||1|56|0||Icepharma hf|Pfizer Ltd.|Axitinib||598571||598571|753089||1 599320|QV03AB9002|Narcostop|stl|5|mg/ml|10|ml|1|hgl|fyrir hunda og ketti|QV03AB90|01.07.2013||R|0|0|0|0|0|0|BVL|1|0|0|100|XEU|4392|8606|vetalmen|||0|10|0||Dýraheilsa ehf|Le Vet B.V.|Atipamesól||4392||4392|8606||2 599460|S01XA2011|Oculac|augndr|50|mg/ml|0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.11.2013||L|0|0|0|0|G|0|CLA|0|0|0|100|DKK|||lyfalmen|||0|8|0||Vistor hf|Alcon Nordic A/S|Gervitár og ađrar óvirkar samsetningar|||||2133||1 599462|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.05.2014||R|0|0|0|0|G|0|JAS|0|0|0|100|SEK|30235|40775|lyfalmen|V0647|40775|1|1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||30235|40775||1 692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|0|0|1|0|0|0|PCO|0|0|0|100|DKK|3990|6547|lyfalmen|||0|100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||3990|6547||1 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|ţpakki||A03FA03|01.05.1998||R|0|0|0|0|0|0|PCO|0|0|1|100|SEK|2592|4635|lyfalmen|||0|100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2592||2592|4635||1 923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|IKR|480|1746|lyfalmen|||0|3,5|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1746||1 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|6273|9670|lyfalmen|||0|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6273||6273|9670||2 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|0|0|0|0|0|0|LDR|0|0|0|100|GBP|18023|25449|lyfalmen|||0|100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||18023||18023|25449||2 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|0|0|0|0|0|0|PCO|0|0|0|100|GBP|2941|5112|lyfalmen|||0|1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||2941||2941|5112||1 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5242|8260|lyfalmen|||0|100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5242||5242|8260||1 944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|342|1557|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1557||2 944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|664|1998|lyfalmen|||0|12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1998||2 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|0|0|0|0|0|0|PCO|0|0|1|100|IKR|2293|4226|lyfalmen|||0|10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4226||1 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|5033|7974|lyfalmen|||0|100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7974||2 951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|0|0|0|0|0|0|PCO|0|0|1|100|DKK|5242|8260|lyfalmen|||0|100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5242||5242|8260||1 954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|4571|7342|lyfalmen|||0|150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||4571||4571|7342||2 954851|V09AB0301|DaTSCAN|stl|74|MBq/ml|5|ml|1|hgl||V09AB03|01.10.2013||R|0|0|0|1|0|1|GEL|0|0|0|100|NOK|143710|182239|lyfsjukr|||1|5|0||Icepharma hf|GE Healthcare Limited|Lofendýlat||143710||143710|182239||2 957657|A12BA0201|Polycítra - forskriftarlyf|mixtúra|||500|ml|1|fl|Potassium citrats 102 mg/g|A12BA02|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|15120|21806|lyfalmen|||0|500|0|12,7500|PharmArctica ehf|PharmArctica - forskriftarlyf|potassium citrate||15120||15120|21806||2 957665|A12BA0102|Kalíum Klóriđ - forskriftarlyf|mixtúra|33|mg/g|300|ml|1|fl|35,34 mg/ml|A12BA01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2610|4660|lyfalmen|||0|300|0|3,5400|PharmArctica ehf|PharmArctica - forskriftarlyf|Kalíumklóríđ||2610||2610|4660||2 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|ţpakki||A04AD05|01.01.1998||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1257|2809|lyfalmen|||0|20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1257||1257|2809||2 961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|ţpakki||H02AB09|01.08.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|1430|3046|lyfalmen|||0|20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1430||1430|3046||2 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|6231|9613|lyfalmen|||0|25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||6231||6231|9613||2 962234|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||300|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1610|3292|lyfalmen|||0|300|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1610||1610|3292||2 962242|R05DA2001|SEM mixtúra - forskriftarlyf|mixtúra|||100|ml|1|fl|Kodein 2,53 mg/ml|R05DA20|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1030|2498|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Blöndur||1030||1030|2498||2 962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|0|0|0|0|0|0|LDR|0|0|1|100|IKR|3961|6508|lyfalmen|||0|30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||3961||3961|6508||2 965171|D08AX0001|Bórsýruslím - forskriftarlyf|lausn|2|%|500|ml|1|fl||D08AX|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2340|4290|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Ýmis sótthreinsandi lyf||2340||2340|4290||2 965858|QI04AB0901|Gudair|stl|||30|ml|1|glas|dreifa|QI04AB09|01.09.2014||R|0|0|0|0|0|0|CZV|1|0|0|100|XEU|6417|11194|vetorma|||0|30|0||Vistor hf|CZ Veterinaria SA|Bóluefni gegn Mycobacterium||||6417|11194||1 967333|N05AH0408|Quetiapin Bluefish|filmhtfl|25|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|1200|2184|lyfalmen|V0284|1310|2|60|0|3,7500|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||800||800|2184||2 967341|N05AH0408|Quetiapin Bluefish|filmhtfl|100|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|6800|3483|lyfalmen|V0285|2705|2|60|0|15,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||1750||1750|3483||2 967359|N05AH0408|Quetiapin Bluefish|filmhtfl|200|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|12500|6219|lyfalmen|V0286|5783|2|60|0|30,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||3750||3750|6219||2 967367|N05AH0408|Quetiapin Bluefish|filmhtfl|300|mg|60|stk|1|ţpakki||N05AH04|01.09.2012||R|1|0|0|0|G|0|BLP|0|0|0|100|IKR|25000|27052|lyfalmen|V0287|27052|2|60|0|45,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Quetíapín||19300||19300|27052||2 968365|D07CB0101|TNG-smyrsl - forskriftarlyf|smyrsli|||15|ml|1|dos||D07CB01|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|1522|3171|lyfalmen|||0|15|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Triamcinolonum og sýklalyf||1522||1522|3171||2 968373|V03AB1505|Naloxonhydrochlorid - forskriftarlyf|mixtúra|1|mg/ml|500|ml|1|fl||V03AB15|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|18870|26512|lyfalmen|||0|500|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Naloxón||18870||18870|26512||2 968399|A03AA0704|Dicykloverine hydrochloride-forsk.lyf|mixtúra|2|mg/ml|100|ml|1|fl||A03AA07|01.04.2014||R|0|0|0|1|0|0|PAR|0|0|0|100|IKR|7066|10755|lyfalmen|||0|100|0|2,5000|PharmArctica ehf|PharmArctica - forskriftarlyf|Dícýklóverín||7066||7066|10755||2 968406|D05AA0001|Tjara 26 / ASVEP - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|2929|5096|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||2929||2929|5096||2 968414|D05AA0002|Koltjörusmyrsl - forskriftarlyf|smyrsli|||100|ml|1|dos||D05AA|01.04.2014||R|0|0|0|0|0|0|PAR|0|0|0|100|IKR|3650|6082|lyfalmen|||0|100|0||PharmArctica ehf|PharmArctica - forskriftarlyf|Tjörur||3650||3650|6082||2 969115|L02BA0108|Tamoxifen Aliud|töflur|20|mg|100|stk|1|ţpakki||L02BA01|01.03.2014||R|0|0|0|0|G|0|LDR|0|0|0|100|XEU|3575|5980|lyfalmen|||2|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Tamoxífen||3575||3575|5980||2 969123|L02BA0108|Tamoxifen Aliud|töflur|10|mg|100|stk|1|ţpakki||L02BA01|01.03.2014||R|0|0|0|0|G|0|LDR|0|0|0|100|XEU|3465|5829|lyfalmen|||2|100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Tamoxífen||||3465|5829||2 969149|H03BB0102|Carbimazol|töflur|5|mg|100|stk|1|ţpakki||H03BB01|01.02.2014||R|0|0|0|0|0|0|LDR|0|0|0|100|IKR|1380|2977|lyfalmen|||0|100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1380||1380|2977||2 969181|N02AA0111|Morfin "DAK"|töflur|10|mg|100|stk|1|pakki||N02AA01|01.05.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|2948|5122|lyfalmen|||0|100|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||2948||2948|5122||2 969412|J01CA0416|Amoxicillin AL|mixt.kyr|50|mg/ml|100|ml|1|glas||J01CA04|01.08.2014||R|0|0|0|0|0|0|PCO|0|0|1|100|XEU|2183|4076|lyfalmen|||2|100|1|5,0000|Distica|Distica - óskráđ lyf|Amoxicillín||||2183|4076||1 969777|N02AA0111|Morfin "DAK"|töflur|10|mg|10|stk|1|ţpakki||N02AA01|01.07.2014||R|0|0|1|0|0|0|LDR|0|0|0|100|IKR|450|1705|lyfalmen|||0|10|1|1,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||450||450|1705||2